PedAM

Pediatric Disease Annotations & Medicines


	prostate cancer

Disease ID	484
Disease	prostate cancer
Definition	The prostate is the gland below a man's bladder that produces fluid for semen. Prostate cancer is common among older men. It is rare in men younger than 40. Risk factors for developing prostate cancer include being over 65 years of age, family history, and being African-American. Symptoms of prostate cancer may include Problems passing urine, such as pain, difficulty starting or stopping the stream, or dribbling Low back pain Pain with ejaculation To diagnose prostate cancer, you doctor may do a digital rectal exam to feel the prostate for lumps or anything unusual. You may also get a blood test for prostate-specific antigen (PSA). These tests are also used in prostate cancer screening, which looks for cancer before you have symptoms. If your results are abnormal, you may need more tests, such as an ultrasound, MRI, or biopsy. Treatment often depends on the stage of the cancer. How fast the cancer grows and how different it is from surrounding tissue helps determine the stage. Men with prostate cancer have many treatment options. The treatment that's best for one man may not be best for another. The options include watchful waiting, surgery, radiation therapy, hormone therapy, and chemotherapy. You may have a combination of treatments. NIH: National Cancer Institute
Synonym	#NAME? ca - cancer of prostate cancer of prostate cancer of the prostate cancer, prostate cancer, prostatic cancers, prostate cancers, prostatic malign neopl prostate malignant neoplasm of prostate malignant neoplasm of the prostate malignant neoplasm prostate malignant prostate neoplasm malignant prostate tumor malignant prostatic tumor malignant prostatic tumour malignant tumor of prostate malignant tumor of prostate (disorder) malignant tumor of the prostate malignant tumour of prostate prostate cancers prostate--cancer prostatic cancer prostatic cancers
OMIM	OMIM:176807
DOID	DOID:10283 DOID:10286
ICD10	ICD10CM:C61
UMLS	C0376358
SNOMED-CT	SNOMEDCT_US_2016_09_01:399068003
Comorbidity	UMLS \| Disease \| Sentences' Count(Total Sentences:184) C0028754 \| obesity \| 34 C0011847 \| diabetes \| 33 C0029456 \| osteoporosis \| 24 C0686619 \| lymph node metastases \| 19 C0011849 \| diabetes mellitus \| 14 C0948265 \| metabolic syndrome \| 11 C0011570 \| depression \| 11 C0006142 \| breast cancer \| 10 C0242350 \| erectile dysfunction \| 9 C0042373 \| vascular disease \| 9 C0003467 \| anxiety \| 9 C0011860 \| type 2 diabetes \| 9 C0033581 \| prostatitis \| 9 C0007222 \| cardiovascular disease \| 9 C0005940 \| bone disease \| 8 C0023418 \| leukemia \| 6 C0001418 \| adenocarcinoma \| 5 C0025202 \| melanoma \| 5 C0033953 \| sexual dysfunction \| 5 C0242379 \| lung cancer \| 5 C0018799 \| heart disease \| 4 C0042870 \| vitamin d defic \| 4 C0042870 \| vitamin d deficiency \| 4 C0009402 \| colorectal cancer \| 4 C0007113 \| rectal cancer \| 4 C0033246 \| proctitis \| 4 C0020619 \| hypogonadism \| 4 C0030567 \| parkinson's disease \| 3 C0005684 \| bladder cancer \| 3 C0020443 \| hypercholesterolemia \| 3 C0002871 \| anaemia \| 3 C0026934 \| mycoplasma \| 3 C0494165 \| liver metastases \| 3 C0026764 \| myeloma \| 3 C0026764 \| multiple myeloma \| 3 C0035078 \| renal failure \| 3 C0028754 \| adiposity \| 3 C0220650 \| brain metastases \| 2 C0740457 \| kidney cancer \| 2 C0004623 \| bacterial infection \| 2 C0033575 \| prostatic disease \| 2 C0010692 \| cystitis \| 2 C1527263 \| prostatic hypertrophy \| 2 C0005694 \| bladder outlet obstruction \| 2 C0040053 \| thrombosis \| 2 C0376358 \| cancer of the prostate \| 2 C0018418 \| gynecomastia \| 2 C0021364 \| male infertility \| 2 C0153676 \| lung metastasis \| 2 C0003864 \| arthritis \| 2 C0029401 \| paget's disease \| 2 C0238033 \| male breast cancer \| 2 C0302592 \| cervical ca \| 2 C0007104 \| female breast cancer \| 2 C0018081 \| gonorrhea \| 2 C0007112 \| prostate adenocarcinoma \| 2 C0007847 \| cervical cancer \| 2 C0024299 \| lymphoma \| 2 C0007102 \| colon cancer \| 2 C0010068 \| coronary artery disease \| 2 C0021359 \| infertility \| 2 C0020538 \| hypertension \| 2 C1333990 \| lynch syndrome \| 2 C0156270 \| radiation cystitis \| 2 C0004096 \| asthma \| 2 C0032285 \| pneumonia \| 2 C0021053 \| immune dysfunction \| 2 C0039590 \| testicular cancer \| 2 C0018553 \| cowden syndrome \| 1 C0040034 \| thrombocytopenia \| 1 C0020550 \| hyperthyroidism \| 1 C0041956 \| ureteral obstruction \| 1 C0040188 \| tic disorders \| 1 C0153685 \| metastases to the kidney \| 1 C0013592 \| ectropion \| 1 C0020459 \| hyperinsulinemia \| 1 C0153676 \| pulmonary metastases \| 1 C0948303 \| peritoneal carcinoma \| 1 C0155626 \| acute myocardial infarction \| 1 C0018995 \| hemochromatosis \| 1 C0035335 \| retinoblastoma \| 1 C0019294 \| inguinal hernias \| 1 C0038436 \| post-traumatic stress disorder \| 1 C0036341 \| schizophrenia \| 1 C1140680 \| ovarian cancer \| 1 C0021141 \| syndrome of inappropriate antidiuretic hormone secretion \| 1 C0006413 \| burkitt's lymphoma \| 1 C0012739 \| disseminated intravascular coagulation \| 1 C0030185 \| mammary paget's disease \| 1 C0003873 \| rheumatoid arthritis \| 1 C0178879 \| urinary obstruction \| 1 C0004623 \| bacterial infections \| 1 C0020459 \| hyperinsulinaemia \| 1 C0011860 \| diabetes mellitus type 2 \| 1 C0007115 \| thyroid ca \| 1 C0019322 \| umbilical hernia \| 1 C0002871 \| anemia \| 1 C0025193 \| melancholia \| 1 C0085692 \| hemorrhagic cystitis \| 1 C0024236 \| lymphedema \| 1 C0600139 \| prostatic carcinoma \| 1 C0029442 \| osteomalacia \| 1 C0003469 \| anxiety disorders \| 1 C0020443 \| elevated cholesterol \| 1 C0035222 \| acute respiratory distress syndrome \| 1 C1704231 \| leptomeningeal metastasis \| 1 C0038362 \| stomatitis \| 1 C0149925 \| small cell carcinoma \| 1 C0699885 \| carcinoma of the bladder \| 1 C0019294 \| inguinal hernia \| 1 C0011991 \| diarrhea \| 1 C0020598 \| hypoglycaemia \| 1 C0153633 \| brain cancer \| 1 C0235974 \| pancreatic cancer \| 1 C0020635 \| hypopituitarism \| 1 C0005684 \| urinary bladder cancer \| 1 C0687720 \| central diabetes insipidus \| 1 C0030186 \| extramammary paget's disease \| 1 C0019061 \| hemolytic uremic syndrome \| 1 C1140680 \| ovarian ca \| 1 C0024248 \| lymphocele \| 1 C0027051 \| myocardial infarct \| 1 C0029443 \| osteomyelitis \| 1 C0018418 \| gynaecomastia \| 1 C0041974 \| urethral stricture \| 1 C0007177 \| pericardial tamponade \| 1 C0018799 \| cardiac disease \| 1 C0085693 \| acute appendicitis \| 1 C0022658 \| nephropathy \| 1 C0011848 \| diabetes insipidus \| 1 C0001430 \| adenoma \| 1 C0003615 \| appendicitis \| 1 C0376545 \| hematological malignancies \| 1 C0040921 \| trichomonosis \| 1 C0018801 \| heart failure \| 1 C0600139 \| carcinoma of the prostate \| 1 C1527249 \| colorectal cancers \| 1 C0020538 \| high blood pressure \| 1 C1261473 \| sarcoma \| 1 C0029464 \| osteosclerosis \| 1 C0027051 \| myocardial infarction \| 1 C0027830 \| neurofibroma \| 1 C0001125 \| lactic acidosis \| 1 C0032001 \| pituitary apoplexy \| 1 C1704437 \| respiratory distress syndrome \| 1 C0023448 \| lymphocytic leukemia \| 1 C0162871 \| abdominal aortic aneurysm \| 1 C0868908 \| pancolitis \| 1 C0018621 \| hayfever \| 1 C0024141 \| systemic lupus erythematosus \| 1 C0007138 \| urothelial carcinoma \| 1 C0022735 \| primary hypogonadism \| 1 C0007115 \| thyroid cancer \| 1 C0005001 \| benign prostatic hypertrophy \| 1 C0011860 \| type 2 diabetes mellitus \| 1 C0038436 \| posttraumatic stress disorder \| 1 C0020514 \| hyperprolactinemia \| 1 C0039128 \| syphilis \| 1 C0494165 \| liver metastasis \| 1 C0016977 \| biliary disease \| 1 C0242350 \| impotent \| 1 C0037317 \| sleep disturbance \| 1 C0009319 \| colitis \| 1 C0376358 \| prostate cancers \| 1 C0007787 \| transient ischaemic attack \| 1 C0007787 \| transient ischaemic attacks \| 1 C0032285 \| pneumonitis \| 1 C0001418 \| adenocarcinomas \| 1 C0242350 \| impotence \| 1 C0000889 \| acanthosis nigricans \| 1 C0751571 \| urological cancer \| 1 C0740457 \| renal cancer \| 1 C0003469 \| anxiety disorder \| 1 C0153676 \| lung metastases \| 1 C0022660 \| acute renal failure \| 1 C0019069 \| hemophilia \| 1 C0153676 \| pulmonary metastasis \| 1 C0002726 \| amyloidosis \| 1 C0023434 \| chronic lymphocytic leukemia \| 1 C0027708 \| wilm's tumor \| 1 C0015464 \| facial nerve palsy \| 1 C0010481 \| cushing syndrome \| 1 C0034065 \| pulmonary embolism \| 1 C0600139 \| prostate carcinoma \| 1
Curated Gene	Entrez_id \| Symbol \| Resource(Total Genes:96) BRCA2 \| 675 \| CLINVAR;GHR BRCA1 \| 672 \| GHR CEP152 \| 22995 \| GWASCAT TP53 \| 7157 \| CLINVAR STAT3 \| 6774 \| GHR UPF2 \| 26019 \| GWASCAT EZH2 \| 2146 \| GHR RAD51B \| 5890 \| GWASCAT FGFR2 \| 2263 \| GHR HNF1B \| 6928 \| GWASCAT;GHR MMP7 \| 4316 \| GWASCAT THADA \| 63892 \| GWASCAT TNRC6B \| 23112 \| GWASCAT IGF2 \| 3481 \| GHR WT1 \| 7490 \| GHR MXI1 \| 4601 \| CLINVAR;UNIPROT;GHR KCNN3 \| 3782 \| GWASCAT MED12 \| 9968 \| GHR PTEN \| 5728 \| GHR;UNIPROT SIDT1 \| 54847 \| GWASCAT MSR1 \| 4481 \| CLINVAR;GHR DNAH12 \| 201625 \| GWASCAT TERT \| 7015 \| GWASCAT CHEK2 \| 11200 \| GHR;UNIPROT NBN \| 4683 \| GHR WRN \| 7486 \| GHR RFX6 \| 222546 \| GWASCAT TBX1 \| 6899 \| GWASCAT GRHL1 \| 29841 \| GWASCAT GNMT \| 27232 \| GHR PDLIM5 \| 10611 \| GWASCAT MYO6 \| 4646 \| GWASCAT CTNNB1 \| 1499 \| CLINVAR KLK3 \| 354 \| GWASCAT MDM4 \| 4194 \| GWASCAT AR \| 367 \| CLINVAR;GHR ELAC2 \| 60528 \| GHR TGFBR1 \| 7046 \| GHR ZGPAT \| 84619 \| GWASCAT EP300 \| 2033 \| GHR MSMB \| 4477 \| GWASCAT;GHR MLPH \| 79083 \| GWASCAT CASC17 \| 101928165 \| GWASCAT MAD1L1 \| 8379 \| GHR ITGA6 \| 3655 \| GWASCAT;GHR KLF6 \| 1316 \| GHR FERMT2 \| 10979 \| GWASCAT VPS53 \| 55275 \| GWASCAT AFM \| 173 \| GWASCAT LMTK2 \| 22853 \| GWASCAT CDKN2B-AS1 \| 100048912 \| GWASCAT CD82 \| 3732 \| GHR FGFR4 \| 2264 \| GHR HTR3B \| 9177 \| GWASCAT BAIAP2L1 \| 55971 \| GWASCAT EEFSEC \| 60678 \| GWASCAT HOXB13 \| 10481 \| UNIPROT;GHR CDH1 \| 999 \| GHR CASC8 \| 727677 \| GWASCAT NOTCH4 \| 4855 \| GWASCAT FARP2 \| 9855 \| GWASCAT ADNP \| 23394 \| GWASCAT SLC22A3 \| 6581 \| GWASCAT CCAT2 \| 101805488 \| GWASCAT LRP2 \| 4036 \| GHR PHLPP2 \| 23035 \| GWASCAT PLXNB1 \| 5364 \| GHR ZFHX3 \| 463 \| GHR RNASEL \| 6041 \| GHR CCHCR1 \| 54535 \| GWASCAT RNASE9 \| 390443 \| GWASCAT LINC00506 \| 100846978 \| GWASCAT NEDD9 \| 4739 \| GWASCAT EPHB2 \| 2048 \| UNIPROT;GHR EHBP1 \| 23301 \| GWASCAT;GHR PEX14 \| 5195 \| GWASCAT CTBP2 \| 1488 \| GWASCAT GOLPH3L \| 55204 \| GWASCAT SLC41A1 \| 254428 \| GWASCAT XAGE3 \| 170626 \| GWASCAT ZBTB38 \| 253461 \| GWASCAT TRIM31 \| 11074 \| GWASCAT RGS17 \| 26575 \| GWASCAT PCAT19 \| 100505495 \| GWASCAT TNS3 \| 64759 \| GWASCAT PCNT \| 5116 \| GHR FGF10 \| 2255 \| GWASCAT NOL10 \| 79954 \| GWASCAT PRNCR1 \| 101867536 \| GWASCAT ZNF652 \| 22834 \| GWASCAT FOXP4 \| 116113 \| GWASCAT ARMC2 \| 84071 \| GWASCAT EBF2 \| 64641 \| GWASCAT SHROOM2 \| 357 \| GWASCAT POLK \| 51426 \| CLINVAR TRIM8 \| 81603 \| GWASCAT
Inferring Gene	Entrez_id \| Symbol \| Resource(Total Genes:494) 5243 \| ABCB1 \| infer 6059 \| ABCE1 \| infer 9429 \| ABCG2 \| infer 1636 \| ACE \| infer 53 \| ACP2 \| infer 23305 \| ACSL6 \| infer 90 \| ACVR1 \| infer 92 \| ACVR2A \| infer 9370 \| ADIPOQ \| infer 185 \| AGTR1 \| infer 9131 \| AIFM1 \| infer 1646 \| AKR1C2 \| infer 8644 \| AKR1C3 \| infer 207 \| AKT1 \| infer 10840 \| ALDH1L1 \| infer 217 \| ALDH2 \| infer 239 \| ALOX12 \| infer 240 \| ALOX5 \| infer 23600 \| AMACR \| infer 287 \| ANK2 \| infer 79722 \| ANKRD55 \| infer 302 \| ANXA2 \| infer 324 \| APC \| infer 328 \| APEX1 \| infer 348 \| APOE \| infer 80833 \| APOL3 \| infer 54840 \| APTX \| infer 367 \| AR \| infer 397 \| ARHGDIB \| infer 84071 \| ARMC2 \| infer 406 \| ARNTL \| infer 472 \| ATM \| infer 498 \| ATP5A1 \| infer 509 \| ATP5C1 \| infer 515 \| ATP5F1 \| infer 517 \| ATP5G2 \| infer 522 \| ATP5J \| infer 9551 \| ATP5J2 \| infer 539 \| ATP5O \| infer 6790 \| AURKA \| infer 8537 \| BCAS1 \| infer 56647 \| BCCIP \| infer 596 \| BCL2 \| infer 598 \| BCL2L1 \| infer 23786 \| BCL2L13 \| infer 632 \| BGLAP \| infer 636 \| BICD1 \| infer 638 \| BIK \| infer 662 \| BNIP1 \| infer 665 \| BNIP3L \| infer 672 \| BRCA1 \| infer 675 \| BRCA2 \| infer 83990 \| BRIP1 \| infer 29919 \| C18orf8 \| infer 389073 \| C2orf80 \| infer 57118 \| CAMK1D \| infer 841 \| CASP8 \| infer 842 \| CASP9 \| infer 846 \| CASR \| infer 847 \| CAT \| infer 857 \| CAV1 \| infer 858 \| CAV2 \| infer 875 \| CBS \| infer 6347 \| CCL2 \| infer 6352 \| CCL5 \| infer 595 \| CCND1 \| infer 729230 \| CCR2 \| infer 1234 \| CCR5 \| infer 929 \| CD14 \| infer 10666 \| CD226 \| infer 999 \| CDH1 \| infer 1026 \| CDKN1A \| infer 1027 \| CDKN1B \| infer 1080 \| CFTR \| infer 1081 \| CGA \| infer 11200 \| CHEK2 \| infer 1113 \| CHGA \| infer 50515 \| CHST11 \| infer 27141 \| CIDEB \| infer 9575 \| CLOCK \| infer 80781 \| COL18A1 \| infer 1284 \| COL4A2 \| infer 1312 \| COMT \| infer 84701 \| COX4I2 \| infer 1345 \| COX6C \| infer 1347 \| COX7A2 \| infer 9167 \| COX7A2L \| infer 170712 \| COX7B2 \| infer 51200 \| CPA4 \| infer 9586 \| CREB5 \| infer 1401 \| CRP \| infer 1407 \| CRY1 \| infer 1408 \| CRY2 \| infer 1454 \| CSNK1E \| infer 1488 \| CTBP2 \| infer 10217 \| CTDSPL \| infer 1508 \| CTSB \| infer 8029 \| CUBN \| infer 1524 \| CX3CR1 \| infer 6387 \| CXCL12 \| infer 340602 \| CXorf67 \| infer 1583 \| CYP11A1 \| infer 1585 \| CYP11B2 \| infer 1586 \| CYP17A1 \| infer 1588 \| CYP19A1 \| infer 1543 \| CYP1A1 \| infer 1544 \| CYP1A2 \| infer 1545 \| CYP1B1 \| infer 1591 \| CYP24A1 \| infer 1593 \| CYP27A1 \| infer 1594 \| CYP27B1 \| infer 1555 \| CYP2B6 \| infer 1557 \| CYP2C19 \| infer 1559 \| CYP2C9 \| infer 1565 \| CYP2D6 \| infer 1571 \| CYP2E1 \| infer 1576 \| CYP3A4 \| infer 64816 \| CYP3A43 \| infer 1577 \| CYP3A5 \| infer 1551 \| CYP3A7 \| infer 153090 \| DAB2IP \| infer 7818 \| DAP3 \| infer 1719 \| DHFR \| infer 10395 \| DLC1 \| infer 1789 \| DNMT3B \| infer 55862 \| ECHDC1 \| infer 60678 \| EEFSEC \| infer 1950 \| EGF \| infer 1956 \| EGFR \| infer 23301 \| EHBP1 \| infer 60528 \| ELAC2 \| infer 2014 \| EMP3 \| infer 54749 \| EPDR1 \| infer 2048 \| EPHB2 \| infer 2052 \| EPHX1 \| infer 2064 \| ERBB2 \| infer 2067 \| ERCC1 \| infer 2068 \| ERCC2 \| infer 2072 \| ERCC4 \| infer 2073 \| ERCC5 \| infer 2074 \| ERCC6 \| infer 2078 \| ERG \| infer 114799 \| ESCO1 \| infer 2099 \| ESR1 \| infer 2100 \| ESR2 \| infer 2103 \| ESRRB \| infer 2115 \| ETV1 \| infer 2146 \| EZH2 \| infer 2160 \| F11 \| infer 157638 \| FAM84B \| infer 2177 \| FANCD2 \| infer 2189 \| FANCG \| infer 2194 \| FASN \| infer 2261 \| FGFR3 \| infer 2264 \| FGFR4 \| infer 2271 \| FH \| infer 2272 \| FHIT \| infer 342184 \| FMN1 \| infer 2346 \| FOLH1 \| infer 116113 \| FOXP4 \| infer 2487 \| FRZB \| infer 2488 \| FSHB \| infer 2492 \| FSHR \| infer 11167 \| FSTL1 \| infer 2395 \| FXN \| infer 2638 \| GC \| infer 2651 \| GCNT2 \| infer 9518 \| GDF15 \| infer 2690 \| GHR \| infer 2778 \| GNAS \| infer 27232 \| GNMT \| infer 2796 \| GNRH1 \| infer 222545 \| GPRC6A \| infer 2876 \| GPX1 \| infer 2879 \| GPX4 \| infer 23708 \| GSPT2 \| infer 2938 \| GSTA1 \| infer 2939 \| GSTA2 \| infer 2944 \| GSTM1 \| infer 2947 \| GSTM3 \| infer 9446 \| GSTO1 \| infer 2950 \| GSTP1 \| infer 2952 \| GSTT1 \| infer 55506 \| H2AFY2 \| infer 3030 \| HADHA \| infer 1404 \| HAPLN1 \| infer 3077 \| HFE \| infer 3082 \| HGF \| infer 3091 \| HIF1A \| infer 55662 \| HIF1AN \| infer 3105 \| HLA-A \| infer 6928 \| HNF1B \| infer 9566 \| HPCX \| infer 3249 \| HPN \| infer 3292 \| HSD17B1 \| infer 3294 \| HSD17B2 \| infer 3293 \| HSD17B3 \| infer 3295 \| HSD17B4 \| infer 3283 \| HSD3B1 \| infer 3284 \| HSD3B2 \| infer 3305 \| HSPA1L \| infer 3383 \| ICAM1 \| infer 7087 \| ICAM5 \| infer 3399 \| ID3 \| infer 3479 \| IGF1 \| infer 3480 \| IGF1R \| infer 3481 \| IGF2 \| infer 3483 \| IGFALS \| infer 3484 \| IGFBP1 \| infer 3486 \| IGFBP3 \| infer 3586 \| IL10 \| infer 3596 \| IL13 \| infer 3606 \| IL18 \| infer 3552 \| IL1A \| infer 3553 \| IL1B \| infer 3557 \| IL1RN \| infer 3558 \| IL2 \| infer 3560 \| IL2RB \| infer 3565 \| IL4 \| infer 3567 \| IL5 \| infer 3569 \| IL6 \| infer 3623 \| INHA \| infer 3624 \| INHBA \| infer 3625 \| INHBB \| infer 3630 \| INS \| infer 3654 \| IRAK1 \| infer 51135 \| IRAK4 \| infer 3667 \| IRS1 \| infer 8660 \| IRS2 \| infer 3673 \| ITGA2 \| infer 3655 \| ITGA6 \| infer 3688 \| ITGB1 \| infer 3690 \| ITGB3 \| infer 221895 \| JAZF1 \| infer 8997 \| KALRN \| infer 22920 \| KIFAP3 \| infer 1316 \| KLF6 \| infer 3816 \| KLK1 \| infer 5655 \| KLK10 \| infer 11012 \| KLK11 \| infer 43849 \| KLK12 \| infer 26085 \| KLK13 \| infer 43847 \| KLK14 \| infer 55554 \| KLK15 \| infer 3817 \| KLK2 \| infer 354 \| KLK3 \| infer 9622 \| KLK4 \| infer 25818 \| KLK5 \| infer 5653 \| KLK6 \| infer 5650 \| KLK7 \| infer 11202 \| KLK8 \| infer 284366 \| KLK9 \| infer 3952 \| LEP \| infer 3953 \| LEPR \| infer 3972 \| LHB \| infer 3973 \| LHCGR \| infer 3981 \| LIG4 \| infer 22853 \| LMTK2 \| infer 4036 \| LRP2 \| infer 4049 \| LTA \| infer 11178 \| LZTS1 \| infer 9500 \| MAGED1 \| infer 4128 \| MAOA \| infer 4141 \| MARS \| infer 4157 \| MC1R \| infer 4158 \| MC2R \| infer 27349 \| MCAT \| infer 4193 \| MDM2 \| infer 4194 \| MDM4 \| infer 5469 \| MED1 \| infer 4255 \| MGMT \| infer 4273 \| MIC12 \| infer 4282 \| MIF \| infer 406938 \| MIR146A \| infer 4292 \| MLH1 \| infer 4312 \| MMP1 \| infer 4313 \| MMP2 \| infer 4316 \| MMP7 \| infer 4318 \| MMP9 \| infer 4353 \| MPO \| infer 10335 \| MRVI1 \| infer 4436 \| MSH2 \| infer 4437 \| MSH3 \| infer 2956 \| MSH6 \| infer 4477 \| MSMB \| infer 4481 \| MSR1 \| infer 4515 \| MTCP1 \| infer 4522 \| MTHFD1 \| infer 4524 \| MTHFR \| infer 4548 \| MTR \| infer 4552 \| MTRR \| infer 9788 \| MTSS1 \| infer 4582 \| MUC1 \| infer 4594 \| MUT \| infer 4595 \| MUTYH \| infer 4609 \| MYC \| infer 4629 \| MYH11 \| infer 9 \| NAT1 \| infer 10 \| NAT2 \| infer 4683 \| NBN \| infer 8648 \| NCOA1 \| infer 10499 \| NCOA2 \| infer 8202 \| NCOA3 \| infer 8031 \| NCOA4 \| infer 4705 \| NDUFA10 \| infer 4698 \| NDUFA5 \| infer 4704 \| NDUFA9 \| infer 91942 \| NDUFAF2 \| infer 4708 \| NDUFB2 \| infer 4711 \| NDUFB5 \| infer 4712 \| NDUFB6 \| infer 4714 \| NDUFB8 \| infer 4715 \| NDUFB9 \| infer 4718 \| NDUFC2 \| infer 4719 \| NDUFS1 \| infer 4720 \| NDUFS2 \| infer 4724 \| NDUFS4 \| infer 4725 \| NDUFS5 \| infer 4726 \| NDUFS6 \| infer 4729 \| NDUFV2 \| infer 4731 \| NDUFV3 \| infer 4790 \| NFKB1 \| infer 4824 \| NKX3-1 \| infer 4843 \| NOS2 \| infer 4846 \| NOS3 \| infer 4862 \| NPAS2 \| infer 1728 \| NQO1 \| infer 2908 \| NR3C1 \| infer 286053 \| NSMCE2 \| infer 170685 \| NUDT10 \| infer 55190 \| NUDT11 \| infer 30010 \| NXPH1 \| infer 4968 \| OGG1 \| infer 11252 \| PACSIN2 \| infer 5053 \| PAH \| infer 79728 \| PALB2 \| infer 24145 \| PANX1 \| infer 142 \| PARP1 \| infer 64002 \| PCGEM1 \| infer 7703 \| PCGF2 \| infer 64146 \| PDF \| infer 2923 \| PDIA3 \| infer 10611 \| PDLIM5 \| infer 5187 \| PER1 \| infer 8864 \| PER2 \| infer 8863 \| PER3 \| infer 5230 \| PGK1 \| infer 5241 \| PGR \| infer 118788 \| PIK3AP1 \| infer 5286 \| PIK3C2A \| infer 5287 \| PIK3C2B \| infer 5290 \| PIK3CA \| infer 5293 \| PIK3CD \| infer 5295 \| PIK3R1 \| infer 8503 \| PIK3R3 \| infer 5304 \| PIP \| infer 5314 \| PKHD1 \| infer 5328 \| PLAU \| infer 5395 \| PMS2 \| infer 5420 \| PODXL \| infer 11201 \| POLI \| infer 5443 \| POMC \| infer 5444 \| PON1 \| infer 5465 \| PPARA \| infer 5468 \| PPARG \| infer 10891 \| PPARGC1A \| infer 133522 \| PPARGC1B \| infer 5591 \| PRKDC \| infer 5617 \| PRL \| infer 5618 \| PRLR \| infer 5660 \| PSAP \| infer 23362 \| PSD3 \| infer 5728 \| PTEN \| infer 5743 \| PTGS2 \| infer 5820 \| PVT1 \| infer 5888 \| RAD51 \| infer 5893 \| RAD52 \| infer 5971 \| RELB \| infer 5981 \| RFC1 \| infer 222546 \| RFX6 \| infer 54933 \| RHBDL2 \| infer 80010 \| RMI1 \| infer 6035 \| RNASE1 \| infer 6041 \| RNASEL \| infer 6184 \| RPN1 \| infer 861 \| RUNX1 \| infer 6256 \| RXRA \| infer 6257 \| RXRB \| infer 6261 \| RYR1 \| infer 9092 \| SART1 \| infer 6389 \| SDHA \| infer 6390 \| SDHB \| infer 6391 \| SDHC \| infer 23541 \| SEC14L2 \| infer 7869 \| SEMA3B \| infer 6405 \| SEMA3F \| infer 5273 \| SERPINB10 \| infer 5054 \| SERPINE1 \| infer 85358 \| SHANK3 \| infer 6462 \| SHBG \| infer 6470 \| SHMT1 \| infer 57084 \| SLC17A6 \| infer 6573 \| SLC19A1 \| infer 6581 \| SLC22A3 \| infer 55532 \| SLC30A10 \| infer 7780 \| SLC30A2 \| infer 64924 \| SLC30A5 \| infer 55676 \| SLC30A6 \| infer 148867 \| SLC30A7 \| infer 169026 \| SLC30A8 \| infer 10463 \| SLC30A9 \| infer 57181 \| SLC39A10 \| infer 221074 \| SLC39A12 \| infer 91252 \| SLC39A13 \| infer 64116 \| SLC39A8 \| infer 55334 \| SLC39A9 \| infer 28234 \| SLCO1B3 \| infer 4088 \| SMAD3 \| infer 23137 \| SMC5 \| infer 6647 \| SOD1 \| infer 6648 \| SOD2 \| infer 6649 \| SOD3 \| infer 57537 \| SORCS2 \| infer 6715 \| SRD5A1 \| infer 6716 \| SRD5A2 \| infer 6750 \| SST \| infer 6751 \| SSTR1 \| infer 6752 \| SSTR2 \| infer 6753 \| SSTR3 \| infer 6754 \| SSTR4 \| infer 6755 \| SSTR5 \| infer 6817 \| SULT1A1 \| infer 6799 \| SULT1A2 \| infer 6822 \| SULT2A1 \| infer 6876 \| TAGLN \| infer 6942 \| TCF20 \| infer 6934 \| TCF7L2 \| infer 6947 \| TCN1 \| infer 6948 \| TCN2 \| infer 7015 \| TERT \| infer 26136 \| TES \| infer 54790 \| TET2 \| infer 7040 \| TGFB1 \| infer 7046 \| TGFBR1 \| infer 7054 \| TH \| infer 63892 \| THADA \| infer 7057 \| THBS1 \| infer 8914 \| TIMELESS \| infer 114609 \| TIRAP \| infer 7096 \| TLR1 \| infer 81793 \| TLR10 \| infer 7097 \| TLR2 \| infer 7098 \| TLR3 \| infer 7099 \| TLR4 \| infer 7100 \| TLR5 \| infer 10333 \| TLR6 \| infer 51284 \| TLR7 \| infer 51311 \| TLR8 \| infer 54106 \| TLR9 \| infer 7113 \| TMPRSS2 \| infer 7124 \| TNF \| infer 8797 \| TNFRSF10A \| infer 4982 \| TNFRSF11B \| infer 23112 \| TNRC6B \| infer 7157 \| TP53 \| infer 55503 \| TRPV6 \| infer 25809 \| TTLL1 \| infer 7274 \| TTPA \| infer 7275 \| TUB \| infer 7298 \| TYMS \| infer 7299 \| TYR \| infer 54658 \| UGT1A1 \| infer 54600 \| UGT1A9 \| infer 7366 \| UGT2B15 \| infer 7367 \| UGT2B17 \| infer 7364 \| UGT2B7 \| infer 7374 \| UNG \| infer 7381 \| UQCRB \| infer 7386 \| UQCRFS1 \| infer 7874 \| USP7 \| infer 7421 \| VDR \| infer 7422 \| VEGFA \| infer 79001 \| VKORC1 \| infer 6293 \| VPS52 \| infer 7508 \| XPC \| infer 9213 \| XPR1 \| infer 7515 \| XRCC1 \| infer 7517 \| XRCC3 \| infer 7518 \| XRCC4 \| infer 2547 \| XRCC6 \| infer 463 \| ZFHX3 \| infer 22882 \| ZHX2 \| infer 58499 \| ZNF462 \| infer 255403 \| ZNF718 \| infer
Text Mined Gene	Entrez_id \| Symbol \| Score \| Resource(Total Genes:1738) 253868 \| C20orf166-AS1 \| DISEASES 103021165 \| CASC19 \| DISEASES 100506428 \| CBR3-AS1 \| DISEASES 100048912 \| CDKN2B-AS1 \| DISEASES 285463 \| CTBP1-AS \| DISEASES 282706 \| DAOA-AS1 \| DISEASES 101927125 \| ELFN1-AS1 \| DISEASES 2288 \| FKBP4 \| DISEASES 5898 \| RALA \| DISEASES 6376 \| CX3CL1 \| DISEASES 4706 \| NDUFAB1 \| DISEASES 3675 \| ITGA3 \| DISEASES 928 \| CD9 \| DISEASES 4830 \| NME1 \| DISEASES 2067 \| ERCC1 \| DISEASES 6591 \| SNAI2 \| DISEASES 1015 \| CDH17 \| DISEASES 7544 \| ZFY \| DISEASES 43847 \| KLK14 \| DISEASES 55808 \| ST6GALNAC1 \| DISEASES 29995 \| LMCD1 \| DISEASES 23030 \| KDM4B \| DISEASES 634 \| CEACAM1 \| DISEASES 7132 \| TNFRSF1A \| DISEASES 3861 \| KRT14 \| DISEASES 7145 \| TNS1 \| DISEASES 4804 \| NGFR \| DISEASES 6793 \| STK10 \| DISEASES 5607 \| MAP2K5 \| DISEASES 63897 \| HEATR6 \| DISEASES 10777 \| ARPP21 \| DISEASES 8895 \| CPNE3 \| DISEASES 3294 \| HSD17B2 \| DISEASES 3691 \| ITGB4 \| DISEASES 2099 \| ESR1 \| DISEASES 6913 \| TBX15 \| DISEASES 990 \| CDC6 \| DISEASES 7414 \| VCL \| DISEASES 23411 \| SIRT1 \| DISEASES 7049 \| TGFBR3 \| DISEASES 4320 \| MMP11 \| DISEASES 4282 \| MIF \| DISEASES 5008 \| OSM \| DISEASES 5594 \| MAPK1 \| DISEASES 3162 \| HMOX1 \| DISEASES 4174 \| MCM5 \| DISEASES 23170 \| TTLL12 \| DISEASES 7380 \| UPK3A \| DISEASES 9978 \| RBX1 \| DISEASES 2999 \| GZMH \| DISEASES 3002 \| GZMB \| DISEASES 8846 \| ALKBH1 \| DISEASES 1113 \| CHGA \| DISEASES 51635 \| DHRS7 \| DISEASES 6554 \| SLC10A1 \| DISEASES 328 \| APEX1 \| DISEASES 4792 \| NFKBIA \| DISEASES 1591 \| CYP24A1 \| DISEASES 6790 \| AURKA \| DISEASES 4605 \| MYBL2 \| DISEASES 57167 \| SALL4 \| DISEASES 79444 \| BIRC7 \| DISEASES 1917 \| EEF1A2 \| DISEASES 5753 \| PTK6 \| DISEASES 6880 \| TAF9 \| DISEASES 412 \| STS \| DISEASES 9506 \| PAGE4 \| DISEASES 7076 \| TIMP1 \| DISEASES 10916 \| MAGED2 \| DISEASES 54 \| ACP5 \| DISEASES 4313 \| MMP2 \| DISEASES 56942 \| CMC2 \| DISEASES 58189 \| WFDC1 \| DISEASES 10273 \| STUB1 \| DISEASES 4150 \| MAZ \| DISEASES 51285 \| RASL12 \| DISEASES 29106 \| SCG3 \| DISEASES 55824 \| PAG1 \| DISEASES 1666 \| DECR1 \| DISEASES 6422 \| SFRP1 \| DISEASES 5327 \| PLAT \| DISEASES 8797 \| TNFRSF10A \| DISEASES 5516 \| PPP2CB \| DISEASES 7991 \| TUSC3 \| DISEASES 3191 \| HNRNPL \| DISEASES 5971 \| RELB \| DISEASES 27120 \| DKKL1 \| DISEASES 6449 \| SGTA \| DISEASES 79852 \| EPHX3 \| DISEASES 7040 \| TGFB1 \| DISEASES 1048 \| CEACAM5 \| DISEASES 6822 \| SULT2A1 \| DISEASES 6528 \| SLC5A5 \| DISEASES 2931 \| GSK3A \| DISEASES 64816 \| CYP3A43 \| DISEASES 3082 \| HGF \| DISEASES 51200 \| CPA4 \| DISEASES 85865 \| GTPBP10 \| DISEASES 26959 \| HBP1 \| DISEASES 858 \| CAV2 \| DISEASES 1577 \| CYP3A5 \| DISEASES 64598 \| MOSPD3 \| DISEASES 5054 \| SERPINE1 \| DISEASES 6013 \| RLN1 \| DISEASES 7431 \| VIM \| DISEASES 29760 \| BLNK \| DISEASES 6143 \| RPL19 \| DISEASES 1440 \| CSF3 \| DISEASES 6198 \| RPS6KB1 \| DISEASES 10951 \| CBX1 \| DISEASES 51655 \| RASD1 \| DISEASES 1362 \| CPD \| DISEASES 1655 \| DDX5 \| DISEASES 6347 \| CCL2 \| DISEASES 6928 \| HNF1B \| DISEASES 7448 \| VTN \| DISEASES 3381 \| IBSP \| DISEASES 6372 \| CXCL6 \| DISEASES 2798 \| GNRHR \| DISEASES 4790 \| NFKB1 \| DISEASES 3558 \| IL2 \| DISEASES 3732 \| CD82 \| DISEASES 595 \| CCND1 \| DISEASES 329 \| BIRC2 \| DISEASES 5829 \| PXN \| DISEASES 1594 \| CYP27B1 \| DISEASES 2735 \| GLI1 \| DISEASES 2251 \| FGF6 \| DISEASES 1027 \| CDKN1B \| DISEASES 4055 \| LTBR \| DISEASES 3458 \| IFNG \| DISEASES 2597 \| GAPDH \| DISEASES 8078 \| USP5 \| DISEASES 2026 \| ENO2 \| DISEASES 79923 \| NANOG \| DISEASES 1432 \| MAPK14 \| DISEASES 135152 \| B3GAT2 \| DISEASES 6908 \| TBP \| DISEASES 55754 \| TMEM30A \| DISEASES 1839 \| HBEGF \| DISEASES 4015 \| LOX \| DISEASES 6678 \| SPARC \| DISEASES 50805 \| IRX4 \| DISEASES 3565 \| IL4 \| DISEASES 6500 \| SKP1 \| DISEASES 2908 \| NR3C1 \| DISEASES 5917 \| RARS \| DISEASES 4292 \| MLH1 \| DISEASES 54497 \| HEATR5B \| DISEASES 4436 \| MSH2 \| DISEASES 29959 \| NRBP1 \| DISEASES 374291 \| NDUFS7 \| DISEASES 3485 \| IGFBP2 \| DISEASES 3488 \| IGFBP5 \| DISEASES 3398 \| ID2 \| DISEASES 4953 \| ODC1 \| DISEASES 9687 \| GREB1 \| DISEASES 23683 \| PRKD3 \| DISEASES 5341 \| PLEK \| DISEASES 84634 \| KISS1R \| DISEASES 2956 \| MSH6 \| DISEASES 2023 \| ENO1 \| DISEASES 6301 \| SARS \| DISEASES 79084 \| WDR77 \| DISEASES 1509 \| CTSD \| DISEASES 7276 \| TTR \| DISEASES 2691 \| GHRH \| DISEASES 9429 \| ABCG2 \| DISEASES 51692 \| CPSF3 \| DISEASES 7043 \| TGFB3 \| DISEASES 1843 \| DUSP1 \| DISEASES 8600 \| TNFSF11 \| DISEASES 29880 \| ALG5 \| DISEASES 1958 \| EGR1 \| DISEASES 8405 \| SPOP \| DISEASES 847 \| CAT \| DISEASES 8743 \| TNFSF10 \| DISEASES 92 \| ACVR2A \| DISEASES 2322 \| FLT3 \| DISEASES 387496 \| RASL11A \| DISEASES 4852 \| NPY \| DISEASES 7291 \| TWIST1 \| DISEASES 7374 \| UNG \| DISEASES 54800 \| KLHL24 \| DISEASES 3223 \| HOXC6 \| DISEASES 2166 \| FAAH \| DISEASES 140687 \| GCNT7 \| DISEASES 5266 \| PI3 \| DISEASES 6615 \| SNAI1 \| DISEASES 1026 \| CDKN1A \| DISEASES 6659 \| SOX4 \| DISEASES 2069 \| EREG \| DISEASES 4502 \| MT2A \| DISEASES 2806 \| GOT2 \| DISEASES 6555 \| SLC10A2 \| DISEASES 652 \| BMP4 \| DISEASES 6662 \| SOX9 \| DISEASES 84266 \| ALKBH7 \| DISEASES 8744 \| TNFSF9 \| DISEASES 994 \| CDC25B \| DISEASES 2797 \| GNRH2 \| DISEASES 1236 \| CCR7 \| DISEASES 10131 \| TRAP1 \| DISEASES 84081 \| NSRP1 \| DISEASES 7355 \| SLC35A2 \| DISEASES 59269 \| HIVEP3 \| DISEASES 5300 \| PIN1 \| DISEASES 3315 \| HSPB1 \| DISEASES 2952 \| GSTT1 \| DISEASES 5880 \| RAC2 \| DISEASES 22933 \| SIRT2 \| DISEASES 3232 \| HOXD3 \| DISEASES 8554 \| PIAS1 \| DISEASES 968 \| CD68 \| DISEASES 43849 \| KLK12 \| DISEASES 10038 \| PARP2 \| DISEASES 3169 \| FOXA1 \| DISEASES 5908 \| RAP1B \| DISEASES 9084 \| VCY \| DISEASES 353513 \| VCY1B \| DISEASES 3630 \| INS \| DISEASES 6299 \| SALL1 \| DISEASES 79154 \| DHRS11 \| DISEASES 239 \| ALOX12 \| DISEASES 5157 \| PDGFRL \| DISEASES 79977 \| GRHL2 \| DISEASES 5894 \| RAF1 \| DISEASES 56165 \| TDRD1 \| DISEASES 9440 \| MED17 \| DISEASES 7251 \| TSG101 \| DISEASES 26133 \| TRPC4AP \| DISEASES 3852 \| KRT5 \| DISEASES 27112 \| FAM155B \| DISEASES 9518 \| GDF15 \| DISEASES 3727 \| JUND \| DISEASES 54795 \| TRPM4 \| DISEASES 9104 \| RGN \| DISEASES 8572 \| PDLIM4 \| DISEASES 47 \| ACLY \| DISEASES 84951 \| TNS4 \| DISEASES 79727 \| LIN28A \| DISEASES 3958 \| LGALS3 \| DISEASES 6382 \| SDC1 \| DISEASES 2926 \| GRSF1 \| DISEASES 91107 \| TRIM47 \| DISEASES 182 \| JAG1 \| DISEASES 6754 \| SSTR4 \| DISEASES 1401 \| CRP \| DISEASES 8900 \| CCNA1 \| DISEASES 4922 \| NTS \| DISEASES 3845 \| KRAS \| DISEASES 10894 \| LYVE1 \| DISEASES 9645 \| MICAL2 \| DISEASES 157310 \| PEBP4 \| DISEASES 891 \| CCNB1 \| DISEASES 1022 \| CDK7 \| DISEASES 8553 \| BHLHE40 \| DISEASES 4853 \| NOTCH2 \| DISEASES 10468 \| FST \| DISEASES 2922 \| GRP \| DISEASES 902 \| CCNH \| DISEASES 53 \| ACP2 \| DISEASES 2346 \| FOLH1 \| DISEASES 301 \| ANXA1 \| DISEASES 29969 \| MDFIC \| DISEASES 1019 \| CDK4 \| DISEASES 4829 \| NMBR \| DISEASES 80896 \| NPL \| DISEASES 1593 \| CYP27A1 \| DISEASES 3569 \| IL6 \| DISEASES 3364 \| HUS1 \| DISEASES 6426 \| SRSF1 \| DISEASES 153090 \| DAB2IP \| DISEASES 4856 \| NOV \| DISEASES 5460 \| POU5F1 \| DISEASES 7274 \| TTPA \| DISEASES 9099 \| USP2 \| DISEASES 4316 \| MMP7 \| DISEASES 4322 \| MMP13 \| DISEASES 7057 \| THBS1 \| DISEASES 56924 \| PAK6 \| DISEASES 1588 \| CYP19A1 \| DISEASES 79739 \| TTLL7 \| DISEASES 1545 \| CYP1B1 \| DISEASES 10128 \| LRPPRC \| DISEASES 9360 \| PPIG \| DISEASES 9194 \| SLC16A7 \| DISEASES 28234 \| SLCO1B3 \| DISEASES 894 \| CCND2 \| DISEASES 5037 \| PEBP1 \| DISEASES 4040 \| LRP6 \| DISEASES 7450 \| VWF \| DISEASES 5687 \| PSMA6 \| DISEASES 4124 \| MAN2A1 \| DISEASES 79728 \| PALB2 \| DISEASES 949 \| SCARB1 \| DISEASES 23184 \| MESDC2 \| DISEASES 999 \| CDH1 \| DISEASES 384 \| ARG2 \| DISEASES 5159 \| PDGFRB \| DISEASES 26035 \| GLCE \| DISEASES 2324 \| FLT4 \| DISEASES 3690 \| ITGB3 \| DISEASES 10728 \| PTGES3 \| DISEASES 27075 \| TSPAN13 \| DISEASES 4481 \| MSR1 \| DISEASES 57045 \| TWSG1 \| DISEASES 4092 \| SMAD7 \| DISEASES 4087 \| SMAD2 \| DISEASES 7434 \| VIPR2 \| DISEASES 7528 \| YY1 \| DISEASES 79817 \| MOB3B \| DISEASES 81671 \| VMP1 \| DISEASES 8312 \| AXIN1 \| DISEASES 1387 \| CREBBP \| DISEASES 6416 \| MAP2K4 \| DISEASES 1459 \| CSNK2A2 \| DISEASES 23144 \| ZC3H3 \| DISEASES 3249 \| HPN \| DISEASES 898 \| CCNE1 \| DISEASES 1031 \| CDKN2C \| DISEASES 23239 \| PHLPP1 \| DISEASES 5052 \| PRDX1 \| DISEASES 7077 \| TIMP2 \| DISEASES 3959 \| LGALS3BP \| DISEASES 8178 \| ELL \| DISEASES 25939 \| SAMHD1 \| DISEASES 7515 \| XRCC1 \| DISEASES 1871 \| E2F3 \| DISEASES 10552 \| ARPC1A \| DISEASES 6929 \| TCF3 \| DISEASES 8821 \| INPP4B \| DISEASES 5595 \| MAPK3 \| DISEASES 1109 \| AKR1C4 \| DISEASES 51586 \| MED15 \| DISEASES 6855 \| SYP \| DISEASES 2033 \| EP300 \| DISEASES 50507 \| NOX4 \| DISEASES 3552 \| IL1A \| DISEASES 3553 \| IL1B \| DISEASES 23476 \| BRD4 \| DISEASES 330 \| BIRC3 \| DISEASES 50937 \| CDON \| DISEASES 3933 \| LCN1 \| DISEASES 4072 \| EPCAM \| DISEASES 8850 \| KAT2B \| DISEASES 4722 \| NDUFS3 \| DISEASES 7301 \| TYRO3 \| DISEASES 10000 \| AKT3 \| DISEASES 3791 \| KDR \| DISEASES 5290 \| PIK3CA \| DISEASES 23301 \| EHBP1 \| DISEASES 10664 \| CTCF \| DISEASES 7379 \| UPK2 \| DISEASES 4162 \| MCAM \| DISEASES 10382 \| TUBB4A \| DISEASES 29899 \| GPSM2 \| DISEASES 79644 \| SRD5A3 \| DISEASES 941 \| CD80 \| DISEASES 56925 \| LXN \| DISEASES 8452 \| CUL3 \| DISEASES 1475 \| CSTA \| DISEASES 374 \| AREG \| DISEASES 2247 \| FGF2 \| DISEASES 9759 \| HDAC4 \| DISEASES 7474 \| WNT5A \| DISEASES 6774 \| STAT3 \| DISEASES 2255 \| FGF10 \| DISEASES 3818 \| KLKB1 \| DISEASES 5443 \| POMC \| DISEASES 1788 \| DNMT3A \| DISEASES 5496 \| PPM1G \| DISEASES 8626 \| TP63 \| DISEASES 3383 \| ICAM1 \| DISEASES 306 \| ANXA3 \| DISEASES 54464 \| XRN1 \| DISEASES 84129 \| ACAD11 \| DISEASES 3827 \| KNG1 \| DISEASES 4171 \| MCM2 \| DISEASES 64083 \| GOLPH3 \| DISEASES 1462 \| VCAN \| DISEASES 51176 \| LEF1 \| DISEASES 1950 \| EGF \| DISEASES 54439 \| RBM27 \| DISEASES 57678 \| GPAM \| DISEASES 6722 \| SRF \| DISEASES 10512 \| SEMA3C \| DISEASES 10371 \| SEMA3A \| DISEASES 8829 \| NRP1 \| DISEASES 1390 \| CREM \| DISEASES 11059 \| WWP1 \| DISEASES 7472 \| WNT2 \| DISEASES 25824 \| PRDX5 \| DISEASES 1119 \| CHKA \| DISEASES 5577 \| PRKAR2B \| DISEASES 5243 \| ABCB1 \| DISEASES 1021 \| CDK6 \| DISEASES 11178 \| LZTS1 \| DISEASES 5395 \| PMS2 \| DISEASES 6713 \| SQLE \| DISEASES 1616 \| DAXX \| DISEASES 3373 \| HYAL1 \| DISEASES 3700 \| ITIH4 \| DISEASES 26205 \| GMEB2 \| DISEASES 11083 \| DIDO1 \| DISEASES 7078 \| TIMP3 \| DISEASES 939 \| CD27 \| DISEASES 23519 \| ANP32D \| DISEASES 84298 \| LLPH \| DISEASES 11010 \| GLIPR1 \| DISEASES 429 \| ASCL1 \| DISEASES 1017 \| CDK2 \| DISEASES 6895 \| TARBP2 \| DISEASES 50846 \| DHH \| DISEASES 51380 \| CSAD \| DISEASES 2065 \| ERBB3 \| DISEASES 5925 \| RB1 \| DISEASES 84530 \| SRRM4 \| DISEASES 6751 \| SSTR1 \| DISEASES 2252 \| FGF7 \| DISEASES 597 \| BCL2A1 \| DISEASES 3480 \| IGF1R \| DISEASES 1583 \| CYP11A1 \| DISEASES 463 \| ZFHX3 \| DISEASES 1009 \| CDH11 \| DISEASES 81631 \| MAP1LC3B \| DISEASES 9611 \| NCOR1 \| DISEASES 28987 \| NOB1 \| DISEASES 1000 \| CDH2 \| DISEASES 409 \| ARRB2 \| DISEASES 7157 \| TP53 \| DISEASES 55520 \| ELAC1 \| DISEASES 2064 \| ERBB2 \| DISEASES 3858 \| KRT10 \| DISEASES 3487 \| IGFBP4 \| DISEASES 207 \| AKT1 \| DISEASES 93650 \| ACPT \| DISEASES 25874 \| MPC2 \| DISEASES 1513 \| CTSK \| DISEASES 29956 \| CERS2 \| DISEASES 148327 \| CREB3L4 \| DISEASES 2052 \| EPHX1 \| DISEASES 5972 \| REN \| DISEASES 805 \| CALM2 \| DISEASES 6233 \| RPS27A \| DISEASES 23671 \| TMEFF2 \| DISEASES 55502 \| HES6 \| DISEASES 185 \| AGTR1 \| DISEASES 7220 \| TRPC1 \| DISEASES 55840 \| EAF2 \| DISEASES 10699 \| CORIN \| DISEASES 57563 \| KLHL8 \| DISEASES 890 \| CCNA2 \| DISEASES 6423 \| SFRP2 \| DISEASES 6715 \| SRD5A1 \| DISEASES 6502 \| SKP2 \| DISEASES 5295 \| PIK3R1 \| DISEASES 81786 \| TRIM7 \| DISEASES 50636 \| ANO7 \| DISEASES 6581 \| SLC22A3 \| DISEASES 1956 \| EGFR \| DISEASES 113130 \| CDCA5 \| DISEASES 3484 \| IGFBP1 \| DISEASES 2041 \| EPHA1 \| DISEASES 10395 \| DLC1 \| DISEASES 2796 \| GNRH1 \| DISEASES 8795 \| TNFRSF10B \| DISEASES 1807 \| DPYS \| DISEASES 56169 \| GSDMC \| DISEASES 1030 \| CDKN2B \| DISEASES 3439 \| IFNA1 \| DISEASES 4915 \| NTRK2 \| DISEASES 4851 \| NOTCH1 \| DISEASES 133 \| ADM \| DISEASES 7762 \| ZNF215 \| DISEASES 51144 \| HSD17B12 \| DISEASES 8501 \| SLC43A1 \| DISEASES 23052 \| ENDOD1 \| DISEASES 5058 \| PAK1 \| DISEASES 472 \| ATM \| DISEASES 55004 \| LAMTOR1 \| DISEASES 3145 \| HMBS \| DISEASES 6768 \| ST14 \| DISEASES 6876 \| TAGLN \| DISEASES 339745 \| SPOPL \| DISEASES 27250 \| PDCD4 \| DISEASES 7424 \| VEGFC \| DISEASES 5805 \| PTS \| DISEASES 4613 \| MYCN \| DISEASES 2241 \| FER \| DISEASES 79596 \| RNF219 \| DISEASES 115761 \| ARL11 \| DISEASES 5741 \| PTH \| DISEASES 6695 \| SPOCK1 \| DISEASES 219333 \| USP12 \| DISEASES 55521 \| TRIM36 \| DISEASES 2321 \| FLT1 \| DISEASES 10413 \| YAP1 \| DISEASES 8404 \| SPARCL1 \| DISEASES 23037 \| PDZD2 \| DISEASES 2697 \| GJA1 \| DISEASES 9453 \| GGPS1 \| DISEASES 8467 \| SMARCA5 \| DISEASES 654 \| BMP6 \| DISEASES 79888 \| LPCAT1 \| DISEASES 221895 \| JAZF1 \| DISEASES 1105 \| CHD1 \| DISEASES 7070 \| THY1 \| DISEASES 89780 \| WNT3A \| DISEASES 126731 \| CCSAP \| DISEASES 9087 \| TMSB4Y \| DISEASES 9510 \| ADAMTS1 \| DISEASES 7508 \| XPC \| DISEASES 389 \| RHOC \| DISEASES 1436 \| CSF1R \| DISEASES 10 \| NAT2 \| DISEASES 4325 \| MMP16 \| DISEASES 10563 \| CXCL13 \| DISEASES 219970 \| GLYATL2 \| DISEASES 29028 \| ATAD2 \| DISEASES 701 \| BUB1B \| DISEASES 6750 \| SST \| DISEASES 23420 \| NOMO1 \| DISEASES 9372 \| ZFYVE9 \| DISEASES 6529 \| SLC6A1 \| DISEASES 5468 \| PPARG \| DISEASES 261729 \| STEAP2 \| DISEASES 3156 \| HMGCR \| DISEASES 3815 \| KIT \| DISEASES 9133 \| CCNB2 \| DISEASES 5291 \| PIK3CB \| DISEASES 8365 \| HIST1H4H \| DISEASES 11013 \| TMSB15A \| DISEASES 909 \| CD1A \| DISEASES 11309 \| SLCO2B1 \| DISEASES 10481 \| HOXB13 \| DISEASES 6493 \| SIM2 \| DISEASES 7832 \| BTG2 \| DISEASES 4489 \| MT1A \| DISEASES 1636 \| ACE \| DISEASES 10417 \| SPON2 \| DISEASES 1487 \| CTBP1 \| DISEASES 181 \| AGRP \| DISEASES 5304 \| PIP \| DISEASES 808 \| CALM3 \| DISEASES 7031 \| TFF1 \| DISEASES 29941 \| PKN3 \| DISEASES 643 \| CXCR5 \| DISEASES 729230 \| CCR2 \| DISEASES 1234 \| CCR5 \| DISEASES 563 \| AZGP1 \| DISEASES 2264 \| FGFR4 \| DISEASES 1584 \| CYP11B1 \| DISEASES 4061 \| LY6E \| DISEASES 114757 \| CYGB \| DISEASES 6352 \| CCL5 \| DISEASES 581 \| BAX \| DISEASES 3856 \| KRT8 \| DISEASES 6777 \| STAT5B \| DISEASES 7471 \| WNT1 \| DISEASES 246 \| ALOX15 \| DISEASES 58191 \| CXCL16 \| DISEASES 2256 \| FGF11 \| DISEASES 6755 \| SSTR5 \| DISEASES 10630 \| PDPN \| DISEASES 7412 \| VCAM1 \| DISEASES 5966 \| REL \| DISEASES 2487 \| FRZB \| DISEASES 27306 \| HPGDS \| DISEASES 7039 \| TGFA \| DISEASES 151647 \| FAM19A4 \| DISEASES 116064 \| LRRC58 \| DISEASES 3490 \| IGFBP7 \| DISEASES 3577 \| CXCR1 \| DISEASES 84283 \| TMEM79 \| DISEASES 3549 \| IHH \| DISEASES 57650 \| KIAA1524 \| DISEASES 50852 \| TRAT1 \| DISEASES 5584 \| PRKCI \| DISEASES 152185 \| SPICE1 \| DISEASES 213 \| ALB \| DISEASES 25976 \| TIPARP \| DISEASES 8820 \| HESX1 \| DISEASES 84818 \| IL17RC \| DISEASES 2921 \| CXCL3 \| DISEASES 6374 \| CXCL5 \| DISEASES 7047 \| TGM4 \| DISEASES 64866 \| CDCP1 \| DISEASES 6286 \| S100P \| DISEASES 3015 \| H2AFZ \| DISEASES 5364 \| PLXNB1 \| DISEASES 4486 \| MST1R \| DISEASES 308 \| ANXA5 \| DISEASES 2982 \| GUCY1A3 \| DISEASES 3248 \| HPGD \| DISEASES 3600 \| IL15 \| DISEASES 3673 \| ITGA2 \| DISEASES 6690 \| SPINK1 \| DISEASES 7098 \| TLR3 \| DISEASES 1437 \| CSF2 \| DISEASES 4869 \| NPM1 \| DISEASES 26872 \| STEAP1 \| DISEASES 2171 \| FABP5 \| DISEASES 6469 \| SHH \| DISEASES 84624 \| FNDC1 \| DISEASES 22853 \| LMTK2 \| DISEASES 5885 \| RAD21 \| DISEASES 4982 \| TNFRSF11B \| DISEASES 2020 \| EN2 \| DISEASES 4846 \| NOS3 \| DISEASES 216 \| ALDH1A1 \| DISEASES 115825 \| WDFY2 \| DISEASES 29986 \| SLC39A2 \| DISEASES 57447 \| NDRG2 \| DISEASES 219938 \| SPATA19 \| DISEASES 55662 \| HIF1AN \| DISEASES 27343 \| POLL \| DISEASES 55832 \| CAND1 \| DISEASES 3611 \| ILK \| DISEASES 5055 \| SERPINB2 \| DISEASES 7184 \| HSP90B1 \| DISEASES 4314 \| MMP3 \| DISEASES 89927 \| C16orf45 \| DISEASES 290 \| ANPEP \| DISEASES 5347 \| PLK1 \| DISEASES 4665 \| NAB2 \| DISEASES 6778 \| STAT6 \| DISEASES 7529 \| YWHAB \| DISEASES 6447 \| SCG5 \| DISEASES 59271 \| EVA1C \| DISEASES 2923 \| PDIA3 \| DISEASES 5245 \| PHB \| DISEASES 5469 \| MED1 \| DISEASES 6786 \| STIM1 \| DISEASES 55128 \| TRIM68 \| DISEASES 56547 \| MMP26 \| DISEASES 29123 \| ANKRD11 \| DISEASES 147011 \| PROCA1 \| DISEASES 558 \| AXL \| DISEASES 10653 \| SPINT2 \| DISEASES 8000 \| PSCA \| DISEASES 27043 \| PELP1 \| DISEASES 3816 \| KLK1 \| DISEASES 79085 \| SLC25A23 \| DISEASES 3489 \| IGFBP6 \| DISEASES 332 \| BIRC5 \| DISEASES 50964 \| SOST \| DISEASES 8772 \| FADD \| DISEASES 4054 \| LTBP3 \| DISEASES 51435 \| SCARA3 \| DISEASES 55872 \| PBK \| DISEASES 3960 \| LGALS4 \| DISEASES 4255 \| MGMT \| DISEASES 5617 \| PRL \| DISEASES 221120 \| ALKBH3 \| DISEASES 2637 \| GBX2 \| DISEASES 5604 \| MAP2K1 \| DISEASES 9839 \| ZEB2 \| DISEASES 699 \| BUB1 \| DISEASES 598 \| BCL2L1 \| DISEASES 157638 \| FAM84B \| DISEASES 8313 \| AXIN2 \| DISEASES 3479 \| IGF1 \| DISEASES 23214 \| XPO6 \| DISEASES 10296 \| MAEA \| DISEASES 5734 \| PTGER4 \| DISEASES 5036 \| PA2G4 \| DISEASES 3308 \| HSPA4 \| DISEASES 140738 \| TMEM37 \| DISEASES 9723 \| SEMA3E \| DISEASES 59350 \| RXFP1 \| DISEASES 3688 \| ITGB1 \| DISEASES 8988 \| HSPB3 \| DISEASES 993 \| CDC25A \| DISEASES 5481 \| PPID \| DISEASES 3643 \| INSR \| DISEASES 1493 \| CTLA4 \| DISEASES 7857 \| SCG2 \| DISEASES 5308 \| PITX2 \| DISEASES 7764 \| ZNF217 \| DISEASES 10248 \| POP7 \| DISEASES 10663 \| CXCR6 \| DISEASES 171558 \| PTCRA \| DISEASES 2194 \| FASN \| DISEASES 3667 \| IRS1 \| DISEASES 7543 \| ZFX \| DISEASES 5046 \| PCSK6 \| DISEASES 201931 \| TMEM192 \| DISEASES 154 \| ADRB2 \| DISEASES 1051 \| CEBPB \| DISEASES 2237 \| FEN1 \| DISEASES 84376 \| HOOK3 \| DISEASES 3221 \| HOXC4 \| DISEASES 214 \| ALCAM \| DISEASES 171024 \| SYNPO2 \| DISEASES 2353 \| FOS \| DISEASES 65084 \| TMEM135 \| DISEASES 4968 \| OGG1 \| DISEASES 10484 \| SEC23A \| DISEASES 2119 \| ETV5 \| DISEASES 55689 \| YEATS2 \| DISEASES 3037 \| HAS2 \| DISEASES 646 \| BNC1 \| DISEASES 6383 \| SDC2 \| DISEASES 1501 \| CTNND2 \| DISEASES 160065 \| PATE1 \| DISEASES 9451 \| EIF2AK3 \| DISEASES 57521 \| RPTOR \| DISEASES 4176 \| MCM7 \| DISEASES 57599 \| WDR48 \| DISEASES 9902 \| MRC2 \| DISEASES 124583 \| CANT1 \| DISEASES 4493 \| MT1E \| DISEASES 54205 \| CYCS \| DISEASES 57659 \| ZBTB4 \| DISEASES 6137 \| RPL13 \| DISEASES 948 \| CD36 \| DISEASES 4323 \| MMP14 \| DISEASES 127435 \| PODN \| DISEASES 991 \| CDC20 \| DISEASES 285598 \| ARL10 \| DISEASES 2147 \| F2 \| DISEASES 84733 \| CBX2 \| DISEASES 660 \| BMX \| DISEASES 1540 \| CYLD \| DISEASES 5340 \| PLG \| DISEASES 79370 \| BCL2L14 \| DISEASES 5653 \| KLK6 \| DISEASES 9134 \| CCNE2 \| DISEASES 8763 \| CD164 \| DISEASES 5707 \| PSMD1 \| DISEASES 222545 \| GPRC6A \| DISEASES 7534 \| YWHAZ \| DISEASES 7015 \| TERT \| DISEASES 3964 \| LGALS8 \| DISEASES 1072 \| CFL1 \| DISEASES 27173 \| SLC39A1 \| DISEASES 200316 \| APOBEC3F \| DISEASES 116113 \| FOXP4 \| DISEASES 3265 \| HRAS \| DISEASES 947 \| CD34 \| DISEASES 8061 \| FOSL1 \| DISEASES 26512 \| INTS6 \| DISEASES 8793 \| TNFRSF10D \| DISEASES 27243 \| CHMP2A \| DISEASES 392 \| ARHGAP1 \| DISEASES 83591 \| THAP2 \| DISEASES 5598 \| MAPK7 \| DISEASES 2001 \| ELF5 \| DISEASES 836 \| CASP3 \| DISEASES 286827 \| TRIM59 \| DISEASES 147687 \| ZNF417 \| DISEASES 5883 \| RAD9A \| DISEASES 2944 \| GSTM1 \| DISEASES 10290 \| SPEG \| DISEASES 2250 \| FGF5 \| DISEASES 5655 \| KLK10 \| DISEASES 83637 \| ZMIZ2 \| DISEASES 1488 \| CTBP2 \| DISEASES 10221 \| TRIB1 \| DISEASES 5319 \| PLA2G1B \| DISEASES 8837 \| CFLAR \| DISEASES 64801 \| ARV1 \| DISEASES 8557 \| TCAP \| DISEASES 3952 \| LEP \| DISEASES 835 \| CASP2 \| DISEASES 10645 \| CAMKK2 \| DISEASES 3172 \| HNF4A \| DISEASES 26986 \| PABPC1 \| DISEASES 4117 \| MAK \| DISEASES 1601 \| DAB2 \| DISEASES 5591 \| PRKDC \| DISEASES 3817 \| KLK2 \| DISEASES 8877 \| SPHK1 \| DISEASES 10657 \| KHDRBS1 \| DISEASES 23047 \| PDS5B \| DISEASES 3090 \| HIC1 \| DISEASES 354 \| KLK3 \| DISEASES 998 \| CDC42 \| DISEASES 285 \| ANGPT2 \| DISEASES 27122 \| DKK3 \| DISEASES 56475 \| RPRM \| DISEASES 1909 \| EDNRA \| DISEASES 1191 \| CLU \| DISEASES 55164 \| SHQ1 \| DISEASES 284459 \| HKR1 \| DISEASES 901 \| CCNG2 \| DISEASES 3936 \| LCP1 \| DISEASES 389289 \| ANXA2R \| DISEASES 3170 \| FOXA2 \| DISEASES 7094 \| TLN1 \| DISEASES 23541 \| SEC14L2 \| DISEASES 8560 \| DEGS1 \| DISEASES 23512 \| SUZ12 \| DISEASES 57610 \| RANBP10 \| DISEASES 10170 \| DHRS9 \| DISEASES 5551 \| PRF1 \| DISEASES 135886 \| WBSCR28 \| DISEASES 4233 \| MET \| DISEASES 2744 \| GLS \| DISEASES 9702 \| CEP57 \| DISEASES 1960 \| EGR3 \| DISEASES 80267 \| EDEM3 \| DISEASES 4684 \| NCAM1 \| DISEASES 90655 \| TGIF2LY \| DISEASES 8630 \| HSD17B6 \| DISEASES 171483 \| FAM9B \| DISEASES 27319 \| BHLHE22 \| DISEASES 27086 \| FOXP1 \| DISEASES 2814 \| GP5 \| DISEASES 7358 \| UGDH \| DISEASES 6819 \| SULT1C2 \| DISEASES 3579 \| CXCR2 \| DISEASES 5652 \| PRSS8 \| DISEASES 1728 \| NQO1 \| DISEASES 10397 \| NDRG1 \| DISEASES 9120 \| SLC16A6 \| DISEASES 80381 \| CD276 \| DISEASES 2146 \| EZH2 \| DISEASES 5315 \| PKM \| DISEASES 2692 \| GHRHR \| DISEASES 54822 \| TRPM7 \| DISEASES 7367 \| UGT2B17 \| DISEASES 7182 \| NR2C2 \| DISEASES 54556 \| ING3 \| DISEASES 9370 \| ADIPOQ \| DISEASES 811 \| CALR \| DISEASES 23765 \| IL17RA \| DISEASES 8648 \| NCOA1 \| DISEASES 2149 \| F2R \| DISEASES 3615 \| IMPDH2 \| DISEASES 995 \| CDC25C \| DISEASES 2253 \| FGF8 \| DISEASES 2118 \| ETV4 \| DISEASES 5345 \| SERPINF2 \| DISEASES 6817 \| SULT1A1 \| DISEASES 93129 \| ORAI3 \| DISEASES 57191 \| VN1R1 \| DISEASES 23212 \| RRS1 \| DISEASES 3039 \| HBA1 \| DISEASES 6478 \| SIAH2 \| DISEASES 4312 \| MMP1 \| DISEASES 2274 \| FHL2 \| DISEASES 23635 \| SSBP2 \| DISEASES 55 \| ACPP \| DISEASES 923 \| CD6 \| DISEASES 6657 \| SOX2 \| DISEASES 55818 \| KDM3A \| DISEASES 51341 \| ZBTB7A \| DISEASES 9282 \| MED14 \| DISEASES 79054 \| TRPM8 \| DISEASES 2 \| A2M \| DISEASES 6605 \| SMARCE1 \| DISEASES 977 \| CD151 \| DISEASES 3309 \| HSPA5 \| DISEASES 8408 \| ULK1 \| DISEASES 1555 \| CYP2B6 \| DISEASES 9235 \| IL32 \| DISEASES 2932 \| GSK3B \| DISEASES 9604 \| RNF14 \| DISEASES 5520 \| PPP2R2A \| DISEASES 5241 \| PGR \| DISEASES 3032 \| HADHB \| DISEASES 3927 \| LASP1 \| DISEASES 55201 \| MAP1S \| DISEASES 7481 \| WNT11 \| DISEASES 10498 \| CARM1 \| DISEASES 7025 \| NR2F1 \| DISEASES 1585 \| CYP11B2 \| DISEASES 113746 \| ODF3 \| DISEASES 5499 \| PPP1CA \| DISEASES 5366 \| PMAIP1 \| DISEASES 9622 \| KLK4 \| DISEASES 3052 \| HCCS \| DISEASES 81857 \| MED25 \| DISEASES 8454 \| CUL1 \| DISEASES 7433 \| VIPR1 \| DISEASES 1435 \| CSF1 \| DISEASES 4991 \| OR1D2 \| DISEASES 5034 \| P4HB \| DISEASES 4772 \| NFATC1 \| DISEASES 5074 \| PAWR \| DISEASES 64806 \| IL25 \| DISEASES 9241 \| NOG \| DISEASES 84876 \| ORAI1 \| DISEASES 10362 \| HMG20B \| DISEASES 338707 \| B4GALNT4 \| DISEASES 1789 \| DNMT3B \| DISEASES 10614 \| HEXIM1 \| DISEASES 8905 \| AP1S2 \| DISEASES 131096 \| KCNH8 \| DISEASES 5831 \| PYCR1 \| DISEASES 7404 \| UTY \| DISEASES 9083 \| BPY2 \| DISEASES 3855 \| KRT7 \| DISEASES 6667 \| SP1 \| DISEASES 399694 \| SHC4 \| DISEASES 1915 \| EEF1A1 \| DISEASES 6753 \| SSTR3 \| DISEASES 842 \| CASP9 \| DISEASES 2831 \| NPBWR1 \| DISEASES 9021 \| SOCS3 \| DISEASES 6612 \| SUMO3 \| DISEASES 5155 \| PDGFB \| DISEASES 8519 \| IFITM1 \| DISEASES 146852 \| ODF4 \| DISEASES 4601 \| MXI1 \| DISEASES 54584 \| GNB1L \| DISEASES 7490 \| WT1 \| DISEASES 2192 \| FBLN1 \| DISEASES 6401 \| SELE \| DISEASES 796 \| CALCA \| DISEASES 2621 \| GAS6 \| DISEASES 942 \| CD86 \| DISEASES 124989 \| EFCAB13 \| DISEASES 222546 \| RFX6 \| DISEASES 220 \| ALDH1A3 \| DISEASES 5915 \| RARB \| DISEASES 5727 \| PTCH1 \| DISEASES 3838 \| KPNA2 \| DISEASES 168374 \| ZNF92 \| DISEASES 1485 \| CTAG1B \| DISEASES 5813 \| PURA \| DISEASES 2185 \| PTK2B \| DISEASES 4088 \| SMAD3 \| DISEASES 203074 \| PRSS55 \| DISEASES 5104 \| SERPINA5 \| DISEASES 7181 \| NR2C1 \| DISEASES 340075 \| ARSI \| DISEASES 5587 \| PRKD1 \| DISEASES 9112 \| MTA1 \| DISEASES 30 \| ACAA1 \| DISEASES 682 \| BSG \| DISEASES 60487 \| TRMT11 \| DISEASES 10013 \| HDAC6 \| DISEASES 2152 \| F3 \| DISEASES 54490 \| UGT2B28 \| DISEASES 10579 \| TACC2 \| DISEASES 10732 \| TCFL5 \| DISEASES 120227 \| CYP2R1 \| DISEASES 199720 \| GGN \| DISEASES 5133 \| PDCD1 \| DISEASES 3320 \| HSP90AA1 \| DISEASES 129080 \| EMID1 \| DISEASES 2938 \| GSTA1 \| DISEASES 8856 \| NR1I2 \| DISEASES 11335 \| CBX3 \| DISEASES 3984 \| LIMK1 \| DISEASES 283 \| ANG \| DISEASES 115286 \| SLC25A26 \| DISEASES 9547 \| CXCL14 \| DISEASES 4221 \| MEN1 \| DISEASES 9138 \| ARHGEF1 \| DISEASES 8409 \| UXT \| DISEASES 8372 \| HYAL3 \| DISEASES 60528 \| ELAC2 \| DISEASES 1551 \| CYP3A7 \| DISEASES 2042 \| EPHA3 \| DISEASES 7095 \| SEC62 \| DISEASES 25818 \| KLK5 \| DISEASES 4835 \| NQO2 \| DISEASES 7189 \| TRAF6 \| DISEASES 1576 \| CYP3A4 \| DISEASES 3091 \| HIF1A \| DISEASES 2289 \| FKBP5 \| DISEASES 92140 \| MTDH \| DISEASES 23462 \| HEY1 \| DISEASES 4862 \| NPAS2 \| DISEASES 5269 \| SERPINB6 \| DISEASES 2246 \| FGF1 \| DISEASES 23583 \| SMUG1 \| DISEASES 7430 \| EZR \| DISEASES 2885 \| GRB2 \| DISEASES 3266 \| ERAS \| DISEASES 857 \| CAV1 \| DISEASES 5329 \| PLAUR \| DISEASES 346689 \| KLRG2 \| DISEASES 8835 \| SOCS2 \| DISEASES 2309 \| FOXO3 \| DISEASES 2261 \| FGFR3 \| DISEASES 4602 \| MYB \| DISEASES 11315 \| PARK7 \| DISEASES 8788 \| DLK1 \| DISEASES 10524 \| KAT5 \| DISEASES 8805 \| TRIM24 \| DISEASES 4128 \| MAOA \| DISEASES 1978 \| EIF4EBP1 \| DISEASES 10755 \| GIPC1 \| DISEASES 7225 \| TRPC6 \| DISEASES 2810 \| SFN \| DISEASES 7366 \| UGT2B15 \| DISEASES 23136 \| EPB41L3 \| DISEASES 5764 \| PTN \| DISEASES 5747 \| PTK2 \| DISEASES 6776 \| STAT5A \| DISEASES 8717 \| TRADD \| DISEASES 123103 \| KLHL33 \| DISEASES 4089 \| SMAD4 \| DISEASES 84335 \| AKT1S1 \| DISEASES 1544 \| CYP1A2 \| DISEASES 7518 \| XRCC4 \| DISEASES 1508 \| CTSB \| DISEASES 2272 \| FHIT \| DISEASES 6692 \| SPINT1 \| DISEASES 6049 \| RNF6 \| DISEASES 51393 \| TRPV2 \| DISEASES 2066 \| ERBB4 \| DISEASES 2305 \| FOXM1 \| DISEASES 9536 \| PTGES \| DISEASES 1364 \| CLDN4 \| DISEASES 10193 \| RNF41 \| DISEASES 8287 \| USP9Y \| DISEASES 23650 \| TRIM29 \| DISEASES 3716 \| JAK1 \| DISEASES 8360 \| HIST1H4D \| DISEASES 9474 \| ATG5 \| DISEASES 5585 \| PKN1 \| DISEASES 7517 \| XRCC3 \| DISEASES 7874 \| USP7 \| DISEASES 1809 \| DPYSL3 \| DISEASES 23405 \| DICER1 \| DISEASES 10252 \| SPRY1 \| DISEASES 27068 \| PPA2 \| DISEASES 2100 \| ESR2 \| DISEASES 257101 \| ZNF683 \| DISEASES 3605 \| IL17A \| DISEASES 94241 \| TP53INP1 \| DISEASES 467 \| ATF3 \| DISEASES 1499 \| CTNNB1 \| DISEASES 7316 \| UBC \| DISEASES 9232 \| PTTG1 \| DISEASES 5606 \| MAP2K3 \| DISEASES 1102 \| RCBTB2 \| DISEASES 347 \| APOD \| DISEASES 57446 \| NDRG3 \| DISEASES 4734 \| NEDD4 \| DISEASES 1869 \| E2F1 \| DISEASES 2624 \| GATA2 \| DISEASES 56937 \| PMEPA1 \| DISEASES 6677 \| SPAM1 \| DISEASES 302 \| ANXA2 \| DISEASES 3921 \| RPSA \| DISEASES 2879 \| GPX4 \| DISEASES 258010 \| SVIP \| DISEASES 9863 \| MAGI2 \| DISEASES 54963 \| UCKL1 \| DISEASES 6275 \| S100A4 \| DISEASES 8294 \| HIST1H4I \| DISEASES 6050 \| RNH1 \| DISEASES 10533 \| ATG7 \| DISEASES 2534 \| FYN \| DISEASES 729873 \| TBC1D3 \| DISEASES 3181 \| HNRNPA2B1 \| DISEASES 27044 \| SND1 \| DISEASES 2335 \| FN1 \| DISEASES 51322 \| WAC \| DISEASES 8654 \| PDE5A \| DISEASES 8363 \| HIST1H4J \| DISEASES 8650 \| NUMB \| DISEASES 4110 \| MAGEA11 \| DISEASES 55750 \| AGK \| DISEASES 80781 \| COL18A1 \| DISEASES 341676 \| NEK5 \| DISEASES 331 \| XIAP \| DISEASES 1785 \| DNM2 \| DISEASES 355 \| FAS \| DISEASES 5265 \| SERPINA1 \| DISEASES 6720 \| SREBF1 \| DISEASES 6840 \| SVIL \| DISEASES 26996 \| GPR160 \| DISEASES 3240 \| HP \| DISEASES 9644 \| SH3PXD2A \| DISEASES 8368 \| HIST1H4L \| DISEASES 84458 \| LCOR \| DISEASES 51155 \| HN1 \| DISEASES 3914 \| LAMB3 \| DISEASES 26751 \| SH3YL1 \| DISEASES 23035 \| PHLPP2 \| DISEASES 5906 \| RAP1A \| DISEASES 7068 \| THRB \| DISEASES 26084 \| ARHGEF26 \| DISEASES 11065 \| UBE2C \| DISEASES 2224 \| FDPS \| DISEASES 8794 \| TNFRSF10C \| DISEASES 3981 \| LIG4 \| DISEASES 8751 \| ADAM15 \| DISEASES 801 \| CALM1 \| DISEASES 23513 \| SCRIB \| DISEASES 284119 \| PTRF \| DISEASES 11186 \| RASSF1 \| DISEASES 9185 \| REPS2 \| DISEASES 253260 \| RICTOR \| DISEASES 60 \| ACTB \| DISEASES 2181 \| ACSL3 \| DISEASES 728378 \| POTEF \| DISEASES 51367 \| POP5 \| DISEASES 5350 \| PLN \| DISEASES 8362 \| HIST1H4K \| DISEASES 6752 \| SSTR2 \| DISEASES 10505 \| SEMA4F \| DISEASES 23133 \| PHF8 \| DISEASES 2005 \| ELK4 \| DISEASES 121504 \| HIST4H4 \| DISEASES 1612 \| DAPK1 \| DISEASES 79366 \| HMGN5 \| DISEASES 2050 \| EPHB4 \| DISEASES 6714 \| SRC \| DISEASES 51170 \| HSD17B11 \| DISEASES 10298 \| PAK4 \| DISEASES 1969 \| EPHA2 \| DISEASES 841 \| CASP8 \| DISEASES 4477 \| MSMB \| DISEASES 405 \| ARNT \| DISEASES 11091 \| WDR5 \| DISEASES 286075 \| ZNF707 \| DISEASES 79694 \| MANEA \| DISEASES 1902 \| LPAR1 \| DISEASES 7048 \| TGFBR2 \| DISEASES 4217 \| MAP3K5 \| DISEASES 55028 \| C17orf80 \| DISEASES 5294 \| PIK3CG \| DISEASES 2547 \| XRCC6 \| DISEASES 116173 \| CMTM5 \| DISEASES 1735 \| DIO3 \| DISEASES 55503 \| TRPV6 \| DISEASES 753 \| LDLRAD4 \| DISEASES 1786 \| DNMT1 \| DISEASES 799 \| CALCR \| DISEASES 57016 \| AKR1B10 \| DISEASES 145864 \| HAPLN3 \| DISEASES 1999 \| ELF3 \| DISEASES 79683 \| ZDHHC14 \| DISEASES 4192 \| MDK \| DISEASES 1454 \| CSNK1E \| DISEASES 8359 \| HIST1H4A \| DISEASES 161198 \| CLEC14A \| DISEASES 132946 \| ARL9 \| DISEASES 7037 \| TFRC \| DISEASES 51290 \| ERGIC2 \| DISEASES 2114 \| ETS2 \| DISEASES 5599 \| MAPK8 \| DISEASES 8367 \| HIST1H4E \| DISEASES 4311 \| MME \| DISEASES 1066 \| CES1 \| DISEASES 1803 \| DPP4 \| DISEASES 1565 \| CYP2D6 \| DISEASES 415116 \| PIM3 \| DISEASES 54106 \| TLR9 \| DISEASES 578 \| BAK1 \| DISEASES 80274 \| SCUBE1 \| DISEASES 8662 \| EIF3B \| DISEASES 4916 \| NTRK3 \| DISEASES 6772 \| STAT1 \| DISEASES 6721 \| SREBF2 \| DISEASES 1745 \| DLX1 \| DISEASES 6935 \| ZEB1 \| DISEASES 4512 \| MT-CO1 \| DISEASES 1312 \| COMT \| DISEASES 7150 \| TOP1 \| DISEASES 2475 \| MTOR \| DISEASES 114814 \| GNRHR2 \| DISEASES 123920 \| CMTM3 \| DISEASES 2736 \| GLI2 \| DISEASES 7855 \| FZD5 \| DISEASES 5742 \| PTGS1 \| DISEASES 22834 \| ZNF652 \| DISEASES 54739 \| XAF1 \| DISEASES 1196 \| CLK2 \| DISEASES 9706 \| ULK2 \| DISEASES 2705 \| GJB1 \| DISEASES 24149 \| ZNF318 \| DISEASES 25853 \| DCAF12 \| DISEASES 90316 \| TGIF2LX \| DISEASES 90362 \| FAM110B \| DISEASES 4537 \| MT-ND3 \| DISEASES 8678 \| BECN1 \| DISEASES 23381 \| SMG5 \| DISEASES 83259 \| PCDH11Y \| DISEASES 28514 \| DLL1 \| DISEASES 7058 \| THBS2 \| DISEASES 142 \| PARP1 \| DISEASES 11221 \| DUSP10 \| DISEASES 2058 \| EPRS \| DISEASES 7042 \| TGFB2 \| DISEASES 1063 \| CENPF \| DISEASES 7779 \| SLC30A1 \| DISEASES 6648 \| SOD2 \| DISEASES 85414 \| SLC45A3 \| DISEASES 3814 \| KISS1 \| DISEASES 7432 \| VIP \| DISEASES 10765 \| KDM5B \| DISEASES 5788 \| PTPRC \| DISEASES 3075 \| CFH \| DISEASES 5743 \| PTGS2 \| DISEASES 6041 \| RNASEL \| DISEASES 9213 \| XPR1 \| DISEASES 5768 \| QSOX1 \| DISEASES 462 \| SERPINC1 \| DISEASES 356 \| FASLG \| DISEASES 55827 \| DCAF6 \| DISEASES 6446 \| SGK1 \| DISEASES 6675 \| UAP1 \| DISEASES 22926 \| ATF6 \| DISEASES 6391 \| SDHC \| DISEASES 4720 \| NDUFS2 \| DISEASES 383 \| ARG1 \| DISEASES 910 \| CD1B \| DISEASES 911 \| CD1C \| DISEASES 2117 \| ETV3 \| DISEASES 10763 \| NES \| DISEASES 632 \| BGLAP \| DISEASES 4582 \| MUC1 \| DISEASES 1942 \| EFNA1 \| DISEASES 154215 \| NKAIN2 \| DISEASES 103 \| ADAR \| DISEASES 3570 \| IL6R \| DISEASES 2444 \| FRK \| DISEASES 664 \| BNIP3 \| DISEASES 4288 \| MKI67 \| DISEASES 23557 \| SNAPIN \| DISEASES 6277 \| S100A6 \| DISEASES 8991 \| SELENBP1 \| DISEASES 262 \| AMD1 \| DISEASES 6944 \| VPS72 \| DISEASES 23097 \| CDK19 \| DISEASES 10500 \| SEMA6C \| DISEASES 54964 \| C1orf56 \| DISEASES 4170 \| MCL1 \| DISEASES 9900 \| SV2A \| DISEASES 554313 \| HIST2H4B \| DISEASES 8370 \| HIST2H4A \| DISEASES 2209 \| FCGR1A \| DISEASES 51463 \| GPR89B \| DISEASES 840 \| CASP7 \| DISEASES 6885 \| MAP3K7 \| DISEASES 653820 \| FAM72B \| DISEASES 3283 \| HSD3B1 \| DISEASES 3284 \| HSD3B2 \| DISEASES 1268 \| CNR1 \| DISEASES 4803 \| NGF \| DISEASES 7162 \| TPBG \| DISEASES 7272 \| TTK \| DISEASES 79574 \| EPS8L3 \| DISEASES 2316 \| FLNA \| DISEASES 1586 \| CYP17A1 \| DISEASES 4646 \| MYO6 \| DISEASES 10451 \| VAV3 \| DISEASES 55170 \| PRMT6 \| DISEASES 8945 \| BTRC \| DISEASES 84445 \| LZTS2 \| DISEASES 2564 \| GABRE \| DISEASES 55510 \| DDX43 \| DISEASES 1147 \| CHUK \| DISEASES 494118 \| SPANXN1 \| DISEASES 4923 \| NTSR1 \| DISEASES 139067 \| SPANXN3 \| DISEASES 64648 \| SPANXD \| DISEASES 30014 \| SPANXA1 \| DISEASES 5586 \| PKN2 \| DISEASES 347487 \| CXorf66 \| DISEASES 2258 \| FGF13 \| DISEASES 959 \| CD40LG \| DISEASES 5688 \| PSMA7 \| DISEASES 9077 \| DIRAS3 \| DISEASES 1647 \| GADD45A \| DISEASES 23223 \| RRP12 \| DISEASES 1791 \| DNTT \| DISEASES 127795 \| C1orf87 \| DISEASES 3725 \| JUN \| DISEASES 4070 \| TACSTD2 \| DISEASES 1718 \| DHCR24 \| DISEASES 1558 \| CYP2C8 \| DISEASES 388633 \| LDLRAD1 \| DISEASES 860 \| RUNX2 \| DISEASES 5865 \| RAB3B \| DISEASES 138307 \| LCN8 \| DISEASES 9334 \| B4GALT5 \| DISEASES 387700 \| SLC16A12 \| DISEASES 1757 \| SARDH \| DISEASES 186 \| AGTR2 \| DISEASES 57580 \| PREX1 \| DISEASES 5728 \| PTEN \| DISEASES 8202 \| NCOA3 \| DISEASES 10103 \| TSPAN1 \| DISEASES 7422 \| VEGFA \| DISEASES 4318 \| MMP9 \| DISEASES 9682 \| KDM4A \| DISEASES 4904 \| YBX1 \| DISEASES 79717 \| PPCS \| DISEASES 10864 \| SLC22A7 \| DISEASES 5328 \| PLAU \| DISEASES 6406 \| SEMG1 \| DISEASES 27232 \| GNMT \| DISEASES 310 \| ANXA7 \| DISEASES 896 \| CCND3 \| DISEASES 5225 \| PGC \| DISEASES 127687 \| C1orf122 \| DISEASES 2022 \| ENG \| DISEASES 5230 \| PGK1 \| DISEASES 2739 \| GLO1 \| DISEASES 139596 \| UPRT \| DISEASES 5292 \| PIM1 \| DISEASES 3065 \| HDAC1 \| DISEASES 5933 \| RBL1 \| DISEASES 5303 \| PIN4 \| DISEASES 220202 \| ATOH7 \| DISEASES 221476 \| PI16 \| DISEASES 2170 \| FABP3 \| DISEASES 79570 \| NKAIN1 \| DISEASES 2934 \| GSN \| DISEASES 6732 \| SRPK1 \| DISEASES 220965 \| FAM13C \| DISEASES 22943 \| DKK1 \| DISEASES 7099 \| TLR4 \| DISEASES 25803 \| SPDEF \| DISEASES 9968 \| MED12 \| DISEASES 7780 \| SLC30A2 \| DISEASES 240 \| ALOX5 \| DISEASES 7295 \| TXN \| DISEASES 3399 \| ID3 \| DISEASES 54566 \| EPB41L4B \| DISEASES 659 \| BMPR2 \| DISEASES 2048 \| EPHB2 \| DISEASES 9314 \| KLF4 \| DISEASES 367 \| AR \| DISEASES 316 \| AOX1 \| DISEASES 19 \| ABCA1 \| DISEASES 84557 \| MAP1LC3A \| DISEASES 1889 \| ECE1 \| DISEASES 7046 \| TGFBR1 \| DISEASES 4855 \| NOTCH4 \| DISEASES 55450 \| CAMK2N1 \| DISEASES 5320 \| PLA2G2A \| DISEASES 3014 \| H2AFX \| DISEASES 128864 \| C20orf144 \| DISEASES 3293 \| HSD17B3 \| DISEASES 8451 \| CUL4A \| DISEASES 2155 \| F7 \| DISEASES 3303 \| HSPA1A \| DISEASES 1164 \| CKS2 \| DISEASES 3055 \| HCK \| DISEASES 8660 \| IRS2 \| DISEASES 55190 \| NUDT11 \| DISEASES 114827 \| FHAD1 \| DISEASES 3397 \| ID1 \| DISEASES 50943 \| FOXP3 \| DISEASES 3190 \| HNRNPK \| DISEASES 57512 \| GPR158 \| DISEASES 256297 \| PTF1A \| DISEASES 11040 \| PIM2 \| DISEASES 8428 \| STK24 \| DISEASES 2017 \| CTTN \| DISEASES 780 \| DDR1 \| DISEASES 29968 \| PSAT1 \| DISEASES 4524 \| MTHFR \| DISEASES 648 \| BMI1 \| DISEASES 158471 \| PRUNE2 \| DISEASES 2650 \| GCNT1 \| DISEASES 55312 \| RFK \| DISEASES 5935 \| RBM3 \| DISEASES 3105 \| HLA-A \| DISEASES 29914 \| UBIAD1 \| DISEASES 284366 \| KLK9 \| DISEASES 10257 \| ABCC4 \| DISEASES 369 \| ARAF \| DISEASES 10253 \| SPRY2 \| DISEASES 1910 \| EDNRB \| DISEASES 22883 \| CLSTN1 \| DISEASES 8928 \| FOXH1 \| DISEASES 8366 \| HIST1H4B \| DISEASES 688 \| KLF5 \| DISEASES 8361 \| HIST1H4F \| DISEASES 8364 \| HIST1H4C \| DISEASES 27253 \| PCDH17 \| DISEASES 8434 \| RECK \| DISEASES 7403 \| KDM6A \| DISEASES 4609 \| MYC \| DISEASES 768 \| CA9 \| DISEASES 27237 \| ARHGEF16 \| DISEASES 3400 \| ID4 \| DISEASES 650 \| BMP2 \| DISEASES 1114 \| CHGB \| DISEASES 190 \| NR0B1 \| DISEASES 7163 \| TPD52 \| DISEASES 9308 \| CD83 \| DISEASES 6303 \| SAT1 \| DISEASES 2625 \| GATA3 \| DISEASES 28984 \| RGCC \| DISEASES 1906 \| EDN1 \| DISEASES 1874 \| E2F4 \| DISEASES 2308 \| FOXO1 \| DISEASES 6197 \| RPS6KA3 \| DISEASES 1543 \| CYP1A1 \| DISEASES 10631 \| POSTN \| DISEASES 81567 \| TXNDC5 \| DISEASES 7010 \| TEK \| DISEASES 79689 \| STEAP4 \| DISEASES 675 \| BRCA2 \| DISEASES 247 \| ALOX15B \| DISEASES 3456 \| IFNB1 \| DISEASES 2925 \| GRPR \| DISEASES 6194 \| RPS6 \| DISEASES 6462 \| SHBG \| DISEASES 833 \| CARS \| DISEASES 8644 \| AKR1C3 \| DISEASES 11168 \| PSIP1 \| DISEASES 1646 \| AKR1C2 \| DISEASES 4824 \| NKX3-1 \| DISEASES 1645 \| AKR1C1 \| DISEASES 2103 \| ESRRB \| DISEASES 1854 \| DUT \| DISEASES 1045 \| CDX2 \| DISEASES 3486 \| IGFBP3 \| DISEASES 23081 \| KDM4C \| DISEASES 283820 \| NOMO2 \| DISEASES 1876 \| E2F6 \| DISEASES 1024 \| CDK8 \| DISEASES 29126 \| CD274 \| DISEASES 6019 \| RLN2 \| DISEASES 3717 \| JAK2 \| DISEASES 427 \| ASAH1 \| DISEASES 10188 \| TNK2 \| DISEASES 10333 \| TLR6 \| DISEASES 5618 \| PRLR \| DISEASES 7158 \| TP53BP1 \| DISEASES 23600 \| AMACR \| DISEASES 442868 \| BPY2C \| DISEASES 2254 \| FGF9 \| DISEASES 442867 \| BPY2B \| DISEASES 11200 \| CHEK2 \| DISEASES 5888 \| RAD51 \| DISEASES 5268 \| SERPINB5 \| DISEASES 3083 \| HGFAC \| DISEASES 2235 \| FECH \| DISEASES 6736 \| SRY \| DISEASES 344787 \| ZNF860 \| DISEASES 152098 \| ZCWPW2 \| DISEASES 51280 \| GOLM1 \| DISEASES 2878 \| GPX3 \| DISEASES 3875 \| KRT18 \| DISEASES 79400 \| NOX5 \| DISEASES 64754 \| SMYD3 \| DISEASES 238 \| ALK \| DISEASES 51491 \| NOP16 \| DISEASES 2877 \| GPX2 \| DISEASES 727936 \| GXYLT2 \| DISEASES 344758 \| GPR149 \| DISEASES 8878 \| SQSTM1 \| DISEASES 5462 \| POU5F1B \| DISEASES 53635 \| PTOV1 \| DISEASES 147906 \| DACT3 \| DISEASES 11009 \| IL24 \| DISEASES 2068 \| ERCC2 \| DISEASES 208 \| AKT2 \| DISEASES 7520 \| XRCC5 \| DISEASES 7341 \| SUMO1 \| DISEASES 5901 \| RAN \| DISEASES 6397 \| SEC14L1 \| DISEASES 2113 \| ETS1 \| DISEASES 12 \| SERPINA3 \| DISEASES 55240 \| STEAP3 \| DISEASES 80310 \| PDGFD \| DISEASES 654364 \| NME1-NME2 \| DISEASES 4831 \| NME2 \| DISEASES 10018 \| BCL2L11 \| DISEASES 164 \| AP1G1 \| DISEASES 3161 \| HMMR \| DISEASES 65057 \| ACD \| DISEASES 3885 \| KRT34 \| DISEASES 7026 \| NR2F2 \| DISEASES 84299 \| MIEN1 \| DISEASES 5627 \| PROS1 \| DISEASES 4501 \| MT1X \| DISEASES 4828 \| NMB \| DISEASES 7041 \| TGFB1I1 \| DISEASES 145957 \| NRG4 \| DISEASES 5660 \| PSAP \| DISEASES 51474 \| LIMA1 \| DISEASES 6696 \| SPP1 \| DISEASES 1365 \| CLDN3 \| DISEASES 983 \| CDK1 \| DISEASES 27297 \| CRCP \| DISEASES 26471 \| NUPR1 \| DISEASES 147166 \| TRIM16L \| DISEASES 7227 \| TRPS1 \| DISEASES 685 \| BTC \| DISEASES 2919 \| CXCL1 \| DISEASES 174 \| AFP \| DISEASES 6387 \| CXCL12 \| DISEASES 655 \| BMP7 \| DISEASES 5744 \| PTHLH \| DISEASES 117 \| ADCYAP1R1 \| DISEASES 114884 \| OSBPL10 \| DISEASES 81285 \| OR51E2 \| DISEASES 143503 \| OR51E1 \| DISEASES 11069 \| RAPGEF4 \| DISEASES 100137047 \| JMJD7 \| DISEASES 344148 \| NCKAP5 \| DISEASES 5609 \| MAP2K7 \| DISEASES 594857 \| NPS \| DISEASES 389136 \| VGLL3 \| DISEASES 7110 \| TMF1 \| DISEASES 7113 \| TMPRSS2 \| DISEASES 2950 \| GSTP1 \| DISEASES 81858 \| SHARPIN \| DISEASES 2078 \| ERG \| DISEASES 1500 \| CTNND1 \| DISEASES 221037 \| JMJD1C \| DISEASES 408050 \| NOMO3 \| DISEASES 4214 \| MAP3K1 \| DISEASES 7442 \| TRPV1 \| DISEASES 6093 \| ROCK1 \| DISEASES 23028 \| KDM1A \| DISEASES 283514 \| SIAH3 \| DISEASES 10587 \| TXNRD2 \| DISEASES 24144 \| TFIP11 \| DISEASES 55209 \| SETD5 \| DISEASES 9612 \| NCOR2 \| DISEASES 8091 \| HMGA2 \| DISEASES 10525 \| HYOU1 \| DISEASES 25780 \| RASGRP3 \| DISEASES 23192 \| ATG4B \| DISEASES 5970 \| RELA \| DISEASES 256227 \| STEAP1B \| DISEASES 57481 \| KIAA1210 \| DISEASES 2492 \| FSHR \| DISEASES 7514 \| XPO1 \| DISEASES 9866 \| TRIM66 \| DISEASES 1994 \| ELAVL1 \| DISEASES 2115 \| ETV1 \| DISEASES 7018 \| TF \| DISEASES 221935 \| SDK1 \| DISEASES 2104 \| ESRRG \| DISEASES 6335 \| SCN9A \| DISEASES 11264 \| PXMP4 \| DISEASES 23132 \| RAD54L2 \| DISEASES 7852 \| CXCR4 \| DISEASES 3655 \| ITGA6 \| DISEASES 501 \| ALDH7A1 \| DISEASES 23066 \| CAND2 \| DISEASES 10720 \| UGT2B11 \| DISEASES 1385 \| CREB1 \| DISEASES 1111 \| CHEK1 \| DISEASES 201965 \| RWDD4 \| DISEASES 10321 \| CRISP3 \| DISEASES 5601 \| MAPK9 \| DISEASES 79156 \| PLEKHF1 \| DISEASES 6336 \| SCN10A \| DISEASES 10551 \| AGR2 \| DISEASES 9564 \| BCAR1 \| DISEASES 3481 \| IGF2 \| DISEASES 2260 \| FGFR1 \| DISEASES 8399 \| PLA2G10 \| DISEASES 29843 \| SENP1 \| DISEASES 5783 \| PTPN13 \| DISEASES 1029 \| CDKN2A \| DISEASES 8031 \| NCOA4 \| DISEASES 4204 \| MECP2 \| DISEASES 26354 \| GNL3 \| DISEASES 5076 \| PAX2 \| DISEASES 390245 \| KDM4E \| DISEASES 8848 \| TSC22D1 \| DISEASES 1875 \| E2F5 \| DISEASES 56616 \| DIABLO \| DISEASES 960 \| CD44 \| DISEASES 7124 \| TNF \| DISEASES 3491 \| CYR61 \| DISEASES 339123 \| JMJD8 \| DISEASES 6304 \| SATB1 \| DISEASES 10216 \| PRG4 \| DISEASES 10499 \| NCOA2 \| DISEASES 84752 \| B3GNT9 \| DISEASES 387 \| RHOA \| DISEASES 6464 \| SHC1 \| DISEASES 441581 \| FRG2B \| DISEASES 403273 \| OR5H14 \| DISEASES 5706 \| PSMC6 \| DISEASES 23112 \| TNRC6B \| DISEASES 7465 \| WEE1 \| DISEASES 27151 \| CPAMD8 \| DISEASES 53840 \| TRIM34 \| DISEASES 79993 \| ELOVL7 \| DISEASES 7258 \| TSPY1 \| DISEASES 254827 \| NAALADL2 \| DISEASES 441525 \| SPANXN4 \| DISEASES 79718 \| TBL1XR1 \| DISEASES 6613 \| SUMO2 \| DISEASES 91833 \| WDR20 \| DISEASES 100289087 \| TSPY10 \| DISEASES 23098 \| SARM1 \| DISEASES 57862 \| ZNF410 \| DISEASES 2876 \| GPX1 \| DISEASES 55289 \| ACOXL \| DISEASES 1012 \| CDH13 \| DISEASES 1154 \| CISH \| DISEASES 6293 \| VPS52 \| DISEASES 834 \| CASP1 \| DISEASES 2263 \| FGFR2 \| DISEASES 3925 \| STMN1 \| DISEASES 6424 \| SFRP4 \| DISEASES 100289678 \| ZNF783 \| DISEASES 7153 \| TOP2A \| DISEASES 3586 \| IL10 \| DISEASES 54475 \| NLE1 \| DISEASES 5682 \| PSMA1 \| DISEASES 8842 \| PROM1 \| DISEASES 5270 \| SERPINE2 \| DISEASES 6513 \| SLC2A1 \| DISEASES 4193 \| MDM2 \| DISEASES 9296 \| ATP6V1F \| DISEASES 286451 \| YIPF6 \| DISEASES 8125 \| ANP32A \| DISEASES 672 \| BRCA1 \| DISEASES 692094 \| MSMP \| DISEASES 2128 \| EVX1 \| DISEASES 5478 \| PPIA \| DISEASES 8754 \| ADAM9 \| DISEASES 23429 \| RYBP \| DISEASES 1020 \| CDK5 \| DISEASES 1316 \| KLF6 \| DISEASES 846 \| CASR \| DISEASES 573 \| BAG1 \| DISEASES 3295 \| HSD17B4 \| DISEASES 84948 \| TIGD5 \| DISEASES 2638 \| GC \| DISEASES 25816 \| TNFAIP8 \| DISEASES 131870 \| NUDT16 \| DISEASES 51428 \| DDX41 \| DISEASES 51079 \| NDUFA13 \| DISEASES 285782 \| CAGE1 \| DISEASES 1977 \| EIF4E \| DISEASES 6196 \| RPS6KA2 \| DISEASES 284 \| ANGPT1 \| DISEASES 399474 \| TMEM200B \| DISEASES 4067 \| LYN \| DISEASES 9788 \| MTSS1 \| DISEASES 10687 \| PNMA2 \| DISEASES 8667 \| EIF3H \| DISEASES 3066 \| HDAC2 \| DISEASES 3551 \| IKBKB \| DISEASES 7033 \| TFF3 \| DISEASES 2977 \| GUCY1A2 \| DISEASES 4914 \| NTRK1 \| DISEASES 7178 \| TPT1 \| DISEASES 161142 \| FAM71D \| DISEASES 59351 \| PBOV1 \| DISEASES 63970 \| TP53AIP1 \| DISEASES 23310 \| NCAPD3 \| DISEASES 8111 \| GPR68 \| DISEASES 7296 \| TXNRD1 \| DISEASES 6195 \| RPS6KA1 \| DISEASES 26298 \| EHF \| DISEASES 54682 \| MANSC1 \| DISEASES 7739 \| ZNF185 \| DISEASES 7694 \| ZNF135 \| DISEASES 3684 \| ITGAM \| DISEASES 3250 \| HPR \| DISEASES 4090 \| SMAD5 \| DISEASES 5027 \| P2RX7 \| DISEASES 9 \| NAT1 \| DISEASES 8284 \| KDM5D \| DISEASES 6510 \| SLC1A5 \| DISEASES 6934 \| TCF7L2 \| DISEASES 3939 \| LDHA \| DISEASES 440689 \| HIST2H2BF \| DISEASES 80790 \| CMIP \| DISEASES 5125 \| PCSK5 \| DISEASES 11153 \| FICD \| DISEASES 11176 \| BAZ2A \| DISEASES 7421 \| VDR \| DISEASES 8972 \| MGAM \| DISEASES 1649 \| DDIT3 \| DISEASES 317 \| APAF1 \| DISEASES 2972 \| BRF1 \| DISEASES 124944 \| C17orf49 \| DISEASES 8499 \| PPFIA2 \| DISEASES 3679 \| ITGA7 \| DISEASES 567 \| B2M \| DISEASES 7090 \| TLE3 \| DISEASES 51203 \| NUSAP1 \| DISEASES 100287482 \| SMKR1 \| DISEASES 51741 \| WWOX \| DISEASES 286527 \| TMSB15B \| DISEASES 3316 \| HSPB2 \| DISEASES 1506 \| CTRL \| DISEASES 147660 \| ZNF578 \| DISEASES 9212 \| AURKB \| DISEASES 984 \| CDK11B \| DISEASES 8792 \| TNFRSF11A \| DISEASES 9063 \| PIAS2 \| DISEASES 3292 \| HSD17B1 \| DISEASES 5608 \| MAP2K6 \| DISEASES 79990 \| PLEKHH3 \| DISEASES 2323 \| FLT3LG \| DISEASES 55554 \| KLK15 \| DISEASES 246734 \| NPCDR1 \| DISEASES 54938 \| SARS2 \| DISEASES 11012 \| KLK11 \| DISEASES 60674 \| GAS5 \| DISEASES 389741 \| GLIDR \| DISEASES 493812 \| HCG11 \| DISEASES 100124700 \| HOTAIR \| DISEASES 100506190 \| LINC00963 \| DISEASES 375295 \| LINC01116 \| DISEASES 388685 \| LINC01138 \| DISEASES 101927624 \| LINC01150 \| DISEASES 149134 \| LINC01341 \| DISEASES 101928176 \| LINC01411 \| DISEASES 378938 \| MALAT1 \| DISEASES 114614 \| MIR155HG \| DISEASES 407975 \| MIR17HG \| DISEASES 100506211 \| MIR210HG \| DISEASES 4550 \| MT-RNR2 \| DISEASES 348808 \| NPHP3-AS1 \| DISEASES 25859 \| PART1 \| DISEASES 50652 \| PCA3 \| DISEASES 100750225 \| PCAT1 \| DISEASES 101978785 \| PCAT14 \| DISEASES 728606 \| PCAT18 \| DISEASES 103164619 \| PCAT2 \| DISEASES 104472713 \| PCAT29 \| DISEASES 118425 \| PCAT4 \| DISEASES 100506696 \| PCAT6 \| DISEASES 64002 \| PCGEM1 \| DISEASES 101867536 \| PRNCR1 \| DISEASES 5820 \| PVT1 \| DISEASES 101669767 \| SCHLAP1 \| DISEASES 677834 \| SNORA55 \| DISEASES 692229 \| SNORD105 \| DISEASES 26807 \| SNORD43 \| DISEASES 26806 \| SNORD44 \| DISEASES 26801 \| SNORD48 \| DISEASES 26799 \| SNORD50A \| DISEASES 26789 \| SNORD59A \| DISEASES 619498 \| SNORD74 \| DISEASES 144481 \| SOCS2-AS1 \| DISEASES 101928607 \| TRPM2-AS \| DISEASES 64595 \| TTTY15 \| DISEASES
Locus	(Waiting for update.)

Disease ID	484
Disease	prostate cancer
Integrated Phenotype	HPO \| Name(Total Integrated Phenotypes:1) HP:0012125 \| Prostate cancer
Text Mined Phenotype	HPO \| Name \| Sentences' Count(Total Phenotypes:123) HP:0002664 \| Neoplasia \| 226 HP:0001513 \| Obesity \| 34 HP:0012531 \| Pain \| 26 HP:0000939 \| Osteoporosis \| 24 HP:0000718 \| Aggressive behaviour \| 24 HP:0012378 \| Fatigue \| 21 HP:0000819 \| Diabetes mellitus \| 14 HP:0008711 \| Benign prostatic hypertrophy \| 14 HP:0000716 \| Depression \| 11 HP:0002653 \| Bone pain \| 11 HP:0003002 \| Breast carcinoma \| 10 HP:0000802 \| Erectile dysfunction \| 10 HP:0000024 \| Inflammation of the prostate \| 9 HP:0000739 \| Anxiety \| 9 HP:0001919 \| Acute renal failure \| 8 HP:0001907 \| Thromboembolic disease \| 7 HP:0001297 \| Cerebral vascular events \| 6 HP:0001909 \| Leukemia \| 6 HP:0002861 \| Melanoma \| 5 HP:0030731 \| Carcinoma \| 4 HP:0001903 \| Anemia \| 4 HP:0100512 \| Vitamin D deficiency \| 4 HP:0002176 \| Spinal cord compression \| 4 HP:0000135 \| Hypogonadism \| 4 HP:0009725 \| Bladder neoplasm \| 3 HP:0006775 \| Multiple myeloma \| 3 HP:0000790 \| Hematuria \| 3 HP:0001289 \| Confusion \| 3 HP:0000083 \| Renal insufficiency \| 3 HP:0002573 \| Bloody diarrhea \| 3 HP:0003124 \| Elevated serum cholesterol \| 3 HP:0000855 \| Insulin resistance \| 3 HP:0000771 \| Gynaecomastia \| 3 HP:0002099 \| Asthma \| 2 HP:0002716 \| Lymph node hyperplasia \| 2 HP:0000822 \| Hypertension \| 2 HP:0000020 \| Bladder incontinence \| 2 HP:0000938 \| Decreased bone mineral density \| 2 HP:0000789 \| Infertility \| 2 HP:0003251 \| Male infertility \| 2 HP:0001369 \| Arthritis \| 2 HP:0003003 \| Colon cancer \| 2 HP:0001510 \| Growth deficiency \| 2 HP:0002090 \| Pneumonia \| 2 HP:0002665 \| Lymphoma \| 2 HP:0001677 \| Coronary artery disease \| 2 HP:0005550 \| Chronic lymphatic leukemia \| 1 HP:0002583 \| Colitis \| 1 HP:0001061 \| Acne \| 1 HP:0002667 \| Wilms tumor \| 1 HP:0100526 \| Neoplasm of the lung \| 1 HP:0030838 \| Hip pain \| 1 HP:0008940 \| Generalized lymphadenopathy \| 1 HP:0006515 \| Interstitial pneumonitis \| 1 HP:0000023 \| Inguinal hernia \| 1 HP:0025020 \| Elevated prostate-specific antigen level \| 1 HP:0001943 \| Hypoglycemia \| 1 HP:0000815 \| Primary hypogonadism \| 1 HP:0002754 \| Bone infection \| 1 HP:0002098 \| Respiratory distress \| 1 HP:0002315 \| Headaches \| 1 HP:0001342 \| Intracerebral hemorrhage \| 1 HP:0002607 \| Anal incontinence \| 1 HP:0100033 \| Tic disorder \| 1 HP:0000870 \| Hyperprolactinemia \| 1 HP:0001658 \| Myocardial infarction \| 1 HP:0003128 \| Lactic acidosis \| 1 HP:0010885 \| Aseptic necrosis \| 1 HP:0000956 \| Keratosis nigricans \| 1 HP:0003287 \| Abnormality of mitochondrial metabolism \| 1 HP:0100242 \| Sarcoma \| 1 HP:0200026 \| Ocular pain \| 1 HP:0012281 \| Chylous ascites \| 1 HP:0006000 \| Ureteral obstruction \| 1 HP:0002297 \| Red hair \| 1 HP:0100543 \| Cognitive deficits \| 1 HP:0000836 \| Overactive thyroid \| 1 HP:0001537 \| Umbilical hernias \| 1 HP:0002894 \| Neoplasia of the pancreas \| 1 HP:0011001 \| Increased bone mineral density \| 1 HP:0002202 \| Pleural effusion \| 1 HP:0010280 \| Stomatitis \| 1 HP:0000016 \| Urinary retention \| 1 HP:0004953 \| Abdominal aortic aneurysm \| 1 HP:0000112 \| Nephropathy \| 1 HP:0000010 \| Frequent urinary tract infections \| 1 HP:0002721 \| Immunodeficiency \| 1 HP:0000873 \| Diabetes insipidus \| 1 HP:0040075 \| Hypopituitarism \| 1 HP:0002756 \| Pathologic fracture \| 1 HP:0001004 \| Lymphatic obstruction \| 1 HP:0002360 \| Sleep disturbance \| 1 HP:0012227 \| Urethral stricture \| 1 HP:0200043 \| Verrucae \| 1 HP:0002204 \| Pulmonary embolism \| 1 HP:0001635 \| Congestive heart failure \| 1 HP:0010783 \| Erythema \| 1 HP:0005575 \| Hemolytic-uremic syndrome \| 1 HP:0000863 \| Neurohypophyseal diabetes insipidus \| 1 HP:0000656 \| Ectropion \| 1 HP:0001941 \| acidemia \| 1 HP:0001370 \| Rheumatoid arthritis \| 1 HP:0010628 \| Facial palsy, unilateral or bilateral \| 1 HP:0001873 \| Low platelet count \| 1 HP:0100753 \| Schizophrenia \| 1 HP:0001880 \| Eosinophilia \| 1 HP:0002647 \| Aortic dissection \| 1 HP:0100785 \| Insomnia \| 1 HP:0004900 \| Severe lactic acidosis \| 1 HP:0002725 \| Systemic lupus erythematosus \| 1 HP:0002749 \| Osteomalacia \| 1 HP:0012743 \| Central obesity \| 1 HP:0000512 \| ERG abnormal \| 1 HP:0011034 \| Amyloid disease \| 1 HP:0000842 \| Elevated insulin level \| 1 HP:0012587 \| Gross hematuria \| 1 HP:0009919 \| Retinoblastoma \| 1 HP:0001596 \| Hair loss \| 1 HP:0002901 \| Hypocalcemia \| 1 HP:0005521 \| Disseminated intravascular coagulation \| 1 HP:0002014 \| Diarrhea \| 1 HP:0001541 \| Ascites \| 1 HP:0001578 \| Hypercortisolism \| 1

Disease ID	484
Disease	prostate cancer
Manually Symptom	(Waiting for update.)
Text Mined Symptom	UMLS \| Name \| Sentences' Count(Total Symptoms:69) C0153690 \| bone metastases \| 123 C0153690 \| bone metastasis \| 82 C0028754 \| obesity \| 34 C0030193 \| pain \| 26 C0029456 \| osteoporosis \| 24 C0015672 \| fatigue \| 21 C0686619 \| lymph node metastases \| 19 C0009450 \| infection \| 19 C0231303 \| distress \| 14 C0011849 \| diabetes mellitus \| 14 C0574785 \| lower urinary tract symptoms \| 12 C0151825 \| bone pain \| 11 C0948265 \| metabolic syndrome \| 11 C0011570 \| depression \| 11 C0003467 \| anxiety \| 9 C0033581 \| prostatitis \| 9 C1168327 \| high-grade prostatic intraepithelial neoplasia \| 9 C0007222 \| cardiovascular disease \| 9 C0242350 \| erectile dysfunction \| 9 C0005940 \| bone disease \| 8 C0029896 \| ent disease \| 7 C0033953 \| sexual dysfunction \| 5 C0600142 \| hot flashes \| 4 C0042870 \| vitamin d deficiency \| 4 C0021167 \| incontinence \| 4 C0033246 \| proctitis \| 4 C0037926 \| spinal cord compression \| 4 C0005684 \| bladder cancer \| 3 C0086132 \| depressive symptoms \| 3 C0002871 \| anaemia \| 3 C0153690 \| bony metastasis \| 3 C0153676 \| lung metastasis \| 2 C0024232 \| lymphatic metastasis \| 2 C0025517 \| metabolic disorder \| 2 C0018418 \| gynecomastia \| 2 C0238033 \| male breast cancer \| 2 C0002793 \| dedifferentiation \| 2 C0024902 \| breast pain \| 2 C0024228 \| lymphadenopathy \| 2 C0030472 \| paraneoplastic syndrome \| 2 C1608408 \| malignant transformation \| 2 C0220650 \| brain metastases \| 2 C0019080 \| hemorrhage \| 2 C0600142 \| hot flushes \| 2 C0153690 \| bony metastases \| 2 C0042024 \| urinary incontinence \| 2 C0005694 \| bladder outlet obstruction \| 2 C0153676 \| pulmonary metastasis \| 1 C0153687 \| cutaneous metastasis \| 1 C0178879 \| urinary obstruction \| 1 C0012739 \| disseminated intravascular coagulation \| 1 C0153690 \| osseous metastasis \| 1 C1332128 \| peritoneal carcinomatosis \| 1 C0041956 \| ureteral obstruction \| 1 C0034065 \| pulmonary embolism \| 1 C0020635 \| hypopituitarism \| 1 C0085692 \| hemorrhagic cystitis \| 1 C0038436 \| post-traumatic stress disorder \| 1 C0029443 \| osteomyelitis \| 1 C1510885 \| angiogenic switch \| 1 C0004093 \| weakness \| 1 C0220656 \| malignant ascites \| 1 C0002871 \| anemia \| 1 C0021079 \| immunosuppression \| 1 C0262471 \| ent problem \| 1 C1274103 \| oncogenic osteomalacia \| 1 C0030472 \| paraneoplastic syndromes \| 1 C0018418 \| gynaecomastia \| 1 C0877420 \| metastatic bone pain \| 1

Manually Genotype(Total Text Mining Genotypes:0)
(Waiting for update.)

All Snps(Total Genotypes:747)
snpId	pubmedId	geneId	geneSymbol	diseaseId	sourceId	sentence	score	Year	geneSymbol_dbSNP	CHROMOSOME	POS	REF	ALT
rs10046	19952760	2099	ESR1	umls:C0376358	BeFree	The combination of the TTTA long repeats and the minor alleles of rs10046 in CYP19A1 and rs2077647 in ESR-alpha was a high risk for prostate cancer despite greater than or equal to 60 mg isoflavones/day.	0.060793181	2010	CYP19A1;PIRC66	15	51210789	G	A
rs10046	19952760	1588	CYP19A1	umls:C0376358	BeFree	The combination of the TTTA long repeats and the minor alleles of rs10046 in CYP19A1 and rs2077647 in ESR-alpha was a high risk for prostate cancer despite greater than or equal to 60 mg isoflavones/day.	0.050869384	2010	CYP19A1;PIRC66	15	51210789	G	A
rs10090154	22549899	354	KLK3	umls:C0376358	BeFree	Four GWAS replication SNPs (rs2660753, rs13254738, rs10090154, rs2735839) and seven flanking SNPs were associated with CaP aggressiveness (P < 0.05) in three genomic regions: One at 3p12 (EA), seven at 8q24 (5 AA, 2 EA), and three at 19q13 at the kallilkrein-related peptidase 3 (KLK3) locus (two AA, one AA and EA).	0.261542831	2013	NA	8	127519892	T	C
rs1012477	19934327	4862	NPAS2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005276948	2009	PER3	1	7798075	G	C
rs1012477	19934327	406	ARNTL	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	PER3	1	7798075	G	C
rs1012477	19934327	8863	PER3	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005005506	2009	PER3	1	7798075	G	C
rs1012477	19934327	5187	PER1	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.00554839	2009	PER3	1	7798075	G	C
rs1012477	19934327	1408	CRY2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005276948	2009	PER3	1	7798075	G	C
rs1012477	19934327	8864	PER2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	PER3	1	7798075	G	C
rs1012477	19934327	1407	CRY1	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	PER3	1	7798075	G	C
rs1012477	19934327	9575	CLOCK	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002909916	2009	PER3	1	7798075	G	C
rs1016343	21743057	101867536	PRNCR1	umls:C0376358	GWASCAT	Genome-wide association study identifies new prostate cancer susceptibility loci.	0.121357209	2011	PRNCR1;PCAT2	8	127081052	C	T
rs1016343	18264097	101867536	PRNCR1	umls:C0376358	GWASCAT	Multiple newly identified loci associated with prostate cancer susceptibility.	0.121357209	2008	PRNCR1;PCAT2	8	127081052	C	T
rs1042522	25213701	7157	TP53	umls:C0376358	BeFree	Detection of human papillomavirus (HPV) DNA prevalence and p53 codon 72 (Arg72Pro) polymorphism in prostate cancer in a Greek group of patients.	0.22992416	2014	TP53	17	7676154	G	T,C
rs1042522	17785557	7157	TP53	umls:C0376358	BeFree	Although we did not find a significant relationship between the frequency of the Arg/Pro + Pro/Pro genotype of p53 Arg72Pro and susceptibility in PC, there was a combined effect of CXCL12 GA + AA genotype and the p53 72Arg/Pro + Pro/Pro genotype on the frequency of PC.	0.22992416	2007	TP53	17	7676154	G	T,C
rs10426628	24682418	1545	CYP1B1	umls:C0376358	BeFree	According to a multivariate analysis, CYP1B1 (rs1800440), COMT (rs16982844), and SULT2B1 (rs12460535, rs2665582, rs10426628) were significantly associated with prostate cancer progression and hormone levels.	0.041205759	2015	SULT2B1	19	48589173	A	G
rs10426628	24682418	1312	COMT	umls:C0376358	BeFree	According to a multivariate analysis, CYP1B1 (rs1800440), COMT (rs16982844), and SULT2B1 (rs12460535, rs2665582, rs10426628) were significantly associated with prostate cancer progression and hormone levels.	0.021107791	2015	SULT2B1	19	48589173	A	G
rs10432782	20477822	6648	SOD2	umls:C0376358	BeFree	Two variants in SOD2 were significantly associated with the risk of aggressive prostate cancer (rs17884057, odds ratio 0.83, 95% confidence interval 0.70-0.99; and rs4816407, 1.27, 1.02-1.57); men with A alleles at rs2842958 in SOD2 had lower plasma selenium levels (median 116 vs 121.8 µg/L, P= 0.03); and the association between plasma selenium levels and risk of aggressive prostate cancer was modified by SOD1 (rs10432782) and SOD2 (rs2758330).	0.044854055	2011	SOD1	21	31664078	T	G
rs10432782	20477822	6647	SOD1	umls:C0376358	BeFree	Two variants in SOD2 were significantly associated with the risk of aggressive prostate cancer (rs17884057, odds ratio 0.83, 95% confidence interval 0.70-0.99; and rs4816407, 1.27, 1.02-1.57); men with A alleles at rs2842958 in SOD2 had lower plasma selenium levels (median 116 vs 121.8 µg/L, P= 0.03); and the association between plasma selenium levels and risk of aggressive prostate cancer was modified by SOD1 (rs10432782) and SOD2 (rs2758330).	0.010553895	2011	SOD1	21	31664078	T	G
rs1045485	25292051	841	CASP8	umls:C0376358	BeFree	Impact of caspase-8 (CASP8) -652 6N del and D302H polymorphisms on prostate cancer in different ethnic groups.	0.004538567	2015	CASP8	2	201284866	G	C
rs10486567	20460480	3817	KLK2	umls:C0376358	BeFree	The rs61752561 in KLK3 and rs2735839 in the KLK2-KLK3 intergenic region were strongly associated with prostate cancer-specific survival, and rs10486567 in the 7JAZF1 gene were associated with biochemical recurrence.	0.030456367	2010	JAZF1	7	27936944	G	A
rs10486567	20460480	354	KLK3	umls:C0376358	BeFree	The rs61752561 in KLK3 and rs2735839 in the KLK2-KLK3 intergenic region were strongly associated with prostate cancer-specific survival, and rs10486567 in the 7JAZF1 gene were associated with biochemical recurrence.	0.261542831	2010	JAZF1	7	27936944	G	A
rs1048943	16614120	2052	EPHX1	umls:C0376358	BeFree	To investigate this, we studied the association between prostate cancer and smoking, as well as the main and modifying effects of functional polymorphisms in genes that metabolize polycyclic aromatic hydrocarbons (CYP1A1 Ile(462)Val, microsomal epoxide hydrolase His(139)Arg) and detoxify reactive derivatives (GSTM1 null deletion, GSTT1 null deletion, GSTP1 Ile(105)Val and Ala(114)Val) using a family-based case-control design (439 prostate cancer cases and 479 brother controls).	0.008186863	2006	CYP1A1	15	74720644	T	G,C,A
rs1048943	16614120	2952	GSTT1	umls:C0376358	BeFree	To investigate this, we studied the association between prostate cancer and smoking, as well as the main and modifying effects of functional polymorphisms in genes that metabolize polycyclic aromatic hydrocarbons (CYP1A1 Ile(462)Val, microsomal epoxide hydrolase His(139)Arg) and detoxify reactive derivatives (GSTM1 null deletion, GSTT1 null deletion, GSTP1 Ile(105)Val and Ala(114)Val) using a family-based case-control design (439 prostate cancer cases and 479 brother controls).	0.08132575	2006	CYP1A1	15	74720644	T	G,C,A
rs1048943	23381648	1543	CYP1A1	umls:C0376358	BeFree	Quantitative synthesis of the association between the cytochrome P450 1A1 Ile462Val polymorphism and prostate cancer risk.	0.07488709	2013	CYP1A1	15	74720644	T	G,C,A
rs1048943	16614120	1543	CYP1A1	umls:C0376358	BeFree	To investigate this, we studied the association between prostate cancer and smoking, as well as the main and modifying effects of functional polymorphisms in genes that metabolize polycyclic aromatic hydrocarbons (CYP1A1 Ile(462)Val, microsomal epoxide hydrolase His(139)Arg) and detoxify reactive derivatives (GSTM1 null deletion, GSTT1 null deletion, GSTP1 Ile(105)Val and Ala(114)Val) using a family-based case-control design (439 prostate cancer cases and 479 brother controls).	0.07488709	2006	CYP1A1	15	74720644	T	G,C,A
rs1048943	16614120	2950	GSTP1	umls:C0376358	BeFree	To investigate this, we studied the association between prostate cancer and smoking, as well as the main and modifying effects of functional polymorphisms in genes that metabolize polycyclic aromatic hydrocarbons (CYP1A1 Ile(462)Val, microsomal epoxide hydrolase His(139)Arg) and detoxify reactive derivatives (GSTM1 null deletion, GSTT1 null deletion, GSTP1 Ile(105)Val and Ala(114)Val) using a family-based case-control design (439 prostate cancer cases and 479 brother controls).	0.087329809	2006	CYP1A1	15	74720644	T	G,C,A
rs10498792	17903305	5314	PKHD1	umls:C0376358	GAD	[A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.]	0.002367032	2007	PKHD1	6	51801833	T	C
rs1050450	24610081	6648	SOD2	umls:C0376358	BeFree	In the present study we investigated the association of a number of polymorphic changes in antioxidant system genes (SNPs rs1050450 in the GPX1 gene, rs1695 and rs1138272 in the GSTP1 gene and rs4880 in the MnSOD gene) with the risk of prostate cancer.	0.044854055	2014	GPX1	3	49357401	G	A
rs1050450	23975365	2876	GPX1	umls:C0376358	BeFree	The rs1050450 C > T polymorphism of GPX1 is associated with the risk of bladder but not prostate cancer: evidence from a meta-analysis.	0.012996872	2013	GPX1	3	49357401	G	A
rs1050450	24610081	2876	GPX1	umls:C0376358	BeFree	In the present study we investigated the association of a number of polymorphic changes in antioxidant system genes (SNPs rs1050450 in the GPX1 gene, rs1695 and rs1138272 in the GSTP1 gene and rs4880 in the MnSOD gene) with the risk of prostate cancer.	0.012996872	2014	GPX1	3	49357401	G	A
rs1050450	24610081	2950	GSTP1	umls:C0376358	BeFree	In the present study we investigated the association of a number of polymorphic changes in antioxidant system genes (SNPs rs1050450 in the GPX1 gene, rs1695 and rs1138272 in the GSTP1 gene and rs4880 in the MnSOD gene) with the risk of prostate cancer.	0.087329809	2014	GPX1	3	49357401	G	A
rs1050450	23363810	2876	GPX1	umls:C0376358	BeFree	However, the GPx1 rs1050450 allele T in association with prostate cancer recorded a significantly higher GPx activity compared to the controls.	0.012996872	2012	GPX1	3	49357401	G	A
rs1052133	21914193	4968	OGG1	umls:C0376358	BeFree	The hOGG1 Ser326Cys polymorphism and prostate cancer risk: a meta-analysis of 2584 cases and 3234 controls.	0.020097968	2011	OGG1;CAMK1	3	9757089	C	G
rs1052133	19914098	7515	XRCC1	umls:C0376358	BeFree	We examined the association between PC risk with nonsynonymous SNPs (nsSNPs) in 5 genes involved in 3 DNA-repair pathways: (1) base excision repair (BER): hOGG1 C1245G (Ser326Cys) and XRCC1 G28152A (Arg399Gln); (2) nucleotide excision repair (NER): XPD G23591A (Asp312Asn); (3) homologous recombination repair: RAD51 G135C (in 5' untranslated region) and XRCC3 C18067T (Thr241Met).	0.04702559	2011	OGG1;CAMK1	3	9757089	C	G
rs1052133	19914098	2068	ERCC2	umls:C0376358	BeFree	We examined the association between PC risk with nonsynonymous SNPs (nsSNPs) in 5 genes involved in 3 DNA-repair pathways: (1) base excision repair (BER): hOGG1 C1245G (Ser326Cys) and XRCC1 G28152A (Arg399Gln); (2) nucleotide excision repair (NER): XPD G23591A (Asp312Asn); (3) homologous recombination repair: RAD51 G135C (in 5' untranslated region) and XRCC3 C18067T (Thr241Met).	0.01482102	2011	OGG1;CAMK1	3	9757089	C	G
rs1052133	19914098	7517	XRCC3	umls:C0376358	BeFree	We examined the association between PC risk with nonsynonymous SNPs (nsSNPs) in 5 genes involved in 3 DNA-repair pathways: (1) base excision repair (BER): hOGG1 C1245G (Ser326Cys) and XRCC1 G28152A (Arg399Gln); (2) nucleotide excision repair (NER): XPD G23591A (Asp312Asn); (3) homologous recombination repair: RAD51 G135C (in 5' untranslated region) and XRCC3 C18067T (Thr241Met).	0.008458305	2011	OGG1;CAMK1	3	9757089	C	G
rs1052133	14634453	4968	OGG1	umls:C0376358	BeFree	These results suggest that hOGG1 may have a role in the repair of 8-OH-dG adducts in prostate tissue and hOGG1 Ser326Cys polymorphism is associated with prostate cancer risk.	0.020097968	2003	OGG1;CAMK1	3	9757089	C	G
rs1052133	19914098	5888	RAD51	umls:C0376358	BeFree	We examined the association between PC risk with nonsynonymous SNPs (nsSNPs) in 5 genes involved in 3 DNA-repair pathways: (1) base excision repair (BER): hOGG1 C1245G (Ser326Cys) and XRCC1 G28152A (Arg399Gln); (2) nucleotide excision repair (NER): XPD G23591A (Asp312Asn); (3) homologous recombination repair: RAD51 G135C (in 5' untranslated region) and XRCC3 C18067T (Thr241Met).	0.003995683	2011	OGG1;CAMK1	3	9757089	C	G
rs1056836	22327650	1545	CYP1B1	umls:C0376358	BeFree	Association of the CYP1B1 Leu432Val polymorphism with the risk of prostate cancer: a meta-analysis.	0.041205759	2012	CYP1B1	2	38071060	G	C
rs1056836	22504876	1545	CYP1B1	umls:C0376358	BeFree	Prostate cancer risk and aggressiveness associated with the CYP1B1 4326C/G (Leu432Val) polymorphism: a meta-analysis of 2788 cases and 2968 controls.	0.041205759	2012	CYP1B1	2	38071060	G	C
rs10761581	20717903	4477	MSMB	umls:C0376358	BeFree	Of note, rs7000448 is in strong linkage disequilibrium with rs10761581 in NCOA4, a SNP that has been implicated to be independently associated, with respect to the widely reported SNP rs10993994 in the nearby gene MSMB, with prostate cancer in men of European descent.	0.255559841	2011	NCOA4	10	46027444	A	C
rs10761581	20717903	8031	NCOA4	umls:C0376358	BeFree	Of note, rs7000448 is in strong linkage disequilibrium with rs10761581 in NCOA4, a SNP that has been implicated to be independently associated, with respect to the widely reported SNP rs10993994 in the nearby gene MSMB, with prostate cancer in men of European descent.	0.005352893	2011	NCOA4	10	46027444	A	C
rs10788160	23246478	354	KLK3	umls:C0376358	BeFree	The genotypes of 4 single nucleotide polymorphisms previously associated with serum prostate specific antigen levels (rs2736098, rs10788160, rs11067228 and rs17632542) were determined in 964 healthy Caucasian volunteers without prostate cancer.	0.261542831	2013	NA	10	121274035	G	A
rs10795917	22219177	26019	UPF2	umls:C0376358	GWASCAT	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	0.12	2012	UPF2	10	12009817	G	A
rs10895304	20605361	4316	MMP7	umls:C0376358	BeFree	The matrix metalloproteinase-7 polymorphism rs10895304 is associated with increased recurrence risk in patients with clinically localized prostate cancer.	0.124538567	2011	NA	11	102519261	A	G
rs10899221	23830236	56946	C11orf30	umls:C0376358	BeFree	Correlated intronic SNPs rs10899221 and rs72944758 formed with other EMSY variants common and rare haplotypes that were associated with increased risk (P=4.0 × 10(-4)) and decreased risk (P=0.01) of PrCa, respectively.	0.000542884	2013	C11orf30	11	76470587	G	A
rs10934853	19767754	60678	EEFSEC	umls:C0376358	GWASCAT	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	0.124734064	2009	EEFSEC	3	128319530	C	A
rs10987883	21308720	80142	PTGES2	umls:C0376358	BeFree	Among non-obese individuals, the GG genotype of PTGES2 rs10987883 was associated with an increased risk for prostate cancer (unadjusted, recessive model OR = 3.23, 95% CI: 1.27-8.23).	0.000271442	2011	SLC25A25-AS1	9	128118550	G	A
rs10993994	20676098	4477	MSMB	umls:C0376358	GWASCAT	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	0.255559841	2010	MSMB	10	46046326	A	G
rs10993994	23608167	4477	MSMB	umls:C0376358	BeFree	Association of prostate cancer susceptibility variant (MSMB) rs10993994 with risk of spermatogenic failure.	0.255559841	2013	MSMB	10	46046326	A	G
rs10993994	24740154	4477	MSMB	umls:C0376358	GWASCAT	Genome-wide association scan for variants associated with early-onset prostate cancer.	0.255559841	2014	MSMB	10	46046326	A	G
rs10993994	20967219	4477	MSMB	umls:C0376358	GAD	[The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine.]	0.255559841	2010	MSMB	10	46046326	A	G
rs10993994	24753544	4477	MSMB	umls:C0376358	GWASCAT	Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.	0.255559841	2015	MSMB	10	46046326	A	G
rs10993994	18264096	4477	MSMB	umls:C0376358	GWASCAT	Loci on chromosome 10 include MSMB, which encodes beta-microseminoprotein, a primary constituent of semen and a proposed prostate cancer biomarker, and CTBP2, a gene with antiapoptotic activity; the locus on chromosome 7 is at JAZF1, a transcriptional repressor that is fused by chromosome translocation to SUZ12 in endometrial cancer.	0.255559841	2008	MSMB	10	46046326	A	G
rs10993994	23608167	100653377	SPGF2	umls:C0376358	BeFree	Association of prostate cancer susceptibility variant (MSMB) rs10993994 with risk of spermatogenic failure.	0.000542884	2013	MSMB	10	46046326	A	G
rs10993994	20967219	4477	MSMB	umls:C0376358	BeFree	The rs10993994 risk allele for prostate cancer results in clinically relevant changes in microseminoprotein-beta expression in tissue and urine.	0.255559841	2010	MSMB	10	46046326	A	G
rs10993994	20717903	8031	NCOA4	umls:C0376358	BeFree	Of note, rs7000448 is in strong linkage disequilibrium with rs10761581 in NCOA4, a SNP that has been implicated to be independently associated, with respect to the widely reported SNP rs10993994 in the nearby gene MSMB, with prostate cancer in men of European descent.	0.005352893	2011	MSMB	10	46046326	A	G
rs10993994	18264097	4477	MSMB	umls:C0376358	GWASCAT	Multiple newly identified loci associated with prostate cancer susceptibility.	0.255559841	2008	MSMB	10	46046326	A	G
rs10993994	20717903	4477	MSMB	umls:C0376358	BeFree	Of note, rs7000448 is in strong linkage disequilibrium with rs10761581 in NCOA4, a SNP that has been implicated to be independently associated, with respect to the widely reported SNP rs10993994 in the nearby gene MSMB, with prostate cancer in men of European descent.	0.255559841	2011	MSMB	10	46046326	A	G
rs11067228	23246478	354	KLK3	umls:C0376358	BeFree	The genotypes of 4 single nucleotide polymorphisms previously associated with serum prostate specific antigen levels (rs2736098, rs10788160, rs11067228 and rs17632542) were determined in 964 healthy Caucasian volunteers without prostate cancer.	0.261542831	2013	NA	12	114656455	A	G
rs11079344	21716162	10587	TXNRD2	umls:C0376358	BeFree	Among men carrying the variant allele for thioredoxin reductase 2 (TXNRD2) rs4485648, microsomal epoxide hydrolase 1 (EPHX1) rs17309872, or myeloperoxidase (MPO) rs11079344, an increased prostate cancer risk was observed with high, compared with no, petroleum oil/petroleum distillate (OR=1.9, 95% CI: 1.1-3.2, P interaction=0.01; OR=2.1, 95% CI: 1.1-4.0, P interaction=0.01), or terbufos (OR=3.0, 95% CI: 1.5-6.0, P interaction=2.0×10(-3)) use, respectively.	0.000814326	2011	NA	17	58297122	A	G
rs11079344	21716162	4353	MPO	umls:C0376358	BeFree	Among men carrying the variant allele for thioredoxin reductase 2 (TXNRD2) rs4485648, microsomal epoxide hydrolase 1 (EPHX1) rs17309872, or myeloperoxidase (MPO) rs11079344, an increased prostate cancer risk was observed with high, compared with no, petroleum oil/petroleum distillate (OR=1.9, 95% CI: 1.1-3.2, P interaction=0.01; OR=2.1, 95% CI: 1.1-4.0, P interaction=0.01), or terbufos (OR=3.0, 95% CI: 1.5-6.0, P interaction=2.0×10(-3)) use, respectively.	0.003995683	2011	NA	17	58297122	A	G
rs11079344	21716162	2052	EPHX1	umls:C0376358	BeFree	Among men carrying the variant allele for thioredoxin reductase 2 (TXNRD2) rs4485648, microsomal epoxide hydrolase 1 (EPHX1) rs17309872, or myeloperoxidase (MPO) rs11079344, an increased prostate cancer risk was observed with high, compared with no, petroleum oil/petroleum distillate (OR=1.9, 95% CI: 1.1-3.2, P interaction=0.01; OR=2.1, 95% CI: 1.1-4.0, P interaction=0.01), or terbufos (OR=3.0, 95% CI: 1.5-6.0, P interaction=2.0×10(-3)) use, respectively.	0.008186863	2011	NA	17	58297122	A	G
rs11102001	19223546	79574	EPS8L3	umls:C0376358	BeFree	The SNP rs11102001, which encodes a nonsynonymous amino acid change P356S in EPS8L3, is a potential candidate modifier of the effect of HCAs on prostate cancer risk.	0.000271442	2009	EPS8L3	1	109757069	G	A
rs11133373	19934327	5187	PER1	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.00554839	2009	SRD5A3	4	55349464	C	G,T
rs11133373	19934327	9575	CLOCK	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002909916	2009	SRD5A3	4	55349464	C	G,T
rs11133373	19934327	1407	CRY1	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	SRD5A3	4	55349464	C	G,T
rs11133373	19934327	406	ARNTL	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	SRD5A3	4	55349464	C	G,T
rs11133373	19934327	4862	NPAS2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005276948	2009	SRD5A3	4	55349464	C	G,T
rs11133373	19934327	8863	PER3	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005005506	2009	SRD5A3	4	55349464	C	G,T
rs11133373	19934327	1408	CRY2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005276948	2009	SRD5A3	4	55349464	C	G,T
rs11133373	19934327	8864	PER2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	SRD5A3	4	55349464	C	G,T
rs11135910	23535732	64641	EBF2	umls:C0376358	GWASCAT	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	0.12	2013	EBF2	8	26034626	C	T
rs111584802	NA	51426	POLK	umls:C0376358	CLINVAR	NA	0.12	NA	POLK	5	75587055	A	G
rs11214775	25217961	9177	HTR3B	umls:C0376358	GWASCAT	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	0.12	2014	HTR3B	11	113936459	G	A
rs1130409	25234162	328	APEX1	umls:C0376358	BeFree	The association between the APE1 Asp148Glu polymorphism and prostate cancer susceptibility: a meta-analysis based on case-control studies.	0.006634157	2014	APEX1;OSGEP	14	20456995	T	A,G
rs1136410	15342424	142	PARP1	umls:C0376358	BeFree	This study is the first to provide evidence that the ADPRT V762A-genetic variant contributes to CaP susceptibility and altered ADPRT/PARP-1 enzyme function in response to oxidative damage.	0.009695963	2004	PARP1	1	226367601	A	G
rs1136410	15868402	142	PARP1	umls:C0376358	BeFree	Genetic analyses of the PARP-1 gene have demonstrated alterations in neoplasms, and a mutation affecting the conserved amino acid E251 in germ cell tumors, as well as an association of a single-nucleotide polymorphism V762A with risk of prostate cancer.	0.009695963	2005	PARP1	1	226367601	A	G
rs1138272	16614120	2052	EPHX1	umls:C0376358	BeFree	To investigate this, we studied the association between prostate cancer and smoking, as well as the main and modifying effects of functional polymorphisms in genes that metabolize polycyclic aromatic hydrocarbons (CYP1A1 Ile(462)Val, microsomal epoxide hydrolase His(139)Arg) and detoxify reactive derivatives (GSTM1 null deletion, GSTT1 null deletion, GSTP1 Ile(105)Val and Ala(114)Val) using a family-based case-control design (439 prostate cancer cases and 479 brother controls).	0.008186863	2006	GSTP1	11	67586108	C	T
rs1138272	16614120	1543	CYP1A1	umls:C0376358	BeFree	To investigate this, we studied the association between prostate cancer and smoking, as well as the main and modifying effects of functional polymorphisms in genes that metabolize polycyclic aromatic hydrocarbons (CYP1A1 Ile(462)Val, microsomal epoxide hydrolase His(139)Arg) and detoxify reactive derivatives (GSTM1 null deletion, GSTT1 null deletion, GSTP1 Ile(105)Val and Ala(114)Val) using a family-based case-control design (439 prostate cancer cases and 479 brother controls).	0.07488709	2006	GSTP1	11	67586108	C	T
rs1138272	16614120	2952	GSTT1	umls:C0376358	BeFree	To investigate this, we studied the association between prostate cancer and smoking, as well as the main and modifying effects of functional polymorphisms in genes that metabolize polycyclic aromatic hydrocarbons (CYP1A1 Ile(462)Val, microsomal epoxide hydrolase His(139)Arg) and detoxify reactive derivatives (GSTM1 null deletion, GSTT1 null deletion, GSTP1 Ile(105)Val and Ala(114)Val) using a family-based case-control design (439 prostate cancer cases and 479 brother controls).	0.08132575	2006	GSTP1	11	67586108	C	T
rs1138272	24610081	2876	GPX1	umls:C0376358	BeFree	In the present study we investigated the association of a number of polymorphic changes in antioxidant system genes (SNPs rs1050450 in the GPX1 gene, rs1695 and rs1138272 in the GSTP1 gene and rs4880 in the MnSOD gene) with the risk of prostate cancer.	0.012996872	2014	GSTP1	11	67586108	C	T
rs1138272	24610081	6648	SOD2	umls:C0376358	BeFree	In the present study we investigated the association of a number of polymorphic changes in antioxidant system genes (SNPs rs1050450 in the GPX1 gene, rs1695 and rs1138272 in the GSTP1 gene and rs4880 in the MnSOD gene) with the risk of prostate cancer.	0.044854055	2014	GSTP1	11	67586108	C	T
rs1138272	16614120	2950	GSTP1	umls:C0376358	BeFree	To investigate this, we studied the association between prostate cancer and smoking, as well as the main and modifying effects of functional polymorphisms in genes that metabolize polycyclic aromatic hydrocarbons (CYP1A1 Ile(462)Val, microsomal epoxide hydrolase His(139)Arg) and detoxify reactive derivatives (GSTM1 null deletion, GSTT1 null deletion, GSTP1 Ile(105)Val and Ala(114)Val) using a family-based case-control design (439 prostate cancer cases and 479 brother controls).	0.087329809	2006	GSTP1	11	67586108	C	T
rs1138272	24610081	2950	GSTP1	umls:C0376358	BeFree	In the present study we investigated the association of a number of polymorphic changes in antioxidant system genes (SNPs rs1050450 in the GPX1 gene, rs1695 and rs1138272 in the GSTP1 gene and rs4880 in the MnSOD gene) with the risk of prostate cancer.	0.087329809	2014	GSTP1	11	67586108	C	T
rs1143634	19474090	3553	IL1B	umls:C0376358	GAD	[Using Multivariate Adaptive Regression Splines modeling for exploratory SNP-SNP interactions, our results showed that more aggressive PCa in Caucasians Americans is associated with the CT genotype at IL8-47 odds ratios (OR) = 3.50; 95% CI = 1.13-10.88 or combined genotypes of IL1B-511CC and IL10-1082GG (OR = 3.38; 95% CI = 1.70-6.71).]	0.017730936	2009	IL1B	2	112832813	G	A
rs11540654	25213701	7157	TP53	umls:C0376358	BeFree	Detection of human papillomavirus (HPV) DNA prevalence and p53 codon 72 (Arg72Pro) polymorphism in prostate cancer in a Greek group of patients.	0.22992416	2014	TP53	17	7676040	C	T,G,A
rs11540654	17785557	7157	TP53	umls:C0376358	BeFree	Although we did not find a significant relationship between the frequency of the Arg/Pro + Pro/Pro genotype of p53 Arg72Pro and susceptibility in PC, there was a combined effect of CXCL12 GA + AA genotype and the p53 72Arg/Pro + Pro/Pro genotype on the frequency of PC.	0.22992416	2007	TP53	17	7676040	C	T,G,A
rs115457135	25217961	11074	TRIM31	umls:C0376358	GWASCAT	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	0.12	2014	NA	NA	NA	NA	NA
rs11549465	16998808	3091	HIF1A	umls:C0376358	BeFree	The homozygous P582S mutation in the oxygen-dependent degradation domain of HIF-1 alpha is associated with increased risk for prostate cancer.	0.02711185	2007	HIF1A;LOC105370526	14	61740839	C	T
rs11549465	23723982	3091	HIF1A	umls:C0376358	BeFree	The current findings suggest that HIF1A P582S polymorphism correlates with urinary cancers risk in Caucasian population, while A588T polymorphism may increase the risk of urinary cancers in Asian population and prostate cancer.	0.02711185	2013	HIF1A;LOC105370526	14	61740839	C	T
rs11549465	18949419	3091	HIF1A	umls:C0376358	BeFree	In previous studies, the C1772T (P582S) or the G1790A (A588T) polymorphisms of the HIF-1alpha gene have been identified in renal cell carcinoma, head and neck and esophageal squamous cell carcinomas as well as colorectal and prostate cancers.	0.02711185	2008	HIF1A;LOC105370526	14	61740839	C	T
rs11549467	18949419	3091	HIF1A	umls:C0376358	BeFree	In previous studies, the C1772T (P582S) or the G1790A (A588T) polymorphisms of the HIF-1alpha gene have been identified in renal cell carcinoma, head and neck and esophageal squamous cell carcinomas as well as colorectal and prostate cancers.	0.02711185	2008	HIF1A;LOC105370526	14	61740857	G	A
rs11549467	23723982	3091	HIF1A	umls:C0376358	BeFree	The current findings suggest that HIF1A P582S polymorphism correlates with urinary cancers risk in Caucasian population, while A588T polymorphism may increase the risk of urinary cancers in Asian population and prostate cancer.	0.02711185	2013	HIF1A;LOC105370526	14	61740857	G	A
rs11568818	23535732	4316	MMP7	umls:C0376358	GWASCAT	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	0.124538567	2013	MMP7	11	102530930	T	C
rs11639960	18398039	4313	MMP2	umls:C0376358	BeFree	In the MMP2 gene, three intronic SNPs, all in linkage disequilibrium, were associated with overall and advanced prostate cancer (for overall prostate cancer, P(trend) = 0.01 for rs1477017, P(trend) = 0.01 for rs17301608, P(trend) = 0.02 for rs11639960).	0.017144445	2008	MMP2	16	55499358	A	G
rs11672691	23065704	100505495	PCAT19	umls:C0376358	GWASCAT	A meta-analysis of genome-wide association studies to identify prostate cancer susceptibility loci associated with aggressive and non-aggressive disease.	0.12	2013	PCAT19	19	41479679	G	A
rs118004742	25335771	9759	HDAC4	umls:C0376358	BeFree	The HDAC4 (2q37.2) variant rs73000144 (OR = 14.6, p = 0.018) and the EFCAB13 (17q21.3) variant rs118004742 (OR = 1.8, p = 0.048) were overrepresented in patients with familial PrCa.	0.000542884	2014	EFCAB13	17	47391492	T	G
rs118004742	25335771	124989	EFCAB13	umls:C0376358	BeFree	The HDAC4 (2q37.2) variant rs73000144 (OR = 14.6, p = 0.018) and the EFCAB13 (17q21.3) variant rs118004742 (OR = 1.8, p = 0.048) were overrepresented in patients with familial PrCa.	0.000271442	2014	EFCAB13	17	47391492	T	G
rs11902171	23065910	3685	ITGAV	umls:C0376358	BeFree	The ITGAv gene SNP rs11902171 may be potentially associated with the risk of prostate cancer.	0.000814326	2012	ITGAV	2	186678500	G	C
rs11902236	23535732	29841	GRHL1	umls:C0376358	GWASCAT	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	0.12	2013	GRHL1	2	9977740	C	T
rs11913319	25284284	10587	TXNRD2	umls:C0376358	BeFree	Less common alleles of rs11913319 in TXNRD2 and rs125701 in OGG1 were associated with an increased risk of high-grade prostate cancer.	0.000814326	2014	TXNRD2	22	19880016	C	G
rs11913319	25284284	4968	OGG1	umls:C0376358	BeFree	Less common alleles of rs11913319 in TXNRD2 and rs125701 in OGG1 were associated with an increased risk of high-grade prostate cancer.	0.020097968	2014	TXNRD2	22	19880016	C	G
rs119484087	16114055	6041	RNASEL	umls:C0376358	BeFree	We examined polymorphisms within ELAC2 (S217L, A541T, E622V), MSR1 (P275A, R293X, aIVS5-59c), and RNASEL (E265X, R462Q, D541E) in 150 European-Americans with metastatic prostate cancer and 170 prostate cancer-free controls using pyrosequencing assays.	0.061998501	2006	ELAC2	17	12995006	T	C,A
rs11986220	19680443	3169	FOXA1	umls:C0376358	BeFree	Two enhancers in one risk region were occupied by AR and responded to androgen treatment; one contained a single nucleotide polymorphism (rs11986220) that resides within a FoxA1 binding site, with the prostate cancer risk allele facilitating both stronger FoxA1 binding and stronger androgen responsiveness.	0.005700279	2009	NA	8	127519444	A	T
rs11986220	19680443	367	AR	umls:C0376358	BeFree	Two enhancers in one risk region were occupied by AR and responded to androgen treatment; one contained a single nucleotide polymorphism (rs11986220) that resides within a FoxA1 binding site, with the prostate cancer risk allele facilitating both stronger FoxA1 binding and stronger androgen responsiveness.	0.28	2009	NA	8	127519444	A	T
rs12051443	25217961	23035	PHLPP2	umls:C0376358	GWASCAT	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	0.12	2014	PHLPP2	16	71657426	G	A
rs121434592	20407443	207	AKT1	umls:C0376358	BeFree	E17K substitution in AKT1 in prostate cancer.	0.017839219	2010	AKT1	14	104780214	C	T
rs1218582	23535732	3782	KCNN3	umls:C0376358	GWASCAT	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	0.12	2013	KCNN3	1	154861707	G	A
rs121908701	12533788	11200	CHEK2	umls:C0376358	UNIPROT	Mutations in CHEK2 associated with prostate cancer risk.	0.138349765	2003	CHEK2	22	28725027	C	T
rs121913343	NA	7157	TP53	umls:C0376358	CLINVAR	NA	0.22992416	NA	TP53	17	7673803	G	T,A
rs12315175	19934327	5187	PER1	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.00554839	2009	NA	12	107105494	T	C
rs12315175	19934327	8864	PER2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	NA	12	107105494	T	C
rs12315175	19934327	406	ARNTL	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	NA	12	107105494	T	C
rs12315175	19934327	4862	NPAS2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005276948	2009	NA	12	107105494	T	C
rs12315175	19934327	1408	CRY2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005276948	2009	NA	12	107105494	T	C
rs12315175	19934327	1407	CRY1	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	NA	12	107105494	T	C
rs12315175	19934327	8863	PER3	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005005506	2009	NA	12	107105494	T	C
rs12315175	19934327	9575	CLOCK	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002909916	2009	NA	12	107105494	T	C
rs12329760	25040002	7113	TMPRSS2	umls:C0376358	BeFree	TMPRSS2 Met160Val polymorphism: significant association with sporadic prostate cancer, but not with latent prostate cancer in Japanese men.	0.052779275	2014	TMPRSS2	21	41480570	C	T
rs12329760	20735386	7113	TMPRSS2	umls:C0376358	BeFree	Racial differences in prediction of time to prostate cancer diagnosis in a prospective screening cohort of high-risk men: effect of TMPRSS2 Met160Val.	0.052779275	2011	TMPRSS2	21	41480570	C	T
rs12338	19930869	1508	CTSB	umls:C0376358	BeFree	Polymorphism L26V in the cathepsin B gene may be associated with a risk of prostate cancer and differentiation.	0.004267125	2009	CTSB	8	11853379	G	T,C,A
rs1243647	22219177	390443	RNASE9	umls:C0376358	GWASCAT	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	0.12	2012	RNASE9	14	20556460	A	G
rs12460535	24682418	1312	COMT	umls:C0376358	BeFree	According to a multivariate analysis, CYP1B1 (rs1800440), COMT (rs16982844), and SULT2B1 (rs12460535, rs2665582, rs10426628) were significantly associated with prostate cancer progression and hormone levels.	0.021107791	2015	SULT2B1	19	48595493	A	G,T
rs12460535	24682418	1545	CYP1B1	umls:C0376358	BeFree	According to a multivariate analysis, CYP1B1 (rs1800440), COMT (rs16982844), and SULT2B1 (rs12460535, rs2665582, rs10426628) were significantly associated with prostate cancer progression and hormone levels.	0.041205759	2015	SULT2B1	19	48595493	A	G,T
rs12480328	25217961	23394	ADNP	umls:C0376358	GWASCAT	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	0.12	2014	ADNP	20	50911385	T	C
rs12500426	19767753	10611	PDLIM5	umls:C0376358	GAD	[Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.]	0.12764398	2009	PDLIM5	4	94593458	A	C
rs12500426	19767753	10611	PDLIM5	umls:C0376358	GWASCAT	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	0.12764398	2009	PDLIM5	4	94593458	A	C
rs12529	23359804	8644	AKR1C3	umls:C0376358	BeFree	We found that after adjusting for known risk factors in multivariate Cox regression models, AKR1C3 rs12529 and AR-CAG repeat length remained significantly associated with prostate cancer-specific mortality (PCSM) after ADT (P ≤ 0.041).	0.009815515	2013	AKR1C3	10	5094459	C	G
rs1256049	24859835	2099	ESR1	umls:C0376358	BeFree	The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk.	0.060793181	2014	ESR2	14	64257333	C	T
rs1256049	24859835	2100	ESR2	umls:C0376358	BeFree	The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk.	0.043724681	2014	ESR2	14	64257333	C	T
rs125701	25284284	10587	TXNRD2	umls:C0376358	BeFree	Less common alleles of rs11913319 in TXNRD2 and rs125701 in OGG1 were associated with an increased risk of high-grade prostate cancer.	0.000814326	2014	OGG1	3	9748794	G	A
rs125701	25284284	4968	OGG1	umls:C0376358	BeFree	Less common alleles of rs11913319 in TXNRD2 and rs125701 in OGG1 were associated with an increased risk of high-grade prostate cancer.	0.020097968	2014	OGG1	3	9748794	G	A
rs125701	21982398	6648	SOD2	umls:C0376358	BeFree	A high tertile selenium level in combination with non-wt rs125701 of the OGG1 gene in combination with smoking status or rs4880 related variation of MnSOD gene appeared to protect from PrCa.	0.044854055	2011	OGG1	3	9748794	G	A
rs125701	21982398	4968	OGG1	umls:C0376358	BeFree	A high tertile selenium level in combination with non-wt rs125701 of the OGG1 gene in combination with smoking status or rs4880 related variation of MnSOD gene appeared to protect from PrCa.	0.020097968	2011	OGG1	3	9748794	G	A
rs12621278	19767753	3655	ITGA6	umls:C0376358	GAD	[Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.]	0.127372538	2009	ITGA6	2	172446825	A	G
rs12621278	19767753	3655	ITGA6	umls:C0376358	GWASCAT	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	0.127372538	2009	ITGA6	2	172446825	A	G
rs12653946	20676098	101929081	CTD-2194D22.4	umls:C0376358	GWASCAT	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	0.12	2010	CTD-2194D22.4	5	1895715	C	T
rs12653946	22923026	101929081	CTD-2194D22.4	umls:C0376358	GWASCAT	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	0.12	2012	CTD-2194D22.4	5	1895715	C	T
rs12653946	22662242	60526	C2orf43	umls:C0376358	BeFree	We successfully replicated the association of rs13385191 (located in the C2orf43 gene, P = 8.60×10(-5)), rs12653946 (P = 1.33×10(-6)), rs1983891 (FOXP4, P = 6.22×10(-5)), and rs339331 (GPRC6A/RFX6, P = 1.42×10(-5)) with prostate cancer.	0.000542884	2012	CTD-2194D22.4	5	1895715	C	T
rs12917	16030105	4255	MGMT	umls:C0376358	BeFree	We found that the XRCC1-Arg399Gln AA and the MGMT-Leu84Phe CT+TT genotypes were associated with an increased risk of prostate cancer [odds ratio (OR), 2.18; 95% confidence interval (CI), 0.99-4.81 and OR, 1.99; 95% CI, 1.19-3.34, respectively].	0.009001189	2005	MGMT	10	129708019	C	T
rs12917	16030105	7515	XRCC1	umls:C0376358	BeFree	We found that the XRCC1-Arg399Gln AA and the MGMT-Leu84Phe CT+TT genotypes were associated with an increased risk of prostate cancer [odds ratio (OR), 2.18; 95% confidence interval (CI), 0.99-4.81 and OR, 1.99; 95% CI, 1.19-3.34, respectively].	0.04702559	2005	MGMT	10	129708019	C	T
rs130067	21743467	54535	CCHCR1	umls:C0376358	GWASCAT	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	0.12	2011	CCHCR1	6	31150734	T	G
rs13119723	20184734	3558	IL2	umls:C0376358	BeFree	We genotyped six variants previously associated with autoimmune disease (namely rs13151961, rs13119723, rs17388568, rs3136534, rs6822844 and rs6840978) and one functional IL-2 promoter variant (rs2069762) for possible association with prostate cancer risk using the Australian Risk Factors for Prostate Cancer case-control Study.	0.006634157	2010	KIAA1109	4	122297158	A	G
rs13151961	20184734	3558	IL2	umls:C0376358	BeFree	We genotyped six variants previously associated with autoimmune disease (namely rs13151961, rs13119723, rs17388568, rs3136534, rs6822844 and rs6840978) and one functional IL-2 promoter variant (rs2069762) for possible association with prostate cancer risk using the Australian Risk Factors for Prostate Cancer case-control Study.	0.006634157	2010	KIAA1109	4	122194347	A	G
rs13181	24289586	2068	ERCC2	umls:C0376358	BeFree	Subjects with XPD rs13181 G allele had a marginally increased risk of prostate cancer, with adjusted OR(95%CI) of 1.53 (1.04-2.37).	0.01482102	2015	ERCC2;KLC3	19	45351661	T	A,G
rs13181	23771356	2068	ERCC2	umls:C0376358	BeFree	The Xeroderma pigmentosum group D (XPD, also referred to as excision repair cross complementing gene 2, ERCC2) is one of key genes involved in nucleotide excision repair and two potentially functional polymorphisms of XPD (Asp312Asn and Lys751Gln) have been widely investigated in various cancers including prostate cancer.	0.01482102	2014	ERCC2;KLC3	19	45351661	T	A,G
rs13254738	22549899	354	KLK3	umls:C0376358	BeFree	Four GWAS replication SNPs (rs2660753, rs13254738, rs10090154, rs2735839) and seven flanking SNPs were associated with CaP aggressiveness (P < 0.05) in three genomic regions: One at 3p12 (EA), seven at 8q24 (5 AA, 2 EA), and three at 19q13 at the kallilkrein-related peptidase 3 (KLK3) locus (two AA, one AA and EA).	0.261542831	2013	PRNCR1	8	127092098	C	A
rs13254738	22923026	101867536	PRNCR1	umls:C0376358	GWASCAT	Evaluating genetic risk for prostate cancer among Japanese and Latinos.	0.121357209	2012	PRNCR1	8	127092098	C	A
rs13385191	22662242	60526	C2orf43	umls:C0376358	BeFree	We successfully replicated the association of rs13385191 (located in the C2orf43 gene, P = 8.60×10(-5)), rs12653946 (P = 1.33×10(-6)), rs1983891 (FOXP4, P = 6.22×10(-5)), and rs339331 (GPRC6A/RFX6, P = 1.42×10(-5)) with prostate cancer.	0.000542884	2012	C2orf43	2	20688505	A	G
rs1369481	19934327	8863	PER3	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005005506	2009	NPAS2	2	100895497	T	C
rs1369481	19934327	9575	CLOCK	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002909916	2009	NPAS2	2	100895497	T	C
rs1369481	19934327	4862	NPAS2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005276948	2009	NPAS2	2	100895497	T	C
rs1369481	19934327	5187	PER1	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.00554839	2009	NPAS2	2	100895497	T	C
rs1369481	19934327	1407	CRY1	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	NPAS2	2	100895497	T	C
rs1369481	19934327	406	ARNTL	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	NPAS2	2	100895497	T	C
rs1369481	19934327	8864	PER2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	NPAS2	2	100895497	T	C
rs1369481	19934327	1408	CRY2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005276948	2009	NPAS2	2	100895497	T	C
rs137852571	NA	367	AR	umls:C0376358	CLINVAR	NA	0.28	NA	AR	X	67717495	G	A
rs137852578	17325038	367	AR	umls:C0376358	BeFree	The PP2A-AR interaction was used to show that an AR mutant in prostate cancer cells (T877A) is activated by multiple ligands without acquiring the same conformation as that induced by androgen.	0.28	2007	AR	X	67723710	A	G
rs137852578	11906285	367	AR	umls:C0376358	BeFree	This mutant AR contains two mutations (L701H and T877A) and was previously reported as a high-affinity cortisol/cortisone responsive AR (AR(ccr)) isolated from the androgen-independent human prostate cancer cell lines MDA PCa 2a and 2b (Zhao et al.	0.28	2002	AR	X	67723710	A	G
rs137852578	17325038	5524	PPP2R4	umls:C0376358	BeFree	The PP2A-AR interaction was used to show that an AR mutant in prostate cancer cells (T877A) is activated by multiple ligands without acquiring the same conformation as that induced by androgen.	0.002442977	2007	AR	X	67723710	A	G
rs137852578	23813737	367	AR	umls:C0376358	BeFree	A total of four human prostate cancer cell models were examined: LNCaP (T877A mutant AR), 22Rv1 (H874Y mutant AR), LAPC4 (wild-type AR), and VCaP (wild-type AR).	0.28	2013	AR	X	67723710	A	G
rs137852578	16636679	367	AR	umls:C0376358	BeFree	Androgen receptor mutation (T877A) promotes prostate cancer cell growth and cell survival.	0.28	2006	AR	X	67723710	A	G
rs137852578	25409505	367	AR	umls:C0376358	BeFree	Proteomic-coupled-network analysis of T877A-androgen receptor interactomes can predict clinical prostate cancer outcomes between White (non-Hispanic) and African-American groups.	0.28	2014	AR	X	67723710	A	G
rs137852578	13679438	367	AR	umls:C0376358	BeFree	This was, however, not a result of the T877A mutation present in AR of LNCaP cells, because that AR mutant was repressed by Pim-1 as efficiently as wild-type AR when expressed in PC-3 prostate cancer cells.	0.28	2003	AR	X	67723710	A	G
rs137852578	25358634	367	AR	umls:C0376358	BeFree	18F-RB390: innovative ligand for imaging the T877A androgen receptor mutant in prostate cancer via positron emission tomography (PET).	0.28	2014	AR	X	67723710	A	G
rs137852578	24874833	367	AR	umls:C0376358	BeFree	It may be particularly effective against prostate cancer cells with the T878A AR mutation but may also enhance degradation of wild-type AR in vivo through a combination of direct and indirect mechanisms.	0.28	2015	AR	X	67723710	A	G
rs137852578	NA	367	AR	umls:C0376358	CLINVAR	NA	0.28	NA	AR	X	67723710	A	G
rs137852580	NA	367	AR	umls:C0376358	CLINVAR	NA	0.28	NA	AR	X	67723711	C	G
rs137852581	NA	367	AR	umls:C0376358	CLINVAR	NA	0.28	NA	AR	X	67723701	C	T
rs137852581	9092797	367	AR	umls:C0376358	BeFree	SfaNI digestion of AR exon H DNA from normal but not from prostate cancer tissue indicated H874Y is a somatic mutation that occurred before the initial tumor transplant.	0.28	1997	AR	X	67723701	C	T
rs137852581	23813737	367	AR	umls:C0376358	BeFree	A total of four human prostate cancer cell models were examined: LNCaP (T877A mutant AR), 22Rv1 (H874Y mutant AR), LAPC4 (wild-type AR), and VCaP (wild-type AR).	0.28	2013	AR	X	67723701	C	T
rs137852582	NA	367	AR	umls:C0376358	CLINVAR	NA	0.28	NA	AR	X	67723786	A	G
rs137852583	NA	367	AR	umls:C0376358	CLINVAR	NA	0.28	NA	AR	X	67711680	G	A
rs137852584	NA	367	AR	umls:C0376358	CLINVAR	NA	0.28	NA	AR	X	67711459	G	A
rs137852593	12602915	367	AR	umls:C0376358	BeFree	To estimate the possible involvement of the prostate cancer predisposing AR Arg726Leu germ-line mutation in MBC, this mutation was tested in 117 MBC patients.	0.28	2003	AR	X	67717484	G	A,C,T
rs137852593	11103816	367	AR	umls:C0376358	BeFree	The present study indicates that the R726L substitution in the AR may confer an up to 6-fold increased risk of prostate cancer and may contribute to cancer development in up to 2% of Finnish prostate cancer patients.	0.28	2000	AR	X	67717484	G	A,C,T
rs137852593	12539229	367	AR	umls:C0376358	BeFree	R726L androgen receptor mutation is uncommon in prostate cancer families in the united states.	0.28	2003	AR	X	67717484	G	A,C,T
rs137852603	NA	4601	MXI1	umls:C0376358	CLINVAR	NA	0.241628651	NA	MXI1	10	110280017	A	C
rs137853009	12454775	11200	CHEK2	umls:C0376358	UNIPROT	CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours.	0.138349765	2002	CHEK2	22	28725030	C	T
rs137853010	12533788	11200	CHEK2	umls:C0376358	UNIPROT	Mutations in CHEK2 associated with prostate cancer risk.	0.138349765	2003	CHEK2	22	28725028	G	C,A
rs1380576	20855462	4194	MDM4	umls:C0376358	BeFree	Both the Mdm4 and Hausp SNPs (rs1380576 and rs1529916) were found to be associated with higher D'Amico risk prostate cancer category at the time of diagnosis (P = 0.023 and P = 0.046, respectively).	0.123724241	2010	MDM4	1	204519150	G	C
rs138213197	22841674	8618	CADPS	umls:C0376358	BeFree	HOXB13 G84E was observed in 1.3% of population controls and was strongly associated with prostate cancer risk (CAPS: odds ratio [OR]: 3.4; 95% confidence interval [CI], 2.2-5.4; Stockholm-1: OR: 3.5; 95% CI, 2.4-5.2).	0.000271442	2012	HOXB13	17	48728343	C	T
rs138213197	23292082	10481	HOXB13	umls:C0376358	BeFree	This study confirms the overall importance of the HOXB13 G84E mutation in prostate cancer susceptibility.	0.128957582	2013	HOXB13	17	48728343	C	T
rs138213197	22781434	10481	HOXB13	umls:C0376358	BeFree	Association between germline HOXB13 G84E mutation and risk of prostate cancer.	0.128957582	2012	HOXB13	17	48728343	C	T
rs138213197	22841674	10481	HOXB13	umls:C0376358	BeFree	A population-based assessment of germline HOXB13 G84E mutation and prostate cancer risk.	0.128957582	2012	HOXB13	17	48728343	C	T
rs138213197	23334858	10481	HOXB13	umls:C0376358	BeFree	The G84E mutation in the HOXB13 gene is associated with an increased risk of prostate cancer in Poland.	0.128957582	2013	HOXB13	17	48728343	C	T
rs138213197	24026887	10481	HOXB13	umls:C0376358	BeFree	G84E mutation in HOXB13 is firmly associated with prostate cancer risk: a meta-analysis.	0.128957582	2013	HOXB13	17	48728343	C	T
rs138213197	24310616	10481	HOXB13	umls:C0376358	BeFree	Prevalence of the HOXB13 G84E mutation among unaffected men with a family history of prostate cancer.	0.128957582	2013	HOXB13	17	48728343	C	T
rs138213197	24550738	10481	HOXB13	umls:C0376358	BeFree	Additional genotyping, conditional regression and haplotype analyses indicated that the newly identified common variants tag a rare, partially correlated coding variant in the HOXB13 gene (G84E, rs138213197), which has been identified recently as a moderate penetrance PrCa susceptibility allele.	0.128957582	2013	HOXB13	17	48728343	C	T
rs138213197	25595936	10481	HOXB13	umls:C0376358	BeFree	Prevalence of the HOXB13 G84E germline mutation in British men and correlation with prostate cancer risk, tumour characteristics and clinical outcomes.	0.128957582	2016	HOXB13	17	48728343	C	T
rs138213197	25629170	10481	HOXB13	umls:C0376358	BeFree	For example, a recent study suggested that one cannot adequately impute the HOXB13 G84E mutation associated with prostate cancer risk (carrier frequency of 0.0034 in European ancestry participants in the 1000 Genomes Project).	0.128957582	2014	HOXB13	17	48728343	C	T
rs138213197	23104005	10481	HOXB13	umls:C0376358	BeFree	We also report results for a previously described HOXB13 variant (rs138213197[T]), confirming it as a prostate cancer risk variant in populations from across Europe.	0.128957582	2012	HOXB13	17	48728343	C	T
rs138213197	23393222	10481	HOXB13	umls:C0376358	BeFree	The G84E mutation of HOXB13 is associated with increased risk for prostate cancer: results from the REDUCE trial.	0.128957582	2013	HOXB13	17	48728343	C	T
rs138213197	24148311	10481	HOXB13	umls:C0376358	BeFree	Prevalence of the HOXB13 G84E prostate cancer risk allele in men treated with radical prostatectomy.	0.128957582	2014	HOXB13	17	48728343	C	T
rs138213197	23457453	10481	HOXB13	umls:C0376358	BeFree	Population-based estimate of prostate cancer risk for carriers of the HOXB13 missense mutation G84E.	0.128957582	2013	HOXB13	17	48728343	C	T
rs138213197	23036981	10481	HOXB13	umls:C0376358	BeFree	The G84E variant of HOXB13 was recently found to be associated with a significantly increased risk of prostate cancer in a case control study.	0.128957582	2013	HOXB13	17	48728343	C	T
rs138213197	24722062	10481	HOXB13	umls:C0376358	BeFree	HOXB13 G84E-related familial prostate cancers: a clinical, histologic, and molecular survey.	0.128957582	2014	HOXB13	17	48728343	C	T
rs138213197	22714738	10481	HOXB13	umls:C0376358	BeFree	The germline mutation G84E of HOXB13 is a rare but recurrent mutation associated with elevated risk of prostate cancer in men of European descent, with an effect size that is greater than observed for previously validated risk variants of genome wide association studies.	0.128957582	2012	HOXB13	17	48728343	C	T
rs138213197	25629170	10481	HOXB13	umls:C0376358	UNIPROT	For example, a recent study suggested that one cannot adequately impute the HOXB13 G84E mutation associated with prostate cancer risk (carrier frequency of 0.0034 in European ancestry participants in the 1000 Genomes Project).	0.128957582	2014	HOXB13	17	48728343	C	T
rs138213197	22841674	828	CAPS	umls:C0376358	BeFree	HOXB13 G84E was observed in 1.3% of population controls and was strongly associated with prostate cancer risk (CAPS: odds ratio [OR]: 3.4; 95% confidence interval [CI], 2.2-5.4; Stockholm-1: OR: 3.5; 95% CI, 2.4-5.2).	0.000271442	2012	HOXB13	17	48728343	C	T
rs139591993	NA	51426	POLK	umls:C0376358	CLINVAR	NA	0.12	NA	POLK	5	75596275	A	C
rs142173175	16155194	2048	EPHB2	umls:C0376358	UNIPROT	A common nonsense mutation in EphB2 is associated with prostate cancer risk in African American men with a positive family history.	0.131867498	2006	EPHB2	1	22906770	T	C
rs1429409	23920401	5713	PSMD7	umls:C0376358	BeFree	We found that PSMD7 rs2387084 and MYCN rs1429409 were significantly related to earlier onset of prostate cancer and advanced clinical stage, respectively.	0.000542884	2013	NA	2	16227278	C	T,A
rs1429409	23920401	4613	MYCN	umls:C0376358	BeFree	We found that PSMD7 rs2387084 and MYCN rs1429409 were significantly related to earlier onset of prostate cancer and advanced clinical stage, respectively.	0.001085767	2013	NA	2	16227278	C	T,A
rs143611747	12533788	11200	CHEK2	umls:C0376358	UNIPROT	Mutations in CHEK2 associated with prostate cancer risk.	0.138349765	2003	CHEK2	22	28699893	C	T
rs1447295	19767754	727677	CASC8	umls:C0376358	GWASCAT	Genome-wide association and replication studies identify four variants associated with prostate cancer susceptibility.	0.12	2009	CASC8	8	127472793	A	C
rs1447295	19562729	4609	MYC	umls:C0376358	BeFree	Forty-nine tagging SNPs including three previously reported significant variants (rs1447295, rs6983267, rs16901979) and seven variants in the 5' upstream region of the MYC proto-oncogene were tested for association with susceptibility to PC and tumor aggressiveness in 596 histologically verified PC cases and 567 ethnically matched controls.	0.019587422	2009	CASC8	8	127472793	A	C
rs1447295	17401366	727677	CASC8	umls:C0376358	GWASCAT	Genome-wide association study identifies a second prostate cancer susceptibility variant at 8q24.	0.12	2007	CASC8	8	127472793	A	C
rs1447295	17401363	727677	CASC8	umls:C0376358	GWASCAT	Genome-wide association study of prostate cancer identifies a second risk locus at 8q24.	0.12	2007	CASC8	8	127472793	A	C
rs1447295	24753544	727677	CASC8	umls:C0376358	GWASCAT	Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.	0.12	2015	CASC8	8	127472793	A	C
rs1456315	25315430	5462	POU5F1B	umls:C0376358	BeFree	These included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01).	0.003181358	2015	PRNCR1	8	127091692	T	C
rs1456315	20676098	101867536	PRNCR1	umls:C0376358	GWASCAT	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	0.121357209	2010	PRNCR1	8	127091692	T	C
rs1456315	23023329	101867536	PRNCR1	umls:C0376358	GWASCAT	Genome-wide association study in Chinese men identifies two new prostate cancer risk loci at 9q31.2 and 19q13.4.	0.121357209	2012	PRNCR1	8	127091692	T	C
rs1456315	25315430	101867536	PRNCR1	umls:C0376358	BeFree	These included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01).	0.121357209	2015	PRNCR1	8	127091692	T	C
rs145889899	23555315	388633	LDLRAD1	umls:C0376358	BeFree	However, only one of the associations (rs145889899 in LDLRAD1, p = 2.5 × 10(-7) only seen in African Americans) for overall breast or prostate cancer risk was statistically significant after correcting for multiple comparisons.	0.000271442	2013	LDLRAD1	1	54010411	C	T
rs146340390	24330748	7157	TP53	umls:C0376358	BeFree	Id4 was over-expressed in prostate cancer cell line DU145 harboring mutant p53 (P223L and V274F) and silenced in LNCaP cells with wild type p53.	0.22992416	2013	TP53	17	7674866	G	A
rs1465618	19767753	63892	THADA	umls:C0376358	GAD	[Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.]	0.127372538	2009	THADA	2	43326810	T	C
rs1465618	19767753	63892	THADA	umls:C0376358	GWASCAT	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	0.127372538	2009	THADA	2	43326810	T	C
rs1477017	18398039	4313	MMP2	umls:C0376358	BeFree	In the MMP2 gene, three intronic SNPs, all in linkage disequilibrium, were associated with overall and advanced prostate cancer (for overall prostate cancer, P(trend) = 0.01 for rs1477017, P(trend) = 0.01 for rs17301608, P(trend) = 0.02 for rs11639960).	0.017144445	2008	MMP2	16	55483250	A	G
rs148960463	NA	51426	POLK	umls:C0376358	CLINVAR	NA	0.12	NA	POLK	5	75547107	G	A
rs1529916	20855462	4194	MDM4	umls:C0376358	BeFree	Both the Mdm4 and Hausp SNPs (rs1380576 and rs1529916) were found to be associated with higher D'Amico risk prostate cancer category at the time of diagnosis (P = 0.023 and P = 0.046, respectively).	0.123724241	2010	USP7	16	8897333	G	A
rs1534891	19934327	5187	PER1	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.00554839	2009	CSNK1E;LOC400927-CSNK1E	22	38299094	T	C
rs1534891	19934327	8863	PER3	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005005506	2009	CSNK1E;LOC400927-CSNK1E	22	38299094	T	C
rs1534891	19934327	1408	CRY2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005276948	2009	CSNK1E;LOC400927-CSNK1E	22	38299094	T	C
rs1534891	19934327	9575	CLOCK	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002909916	2009	CSNK1E;LOC400927-CSNK1E	22	38299094	T	C
rs1534891	19934327	1407	CRY1	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	CSNK1E;LOC400927-CSNK1E	22	38299094	T	C
rs1534891	19934327	406	ARNTL	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	CSNK1E;LOC400927-CSNK1E	22	38299094	T	C
rs1534891	19934327	4862	NPAS2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005276948	2009	CSNK1E;LOC400927-CSNK1E	22	38299094	T	C
rs1534891	19934327	8864	PER2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	CSNK1E;LOC400927-CSNK1E	22	38299094	T	C
rs1571801	18073375	5921	RASA1	umls:C0376358	BeFree	Analysis of the distribution of these SNPs among 1032 prostate cancer patients and 571 control subjects of European descent indicated that one, rs1571801, located in the DAB2IP gene, which encodes a novel Ras GTPase-activating protein and putative prostate tumor suppressor, was associated with aggressive prostate cancer (one-sided P value = .004).	0.001085767	2007	DAB2IP	9	121665094	G	T
rs16901979	19549807	123811	FOPNL	umls:C0376358	BeFree	Two of these 17 SNPs, located at 3p12, and region 2 at 8q24, were significantly associated with prostate cancer risk (P < 0.05), and only SNP rs16901979 at region 2 of 8q24 remained significant after accounting for 20 tests.	0.000814326	2009	NA	8	127112671	C	A
rs16901979	19562729	4609	MYC	umls:C0376358	BeFree	Forty-nine tagging SNPs including three previously reported significant variants (rs1447295, rs6983267, rs16901979) and seven variants in the 5' upstream region of the MYC proto-oncogene were tested for association with susceptibility to PC and tumor aggressiveness in 596 histologically verified PC cases and 567 ethnically matched controls.	0.019587422	2009	NA	8	127112671	C	A
rs16902094	25315430	101867536	PRNCR1	umls:C0376358	BeFree	These included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01).	0.121357209	2015	CASC8;CASC21	8	127308101	A	G
rs16902094	25315430	5462	POU5F1B	umls:C0376358	BeFree	These included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01).	0.003181358	2015	CASC8;CASC21	8	127308101	A	G
rs1695	24610081	6648	SOD2	umls:C0376358	BeFree	In the present study we investigated the association of a number of polymorphic changes in antioxidant system genes (SNPs rs1050450 in the GPX1 gene, rs1695 and rs1138272 in the GSTP1 gene and rs4880 in the MnSOD gene) with the risk of prostate cancer.	0.044854055	2014	GSTP1	11	67585218	A	G
rs1695	20056632	2950	GSTP1	umls:C0376358	BeFree	There was no effect modification of glucosinolate intake and cancer risk by GSTA1 (G-52A) or GSTP1 (A313G) genotype, but serum glutathione S-transferase-alpha concentrations were inversely associated with prostate cancer.	0.087329809	2010	GSTP1	11	67585218	A	G
rs1695	20056632	2938	GSTA1	umls:C0376358	BeFree	There was no effect modification of glucosinolate intake and cancer risk by GSTA1 (G-52A) or GSTP1 (A313G) genotype, but serum glutathione S-transferase-alpha concentrations were inversely associated with prostate cancer.	0.010011012	2010	GSTP1	11	67585218	A	G
rs1695	24610081	2876	GPX1	umls:C0376358	BeFree	In the present study we investigated the association of a number of polymorphic changes in antioxidant system genes (SNPs rs1050450 in the GPX1 gene, rs1695 and rs1138272 in the GSTP1 gene and rs4880 in the MnSOD gene) with the risk of prostate cancer.	0.012996872	2014	GSTP1	11	67585218	A	G
rs1695	24610081	2950	GSTP1	umls:C0376358	BeFree	In the present study we investigated the association of a number of polymorphic changes in antioxidant system genes (SNPs rs1050450 in the GPX1 gene, rs1695 and rs1138272 in the GSTP1 gene and rs4880 in the MnSOD gene) with the risk of prostate cancer.	0.087329809	2014	GSTP1	11	67585218	A	G
rs1695	17067754	2950	GSTP1	umls:C0376358	BeFree	Prostate cancer risk from occupational exposure to polycyclic aromatic hydrocarbons interacting with the GSTP1 Ile105Val polymorphism.	0.087329809	2006	GSTP1	11	67585218	A	G
rs1695	20056632	27306	HPGDS	umls:C0376358	BeFree	There was no effect modification of glucosinolate intake and cancer risk by GSTA1 (G-52A) or GSTP1 (A313G) genotype, but serum glutathione S-transferase-alpha concentrations were inversely associated with prostate cancer.	0.016286512	2010	GSTP1	11	67585218	A	G
rs1695	16614120	2950	GSTP1	umls:C0376358	BeFree	To investigate this, we studied the association between prostate cancer and smoking, as well as the main and modifying effects of functional polymorphisms in genes that metabolize polycyclic aromatic hydrocarbons (CYP1A1 Ile(462)Val, microsomal epoxide hydrolase His(139)Arg) and detoxify reactive derivatives (GSTM1 null deletion, GSTT1 null deletion, GSTP1 Ile(105)Val and Ala(114)Val) using a family-based case-control design (439 prostate cancer cases and 479 brother controls).	0.087329809	2006	GSTP1	11	67585218	A	G
rs1695	16614120	2952	GSTT1	umls:C0376358	BeFree	To investigate this, we studied the association between prostate cancer and smoking, as well as the main and modifying effects of functional polymorphisms in genes that metabolize polycyclic aromatic hydrocarbons (CYP1A1 Ile(462)Val, microsomal epoxide hydrolase His(139)Arg) and detoxify reactive derivatives (GSTM1 null deletion, GSTT1 null deletion, GSTP1 Ile(105)Val and Ala(114)Val) using a family-based case-control design (439 prostate cancer cases and 479 brother controls).	0.08132575	2006	GSTP1	11	67585218	A	G
rs1695	16614120	1543	CYP1A1	umls:C0376358	BeFree	To investigate this, we studied the association between prostate cancer and smoking, as well as the main and modifying effects of functional polymorphisms in genes that metabolize polycyclic aromatic hydrocarbons (CYP1A1 Ile(462)Val, microsomal epoxide hydrolase His(139)Arg) and detoxify reactive derivatives (GSTM1 null deletion, GSTT1 null deletion, GSTP1 Ile(105)Val and Ala(114)Val) using a family-based case-control design (439 prostate cancer cases and 479 brother controls).	0.07488709	2006	GSTP1	11	67585218	A	G
rs1695	16614120	2052	EPHX1	umls:C0376358	BeFree	To investigate this, we studied the association between prostate cancer and smoking, as well as the main and modifying effects of functional polymorphisms in genes that metabolize polycyclic aromatic hydrocarbons (CYP1A1 Ile(462)Val, microsomal epoxide hydrolase His(139)Arg) and detoxify reactive derivatives (GSTM1 null deletion, GSTT1 null deletion, GSTP1 Ile(105)Val and Ala(114)Val) using a family-based case-control design (439 prostate cancer cases and 479 brother controls).	0.008186863	2006	GSTP1	11	67585218	A	G
rs16982844	24682418	1545	CYP1B1	umls:C0376358	BeFree	According to a multivariate analysis, CYP1B1 (rs1800440), COMT (rs16982844), and SULT2B1 (rs12460535, rs2665582, rs10426628) were significantly associated with prostate cancer progression and hormone levels.	0.041205759	2015	COMT	22	19960419	C	A
rs16982844	24682418	1312	COMT	umls:C0376358	BeFree	According to a multivariate analysis, CYP1B1 (rs1800440), COMT (rs16982844), and SULT2B1 (rs12460535, rs2665582, rs10426628) were significantly associated with prostate cancer progression and hormone levels.	0.021107791	2015	COMT	22	19960419	C	A
rs17021918	19767753	10611	PDLIM5	umls:C0376358	GWASCAT	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	0.12764398	2009	PDLIM5	4	94641726	C	T
rs17021918	19767753	10611	PDLIM5	umls:C0376358	GAD	[Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.]	0.12764398	2009	PDLIM5	4	94641726	C	T
rs17024926	19934327	1408	CRY2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005276948	2009	NPAS2	2	100889540	T	C
rs17024926	19934327	4862	NPAS2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005276948	2009	NPAS2	2	100889540	T	C
rs17024926	19934327	9575	CLOCK	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002909916	2009	NPAS2	2	100889540	T	C
rs17024926	19934327	8863	PER3	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005005506	2009	NPAS2	2	100889540	T	C
rs17024926	19934327	8864	PER2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	NPAS2	2	100889540	T	C
rs17024926	19934327	406	ARNTL	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	NPAS2	2	100889540	T	C
rs17024926	19934327	5187	PER1	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.00554839	2009	NPAS2	2	100889540	T	C
rs17024926	19934327	1407	CRY1	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	NPAS2	2	100889540	T	C
rs17181170	19767753	100846978	LINC00506	umls:C0376358	GWASCAT	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	0.12	2009	LINC00506	3	87124174	G	A
rs17301608	18398039	4313	MMP2	umls:C0376358	BeFree	In the MMP2 gene, three intronic SNPs, all in linkage disequilibrium, were associated with overall and advanced prostate cancer (for overall prostate cancer, P(trend) = 0.01 for rs1477017, P(trend) = 0.01 for rs17301608, P(trend) = 0.02 for rs11639960).	0.017144445	2008	MMP2	16	55484698	C	T
rs17309872	21716162	4353	MPO	umls:C0376358	BeFree	Among men carrying the variant allele for thioredoxin reductase 2 (TXNRD2) rs4485648, microsomal epoxide hydrolase 1 (EPHX1) rs17309872, or myeloperoxidase (MPO) rs11079344, an increased prostate cancer risk was observed with high, compared with no, petroleum oil/petroleum distillate (OR=1.9, 95% CI: 1.1-3.2, P interaction=0.01; OR=2.1, 95% CI: 1.1-4.0, P interaction=0.01), or terbufos (OR=3.0, 95% CI: 1.5-6.0, P interaction=2.0×10(-3)) use, respectively.	0.003995683	2011	GSS;ACSS2	20	34927985	A	G,T
rs17309872	21716162	2052	EPHX1	umls:C0376358	BeFree	Among men carrying the variant allele for thioredoxin reductase 2 (TXNRD2) rs4485648, microsomal epoxide hydrolase 1 (EPHX1) rs17309872, or myeloperoxidase (MPO) rs11079344, an increased prostate cancer risk was observed with high, compared with no, petroleum oil/petroleum distillate (OR=1.9, 95% CI: 1.1-3.2, P interaction=0.01; OR=2.1, 95% CI: 1.1-4.0, P interaction=0.01), or terbufos (OR=3.0, 95% CI: 1.5-6.0, P interaction=2.0×10(-3)) use, respectively.	0.008186863	2011	GSS;ACSS2	20	34927985	A	G,T
rs17309872	21716162	10587	TXNRD2	umls:C0376358	BeFree	Among men carrying the variant allele for thioredoxin reductase 2 (TXNRD2) rs4485648, microsomal epoxide hydrolase 1 (EPHX1) rs17309872, or myeloperoxidase (MPO) rs11079344, an increased prostate cancer risk was observed with high, compared with no, petroleum oil/petroleum distillate (OR=1.9, 95% CI: 1.1-3.2, P interaction=0.01; OR=2.1, 95% CI: 1.1-4.0, P interaction=0.01), or terbufos (OR=3.0, 95% CI: 1.5-6.0, P interaction=2.0×10(-3)) use, respectively.	0.000814326	2011	GSS;ACSS2	20	34927985	A	G,T
rs17388568	20184734	3558	IL2	umls:C0376358	BeFree	We genotyped six variants previously associated with autoimmune disease (namely rs13151961, rs13119723, rs17388568, rs3136534, rs6822844 and rs6840978) and one functional IL-2 promoter variant (rs2069762) for possible association with prostate cancer risk using the Australian Risk Factors for Prostate Cancer case-control Study.	0.006634157	2010	ADAD1	4	122408207	G	A
rs17599629	25217961	55204	GOLPH3L	umls:C0376358	GWASCAT	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	0.12	2014	GOLPH3L	1	150685811	A	G
rs17632542	23246478	354	KLK3	umls:C0376358	BeFree	The genotypes of 4 single nucleotide polymorphisms previously associated with serum prostate specific antigen levels (rs2736098, rs10788160, rs11067228 and rs17632542) were determined in 964 healthy Caucasian volunteers without prostate cancer.	0.261542831	2013	KLK3	19	50858501	T	C
rs17632542	24740154	354	KLK3	umls:C0376358	GWASCAT	Genome-wide association scan for variants associated with early-onset prostate cancer.	0.261542831	2014	KLK3	19	50858501	T	C
rs17632542	24753544	354	KLK3	umls:C0376358	GWASCAT	Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.	0.261542831	2015	KLK3	19	50858501	T	C
rs17694493	25217961	100048912	CDKN2B-AS1	umls:C0376358	GWASCAT	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	0.120271442	2014	CDKN2B-AS1	9	22041999	C	G
rs1775148	25217961	254428	SLC41A1	umls:C0376358	GWASCAT	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	0.12	2014	SLC41A1	1	205788696	C	T
rs17884057	20477822	6647	SOD1	umls:C0376358	BeFree	Two variants in SOD2 were significantly associated with the risk of aggressive prostate cancer (rs17884057, odds ratio 0.83, 95% confidence interval 0.70-0.99; and rs4816407, 1.27, 1.02-1.57); men with A alleles at rs2842958 in SOD2 had lower plasma selenium levels (median 116 vs 121.8 µg/L, P= 0.03); and the association between plasma selenium levels and risk of aggressive prostate cancer was modified by SOD1 (rs10432782) and SOD2 (rs2758330).	0.010553895	2011	SOD1	21	31664502	AGA	-
rs17884057	20477822	6648	SOD2	umls:C0376358	BeFree	Two variants in SOD2 were significantly associated with the risk of aggressive prostate cancer (rs17884057, odds ratio 0.83, 95% confidence interval 0.70-0.99; and rs4816407, 1.27, 1.02-1.57); men with A alleles at rs2842958 in SOD2 had lower plasma selenium levels (median 116 vs 121.8 µg/L, P= 0.03); and the association between plasma selenium levels and risk of aggressive prostate cancer was modified by SOD1 (rs10432782) and SOD2 (rs2758330).	0.044854055	2011	SOD1	21	31664502	AGA	-
rs1799782	21647176	7515	XRCC1	umls:C0376358	BeFree	XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis.	0.04702559	2011	XRCC1	19	43553422	G	A
rs1799782	24492938	7515	XRCC1	umls:C0376358	BeFree	In conclusion, the meta-analysis suggests that there is no obvious association between XRCC1 Arg194Trp polymorphism and prostate cancer risk.	0.04702559	2013	XRCC1	19	43553422	G	A
rs1799782	17196815	7515	XRCC1	umls:C0376358	BeFree	This is the first report on the studies of XPC and XRCC1 Arg194Trp polymorphisms in PC, and our present data suggest that XPC Lys939Gln and the T-A haplotype of XRCC1 Arg194Trp and Arg399Gln may be risk factors for PC in Japanese.	0.04702559	2007	XRCC1	19	43553422	G	A
rs1799782	17196815	7508	XPC	umls:C0376358	BeFree	This is the first report on the studies of XPC and XRCC1 Arg194Trp polymorphisms in PC, and our present data suggest that XPC Lys939Gln and the T-A haplotype of XRCC1 Arg194Trp and Arg399Gln may be risk factors for PC in Japanese.	0.006362715	2007	XRCC1	19	43553422	G	A
rs1799793	19914098	7517	XRCC3	umls:C0376358	BeFree	We examined the association between PC risk with nonsynonymous SNPs (nsSNPs) in 5 genes involved in 3 DNA-repair pathways: (1) base excision repair (BER): hOGG1 C1245G (Ser326Cys) and XRCC1 G28152A (Arg399Gln); (2) nucleotide excision repair (NER): XPD G23591A (Asp312Asn); (3) homologous recombination repair: RAD51 G135C (in 5' untranslated region) and XRCC3 C18067T (Thr241Met).	0.008458305	2011	ERCC2	19	45364001	C	T
rs1799793	19914098	7515	XRCC1	umls:C0376358	BeFree	We examined the association between PC risk with nonsynonymous SNPs (nsSNPs) in 5 genes involved in 3 DNA-repair pathways: (1) base excision repair (BER): hOGG1 C1245G (Ser326Cys) and XRCC1 G28152A (Arg399Gln); (2) nucleotide excision repair (NER): XPD G23591A (Asp312Asn); (3) homologous recombination repair: RAD51 G135C (in 5' untranslated region) and XRCC3 C18067T (Thr241Met).	0.04702559	2011	ERCC2	19	45364001	C	T
rs1799793	23771356	2068	ERCC2	umls:C0376358	BeFree	The Xeroderma pigmentosum group D (XPD, also referred to as excision repair cross complementing gene 2, ERCC2) is one of key genes involved in nucleotide excision repair and two potentially functional polymorphisms of XPD (Asp312Asn and Lys751Gln) have been widely investigated in various cancers including prostate cancer.	0.01482102	2014	ERCC2	19	45364001	C	T
rs1799793	19914098	2068	ERCC2	umls:C0376358	BeFree	We examined the association between PC risk with nonsynonymous SNPs (nsSNPs) in 5 genes involved in 3 DNA-repair pathways: (1) base excision repair (BER): hOGG1 C1245G (Ser326Cys) and XRCC1 G28152A (Arg399Gln); (2) nucleotide excision repair (NER): XPD G23591A (Asp312Asn); (3) homologous recombination repair: RAD51 G135C (in 5' untranslated region) and XRCC3 C18067T (Thr241Met).	0.01482102	2011	ERCC2	19	45364001	C	T
rs1799793	19914098	5888	RAD51	umls:C0376358	BeFree	We examined the association between PC risk with nonsynonymous SNPs (nsSNPs) in 5 genes involved in 3 DNA-repair pathways: (1) base excision repair (BER): hOGG1 C1245G (Ser326Cys) and XRCC1 G28152A (Arg399Gln); (2) nucleotide excision repair (NER): XPD G23591A (Asp312Asn); (3) homologous recombination repair: RAD51 G135C (in 5' untranslated region) and XRCC3 C18067T (Thr241Met).	0.003995683	2011	ERCC2	19	45364001	C	T
rs1799983	23015399	4846	NOS3	umls:C0376358	BeFree	Endothelial nitric oxide synthase Glu298Asp polymorphism as a risk factor for prostate cancer.	0.019359587	2012	NOS3	7	150999023	T	G
rs1799983	24756758	4846	NOS3	umls:C0376358	BeFree	This meta-analysis showed the evidence that NOS3 rs1799983 polymorphism was associated with a risk of prostate cancer development in overall populations.	0.019359587	2014	NOS3	7	150999023	T	G
rs1799983	24577889	4846	NOS3	umls:C0376358	BeFree	The Glu298Asp polymorphism in the NOS3 gene and the risk of prostate cancer.	0.019359587	2014	NOS3	7	150999023	T	G
rs1799983	25040995	4846	NOS3	umls:C0376358	BeFree	This meta-analysis indicated that the eNOS T-786C polymorphism is associated with elevated cancer risk; the G894T polymorphism contributes to susceptibility to breast cancer and cancer generally in females; and the 4a/b polymorphism may be associated with prostate cancer risk.	0.019359587	2015	NOS3	7	150999023	T	G
rs1799983	22317880	4846	NOS3	umls:C0376358	BeFree	Effects of the T-786C, G894T, and Intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene on the risk of prostate cancer.	0.019359587	2012	NOS3	7	150999023	T	G
rs1799983	16458450	4846	NOS3	umls:C0376358	BeFree	The endothelial nitric oxide synthase Glu-298-Asp polymorphism and its mRNA expression in the peripheral blood of patients with prostate cancer and benign prostatic hyperplasia.	0.019359587	2006	NOS3	7	150999023	T	G
rs1800054	18565893	472	ATM	umls:C0376358	BeFree	Multifactorially adjusted hazard ratios for ATM Ser49Cys heterozygotes versus noncarriers were 1.2 (95% CI, 0.9 to 1.5) for cancer overall, 0.8 (95% CI, 0.3 to 2.0) for breast cancer, 4.8 (95% CI, 2.2 to 11) for melanoma, 2.3 (95% CI, 1.1 to 5.0) for prostate cancer, and 3.4 (95% CI, 1.1 to 11) for cancer of the oral cavity/pharynx.	0.010977227	2008	ATM	11	108227849	C	G,T
rs1800057	19638463	472	ATM	umls:C0376358	BeFree	A missense variant in ATM, rs1800057, associated with increased prostate cancer risk, was found exclusively in two high toxicity patients but did not reach statistical significance for association with radiosensitivity (P = 0.488).	0.010977227	2009	ATM	11	108272729	C	G
rs1800057	17502119	472	ATM	umls:C0376358	BeFree	ATM missense variant P1054R predisposes to prostate cancer.	0.010977227	2007	ATM	11	108272729	C	G
rs1800440	24682418	1545	CYP1B1	umls:C0376358	BeFree	According to a multivariate analysis, CYP1B1 (rs1800440), COMT (rs16982844), and SULT2B1 (rs12460535, rs2665582, rs10426628) were significantly associated with prostate cancer progression and hormone levels.	0.041205759	2015	CYP1B1	2	38070996	T	G,C
rs1800440	24682418	1312	COMT	umls:C0376358	BeFree	According to a multivariate analysis, CYP1B1 (rs1800440), COMT (rs16982844), and SULT2B1 (rs12460535, rs2665582, rs10426628) were significantly associated with prostate cancer progression and hormone levels.	0.021107791	2015	CYP1B1	2	38070996	T	G,C
rs1800470	19039592	7040	TGFB1	umls:C0376358	BeFree	TGFB1 polymorphism L10P is not strongly associated with prostate cancer risk.	0.027350954	2009	TGFB1	19	41353016	G	C,A
rs1800470	23975370	7040	TGFB1	umls:C0376358	BeFree	TGFβ1 Leu10Pro polymorphism contributes to the development of prostate cancer: evidence from a meta-analysis.	0.027350954	2013	TGFB1	19	41353016	G	C,A
rs1800470	18058470	7040	TGFB1	umls:C0376358	BeFree	We evaluated the influence of the TGFB1 polymorphisms by ARMS-PCR, Leu10Pro, and Arg25Pro, on prostate cancer (PCa) and benign prostatic hyperplasia (BPH).	0.027350954	2007	TGFB1	19	41353016	G	C,A
rs1800471	18058470	7040	TGFB1	umls:C0376358	BeFree	We evaluated the influence of the TGFB1 polymorphisms by ARMS-PCR, Leu10Pro, and Arg25Pro, on prostate cancer (PCa) and benign prostatic hyperplasia (BPH).	0.027350954	2007	TGFB1	19	41352971	C	G
rs1800896	19474090	3586	IL10	umls:C0376358	GAD	[Using Multivariate Adaptive Regression Splines modeling for exploratory SNP-SNP interactions, our results showed that more aggressive PCa in Caucasians Americans is associated with the CT genotype at IL8-47 odds ratios (OR) = 3.50; 95% CI = 1.13-10.88 or combined genotypes of IL1B-511CC and IL10-1082GG (OR = 3.38; 95% CI = 1.70-6.71).]	0.035385928	2009	IL10	1	206773552	T	C
rs1800932	25938433	2956	MSH6	umls:C0376358	BeFree	Concurrent reduction of three MMR genes namely hMLH1, hMSH6 and hMSH2 (34-85%, P<0.05) was observed in prostate cancer tissues. hMSH6 polymorphism rs1800932(Pro92Pro) conferred a borderline protection in cancer patients (OR = 0.33, 95% CI = 0.15-0.75).	0.006905599	2015	MSH6	2	47790942	A	G
rs1800932	25938433	4436	MSH2	umls:C0376358	BeFree	Concurrent reduction of three MMR genes namely hMLH1, hMSH6 and hMSH2 (34-85%, P<0.05) was observed in prostate cancer tissues. hMSH6 polymorphism rs1800932(Pro92Pro) conferred a borderline protection in cancer patients (OR = 0.33, 95% CI = 0.15-0.75).	0.007719925	2015	MSH6	2	47790942	A	G
rs1801155	16537703	324	APC	umls:C0376358	BeFree	APC I1307K and the risk of prostate cancer.	0.086710102	2006	APC	5	112839514	T	A
rs1801278	21204696	3667	IRS1	umls:C0376358	BeFree	Insulin receptor H1085H C>T and insulin receptor substrate 1 G972R polymorphisms and prostate cancer risk: a pilot study.	0.008458305	2011	IRS1	2	226795828	C	T,G,A
rs1801278	15678496	3667	IRS1	umls:C0376358	BeFree	Prostate cancer risk and IRS1, IRS2, IGF1, and INS polymorphisms: strong association of IRS1 G972R variant and cancer risk.	0.008458305	2005	IRS1	2	226795828	C	T,G,A
rs1801278	21204696	3643	INSR	umls:C0376358	BeFree	Insulin receptor H1085H C>T and insulin receptor substrate 1 G972R polymorphisms and prostate cancer risk: a pilot study.	0.004538567	2011	IRS1	2	226795828	C	T,G,A
rs1801282	12609711	5468	PPARG	umls:C0376358	BeFree	Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) gene and risk of prostate cancer among men in a large cancer prevention study.	0.013963088	2003	PPARG	3	12351626	C	G
rs1801394	23459165	4548	MTR	umls:C0376358	BeFree	Genetic polymorphisms in MTHFR (C677T, A1298C), MTR (A2756G) and MTRR (A66G) genes associated with pathological characteristics of prostate cancer in the Ecuadorian population.	0.008729747	2014	MTRR;FASTKD3	5	7870860	A	G
rs1801394	23459165	4552	MTRR	umls:C0376358	BeFree	Genetic polymorphisms in MTHFR (C677T, A1298C), MTR (A2756G) and MTRR (A66G) genes associated with pathological characteristics of prostate cancer in the Ecuadorian population.	0.010011012	2014	MTRR;FASTKD3	5	7870860	A	G
rs1801394	23459165	4524	MTHFR	umls:C0376358	BeFree	Genetic polymorphisms in MTHFR (C677T, A1298C), MTR (A2756G) and MTRR (A66G) genes associated with pathological characteristics of prostate cancer in the Ecuadorian population.	0.03010898	2014	MTRR;FASTKD3	5	7870860	A	G
rs1803205	19474090	3576	CXCL8	umls:C0376358	GAD	[Using Multivariate Adaptive Regression Splines modeling for exploratory SNP-SNP interactions, our results showed that more aggressive PCa in Caucasians Americans is associated with the CT genotype at IL8-47 odds ratios (OR) = 3.50; 95% CI = 1.13-10.88 or combined genotypes of IL1B-511CC and IL10-1082GG (OR = 3.38; 95% CI = 1.70-6.71).]	0.024788425	2009	CXCL8	4	73740676	C	G,T
rs1805087	22803112	6470	SHMT1	umls:C0376358	BeFree	Role of polymorphic variants of MTR gene A2756G and SHMT1 gene C1420T in the development of prostatic cancer in residents of the Western Siberian Region of Russia.	0.00554839	2012	MTR	1	236885200	A	G
rs1805087	23459165	4552	MTRR	umls:C0376358	BeFree	Genetic polymorphisms in MTHFR (C677T, A1298C), MTR (A2756G) and MTRR (A66G) genes associated with pathological characteristics of prostate cancer in the Ecuadorian population.	0.010011012	2014	MTR	1	236885200	A	G
rs1805087	22803112	4548	MTR	umls:C0376358	BeFree	Role of polymorphic variants of MTR gene A2756G and SHMT1 gene C1420T in the development of prostatic cancer in residents of the Western Siberian Region of Russia.	0.008729747	2012	MTR	1	236885200	A	G
rs1805087	23459165	4524	MTHFR	umls:C0376358	BeFree	Genetic polymorphisms in MTHFR (C677T, A1298C), MTR (A2756G) and MTRR (A66G) genes associated with pathological characteristics of prostate cancer in the Ecuadorian population.	0.03010898	2014	MTR	1	236885200	A	G
rs1805087	23459165	4548	MTR	umls:C0376358	BeFree	Genetic polymorphisms in MTHFR (C677T, A1298C), MTR (A2756G) and MTRR (A66G) genes associated with pathological characteristics of prostate cancer in the Ecuadorian population.	0.008729747	2014	MTR	1	236885200	A	G
rs1805192	12609711	5468	PPARG	umls:C0376358	BeFree	Pro12Ala polymorphism in the peroxisome proliferator-activated receptor-gamma (PPAR-gamma) gene and risk of prostate cancer among men in a large cancer prevention study.	0.013963088	2003	PPARG	3	12379739	C	G
rs1805794	22413803	55655	NLRP2	umls:C0376358	BeFree	DNA repair system and prostate cancer progression: the role of NBS1 polymorphism (rs1805794).	0.001900093	2012	NBN	8	89978251	C	G
rs1859962	19767753	101928165	CASC17	umls:C0376358	GWASCAT	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	0.12	2009	CASC17	17	71112612	G	T
rs1859962	17603485	101928165	CASC17	umls:C0376358	GWASCAT	Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes.	0.12	2007	CASC17	17	71112612	G	T
rs1859962	18264097	101928165	CASC17	umls:C0376358	GWASCAT	Multiple newly identified loci associated with prostate cancer susceptibility.	0.12	2008	CASC17	17	71112612	G	T
rs1859962	21743057	101928165	CASC17	umls:C0376358	GWASCAT	Genome-wide association study identifies new prostate cancer susceptibility loci.	0.12	2011	CASC17	17	71112612	G	T
rs1883633	21716162	2729	GCLC	umls:C0376358	BeFree	A positive monotonic interaction was observed between petroleum oil/petroleum distillate use and rs1883633 in the oxidative stress gene glutamate cysteine ligase (GCLC; P interaction=1.0×10(-4)); men carrying at least one variant allele (minor allele) experienced an increased prostate cancer risk (OR=3.7, 95% CI: 1.9-7.3).	0.000271442	2011	LOC101927136	6	53564474	A	G
rs1894292	23535732	173	AFM	umls:C0376358	GWASCAT	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	0.12	2013	AFM	4	73483441	G	A
rs1902023	11129427	7366	UGT2B15	umls:C0376358	BeFree	An allele-specific polymerase chain reaction method for the determination of the D85Y polymorphism in the human UDP-glucuronosyltransferase 2B15 gene in a case-control study of prostate cancer.	0.015635346	2000	UGT2B15	4	68670366	A	C
rs1902023	23098242	7366	UGT2B15	umls:C0376358	BeFree	Logistic regression models adjusting for age and race revealed that homozygosity for the G allele of the UGT2B15(D85Y) polymorphism was directly associated with the prostate cancer risk (OR=2.70, 95% CI=1.28, 5.55).	0.015635346	2013	UGT2B15	4	68670366	A	C
rs1902023	15126881	7366	UGT2B15	umls:C0376358	BeFree	These results suggest that the UGT2B15 enzyme may have a role in the metabolism of dihydrotestosterone in prostate tissue and UGT2B15 Asp85Tyr polymorphism is associated with prostate cancer risk.	0.015635346	2004	UGT2B15	4	68670366	A	C
rs1902023	15065092	7366	UGT2B15	umls:C0376358	BeFree	Prostate cancer and polymorphism D85Y in gene for dihydrotestosterone degrading enzyme UGT2B15: Frequency of DD homozygotes increases with Gleason Score.	0.015635346	2004	UGT2B15	4	68670366	A	C
rs1916284	22219177	201625	DNAH12	umls:C0376358	GWASCAT	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	0.12	2012	DNAH12	3	57409039	T	C
rs1933488	23535732	26575	RGS17	umls:C0376358	GWASCAT	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	0.120271442	2013	RGS17	6	153119944	A	G
rs193920817	NA	7157	TP53	umls:C0376358	CLINVAR	NA	0.22992416	NA	TP53	17	7675131	C	T
rs1978331	21308720	4048	LTA4H	umls:C0376358	BeFree	LTA4H rs1978331 was inversely associated with prostate cancer risk overall (unadjusted, overdominant model OR = 0.68, 95% CI: 0.51-0.91 for TC vs. TT/CC).	0.000271442	2011	LTA4H	12	96015423	A	G
rs1979277	22803112	6470	SHMT1	umls:C0376358	BeFree	Role of polymorphic variants of MTR gene A2756G and SHMT1 gene C1420T in the development of prostatic cancer in residents of the Western Siberian Region of Russia.	0.00554839	2012	SHMT1	17	18328782	G	A
rs1979277	22803112	4548	MTR	umls:C0376358	BeFree	Role of polymorphic variants of MTR gene A2756G and SHMT1 gene C1420T in the development of prostatic cancer in residents of the Western Siberian Region of Russia.	0.008729747	2012	SHMT1	17	18328782	G	A
rs1983891	20676098	116113	FOXP4	umls:C0376358	GWASCAT	In addition, we report here five new loci for prostate cancer susceptibility, at 5p15 (lambda-corrected probability P(GC) = 3.9 x 10(-18)), GPRC6A/RFX6 (P(GC) = 1.6 x 10(-12)), 13q22 (P(GC) = 2.8 x 10(-9)), C2orf43 (P(GC) = 7.5 x 10(-8)) and FOXP4 (P(GC) = 7.6 x 10(-8)).	0.123181358	2010	FOXP4	6	41568689	C	T
rs1983891	22662242	60526	C2orf43	umls:C0376358	BeFree	We successfully replicated the association of rs13385191 (located in the C2orf43 gene, P = 8.60×10(-5)), rs12653946 (P = 1.33×10(-6)), rs1983891 (FOXP4, P = 6.22×10(-5)), and rs339331 (GPRC6A/RFX6, P = 1.42×10(-5)) with prostate cancer.	0.000542884	2012	FOXP4	6	41568689	C	T
rs198977	25847286	3817	KLK2	umls:C0376358	BeFree	The T allele of rs198977, a single nucleotide polymorphism in exon 5 of KLK2, codes for W-hK2 and is associated with lower serum hK2 levels and higher risk of prostate cancer than the C allele encoding R-hK2.	0.030456367	2015	KLK2	19	50878521	C	T
rs198977	17085659	6625	SNRNP70	umls:C0376358	BeFree	Among the SNPs studied, the A allele of the KLK2-SNP1 (G>A, rs2664155) and the T allele of the KLK2-SNP5 (C>T, rs198977) polymorphisms showed positive associations with prostate cancer, adjusted ORs for KLK2-SNP1 AG and AA genotypes being 1.4 [95% confidence interval (95% CI), 1.2-1.8; P=0.002] and for KLK2-SNP5 TT or CT genotypes being 1.3 (95% CI, 1.1-1.6; P=0.05).	0.000814326	2006	KLK2	19	50878521	C	T
rs2005705	24740154	6928	HNF1B	umls:C0376358	GWASCAT	Genome-wide association scan for variants associated with early-onset prostate cancer.	0.168773794	2014	HNF1B	17	37736310	G	A
rs201765376	22803112	6470	SHMT1	umls:C0376358	BeFree	Role of polymorphic variants of MTR gene A2756G and SHMT1 gene C1420T in the development of prostatic cancer in residents of the Western Siberian Region of Russia.	0.00554839	2012	MTR	1	236838504	C	T
rs201765376	22803112	4548	MTR	umls:C0376358	BeFree	Role of polymorphic variants of MTR gene A2756G and SHMT1 gene C1420T in the development of prostatic cancer in residents of the Western Siberian Region of Russia.	0.008729747	2012	MTR	1	236838504	C	T
rs20576	18163425	8797	TNFRSF10A	umls:C0376358	BeFree	The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases.	0.003724241	2008	TNFRSF10A	8	23200707	T	G
rs2066479	12210481	3293	HSD17B3	umls:C0376358	BeFree	Association of the G289S single nucleotide polymorphism in the HSD17B3 gene with prostate cancer in Italian men.	0.010282454	2002	HSD17B3	9	96235528	C	T,G,A
rs2066827	18645269	1027	CDKN1B	umls:C0376358	BeFree	CDKN1B V109G polymorphism frequency and prostate cancer risk in Taiwan.	0.016873003	2008	CDKN1B;GPR19	12	12718165	T	A,C,G
rs2069762	20184734	3558	IL2	umls:C0376358	BeFree	We genotyped six variants previously associated with autoimmune disease (namely rs13151961, rs13119723, rs17388568, rs3136534, rs6822844 and rs6840978) and one functional IL-2 promoter variant (rs2069762) for possible association with prostate cancer risk using the Australian Risk Factors for Prostate Cancer case-control Study.	0.006634157	2010	IL2	4	122456825	A	C
rs2075555	17903305	10217	CTDSPL	umls:C0376358	BeFree	The top SNP associations in GEE models for each trait were as follows: breast cancer, rs2075555, p = 8.0 x 10(-8) in COL1A1; and prostate cancer, rs9311171, p = 1.75 x 10(-6) in CTDSPL.	0.002638474	2007	COL1A1	17	50196930	T	G
rs2077647	19952760	2099	ESR1	umls:C0376358	BeFree	The combination of the TTTA long repeats and the minor alleles of rs10046 in CYP19A1 and rs2077647 in ESR-alpha was a high risk for prostate cancer despite greater than or equal to 60 mg isoflavones/day.	0.060793181	2010	ESR1	6	151807942	T	C,A
rs2077647	19952760	1588	CYP19A1	umls:C0376358	BeFree	The combination of the TTTA long repeats and the minor alleles of rs10046 in CYP19A1 and rs2077647 in ESR-alpha was a high risk for prostate cancer despite greater than or equal to 60 mg isoflavones/day.	0.050869384	2010	ESR1	6	151807942	T	C,A
rs2121875	21743467	2255	FGF10	umls:C0376358	GWASCAT	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	0.12	2011	FGF10	5	44365443	C	A
rs2228001	17196815	7515	XRCC1	umls:C0376358	BeFree	This is the first report on the studies of XPC and XRCC1 Arg194Trp polymorphisms in PC, and our present data suggest that XPC Lys939Gln and the T-A haplotype of XRCC1 Arg194Trp and Arg399Gln may be risk factors for PC in Japanese.	0.04702559	2007	XPC	3	14145949	G	T
rs2228001	17196815	7508	XPC	umls:C0376358	BeFree	This is the first report on the studies of XPC and XRCC1 Arg194Trp polymorphisms in PC, and our present data suggest that XPC Lys939Gln and the T-A haplotype of XRCC1 Arg194Trp and Arg399Gln may be risk factors for PC in Japanese.	0.006362715	2007	XPC	3	14145949	G	T
rs2228013	11980664	4824	NKX3-1	umls:C0376358	BeFree	Occurrence of NKX3.1 C154T polymorphism in men with and without prostate cancer and studies of its effect on protein function.	0.105483198	2002	NKX3-1	8	23682736	G	A
rs2228013	11980664	6722	SRF	umls:C0376358	BeFree	Neither the R52C nor the S48A substitution affected serum response factor coactivation by NKX3.1 We conclude that the polymorphic NKX3.1 allele codes for a variant protein with altered DNA binding activity that may affect prostate cancer risk.	0.002171535	2002	NKX3-1	8	23682736	G	A
rs2228526	24615090	2074	ERCC6	umls:C0376358	BeFree	In conclusion, we found that polymorphisms in XPG rs2296147 and CSB rs2228526 were significantly associated with prostate cancer susceptibility in the Chinese population analyzed.	0.002909916	2015	ERCC6;LOC105378300	10	49470671	T	C
rs2228526	24615090	2073	ERCC5	umls:C0376358	BeFree	In conclusion, we found that polymorphisms in XPG rs2296147 and CSB rs2228526 were significantly associated with prostate cancer susceptibility in the Chinese population analyzed.	0.003995683	2015	ERCC6;LOC105378300	10	49470671	T	C
rs2228526	24289586	2073	ERCC5	umls:C0376358	BeFree	Our study indicates that XPG rs2296147 and CSB rs2228526 polymorphisms are significantly associated with increased risk of prostate cancer, and that combination of XPG rs2296147 T allele and CSB rs2228526 G allele is strongly associated with an increased risk.	0.003995683	2015	ERCC6;LOC105378300	10	49470671	T	C
rs2228526	24289586	2074	ERCC6	umls:C0376358	BeFree	Our study indicates that XPG rs2296147 and CSB rs2228526 polymorphisms are significantly associated with increased risk of prostate cancer, and that combination of XPG rs2296147 T allele and CSB rs2228526 G allele is strongly associated with an increased risk.	0.002909916	2015	ERCC6;LOC105378300	10	49470671	T	C
rs2231142	18710444	9429	ABCG2	umls:C0376358	BeFree	Association of the ABCG2 C421A polymorphism with prostate cancer risk and survival.	0.003181358	2008	ABCG2	4	88131171	G	T
rs2231142	18710444	24	ABCA4	umls:C0376358	BeFree	To determine if the C421A single nucleotide polymorphism (SNP) in the ATP-binding cassette transporter ABCG2 increases prostate cancer risk or affects survival.	0.000542884	2008	ABCG2	4	88131171	G	T
rs2234922	16614120	2952	GSTT1	umls:C0376358	BeFree	To investigate this, we studied the association between prostate cancer and smoking, as well as the main and modifying effects of functional polymorphisms in genes that metabolize polycyclic aromatic hydrocarbons (CYP1A1 Ile(462)Val, microsomal epoxide hydrolase His(139)Arg) and detoxify reactive derivatives (GSTM1 null deletion, GSTT1 null deletion, GSTP1 Ile(105)Val and Ala(114)Val) using a family-based case-control design (439 prostate cancer cases and 479 brother controls).	0.08132575	2006	EPHX1	1	225838705	A	G,T
rs2234922	16614120	1543	CYP1A1	umls:C0376358	BeFree	To investigate this, we studied the association between prostate cancer and smoking, as well as the main and modifying effects of functional polymorphisms in genes that metabolize polycyclic aromatic hydrocarbons (CYP1A1 Ile(462)Val, microsomal epoxide hydrolase His(139)Arg) and detoxify reactive derivatives (GSTM1 null deletion, GSTT1 null deletion, GSTP1 Ile(105)Val and Ala(114)Val) using a family-based case-control design (439 prostate cancer cases and 479 brother controls).	0.07488709	2006	EPHX1	1	225838705	A	G,T
rs2234922	16614120	2950	GSTP1	umls:C0376358	BeFree	To investigate this, we studied the association between prostate cancer and smoking, as well as the main and modifying effects of functional polymorphisms in genes that metabolize polycyclic aromatic hydrocarbons (CYP1A1 Ile(462)Val, microsomal epoxide hydrolase His(139)Arg) and detoxify reactive derivatives (GSTM1 null deletion, GSTT1 null deletion, GSTP1 Ile(105)Val and Ala(114)Val) using a family-based case-control design (439 prostate cancer cases and 479 brother controls).	0.087329809	2006	EPHX1	1	225838705	A	G,T
rs2234922	16614120	2052	EPHX1	umls:C0376358	BeFree	To investigate this, we studied the association between prostate cancer and smoking, as well as the main and modifying effects of functional polymorphisms in genes that metabolize polycyclic aromatic hydrocarbons (CYP1A1 Ile(462)Val, microsomal epoxide hydrolase His(139)Arg) and detoxify reactive derivatives (GSTM1 null deletion, GSTT1 null deletion, GSTP1 Ile(105)Val and Ala(114)Val) using a family-based case-control design (439 prostate cancer cases and 479 brother controls).	0.008186863	2006	EPHX1	1	225838705	A	G,T
rs2238776	25217961	6899	TBX1	umls:C0376358	GWASCAT	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	0.12	2014	TBX1	22	19770369	G	A,T
rs2242652	21743467	7015	TERT	umls:C0376358	GWASCAT	We also identified a SNP in TERT more strongly associated with PrCa than that previously reported.	0.12643866	2011	TERT	5	1279913	G	A
rs2273535	17898866	6790	AURKA	umls:C0376358	BeFree	The single-nucleotide polymorphism T91A (Phe31Ile) has been implicated in AURKA overexpression and has been suggested as a low-penetrance susceptibility allele in multiple human cancers, including prostate cancer.	0.004538567	2007	AURKA	20	56386485	A	T
rs2273669	23535732	84071	ARMC2	umls:C0376358	GWASCAT	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	0.122367032	2013	ARMC2	6	108963986	A	G
rs2274911	23555315	2162	F13A1	umls:C0376358	BeFree	In prostate cancer, one of the most associated SNPs was in the gene GPRC6A (rs2274911, Pro91Ser, OR = 0.88, P = 1.3 × 10(-5)) near to a known risk locus for prostate cancer; other suggestive associations were noted in genes such as F13A1, ANXA4, MANSC1, and GP6.	0.000542884	2013	GPRC6A	6	116809541	G	A
rs2274911	23555315	222545	GPRC6A	umls:C0376358	BeFree	In prostate cancer, one of the most associated SNPs was in the gene GPRC6A (rs2274911, Pro91Ser, OR = 0.88, P = 1.3 × 10(-5)) near to a known risk locus for prostate cancer; other suggestive associations were noted in genes such as F13A1, ANXA4, MANSC1, and GP6.	0.005081451	2013	GPRC6A	6	116809541	G	A
rs2289591	19934327	5187	PER1	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.00554839	2009	PER1;MIR6883;LOC105371522	17	8144692	C	A
rs2289591	19934327	4862	NPAS2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005276948	2009	PER1;MIR6883;LOC105371522	17	8144692	C	A
rs2289591	19934327	406	ARNTL	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	PER1;MIR6883;LOC105371522	17	8144692	C	A
rs2289591	19934327	8864	PER2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	PER1;MIR6883;LOC105371522	17	8144692	C	A
rs2289591	19934327	8863	PER3	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005005506	2009	PER1;MIR6883;LOC105371522	17	8144692	C	A
rs2289591	19934327	1407	CRY1	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	PER1;MIR6883;LOC105371522	17	8144692	C	A
rs2289591	19934327	1408	CRY2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005276948	2009	PER1;MIR6883;LOC105371522	17	8144692	C	A
rs2289591	19934327	9575	CLOCK	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002909916	2009	PER1;MIR6883;LOC105371522	17	8144692	C	A
rs2292884	21743057	79083	MLPH	umls:C0376358	GWASCAT	Genome-wide association study identifies new prostate cancer susceptibility loci.	0.12	2011	MLPH	2	237534583	A	G
rs2292912	19934327	5187	PER1	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.00554839	2009	CRY2	11	45856137	C	T,G
rs2292912	19934327	8864	PER2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	CRY2	11	45856137	C	T,G
rs2292912	19934327	8863	PER3	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005005506	2009	CRY2	11	45856137	C	T,G
rs2292912	19934327	1407	CRY1	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	CRY2	11	45856137	C	T,G
rs2292912	19934327	1408	CRY2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005276948	2009	CRY2	11	45856137	C	T,G
rs2292912	19934327	4862	NPAS2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005276948	2009	CRY2	11	45856137	C	T,G
rs2292912	19934327	406	ARNTL	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	CRY2	11	45856137	C	T,G
rs2292912	19934327	9575	CLOCK	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002909916	2009	CRY2	11	45856137	C	T,G
rs2296147	24615090	2074	ERCC6	umls:C0376358	BeFree	In conclusion, we found that polymorphisms in XPG rs2296147 and CSB rs2228526 were significantly associated with prostate cancer susceptibility in the Chinese population analyzed.	0.002909916	2015	ERCC5;BIVM-ERCC5	13	102846025	T	C
rs2296147	24289586	2074	ERCC6	umls:C0376358	BeFree	Our study indicates that XPG rs2296147 and CSB rs2228526 polymorphisms are significantly associated with increased risk of prostate cancer, and that combination of XPG rs2296147 T allele and CSB rs2228526 G allele is strongly associated with an increased risk.	0.002909916	2015	ERCC5;BIVM-ERCC5	13	102846025	T	C
rs2296147	24615090	2073	ERCC5	umls:C0376358	BeFree	In conclusion, we found that polymorphisms in XPG rs2296147 and CSB rs2228526 were significantly associated with prostate cancer susceptibility in the Chinese population analyzed.	0.003995683	2015	ERCC5;BIVM-ERCC5	13	102846025	T	C
rs2296147	24289586	2073	ERCC5	umls:C0376358	BeFree	Our study indicates that XPG rs2296147 and CSB rs2228526 polymorphisms are significantly associated with increased risk of prostate cancer, and that combination of XPG rs2296147 T allele and CSB rs2228526 G allele is strongly associated with an increased risk.	0.003995683	2015	ERCC5;BIVM-ERCC5	13	102846025	T	C
rs2298881	22102698	2067	ERCC1	umls:C0376358	BeFree	Men carrying the variant A allele at ERCC1 rs2298881 exhibited increased prostate cancer risk with high versus no fonofos use [odds ratio (OR) 2.98; 95% confidence interval (CI) 1.65-5.39; P(interact) = 3.6 × 10(-4); FDR-adjusted P = 0.11].	0.006362715	2012	ERCC1	19	45423658	C	A
rs2308321	20096652	4255	MGMT	umls:C0376358	BeFree	MGMT Ile143Val polymorphism, dietary factors and the risk of breast, colorectal and prostate cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk study.	0.009001189	2010	MGMT;LOC105378559	10	129766800	A	G
rs2387084	23920401	4613	MYCN	umls:C0376358	BeFree	We found that PSMD7 rs2387084 and MYCN rs1429409 were significantly related to earlier onset of prostate cancer and advanced clinical stage, respectively.	0.001085767	2013	NA	16	74054192	T	G
rs2387084	23920401	5713	PSMD7	umls:C0376358	BeFree	We found that PSMD7 rs2387084 and MYCN rs1429409 were significantly related to earlier onset of prostate cancer and advanced clinical stage, respectively.	0.000542884	2013	NA	16	74054192	T	G
rs2405942	23535732	357	SHROOM2	umls:C0376358	GWASCAT	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	0.12	2013	SHROOM2	X	9846095	G	A
rs2410373	17903305	4481	MSR1	umls:C0376358	BeFree	In analysis of selected candidate cancer susceptibility genes, two MSR1 SNPs (rs9325782, GEE p = 0.008 and rs2410373, FBAT p = 0.021) were associated with prostate cancer and three ERBB4 SNPs (rs905883 GEE p = 0.0002, rs7564590 GEE p = 0.003, rs7558615 GEE p = 0.0078) were associated with breast cancer.	0.167839916	2007	NA	8	16066997	A	C
rs25487	19914098	7515	XRCC1	umls:C0376358	BeFree	We examined the association between PC risk with nonsynonymous SNPs (nsSNPs) in 5 genes involved in 3 DNA-repair pathways: (1) base excision repair (BER): hOGG1 C1245G (Ser326Cys) and XRCC1 G28152A (Arg399Gln); (2) nucleotide excision repair (NER): XPD G23591A (Asp312Asn); (3) homologous recombination repair: RAD51 G135C (in 5' untranslated region) and XRCC3 C18067T (Thr241Met).	0.04702559	2011	XRCC1	19	43551574	T	C
rs25487	17196815	7515	XRCC1	umls:C0376358	BeFree	This is the first report on the studies of XPC and XRCC1 Arg194Trp polymorphisms in PC, and our present data suggest that XPC Lys939Gln and the T-A haplotype of XRCC1 Arg194Trp and Arg399Gln may be risk factors for PC in Japanese.	0.04702559	2007	XRCC1	19	43551574	T	C
rs25487	16030105	7515	XRCC1	umls:C0376358	BeFree	We found that the XRCC1-Arg399Gln AA and the MGMT-Leu84Phe CT+TT genotypes were associated with an increased risk of prostate cancer [odds ratio (OR), 2.18; 95% confidence interval (CI), 0.99-4.81 and OR, 1.99; 95% CI, 1.19-3.34, respectively].	0.04702559	2005	XRCC1	19	43551574	T	C
rs25487	21647176	7515	XRCC1	umls:C0376358	BeFree	XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis.	0.04702559	2011	XRCC1	19	43551574	T	C
rs25487	19914098	7517	XRCC3	umls:C0376358	BeFree	We examined the association between PC risk with nonsynonymous SNPs (nsSNPs) in 5 genes involved in 3 DNA-repair pathways: (1) base excision repair (BER): hOGG1 C1245G (Ser326Cys) and XRCC1 G28152A (Arg399Gln); (2) nucleotide excision repair (NER): XPD G23591A (Asp312Asn); (3) homologous recombination repair: RAD51 G135C (in 5' untranslated region) and XRCC3 C18067T (Thr241Met).	0.008458305	2011	XRCC1	19	43551574	T	C
rs25487	25262700	7515	XRCC1	umls:C0376358	BeFree	X-ray repair cross-complementing group 1 (XRCC1) Arg399Gln polymorphism significantly associated with prostate cancer.	0.04702559	2014	XRCC1	19	43551574	T	C
rs25487	19428062	7515	XRCC1	umls:C0376358	BeFree	XRCC1 genetic polymorphism Arg399Gln and prostate cancer risk: a meta-analysis.	0.04702559	2009	XRCC1	19	43551574	T	C
rs25487	19914098	2068	ERCC2	umls:C0376358	BeFree	We examined the association between PC risk with nonsynonymous SNPs (nsSNPs) in 5 genes involved in 3 DNA-repair pathways: (1) base excision repair (BER): hOGG1 C1245G (Ser326Cys) and XRCC1 G28152A (Arg399Gln); (2) nucleotide excision repair (NER): XPD G23591A (Asp312Asn); (3) homologous recombination repair: RAD51 G135C (in 5' untranslated region) and XRCC3 C18067T (Thr241Met).	0.01482102	2011	XRCC1	19	43551574	T	C
rs25487	16030105	4255	MGMT	umls:C0376358	BeFree	We found that the XRCC1-Arg399Gln AA and the MGMT-Leu84Phe CT+TT genotypes were associated with an increased risk of prostate cancer [odds ratio (OR), 2.18; 95% confidence interval (CI), 0.99-4.81 and OR, 1.99; 95% CI, 1.19-3.34, respectively].	0.009001189	2005	XRCC1	19	43551574	T	C
rs25487	17196815	7508	XPC	umls:C0376358	BeFree	This is the first report on the studies of XPC and XRCC1 Arg194Trp polymorphisms in PC, and our present data suggest that XPC Lys939Gln and the T-A haplotype of XRCC1 Arg194Trp and Arg399Gln may be risk factors for PC in Japanese.	0.006362715	2007	XRCC1	19	43551574	T	C
rs25487	19914098	5888	RAD51	umls:C0376358	BeFree	We examined the association between PC risk with nonsynonymous SNPs (nsSNPs) in 5 genes involved in 3 DNA-repair pathways: (1) base excision repair (BER): hOGG1 C1245G (Ser326Cys) and XRCC1 G28152A (Arg399Gln); (2) nucleotide excision repair (NER): XPD G23591A (Asp312Asn); (3) homologous recombination repair: RAD51 G135C (in 5' untranslated region) and XRCC3 C18067T (Thr241Met).	0.003995683	2011	XRCC1	19	43551574	T	C
rs2660	21638280	4938	OAS1	umls:C0376358	BeFree	OAS1 rs2660 may be a prostate cancer susceptibility polymorphism, which is a significant observation, especially in a context of the OAS1-RNaseL pathway.	0.000542884	2011	OAS1	12	112919637	G	A
rs2660753	22549899	354	KLK3	umls:C0376358	BeFree	Four GWAS replication SNPs (rs2660753, rs13254738, rs10090154, rs2735839) and seven flanking SNPs were associated with CaP aggressiveness (P < 0.05) in three genomic regions: One at 3p12 (EA), seven at 8q24 (5 AA, 2 EA), and three at 19q13 at the kallilkrein-related peptidase 3 (KLK3) locus (two AA, one AA and EA).	0.261542831	2013	NA	3	87061524	T	C
rs2664155	17085659	6625	SNRNP70	umls:C0376358	BeFree	Among the SNPs studied, the A allele of the KLK2-SNP1 (G>A, rs2664155) and the T allele of the KLK2-SNP5 (C>T, rs198977) polymorphisms showed positive associations with prostate cancer, adjusted ORs for KLK2-SNP1 AG and AA genotypes being 1.4 [95% confidence interval (95% CI), 1.2-1.8; P=0.002] and for KLK2-SNP5 TT or CT genotypes being 1.3 (95% CI, 1.1-1.6; P=0.05).	0.000814326	2006	KLK3;KLK2	19	50873774	G	A
rs2665582	24682418	1312	COMT	umls:C0376358	BeFree	According to a multivariate analysis, CYP1B1 (rs1800440), COMT (rs16982844), and SULT2B1 (rs12460535, rs2665582, rs10426628) were significantly associated with prostate cancer progression and hormone levels.	0.021107791	2015	SULT2B1	19	48584410	T	C
rs2665582	24682418	1545	CYP1B1	umls:C0376358	BeFree	According to a multivariate analysis, CYP1B1 (rs1800440), COMT (rs16982844), and SULT2B1 (rs12460535, rs2665582, rs10426628) were significantly associated with prostate cancer progression and hormone levels.	0.041205759	2015	SULT2B1	19	48584410	T	C
rs266882	17961073	5660	PSAP	umls:C0376358	GAD	[PSAP may play a significant role in the development of PCa ]	0.003724241	2007	KLK3	19	50854757	G	A
rs266882	23235975	1475	CSTA	umls:C0376358	BeFree	Association of G/A polymorphism, rs266882, in AREI region of the prostate-specific antigen gene with prostate cancer risk and clinicopathological features.	0.001085767	2012	KLK3	19	50854757	G	A
rs266882	18827812	29968	PSAT1	umls:C0376358	BeFree	Effects of G/A polymorphism, rs266882, in the androgen response element 1 of the PSA gene on prostate cancer risk, survival and circulating PSA levels.	0.058631444	2008	KLK3	19	50854757	G	A
rs266882	23235975	354	KLK3	umls:C0376358	BeFree	Association of G/A polymorphism, rs266882, in AREI region of the prostate-specific antigen gene with prostate cancer risk and clinicopathological features.	0.261542831	2012	KLK3	19	50854757	G	A
rs266882	18827812	6293	VPS52	umls:C0376358	BeFree	Studies of a single nucleotide polymorphism (PSA -158 G/A, rs266882) in ARE1 of the PSA gene have been conflicting for risk of prostate cancer and effect on plasma PSA levels.	0.003724241	2008	KLK3	19	50854757	G	A
rs2670660	22067658	22861	NLRP1	umls:C0376358	BeFree	Expression of snpRNAs in human and mouse cells markedly affects cellular behavior and induces allele-specific clinically relevant phenotypic changes: NLRP1-locus snpRNAs rs2670660 exert regulatory effects on monocyte/macrophage transdifferentiation, induce prostate cancer (PC) susceptibility snpRNAs and transform low-malignancy hormone-dependent human PC cells into highly malignant androgen-independent PC.	0.000271442	2011	NA	17	5615686	A	G
rs2735839	20460480	3817	KLK2	umls:C0376358	BeFree	The rs61752561 in KLK3 and rs2735839 in the KLK2-KLK3 intergenic region were strongly associated with prostate cancer-specific survival, and rs10486567 in the 7JAZF1 gene were associated with biochemical recurrence.	0.030456367	2010	KLK3	19	50861367	A	G
rs2735839	25274378	354	KLK3	umls:C0376358	BeFree	The prostate cancer susceptibility variant rs2735839 near KLK3 gene is associated with aggressive prostate cancer and can stratify gleason score 7 patients.	0.261542831	2015	KLK3	19	50861367	A	G
rs2735839	25715684	354	KLK3	umls:C0376358	BeFree	Our results provide further support that a PC-risk SNP rs2735839 near the KLK3 gene on chromosome 19q13 may be associated with aggressive and high-grade PC.	0.261542831	2015	KLK3	19	50861367	A	G
rs2735839	20460480	354	KLK3	umls:C0376358	BeFree	The rs61752561 in KLK3 and rs2735839 in the KLK2-KLK3 intergenic region were strongly associated with prostate cancer-specific survival, and rs10486567 in the 7JAZF1 gene were associated with biochemical recurrence.	0.261542831	2010	KLK3	19	50861367	A	G
rs2735839	22549899	354	KLK3	umls:C0376358	BeFree	Four GWAS replication SNPs (rs2660753, rs13254738, rs10090154, rs2735839) and seven flanking SNPs were associated with CaP aggressiveness (P < 0.05) in three genomic regions: One at 3p12 (EA), seven at 8q24 (5 AA, 2 EA), and three at 19q13 at the kallilkrein-related peptidase 3 (KLK3) locus (two AA, one AA and EA).	0.261542831	2013	KLK3	19	50861367	A	G
rs2736098	23246478	354	KLK3	umls:C0376358	BeFree	The genotypes of 4 single nucleotide polymorphisms previously associated with serum prostate specific antigen levels (rs2736098, rs10788160, rs11067228 and rs17632542) were determined in 964 healthy Caucasian volunteers without prostate cancer.	0.261542831	2013	TERT	5	1293971	C	T
rs2745557	22435969	5743	PTGS2	umls:C0376358	BeFree	Association between COX-2 rs2745557 polymorphism and prostate cancer risk: a systematic review and meta-analysis.	0.048415137	2012	PTGS2;PACERR	1	186680089	A	G
rs2758330	20477822	6648	SOD2	umls:C0376358	BeFree	Two variants in SOD2 were significantly associated with the risk of aggressive prostate cancer (rs17884057, odds ratio 0.83, 95% confidence interval 0.70-0.99; and rs4816407, 1.27, 1.02-1.57); men with A alleles at rs2842958 in SOD2 had lower plasma selenium levels (median 116 vs 121.8 µg/L, P= 0.03); and the association between plasma selenium levels and risk of aggressive prostate cancer was modified by SOD1 (rs10432782) and SOD2 (rs2758330).	0.044854055	2011	SOD2	6	159683812	G	T
rs2758330	20477822	6647	SOD1	umls:C0376358	BeFree	Two variants in SOD2 were significantly associated with the risk of aggressive prostate cancer (rs17884057, odds ratio 0.83, 95% confidence interval 0.70-0.99; and rs4816407, 1.27, 1.02-1.57); men with A alleles at rs2842958 in SOD2 had lower plasma selenium levels (median 116 vs 121.8 µg/L, P= 0.03); and the association between plasma selenium levels and risk of aggressive prostate cancer was modified by SOD1 (rs10432782) and SOD2 (rs2758330).	0.010553895	2011	SOD2	6	159683812	G	T
rs2807031	25217961	170626	XAGE3	umls:C0376358	GWASCAT	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	0.12	2014	XAGE3	X	52867918	T	C
rs2842958	20477822	6648	SOD2	umls:C0376358	BeFree	Two variants in SOD2 were significantly associated with the risk of aggressive prostate cancer (rs17884057, odds ratio 0.83, 95% confidence interval 0.70-0.99; and rs4816407, 1.27, 1.02-1.57); men with A alleles at rs2842958 in SOD2 had lower plasma selenium levels (median 116 vs 121.8 µg/L, P= 0.03); and the association between plasma selenium levels and risk of aggressive prostate cancer was modified by SOD1 (rs10432782) and SOD2 (rs2758330).	0.044854055	2011	SOD2	6	159687393	A	G
rs2842958	20477822	6647	SOD1	umls:C0376358	BeFree	Two variants in SOD2 were significantly associated with the risk of aggressive prostate cancer (rs17884057, odds ratio 0.83, 95% confidence interval 0.70-0.99; and rs4816407, 1.27, 1.02-1.57); men with A alleles at rs2842958 in SOD2 had lower plasma selenium levels (median 116 vs 121.8 µg/L, P= 0.03); and the association between plasma selenium levels and risk of aggressive prostate cancer was modified by SOD1 (rs10432782) and SOD2 (rs2758330).	0.010553895	2011	SOD2	6	159687393	A	G
rs2853669	25296732	7015	TERT	umls:C0376358	BeFree	TERT polymorphisms rs2853669 and rs7726159 influence on prostate cancer risk in Russian population.	0.12643866	2014	TERT	5	1295234	A	G
rs2854774	24457161	3486	IGFBP3	umls:C0376358	BeFree	IGFBP-3 promoter polymorphism -202A>C (rs2854774) contributes to prostate cancer risk: evidence based on 9,482 subjects.	0.041162152	2013	NA	NA	NA	NA	NA
rs28931589	NA	1499	CTNNB1	umls:C0376358	CLINVAR	NA	0.202171535	NA	CTNNB1	3	41224613	G	A,T
rs3096702	23535732	4855	NOTCH4	umls:C0376358	GWASCAT	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	0.12	2013	NOTCH4	6	32224554	A	G
rs3136534	20184734	3558	IL2	umls:C0376358	BeFree	We genotyped six variants previously associated with autoimmune disease (namely rs13151961, rs13119723, rs17388568, rs3136534, rs6822844 and rs6840978) and one functional IL-2 promoter variant (rs2069762) for possible association with prostate cancer risk using the Australian Risk Factors for Prostate Cancer case-control Study.	0.006634157	2010	NA	4	122448621	T	G
rs339331	23803082	222546	RFX6	umls:C0376358	BeFree	rs339331 in the RFX6 gene may be associated with prostate cancer as a susceptibility locus in northern Chinese men.	0.123995683	2014	RFX6	6	116888889	T	C
rs339331	22662242	60526	C2orf43	umls:C0376358	BeFree	We successfully replicated the association of rs13385191 (located in the C2orf43 gene, P = 8.60×10(-5)), rs12653946 (P = 1.33×10(-6)), rs1983891 (FOXP4, P = 6.22×10(-5)), and rs339331 (GPRC6A/RFX6, P = 1.42×10(-5)) with prostate cancer.	0.000542884	2012	RFX6	6	116888889	T	C
rs339331	20676098	222546	RFX6	umls:C0376358	GWASCAT	In addition, we report here five new loci for prostate cancer susceptibility, at 5p15 (lambda-corrected probability P(GC) = 3.9 x 10(-18)), GPRC6A/RFX6 (P(GC) = 1.6 x 10(-12)), 13q22 (P(GC) = 2.8 x 10(-9)), C2orf43 (P(GC) = 7.5 x 10(-8)) and FOXP4 (P(GC) = 7.6 x 10(-8)).	0.123995683	2010	RFX6	6	116888889	T	C
rs34152967	16114055	6041	RNASEL	umls:C0376358	BeFree	We examined polymorphisms within ELAC2 (S217L, A541T, E622V), MSR1 (P275A, R293X, aIVS5-59c), and RNASEL (E265X, R462Q, D541E) in 150 European-Americans with metastatic prostate cancer and 170 prostate cancer-free controls using pyrosequencing assays.	0.061998501	2006	NA	NA	NA	NA	NA
rs351855	19918264	2264	FGFR4	umls:C0376358	BeFree	FGFR4 Gly388Arg polymorphism and prostate cancer risk in Scottish men.	0.013268314	2010	FGFR4	5	177093242	G	A
rs351855	16061909	2264	FGFR4	umls:C0376358	BeFree	The Gly388Arg polymorphism in the FGFR4 gene was reported to modulate cancer cell migration in vitro and to be associated with breast, colon, and prostate cancer prognostic parameters.	0.013268314	2005	FGFR4	5	177093242	G	A
rs351855	21349172	2264	FGFR4	umls:C0376358	BeFree	FGFR4 Gly388Arg polymorphism contributes to prostate cancer development and progression: a meta-analysis of 2618 cases and 2305 controls.	0.013268314	2011	FGFR4	5	177093242	G	A
rs35882952	17344846	2048	EPHB2	umls:C0376358	UNIPROT	Patterns of somatic mutation in human cancer genomes.	0.131867498	2007	EPHB2;MIR4253	1	22863060	G	C,T
rs3734444	22844442	653	BMP5	umls:C0376358	BeFree	Our results suggest that CASP3 rs4862396, BMP5 rs3734444 and IRS2 rs7986346 may affect the survival in patients after ADT for prostate cancer, and the analysis of these SNPs can help identify patients at higher risk of poor outcome.	0.000271442	2012	BMP5	6	55874755	A	G
rs3734444	22844442	8660	IRS2	umls:C0376358	BeFree	Our results suggest that CASP3 rs4862396, BMP5 rs3734444 and IRS2 rs7986346 may affect the survival in patients after ADT for prostate cancer, and the analysis of these SNPs can help identify patients at higher risk of poor outcome.	0.00554839	2012	BMP5	6	55874755	A	G
rs3734444	22844442	836	CASP3	umls:C0376358	BeFree	Our results suggest that CASP3 rs4862396, BMP5 rs3734444 and IRS2 rs7986346 may affect the survival in patients after ADT for prostate cancer, and the analysis of these SNPs can help identify patients at higher risk of poor outcome.	0.005428837	2012	BMP5	6	55874755	A	G
rs3736001	21497359	354	KLK3	umls:C0376358	BeFree	When considering clinical factors, rs3736001, which is a nonsynonymous cDNA single nucleotide polymorphism (Glu39Lys), showed an association with prostate specific antigen 10 ng/ml or greater and prostate cancer risk.	0.261542831	2011	PSCA	8	142681389	G	A
rs3750861	17223258	1316	KLF6	umls:C0376358	BeFree	The rs3750861 affects expression of KLF6 splicing variants in prostate cancer and we found that its rare allele is associated with reduced lung cancer risk (odds ratio, 0.5; 95% CI, 0.3-0.8).	0.012062995	2007	KLF6	10	3782241	C	T
rs3771570	23535732	9855	FARP2	umls:C0376358	GWASCAT	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	0.12	2013	FARP2	2	241443449	C	T
rs378854	21814516	7528	YY1	umls:C0376358	BeFree	In conclusion, we identified a new functional prostate cancer risk variant at the 8q24 locus, rs378854 allele G, that reduces binding of the YY1 protein and is associated with increased expression of PVT1 located 0.5 Mb downstream.	0.000542884	2011	CASC8;CASC21	8	127311574	C	T
rs3803185	22028916	115761	ARL11	umls:C0376358	BeFree	Contribution of ARLTS1 Cys148Arg (T442C) variant with prostate cancer risk and ARLTS1 function in prostate cancer cells.	0.000542884	2011	ARL11	13	49630889	T	C
rs3850699	23535732	81603	TRIM8	umls:C0376358	GWASCAT	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	0.12	2013	TRIM8;LOC105378460	10	102654464	A	G
rs386493716	16030105	4255	MGMT	umls:C0376358	BeFree	We found that the XRCC1-Arg399Gln AA and the MGMT-Leu84Phe CT+TT genotypes were associated with an increased risk of prostate cancer [odds ratio (OR), 2.18; 95% confidence interval (CI), 0.99-4.81 and OR, 1.99; 95% CI, 1.19-3.34, respectively].	0.009001189	2005	NA	NA	NA	NA	NA
rs386493716	25262700	7515	XRCC1	umls:C0376358	BeFree	X-ray repair cross-complementing group 1 (XRCC1) Arg399Gln polymorphism significantly associated with prostate cancer.	0.04702559	2014	NA	NA	NA	NA	NA
rs386493716	16030105	7515	XRCC1	umls:C0376358	BeFree	We found that the XRCC1-Arg399Gln AA and the MGMT-Leu84Phe CT+TT genotypes were associated with an increased risk of prostate cancer [odds ratio (OR), 2.18; 95% confidence interval (CI), 0.99-4.81 and OR, 1.99; 95% CI, 1.19-3.34, respectively].	0.04702559	2005	NA	NA	NA	NA	NA
rs386493716	19914098	7515	XRCC1	umls:C0376358	BeFree	We examined the association between PC risk with nonsynonymous SNPs (nsSNPs) in 5 genes involved in 3 DNA-repair pathways: (1) base excision repair (BER): hOGG1 C1245G (Ser326Cys) and XRCC1 G28152A (Arg399Gln); (2) nucleotide excision repair (NER): XPD G23591A (Asp312Asn); (3) homologous recombination repair: RAD51 G135C (in 5' untranslated region) and XRCC3 C18067T (Thr241Met).	0.04702559	2011	NA	NA	NA	NA	NA
rs386493716	19914098	5888	RAD51	umls:C0376358	BeFree	We examined the association between PC risk with nonsynonymous SNPs (nsSNPs) in 5 genes involved in 3 DNA-repair pathways: (1) base excision repair (BER): hOGG1 C1245G (Ser326Cys) and XRCC1 G28152A (Arg399Gln); (2) nucleotide excision repair (NER): XPD G23591A (Asp312Asn); (3) homologous recombination repair: RAD51 G135C (in 5' untranslated region) and XRCC3 C18067T (Thr241Met).	0.003995683	2011	NA	NA	NA	NA	NA
rs386493716	19914098	2068	ERCC2	umls:C0376358	BeFree	We examined the association between PC risk with nonsynonymous SNPs (nsSNPs) in 5 genes involved in 3 DNA-repair pathways: (1) base excision repair (BER): hOGG1 C1245G (Ser326Cys) and XRCC1 G28152A (Arg399Gln); (2) nucleotide excision repair (NER): XPD G23591A (Asp312Asn); (3) homologous recombination repair: RAD51 G135C (in 5' untranslated region) and XRCC3 C18067T (Thr241Met).	0.01482102	2011	NA	NA	NA	NA	NA
rs386493716	19914098	7517	XRCC3	umls:C0376358	BeFree	We examined the association between PC risk with nonsynonymous SNPs (nsSNPs) in 5 genes involved in 3 DNA-repair pathways: (1) base excision repair (BER): hOGG1 C1245G (Ser326Cys) and XRCC1 G28152A (Arg399Gln); (2) nucleotide excision repair (NER): XPD G23591A (Asp312Asn); (3) homologous recombination repair: RAD51 G135C (in 5' untranslated region) and XRCC3 C18067T (Thr241Met).	0.008458305	2011	NA	NA	NA	NA	NA
rs386493716	19428062	7515	XRCC1	umls:C0376358	BeFree	XRCC1 genetic polymorphism Arg399Gln and prostate cancer risk: a meta-analysis.	0.04702559	2009	NA	NA	NA	NA	NA
rs386493716	17196815	7515	XRCC1	umls:C0376358	BeFree	This is the first report on the studies of XPC and XRCC1 Arg194Trp polymorphisms in PC, and our present data suggest that XPC Lys939Gln and the T-A haplotype of XRCC1 Arg194Trp and Arg399Gln may be risk factors for PC in Japanese.	0.04702559	2007	NA	NA	NA	NA	NA
rs386493716	17196815	7508	XPC	umls:C0376358	BeFree	This is the first report on the studies of XPC and XRCC1 Arg194Trp polymorphisms in PC, and our present data suggest that XPC Lys939Gln and the T-A haplotype of XRCC1 Arg194Trp and Arg399Gln may be risk factors for PC in Japanese.	0.006362715	2007	NA	NA	NA	NA	NA
rs386493716	21647176	7515	XRCC1	umls:C0376358	BeFree	XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis.	0.04702559	2011	NA	NA	NA	NA	NA
rs386519031	18949419	3091	HIF1A	umls:C0376358	BeFree	In previous studies, the C1772T (P582S) or the G1790A (A588T) polymorphisms of the HIF-1alpha gene have been identified in renal cell carcinoma, head and neck and esophageal squamous cell carcinomas as well as colorectal and prostate cancers.	0.02711185	2008	NA	NA	NA	NA	NA
rs386519031	23723982	3091	HIF1A	umls:C0376358	BeFree	The current findings suggest that HIF1A P582S polymorphism correlates with urinary cancers risk in Caucasian population, while A588T polymorphism may increase the risk of urinary cancers in Asian population and prostate cancer.	0.02711185	2013	NA	NA	NA	NA	NA
rs386526551	16030105	7515	XRCC1	umls:C0376358	BeFree	We found that the XRCC1-Arg399Gln AA and the MGMT-Leu84Phe CT+TT genotypes were associated with an increased risk of prostate cancer [odds ratio (OR), 2.18; 95% confidence interval (CI), 0.99-4.81 and OR, 1.99; 95% CI, 1.19-3.34, respectively].	0.04702559	2005	NA	NA	NA	NA	NA
rs386526551	16030105	4255	MGMT	umls:C0376358	BeFree	We found that the XRCC1-Arg399Gln AA and the MGMT-Leu84Phe CT+TT genotypes were associated with an increased risk of prostate cancer [odds ratio (OR), 2.18; 95% confidence interval (CI), 0.99-4.81 and OR, 1.99; 95% CI, 1.19-3.34, respectively].	0.009001189	2005	NA	NA	NA	NA	NA
rs3865443	21741862	43849	KLK12	umls:C0376358	BeFree	Analysis of a combined sample of 3,153 cases and 3,199 controls revealed the KLK12 tagSNP rs3865443 to be marginally statistically significantly associated with risk of prostate cancer.	0.003181358	2011	KLK12	19	51034426	C	A
rs386545044	17661168	11200	CHEK2	umls:C0376358	BeFree	Intriguingly, two other CHEK2 mutations (IVS2+1G>A and I157T) and a CHEK2 large genomic deletion (del9-10) have been associated with an elevated risk for prostate cancer.	0.138349765	2008	NA	NA	NA	NA	NA
rs386545546	21647176	7515	XRCC1	umls:C0376358	BeFree	XRCC1 Arg399Gln and Arg194Trp polymorphisms in prostate cancer risk: a meta-analysis.	0.04702559	2011	NA	NA	NA	NA	NA
rs386545546	24492938	7515	XRCC1	umls:C0376358	BeFree	In conclusion, the meta-analysis suggests that there is no obvious association between XRCC1 Arg194Trp polymorphism and prostate cancer risk.	0.04702559	2013	NA	NA	NA	NA	NA
rs386545546	17196815	7515	XRCC1	umls:C0376358	BeFree	This is the first report on the studies of XPC and XRCC1 Arg194Trp polymorphisms in PC, and our present data suggest that XPC Lys939Gln and the T-A haplotype of XRCC1 Arg194Trp and Arg399Gln may be risk factors for PC in Japanese.	0.04702559	2007	NA	NA	NA	NA	NA
rs386545546	17196815	7508	XPC	umls:C0376358	BeFree	This is the first report on the studies of XPC and XRCC1 Arg194Trp polymorphisms in PC, and our present data suggest that XPC Lys939Gln and the T-A haplotype of XRCC1 Arg194Trp and Arg399Gln may be risk factors for PC in Japanese.	0.006362715	2007	NA	NA	NA	NA	NA
rs386555427	18163425	8797	TNFRSF10A	umls:C0376358	BeFree	The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases.	0.003724241	2008	NA	NA	NA	NA	NA
rs386596027	17407163	6041	RNASEL	umls:C0376358	BeFree	RNASEL Arg462Gln polymorphism and prostate cancer in PLCO.	0.061998501	2007	NA	NA	NA	NA	NA
rs386596027	23098452	6041	RNASEL	umls:C0376358	BeFree	To answer questions regarding the prevalence of XMRV in Iranian patients with prostate cancer and its association with the RNASEL R462Q polymorphism, we here investigated a series of cases in Kerman, in the Southeast of Iran, and sought to verify the association with the R462Q using Real Time PCR Method.	0.061998501	2012	NA	NA	NA	NA	NA
rs386596027	15330212	6041	RNASEL	umls:C0376358	BeFree	Although an increasing number of studies report an association between the RNASEL G1385A variant and prostate cancer risk; this variant does not appear to be implicated in the development of breast cancer.	0.061998501	2004	NA	NA	NA	NA	NA
rs386596027	21656378	6041	RNASEL	umls:C0376358	BeFree	RNASEL Asp541Glu and Arg462Gln polymorphisms in prostate cancer risk: evidences from a meta-analysis.	0.061998501	2012	NA	NA	NA	NA	NA
rs386596027	16054567	6041	RNASEL	umls:C0376358	BeFree	Arg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study.	0.061998501	2005	NA	NA	NA	NA	NA
rs386596027	16114055	6041	RNASEL	umls:C0376358	BeFree	We examined polymorphisms within ELAC2 (S217L, A541T, E622V), MSR1 (P275A, R293X, aIVS5-59c), and RNASEL (E265X, R462Q, D541E) in 150 European-Americans with metastatic prostate cancer and 170 prostate cancer-free controls using pyrosequencing assays.	0.061998501	2006	NA	NA	NA	NA	NA
rs386596027	20936978	6041	RNASEL	umls:C0376358	BeFree	There are questions regarding the prevalence of xenotropic murine leukemia virus-related virus (XMRV) in patients with prostate cancer and its association with the RNASEL R462Q polymorphism.	0.061998501	2010	NA	NA	NA	NA	NA
rs386596027	21447170	6041	RNASEL	umls:C0376358	BeFree	Xenotropic murine leukemia virus (MLV)-related virus (XMRV) was initially identified in prostate cancer (PCa) tissue, particularly in the prostatic stromal fibroblasts, of patients homozygous for the RNASEL R462Q mutation.	0.061998501	2011	NA	NA	NA	NA	NA
rs386596027	12415269	6041	RNASEL	umls:C0376358	BeFree	RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases.	0.061998501	2002	NA	NA	NA	NA	NA
rs386596027	17234723	6041	RNASEL	umls:C0376358	BeFree	This suggests that among Caucasians, positive association between higher trans-fatty acid consumption and prostate cancer may be modified by the functional RNASEL variant R462Q.	0.061998501	2007	NA	NA	NA	NA	NA
rs386596107	17646272	6648	SOD2	umls:C0376358	BeFree	Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study.	0.044854055	2007	NA	NA	NA	NA	NA
rs386596107	19647296	6648	SOD2	umls:C0376358	BeFree	To examine the association between 2 mitochondrial manganese superoxide dismutase (MnSOD) genetic polymorphisms (Ala-9Val and Ala-16Val) and prostate cancer susceptibility.	0.044854055	2009	NA	NA	NA	NA	NA
rs386602167	21656378	6041	RNASEL	umls:C0376358	BeFree	RNASEL Asp541Glu and Arg462Gln polymorphisms in prostate cancer risk: evidences from a meta-analysis.	0.061998501	2012	NA	NA	NA	NA	NA
rs386602167	16114055	6041	RNASEL	umls:C0376358	BeFree	We examined polymorphisms within ELAC2 (S217L, A541T, E622V), MSR1 (P275A, R293X, aIVS5-59c), and RNASEL (E265X, R462Q, D541E) in 150 European-Americans with metastatic prostate cancer and 170 prostate cancer-free controls using pyrosequencing assays.	0.061998501	2006	NA	NA	NA	NA	NA
rs386626619	20966544	3717	JAK2	umls:C0376358	BeFree	Activating mutation (V617F) in the tyrosine kinase JAK2 is absent in locally-confined or castration-resistant prostate cancer.	0.002171535	2010	NA	NA	NA	NA	NA
rs386626619	20966544	6776	STAT5A	umls:C0376358	BeFree	Future work should focus on determining the molecular mechanisms other than V617F mutation of Jak2 resulting in continuous Stat5 activation in clinical prostate cancers.	0.003800186	2010	NA	NA	NA	NA	NA
rs386626619	20966544	6777	STAT5B	umls:C0376358	BeFree	Future work should focus on determining the molecular mechanisms other than V617F mutation of Jak2 resulting in continuous Stat5 activation in clinical prostate cancers.	0.002985861	2010	NA	NA	NA	NA	NA
rs387906417	NA	4601	MXI1	umls:C0376358	CLINVAR	NA	0.241628651	NA	MXI1	10	110279296	T	C
rs397507444	23459165	4524	MTHFR	umls:C0376358	BeFree	Genetic polymorphisms in MTHFR (C677T, A1298C), MTR (A2756G) and MTRR (A66G) genes associated with pathological characteristics of prostate cancer in the Ecuadorian population.	0.03010898	2014	MTHFR	1	11794407	T	G
rs397507444	23459165	4548	MTR	umls:C0376358	BeFree	Genetic polymorphisms in MTHFR (C677T, A1298C), MTR (A2756G) and MTRR (A66G) genes associated with pathological characteristics of prostate cancer in the Ecuadorian population.	0.008729747	2014	MTHFR	1	11794407	T	G
rs397507444	20564317	4524	MTHFR	umls:C0376358	BeFree	Relationship between three polymorphisms of methylenetetrahydrofolate reductase (MTHFR C677T, A1298C, and G1793A) gene and risk of prostate cancer: a case-control study.	0.03010898	2010	MTHFR	1	11794407	T	G
rs397507444	23459165	4552	MTRR	umls:C0376358	BeFree	Genetic polymorphisms in MTHFR (C677T, A1298C), MTR (A2756G) and MTRR (A66G) genes associated with pathological characteristics of prostate cancer in the Ecuadorian population.	0.010011012	2014	MTHFR	1	11794407	T	G
rs397507444	19814618	4524	MTHFR	umls:C0376358	BeFree	The analysis of the relationship between A1298C and C677T polymorphisms of the MTHFR gene with prostate cancer in Eskisehir population.	0.03010898	2009	MTHFR	1	11794407	T	G
rs397507444	15298954	4524	MTHFR	umls:C0376358	BeFree	Relationship between methylenetetrahydrofolate reductase C677T and A1298C genotypes and haplotypes and prostate cancer risk and aggressiveness.	0.03010898	2004	MTHFR	1	11794407	T	G
rs4073	20431935	3576	CXCL8	umls:C0376358	BeFree	After adjustment for confounders, polymorphisms in COX-2 (rs689466) and IL-8 (rs4073) were not significantly associated with prostate cancer risk.	0.024788425	2010	CXCL8	4	73740307	A	T
rs4073	20431935	5743	PTGS2	umls:C0376358	BeFree	After adjustment for confounders, polymorphisms in COX-2 (rs689466) and IL-8 (rs4073) were not significantly associated with prostate cancer risk.	0.048415137	2010	CXCL8	4	73740307	A	T
rs41322052	22317880	4846	NOS3	umls:C0376358	BeFree	Effects of the T-786C, G894T, and Intron 4 VNTR (4a/b) polymorphisms of the endothelial nitric oxide synthase gene on the risk of prostate cancer.	0.019359587	2012	NOS3	7	150993018	C	T
rs41322052	25040995	4846	NOS3	umls:C0376358	BeFree	This meta-analysis indicated that the eNOS T-786C polymorphism is associated with elevated cancer risk; the G894T polymorphism contributes to susceptibility to breast cancer and cancer generally in females; and the 4a/b polymorphism may be associated with prostate cancer risk.	0.019359587	2015	NOS3	7	150993018	C	T
rs41341748	15734964	4481	MSR1	umls:C0376358	BeFree	Macrophage scavenger receptor 1 999C>T (R293X) mutation and risk of prostate cancer.	0.167839916	2005	MSR1	8	16155085	G	A,C
rs41341748	NA	4481	MSR1	umls:C0376358	CLINVAR	NA	0.167839916	NA	MSR1	8	16155085	G	A,C
rs4245739	23535732	4194	MDM4	umls:C0376358	GWASCAT	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	0.123724241	2013	MDM4	1	204549714	C	A
rs4430796	21499250	6928	HNF1B	umls:C0376358	BeFree	We identified an endometrial cancer susceptibility locus close to HNF1B at 17q12 (rs4430796, P = 7.1 × 10(-10)) that is also associated with risk of prostate cancer and is inversely associated with risk of type 2 diabetes.	0.168773794	2011	HNF1B	17	37738049	A	G
rs4430796	25177939	7417	VDAC2	umls:C0376358	BeFree	The meta-analysis of all the studies revealed that the rs4430796 polymorphism was significantly associated with an increased risk of prostate cancer in all contrast models (ORA vs G = 1.25, 95%CI = 1.21-1.30, POR < 0.001; ORAA vs GG = 1.53, 95%CI = 1.45-1.62, POR < 0.001; ORAG vs GG = 1.24, 95%CI = 1.16-1.34, POR < 0.001; ORAA vs AG+GG = 1.36, 95%CI = 1.30-1.42, POR < 0.001; ORAA+AG vs GG = 1.37, 95%CI = 1.30-1.44, POR < 0.001).	0.000271442	2015	HNF1B	17	37738049	A	G
rs4430796	17603485	6928	HNF1B	umls:C0376358	GWASCAT	Two variants on chromosome 17 confer prostate cancer risk, and the one in TCF2 protects against type 2 diabetes.	0.168773794	2007	HNF1B	17	37738049	A	G
rs4430796	18264096	6928	HNF1B	umls:C0376358	GWASCAT	Multiple loci identified in a genome-wide association study of prostate cancer.	0.168773794	2008	HNF1B	17	37738049	A	G
rs4466137	17903305	1404	HAPLN1	umls:C0376358	GAD	[A genome-wide association study of breast and prostate cancer in the NHLBI's Framingham Heart Study.]	0.002367032	2007	HAPLN1	5	83689920	T	G
rs4485648	21716162	4353	MPO	umls:C0376358	BeFree	Among men carrying the variant allele for thioredoxin reductase 2 (TXNRD2) rs4485648, microsomal epoxide hydrolase 1 (EPHX1) rs17309872, or myeloperoxidase (MPO) rs11079344, an increased prostate cancer risk was observed with high, compared with no, petroleum oil/petroleum distillate (OR=1.9, 95% CI: 1.1-3.2, P interaction=0.01; OR=2.1, 95% CI: 1.1-4.0, P interaction=0.01), or terbufos (OR=3.0, 95% CI: 1.5-6.0, P interaction=2.0×10(-3)) use, respectively.	0.003995683	2011	TXNRD2;LOC105377185	22	19931882	T	C
rs4485648	21716162	2052	EPHX1	umls:C0376358	BeFree	Among men carrying the variant allele for thioredoxin reductase 2 (TXNRD2) rs4485648, microsomal epoxide hydrolase 1 (EPHX1) rs17309872, or myeloperoxidase (MPO) rs11079344, an increased prostate cancer risk was observed with high, compared with no, petroleum oil/petroleum distillate (OR=1.9, 95% CI: 1.1-3.2, P interaction=0.01; OR=2.1, 95% CI: 1.1-4.0, P interaction=0.01), or terbufos (OR=3.0, 95% CI: 1.5-6.0, P interaction=2.0×10(-3)) use, respectively.	0.008186863	2011	TXNRD2;LOC105377185	22	19931882	T	C
rs4485648	21716162	10587	TXNRD2	umls:C0376358	BeFree	Among men carrying the variant allele for thioredoxin reductase 2 (TXNRD2) rs4485648, microsomal epoxide hydrolase 1 (EPHX1) rs17309872, or myeloperoxidase (MPO) rs11079344, an increased prostate cancer risk was observed with high, compared with no, petroleum oil/petroleum distillate (OR=1.9, 95% CI: 1.1-3.2, P interaction=0.01; OR=2.1, 95% CI: 1.1-4.0, P interaction=0.01), or terbufos (OR=3.0, 95% CI: 1.5-6.0, P interaction=2.0×10(-3)) use, respectively.	0.000814326	2011	TXNRD2;LOC105377185	22	19931882	T	C
rs4644	21396839	3958	LGALS3	umls:C0376358	BeFree	These results provide first evidence to implicate the functional Pro64His variant of galectin-3 (LGALS3) in the genetic susceptibility towards prostate cancer.	0.002714419	2013	LGALS3	14	55138217	C	A
rs4645978	22616010	842	CASP9	umls:C0376358	BeFree	Our meta-analysis suggests that the caspase 9 rs4645978 most likely contributes to decreased susceptibility to cancer in Caucasians and prostate cancer.	0.005081451	2012	CASP9;DNAJC16	1	15525539	C	T
rs4680	16126332	5324	PLAG1	umls:C0376358	BeFree	The Val158Met polymorphism of the catechol-O-methyltransferase gene is associated with the PSA-progression-free survival in prostate cancer patients treated with estramustine phosphate.	0.058360002	2005	COMT;MIR4761	22	19963748	G	A
rs4680	16126332	5627	PROS1	umls:C0376358	BeFree	The Val158Met polymorphism of the catechol-O-methyltransferase gene is associated with the PSA-progression-free survival in prostate cancer patients treated with estramustine phosphate.	0.058360002	2005	COMT;MIR4761	22	19963748	G	A
rs4680	17018638	1312	COMT	umls:C0376358	BeFree	A total of 11 htSNPs (including COMT Val(158)Met) were selected based on the resequencing and dense genotyping approach of the Breast and Prostate Cancer Cohort Consortium.	0.021107791	2006	COMT;MIR4761	22	19963748	G	A
rs4680	16126332	9520	NPEPPS	umls:C0376358	BeFree	The Val158Met polymorphism of the catechol-O-methyltransferase gene is associated with the PSA-progression-free survival in prostate cancer patients treated with estramustine phosphate.	0.058360002	2005	COMT;MIR4761	22	19963748	G	A
rs4680	23257985	1312	COMT	umls:C0376358	BeFree	Lack of association between COMT Val158Met polymorphism and prostate cancer susceptibility.	0.021107791	2012	COMT;MIR4761	22	19963748	G	A
rs4680	16126332	354	KLK3	umls:C0376358	BeFree	The Val158Met polymorphism of the catechol-O-methyltransferase gene is associated with the PSA-progression-free survival in prostate cancer patients treated with estramustine phosphate.	0.261542831	2005	COMT;MIR4761	22	19963748	G	A
rs4680	23116175	1312	COMT	umls:C0376358	BeFree	No association between COMT Val158Met polymorphism and prostate cancer risk: a meta-analysis.	0.021107791	2013	COMT;MIR4761	22	19963748	G	A
rs4680	16126332	1312	COMT	umls:C0376358	BeFree	The Val158Met polymorphism of the catechol-O-methyltransferase gene is associated with the PSA-progression-free survival in prostate cancer patients treated with estramustine phosphate.	0.021107791	2005	COMT;MIR4761	22	19963748	G	A
rs4680	16126332	29968	PSAT1	umls:C0376358	BeFree	The Val158Met polymorphism of the catechol-O-methyltransferase gene is associated with the PSA-progression-free survival in prostate cancer patients treated with estramustine phosphate.	0.058631444	2005	COMT;MIR4761	22	19963748	G	A
rs4713266	25217961	4739	NEDD9	umls:C0376358	GWASCAT	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	0.12	2014	NEDD9	6	11218797	C	T
rs4714476	26642711	116113	FOXP4	umls:C0376358	BeFree	Association of FOXP4 Gene with Prostate Cancer and the Cumulative Effects of rs4714476 and 8q24 in Chinese Men.	0.123181358	2015	FOXP4;FOXP4-AS1	6	41546002	T	C
rs4792311	16114055	6041	RNASEL	umls:C0376358	BeFree	We examined polymorphisms within ELAC2 (S217L, A541T, E622V), MSR1 (P275A, R293X, aIVS5-59c), and RNASEL (E265X, R462Q, D541E) in 150 European-Americans with metastatic prostate cancer and 170 prostate cancer-free controls using pyrosequencing assays.	0.061998501	2006	ELAC2	17	13011692	G	A
rs4792311	12949798	60528	ELAC2	umls:C0376358	BeFree	Ser217Leu polymorphism of the HPC2/ELAC2 gene associated with prostatic cancer risk in Japanese men.	0.058198314	2003	ELAC2	17	13011692	G	A
rs4793529	24753544	101928165	CASC17	umls:C0376358	GWASCAT	Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.	0.12	2015	CASC17	17	71122495	T	C
rs4810671	22086326	7182	NR2C2	umls:C0376358	BeFree	It identified two high-ranking, biologically interesting interactions: (1) rs748120 of NR2C2 and subregions of 8q24 that contain independent susceptibility loci specific to PRCA and (2) rs4810671 of SULF2 and both JAZF1 and HNF1B that are associated with PRCA and type 2 diabetes.	0.001085767	2011	SULF2	20	47726848	A	G
rs4810671	22086326	6928	HNF1B	umls:C0376358	BeFree	It identified two high-ranking, biologically interesting interactions: (1) rs748120 of NR2C2 and subregions of 8q24 that contain independent susceptibility loci specific to PRCA and (2) rs4810671 of SULF2 and both JAZF1 and HNF1B that are associated with PRCA and type 2 diabetes.	0.168773794	2011	SULF2	20	47726848	A	G
rs4810671	22086326	221895	JAZF1	umls:C0376358	BeFree	It identified two high-ranking, biologically interesting interactions: (1) rs748120 of NR2C2 and subregions of 8q24 that contain independent susceptibility loci specific to PRCA and (2) rs4810671 of SULF2 and both JAZF1 and HNF1B that are associated with PRCA and type 2 diabetes.	0.037134131	2011	SULF2	20	47726848	A	G
rs4816407	20477822	6648	SOD2	umls:C0376358	BeFree	Two variants in SOD2 were significantly associated with the risk of aggressive prostate cancer (rs17884057, odds ratio 0.83, 95% confidence interval 0.70-0.99; and rs4816407, 1.27, 1.02-1.57); men with A alleles at rs2842958 in SOD2 had lower plasma selenium levels (median 116 vs 121.8 µg/L, P= 0.03); and the association between plasma selenium levels and risk of aggressive prostate cancer was modified by SOD1 (rs10432782) and SOD2 (rs2758330).	0.044854055	2011	SOD1	21	31667716	A	G
rs4816407	20477822	6647	SOD1	umls:C0376358	BeFree	Two variants in SOD2 were significantly associated with the risk of aggressive prostate cancer (rs17884057, odds ratio 0.83, 95% confidence interval 0.70-0.99; and rs4816407, 1.27, 1.02-1.57); men with A alleles at rs2842958 in SOD2 had lower plasma selenium levels (median 116 vs 121.8 µg/L, P= 0.03); and the association between plasma selenium levels and risk of aggressive prostate cancer was modified by SOD1 (rs10432782) and SOD2 (rs2758330).	0.010553895	2011	SOD1	21	31667716	A	G
rs4862396	22844442	653	BMP5	umls:C0376358	BeFree	Our results suggest that CASP3 rs4862396, BMP5 rs3734444 and IRS2 rs7986346 may affect the survival in patients after ADT for prostate cancer, and the analysis of these SNPs can help identify patients at higher risk of poor outcome.	0.000271442	2012	LVCAT8	4	184622518	T	C
rs4862396	22844442	836	CASP3	umls:C0376358	BeFree	Our results suggest that CASP3 rs4862396, BMP5 rs3734444 and IRS2 rs7986346 may affect the survival in patients after ADT for prostate cancer, and the analysis of these SNPs can help identify patients at higher risk of poor outcome.	0.005428837	2012	LVCAT8	4	184622518	T	C
rs4862396	22844442	8660	IRS2	umls:C0376358	BeFree	Our results suggest that CASP3 rs4862396, BMP5 rs3734444 and IRS2 rs7986346 may affect the survival in patients after ADT for prostate cancer, and the analysis of these SNPs can help identify patients at higher risk of poor outcome.	0.00554839	2012	LVCAT8	4	184622518	T	C
rs486907	15330212	6041	RNASEL	umls:C0376358	BeFree	Although an increasing number of studies report an association between the RNASEL G1385A variant and prostate cancer risk; this variant does not appear to be implicated in the development of breast cancer.	0.061998501	2004	RNASEL	1	182585422	C	T
rs486907	12415269	6041	RNASEL	umls:C0376358	BeFree	RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases.	0.061998501	2002	RNASEL	1	182585422	C	T
rs486907	17234723	6041	RNASEL	umls:C0376358	BeFree	This suggests that among Caucasians, positive association between higher trans-fatty acid consumption and prostate cancer may be modified by the functional RNASEL variant R462Q.	0.061998501	2007	RNASEL	1	182585422	C	T
rs486907	17407163	6041	RNASEL	umls:C0376358	BeFree	RNASEL Arg462Gln polymorphism and prostate cancer in PLCO.	0.061998501	2007	RNASEL	1	182585422	C	T
rs486907	21447170	6041	RNASEL	umls:C0376358	BeFree	Xenotropic murine leukemia virus (MLV)-related virus (XMRV) was initially identified in prostate cancer (PCa) tissue, particularly in the prostatic stromal fibroblasts, of patients homozygous for the RNASEL R462Q mutation.	0.061998501	2011	RNASEL	1	182585422	C	T
rs486907	20936978	6041	RNASEL	umls:C0376358	BeFree	There are questions regarding the prevalence of xenotropic murine leukemia virus-related virus (XMRV) in patients with prostate cancer and its association with the RNASEL R462Q polymorphism.	0.061998501	2010	RNASEL	1	182585422	C	T
rs486907	23098452	6041	RNASEL	umls:C0376358	BeFree	To answer questions regarding the prevalence of XMRV in Iranian patients with prostate cancer and its association with the RNASEL R462Q polymorphism, we here investigated a series of cases in Kerman, in the Southeast of Iran, and sought to verify the association with the R462Q using Real Time PCR Method.	0.061998501	2012	RNASEL	1	182585422	C	T
rs486907	16054567	6041	RNASEL	umls:C0376358	BeFree	Arg462Gln sequence variation in the prostate-cancer-susceptibility gene RNASEL and age of onset of hereditary non-polyposis colorectal cancer: a case-control study.	0.061998501	2005	RNASEL	1	182585422	C	T
rs486907	16114055	6041	RNASEL	umls:C0376358	BeFree	We examined polymorphisms within ELAC2 (S217L, A541T, E622V), MSR1 (P275A, R293X, aIVS5-59c), and RNASEL (E265X, R462Q, D541E) in 150 European-Americans with metastatic prostate cancer and 170 prostate cancer-free controls using pyrosequencing assays.	0.061998501	2006	RNASEL	1	182585422	C	T
rs486907	21656378	6041	RNASEL	umls:C0376358	BeFree	RNASEL Asp541Glu and Arg462Gln polymorphisms in prostate cancer risk: evidences from a meta-analysis.	0.061998501	2012	RNASEL	1	182585422	C	T
rs4880	24610081	2950	GSTP1	umls:C0376358	BeFree	In the present study we investigated the association of a number of polymorphic changes in antioxidant system genes (SNPs rs1050450 in the GPX1 gene, rs1695 and rs1138272 in the GSTP1 gene and rs4880 in the MnSOD gene) with the risk of prostate cancer.	0.087329809	2014	SOD2	6	159692840	A	G
rs4880	17646272	6648	SOD2	umls:C0376358	BeFree	Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study.	0.044854055	2007	SOD2	6	159692840	A	G
rs4880	24610081	6648	SOD2	umls:C0376358	BeFree	In the present study we investigated the association of a number of polymorphic changes in antioxidant system genes (SNPs rs1050450 in the GPX1 gene, rs1695 and rs1138272 in the GSTP1 gene and rs4880 in the MnSOD gene) with the risk of prostate cancer.	0.044854055	2014	SOD2	6	159692840	A	G
rs4880	21982398	4968	OGG1	umls:C0376358	BeFree	A high tertile selenium level in combination with non-wt rs125701 of the OGG1 gene in combination with smoking status or rs4880 related variation of MnSOD gene appeared to protect from PrCa.	0.020097968	2011	SOD2	6	159692840	A	G
rs4880	21982398	6648	SOD2	umls:C0376358	BeFree	A high tertile selenium level in combination with non-wt rs125701 of the OGG1 gene in combination with smoking status or rs4880 related variation of MnSOD gene appeared to protect from PrCa.	0.044854055	2011	SOD2	6	159692840	A	G
rs4880	24610081	2876	GPX1	umls:C0376358	BeFree	In the present study we investigated the association of a number of polymorphic changes in antioxidant system genes (SNPs rs1050450 in the GPX1 gene, rs1695 and rs1138272 in the GSTP1 gene and rs4880 in the MnSOD gene) with the risk of prostate cancer.	0.012996872	2014	SOD2	6	159692840	A	G
rs4880	19647296	6648	SOD2	umls:C0376358	BeFree	To examine the association between 2 mitochondrial manganese superoxide dismutase (MnSOD) genetic polymorphisms (Ala-9Val and Ala-16Val) and prostate cancer susceptibility.	0.044854055	2009	SOD2	6	159692840	A	G
rs4962416	18264096	1488	CTBP2	umls:C0376358	GAD	[Loci on chromosome 10 include MSMB, which encodes beta-microseminoprotein, a primary constituent of semen and a proposed prostate cancer biomarker, and CTBP2, a gene with antiapoptotic activity; the locus on chromosome 7 is at JAZF1, a transcriptional repressor that is fused by chromosome translocation to SUZ12 in endometrial cancer.]	0.151585741	2008	CTBP2	10	125008303	T	C
rs4962416	18264096	1488	CTBP2	umls:C0376358	GWASCAT	Loci on chromosome 10 include MSMB, which encodes beta-microseminoprotein, a primary constituent of semen and a proposed prostate cancer biomarker, and CTBP2, a gene with antiapoptotic activity; the locus on chromosome 7 is at JAZF1, a transcriptional repressor that is fused by chromosome translocation to SUZ12 in endometrial cancer.	0.151585741	2008	CTBP2	10	125008303	T	C
rs4986938	19654868	6817	SULT1A1	umls:C0376358	BeFree	However, an interactive association with BMI was observed in the relationship between prostate cancer risk and genotypes of ESR2 38 bp 3' of STP G>A (rs4986938) (p = 0.031).	0.008186863	2009	ESR2	14	64233098	C	T
rs4988483	19423539	6755	SSTR5	umls:C0376358	BeFree	Our results suggest that genetic variation in the SSTR5 gene and, particularly, the rs4988483 single nucleotide polymorphism influence circulating IGFI and IGFBP3 hormone levels with no measurable effect on prostate cancer risk.	0.00554839	2009	SSTR5;SSTR5-AS1	16	1079010	C	A
rs523349	19760631	2651	GCNT2	umls:C0376358	BeFree	Increasing studies investigating the association between steroid 5-alpha reductase type II gene polymorphism at codon 89 (SRD5A2 V89L) and susceptibility to prostate cancer (PCa) confer inconsistent results.	0.005352893	2010	SRD5A2	2	31580636	G	C
rs523349	11847524	199720	GGN	umls:C0376358	BeFree	The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer.	0.002714419	2002	SRD5A2	2	31580636	G	C
rs523349	12771801	6716	SRD5A2	umls:C0376358	BeFree	Association of V89L SRD5A2 polymorphism with prostate cancer development in a Japanese population.	0.09601507	2003	SRD5A2	2	31580636	G	C
rs523349	16039774	199720	GGN	umls:C0376358	BeFree	The SRD5A2 polymorphisms A49T, V89L and R227Q, the androgen receptor CAG and GGN repeats and sex hormone status was investigated in men with prostate cancer (CaP) (n=89), benign prostate hyperplasia (n=45) and healthy military conscripts (n=223).	0.002714419	2005	SRD5A2	2	31580636	G	C
rs523349	10606227	6716	SRD5A2	umls:C0376358	BeFree	These data do not support a moderate to large effect of the SRD5A2 V89L polymorphism on plasma AAG levels or CaP risk in this predominantly Caucasian cohort, although a small effect cannot be completely excluded.	0.09601507	1999	SRD5A2	2	31580636	G	C
rs523349	11440959	6716	SRD5A2	umls:C0376358	BeFree	We also found no evidence of a gene-gene interaction between CYP17 and SRD5A2 V89L polymorphisms on prostate cancer risk or endogenous steroid hormone levels.	0.09601507	2001	SRD5A2	2	31580636	G	C
rs523349	18780294	6716	SRD5A2	umls:C0376358	BeFree	The SRD5A2 V89L polymorphism is associated with severity of disease in men with early onset prostate cancer.	0.09601507	2008	SRD5A2	2	31580636	G	C
rs523349	11303586	6716	SRD5A2	umls:C0376358	BeFree	The CYP17 MspA1 I polymorphism has been associated with increased prostate cancer risk, and the SRD5A2 V89L polymorphism has been associated with low A-diol-g in Asian men, a serum marker of 5alpha-reductase activity.	0.09601507	2001	SRD5A2	2	31580636	G	C
rs523349	11303586	1586	CYP17A1	umls:C0376358	BeFree	The CYP17 MspA1 I polymorphism has been associated with increased prostate cancer risk, and the SRD5A2 V89L polymorphism has been associated with low A-diol-g in Asian men, a serum marker of 5alpha-reductase activity.	0.095743629	2001	SRD5A2	2	31580636	G	C
rs523349	19760631	6716	SRD5A2	umls:C0376358	BeFree	SRD5A2 V89L polymorphism and prostate cancer risk: a meta-analysis.	0.09601507	2010	SRD5A2	2	31580636	G	C
rs523349	17448593	6715	SRD5A1	umls:C0376358	BeFree	Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors.	0.017415887	2007	SRD5A2	2	31580636	G	C
rs523349	18483391	1045	CDX2	umls:C0376358	BeFree	Our results indicate that the SRD5A2 V89L VV genotype interacts with VDR FokI TT/CT genotypes in NHW men and VDR CDX2 GG genotypes in HW men to increase the risk for prostate cancer.	0.001628651	2008	SRD5A2	2	31580636	G	C
rs523349	11847524	1586	CYP17A1	umls:C0376358	BeFree	The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer.	0.095743629	2002	SRD5A2	2	31580636	G	C
rs523349	11847524	6716	SRD5A2	umls:C0376358	BeFree	The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer.	0.09601507	2002	SRD5A2	2	31580636	G	C
rs523349	11847524	367	AR	umls:C0376358	BeFree	The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer.	0.28	2002	SRD5A2	2	31580636	G	C
rs523349	12210487	6715	SRD5A1	umls:C0376358	BeFree	Cytosine-adenine-guanine repeat length of the androgen receptor gene and the A49T and V89L polymorphisms of the 5 alpha-reductase (SRD5A2) gene have been associated with prostate cancer.	0.017415887	2002	SRD5A2	2	31580636	G	C
rs523349	23277398	6716	SRD5A2	umls:C0376358	BeFree	Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis.	0.09601507	2013	SRD5A2	2	31580636	G	C
rs523349	19760631	6715	SRD5A1	umls:C0376358	BeFree	Increasing studies investigating the association between steroid 5-alpha reductase type II gene polymorphism at codon 89 (SRD5A2 V89L) and susceptibility to prostate cancer (PCa) confer inconsistent results.	0.017415887	2010	SRD5A2	2	31580636	G	C
rs523349	16039774	6716	SRD5A2	umls:C0376358	BeFree	The SRD5A2 high-activity allele variants A49T AT and V89L LL were more frequent in CaP-patients compared to general population, p=0.026 and p=0.05, respectively.	0.09601507	2005	SRD5A2	2	31580636	G	C
rs523349	18268111	6716	SRD5A2	umls:C0376358	BeFree	V89L polymorphism of the 5alpha-reductase Type II gene (SRD5A2), endogenous sex hormones, and prostate cancer risk.	0.09601507	2008	SRD5A2	2	31580636	G	C
rs523349	18268111	2651	GCNT2	umls:C0376358	BeFree	V89L polymorphism of the 5alpha-reductase Type II gene (SRD5A2), endogenous sex hormones, and prostate cancer risk.	0.005352893	2008	SRD5A2	2	31580636	G	C
rs523349	17448593	6716	SRD5A2	umls:C0376358	BeFree	Low-activity V89L variant in SRD5A2 is associated with aggressive prostate cancer risk: an explanation for the adverse effects observed in chemoprevention trials using 5-alpha-reductase inhibitors.	0.09601507	2007	SRD5A2	2	31580636	G	C
rs523349	14991867	79017	GGCT	umls:C0376358	BeFree	The prostate is an androgen-regulated organ and polymorphisms in genes involved in testosterone synthesis, in particular, SRD5A2 (A49T and V89L variants), CYP17 (MspAI variant), and the AR (CAG, GGC repeats), represent candidate risk factors for prostate cancer incidence and aggressiveness.	0.003528744	2004	SRD5A2	2	31580636	G	C
rs523349	19443907	6716	SRD5A2	umls:C0376358	BeFree	Longer (TA)n repeat but not A49T and V89L polymorphisms in SRD5A2 gene may confer prostate cancer risk in South Indian men.	0.09601507	2009	SRD5A2	2	31580636	G	C
rs523349	14991867	1586	CYP17A1	umls:C0376358	BeFree	The prostate is an androgen-regulated organ and polymorphisms in genes involved in testosterone synthesis, in particular, SRD5A2 (A49T and V89L variants), CYP17 (MspAI variant), and the AR (CAG, GGC repeats), represent candidate risk factors for prostate cancer incidence and aggressiveness.	0.095743629	2004	SRD5A2	2	31580636	G	C
rs523349	12712437	6716	SRD5A2	umls:C0376358	BeFree	Our results do not support the hypothesis that the V89L and A49T polymorphisms in the SRD5A2 gene are related to the risk of prostate cancer, but are compatible with the suggestion from earlier studies that men who are homozygous for the TA(9) or (18) alleles and men who have the TA(9)/TA(18) genotype are at a modestly reduced risk.	0.09601507	2003	SRD5A2	2	31580636	G	C
rs523349	26169017	6716	SRD5A2	umls:C0376358	BeFree	Furthermore, SRD5A2 rs523349 polymorphism may be a promising biomarker for metastatic prostate cancer patients treated with primary ADT and a molecular target for advanced prostate cancer.	0.09601507	2015	SRD5A2	2	31580636	G	C
rs5443	22608746	2784	GNB3	umls:C0376358	BeFree	G Protein β3 subunit gene C825T polymorphism and its association with the presence and clinicopathological characteristics of prostate cancer.	0.000271442	2012	GNB3;CDCA3	12	6845711	C	T
rs56232506	25217961	64759	TNS3	umls:C0376358	GWASCAT	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	0.12	2014	TNS3	7	47397647	G	A
rs5945572	18264098	170685	NUDT10	umls:C0376358	GAD	[Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.]	0.007101096	2008	NA	X	51486831	A	G
rs5945572	18264098	23708	GSPT2	umls:C0376358	GAD	[Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.]	0.002367032	2008	NA	X	51486831	A	G
rs5945572	18264098	55190	NUDT11	umls:C0376358	GAD	[Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.]	0.009468128	2008	NA	X	51486831	A	G
rs5945572	18264098	9500	MAGED1	umls:C0376358	GAD	[Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.]	0.002367032	2008	NA	X	51486831	A	G
rs5945619	18264097	170685	NUDT10	umls:C0376358	GAD	[Multiple newly identified loci associated with prostate cancer susceptibility.]	0.007101096	2008	NA	X	51498820	C	T
rs5945619	18264097	55190	NUDT11	umls:C0376358	GAD	[Multiple newly identified loci associated with prostate cancer susceptibility.]	0.009468128	2008	NA	X	51498820	C	T
rs6013897	23377224	1591	CYP24A1	umls:C0376358	BeFree	We observed a decreased risk of aggressive prostate cancer among men with the allele in rs6013897 near CYP24A1 associated with lower serum 25(OH)D [per A allele, OR, 0.86; 95% confidence interval (CI), 0.80-0.93; Ptrend = 0.0002) but an increased risk for nonaggressive disease (per A allele: OR, 1.10; 95% CI, 1.04-1.17; Ptrend = 0.002).	0.01617823	2013	NA	20	54125940	T	A
rs6062509	23535732	84619	ZGPAT	umls:C0376358	GWASCAT	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	0.120271442	2013	ZGPAT	20	63731211	G	T
rs6152	24665929	367	AR	umls:C0376358	BeFree	Androgenetic alopecia and polymorphism of the androgen receptor gene (SNP rs6152) in patients with benign prostate hyperplasia or prostate cancer.	0.28	2014	AR	X	67545785	G	A
rs61752561	20460480	3817	KLK2	umls:C0376358	BeFree	The rs61752561 in KLK3 and rs2735839 in the KLK2-KLK3 intergenic region were strongly associated with prostate cancer-specific survival, and rs10486567 in the 7JAZF1 gene were associated with biochemical recurrence.	0.030456367	2010	KLK3	19	50858126	G	A
rs61752561	20460480	354	KLK3	umls:C0376358	BeFree	The rs61752561 in KLK3 and rs2735839 in the KLK2-KLK3 intergenic region were strongly associated with prostate cancer-specific survival, and rs10486567 in the 7JAZF1 gene were associated with biochemical recurrence.	0.261542831	2010	KLK3	19	50858126	G	A
rs627928	21656378	6041	RNASEL	umls:C0376358	BeFree	RNASEL Asp541Glu and Arg462Gln polymorphisms in prostate cancer risk: evidences from a meta-analysis.	0.061998501	2012	RNASEL	1	182582202	A	C
rs627928	16114055	6041	RNASEL	umls:C0376358	BeFree	We examined polymorphisms within ELAC2 (S217L, A541T, E622V), MSR1 (P275A, R293X, aIVS5-59c), and RNASEL (E265X, R462Q, D541E) in 150 European-Americans with metastatic prostate cancer and 170 prostate cancer-free controls using pyrosequencing assays.	0.061998501	2006	RNASEL	1	182582202	A	C
rs636291	25217961	5195	PEX14	umls:C0376358	GWASCAT	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	0.12	2014	PEX14	1	10496040	G	A
rs6441224	22573467	5918	RARRES1	umls:C0376358	BeFree	The SNP rs6441224 influences transcriptional activity and prognostically relevant hypermethylation of RARRES1 in prostate cancer.	0.001900093	2012	RARRES1;LOC100287290	3	158732628	T	C
rs6465657	19767753	22853	LMTK2	umls:C0376358	GWASCAT	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	0.146308794	2009	LMTK2	7	98187015	C	T
rs6465657	18264097	22853	LMTK2	umls:C0376358	GWASCAT	Multiple newly identified loci associated with prostate cancer susceptibility.	0.146308794	2008	LMTK2	7	98187015	C	T
rs6763931	21743467	253461	ZBTB38	umls:C0376358	GWASCAT	Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.	0.12	2011	ZBTB38	3	141383991	G	A
rs680055	15894682	64816	CYP3A43	umls:C0376358	BeFree	CYP3A43 Pro(340)Ala polymorphism and prostate cancer risk in African Americans and Caucasians.	0.010825337	2005	CYP3A43	7	99859982	C	G
rs6822844	20184734	3558	IL2	umls:C0376358	BeFree	We genotyped six variants previously associated with autoimmune disease (namely rs13151961, rs13119723, rs17388568, rs3136534, rs6822844 and rs6840978) and one functional IL-2 promoter variant (rs2069762) for possible association with prostate cancer risk using the Australian Risk Factors for Prostate Cancer case-control Study.	0.006634157	2010	NA	4	122588266	G	T
rs6840978	20184734	3558	IL2	umls:C0376358	BeFree	We genotyped six variants previously associated with autoimmune disease (namely rs13151961, rs13119723, rs17388568, rs3136534, rs6822844 and rs6840978) and one functional IL-2 promoter variant (rs2069762) for possible association with prostate cancer risk using the Australian Risk Factors for Prostate Cancer case-control Study.	0.006634157	2010	IL21-AS1	4	122633552	C	T
rs684232	23535732	55275	VPS53	umls:C0376358	GWASCAT	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	0.12	2013	VPS53	17	715725	T	C
rs689465	24203817	354	KLK3	umls:C0376358	BeFree	This study aims to evaluate the relationship between the cyclooxygenase 2 (COX2) G1195A (rs689465) polymorphism and the risk of prostate cancer in a Japanese population and the associations between COX2 polymorphisms and clinicopathological characteristics, including Gleason grade and prostate-specific antigen (PSA) grade.	0.261542831	2013	PTGS2;PACERR	1	186681714	T	C
rs689466	20431935	3576	CXCL8	umls:C0376358	BeFree	After adjustment for confounders, polymorphisms in COX-2 (rs689466) and IL-8 (rs4073) were not significantly associated with prostate cancer risk.	0.024788425	2010	PTGS2;PACERR	1	186681619	T	C
rs689466	20431935	5743	PTGS2	umls:C0376358	BeFree	After adjustment for confounders, polymorphisms in COX-2 (rs689466) and IL-8 (rs4073) were not significantly associated with prostate cancer risk.	0.048415137	2010	PTGS2;PACERR	1	186681619	T	C
rs6983267	25315430	5462	POU5F1B	umls:C0376358	BeFree	These included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01).	0.003181358	2015	CASC8;CCAT2	8	127401060	G	T
rs6983267	18264097	101805488	CCAT2	umls:C0376358	GWASCAT	Multiple newly identified loci associated with prostate cancer susceptibility.	0.12	2008	CASC8;CCAT2	8	127401060	G	T
rs6983267	17401363	101805488	CCAT2	umls:C0376358	GWASCAT	Genome-wide association study of prostate cancer identifies a second risk locus at 8q24.	0.12	2007	CASC8;CCAT2	8	127401060	G	T
rs6983267	24740154	101805488	CCAT2	umls:C0376358	GWASCAT	Genome-wide association scan for variants associated with early-onset prostate cancer.	0.12	2014	CASC8;CCAT2	8	127401060	G	T
rs6983267	25315430	101867536	PRNCR1	umls:C0376358	BeFree	These included correlations between an intergenic CpG site at Chr8:128393157 and the prostate cancer SNP rs16902094 (ρ = -0.54; P = 9.7 × 10(-7); q = 0.002), a PRNCR1 CpG site at Chr8:128167809 and the prostate cancer SNP rs1456315 (ρ = 0.52; P = 1.4 × 10(-6); q = 0.002), and two POU5F1B CpG sites and several prostate/colorectal cancer SNPs (for Chr8:128498051 and rs6983267, ρ = 0.46; P = 2.0 × 10(-5); q = 0.01).	0.121357209	2015	CASC8;CCAT2	8	127401060	G	T
rs6983267	18264096	101805488	CCAT2	umls:C0376358	GWASCAT	Multiple loci identified in a genome-wide association study of prostate cancer.	0.12	2008	CASC8;CCAT2	8	127401060	G	T
rs6983267	24753544	101805488	CCAT2	umls:C0376358	GWASCAT	Genetic variation in prostate-specific antigen-detected prostate cancer and the effect of control selection on genetic association studies.	0.12	2015	CASC8;CCAT2	8	127401060	G	T
rs6983267	19562729	4609	MYC	umls:C0376358	BeFree	Forty-nine tagging SNPs including three previously reported significant variants (rs1447295, rs6983267, rs16901979) and seven variants in the 5' upstream region of the MYC proto-oncogene were tested for association with susceptibility to PC and tumor aggressiveness in 596 histologically verified PC cases and 567 ethnically matched controls.	0.019587422	2009	CASC8;CCAT2	8	127401060	G	T
rs6983561	22144497	354	KLK3	umls:C0376358	BeFree	When combined with PSA, rs6983561 improved predictive accuracy for prostate cancer compared with PSA alone among African American men (PSA = 0.57 vs. PSA + rs6983561 = 0.75, P = 0.03).	0.261542831	2012	NA	8	127094635	A	C
rs7000448	20717903	8031	NCOA4	umls:C0376358	BeFree	Of note, rs7000448 is in strong linkage disequilibrium with rs10761581 in NCOA4, a SNP that has been implicated to be independently associated, with respect to the widely reported SNP rs10993994 in the nearby gene MSMB, with prostate cancer in men of European descent.	0.005352893	2011	CASC8	8	127428925	C	T
rs7000448	20717903	4477	MSMB	umls:C0376358	BeFree	Of note, rs7000448 is in strong linkage disequilibrium with rs10761581 in NCOA4, a SNP that has been implicated to be independently associated, with respect to the widely reported SNP rs10993994 in the nearby gene MSMB, with prostate cancer in men of European descent.	0.255559841	2011	CASC8	8	127428925	C	T
rs7003908	23108991	5591	PRKDC	umls:C0376358	BeFree	This meta-analysis suggests that XRCC7 rs7003908 polymorphism may contribute to cancer susceptibility for prostate cancer, which is recommended to be included in future large-sample studies and functional assays.	0.005819831	2013	PRKDC	8	47858141	C	A
rs7003908	24535266	5591	PRKDC	umls:C0376358	BeFree	In summary, the current meta-analysis confirmed that the rs7003908 polymorphism in the XRCC7 gene might be a risk factor for prostate cancer.	0.005819831	2014	PRKDC	8	47858141	C	A
rs7121	19189654	2778	GNAS	umls:C0376358	BeFree	Lack of involvement of the GNAS1 T393C polymorphism in prostate cancer risk in a Japanese population.	0.000542884	2008	GNAS	20	58903752	C	T
rs7127900	19767753	3630	INS	umls:C0376358	GAD	[Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.]	0.029478882	2009	NA	11	2212344	A	C,G
rs7127900	19767753	3481	IGF2	umls:C0376358	GAD	[Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.]	0.017806881	2009	NA	11	2212344	A	C,G
rs7127900	19767753	7054	TH	umls:C0376358	GAD	[Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.]	0.007372538	2009	NA	11	2212344	A	C,G
rs7141529	23535732	5890	RAD51B	umls:C0376358	GWASCAT	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	0.12	2013	RAD51B;LOC100996664;LOC105370544	14	68660027	T	C
rs7210100	21602798	102724596	LOC102724596	umls:C0376358	GWASCAT	Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21.	0.12	2011	ZNF652;LOC102724596	17	49359387	G	A
rs7210100	21602798	22834	ZNF652	umls:C0376358	GWASCAT	Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21.	0.120542884	2011	ZNF652;LOC102724596	17	49359387	G	A
rs721048	18264098	23301	EHBP1	umls:C0376358	GWASCAT	Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancer.	0.151042858	2008	EHBP1	2	62904596	G	A
rs72552387	NA	4481	MSR1	umls:C0376358	CLINVAR	NA	0.167839916	NA	MSR1	8	16168568	C	A
rs72552787	12783936	5444	PON1	umls:C0376358	BeFree	New paraoxonase 1 polymorphism I102V and the risk of prostate cancer in Finnish men.	0.008458305	2003	PON1	7	95315388	T	C
rs72944758	23830236	56946	C11orf30	umls:C0376358	BeFree	Correlated intronic SNPs rs10899221 and rs72944758 formed with other EMSY variants common and rare haplotypes that were associated with increased risk (P=4.0 × 10(-4)) and decreased risk (P=0.01) of PrCa, respectively.	0.000542884	2013	C11orf30	11	76462904	A	G
rs73000144	25335771	124989	EFCAB13	umls:C0376358	BeFree	The HDAC4 (2q37.2) variant rs73000144 (OR = 14.6, p = 0.018) and the EFCAB13 (17q21.3) variant rs118004742 (OR = 1.8, p = 0.048) were overrepresented in patients with familial PrCa.	0.000271442	2014	HDAC4	2	239139704	C	T
rs73000144	25335771	9759	HDAC4	umls:C0376358	BeFree	The HDAC4 (2q37.2) variant rs73000144 (OR = 14.6, p = 0.018) and the EFCAB13 (17q21.3) variant rs118004742 (OR = 1.8, p = 0.048) were overrepresented in patients with familial PrCa.	0.000542884	2014	HDAC4	2	239139704	C	T
rs743572	17961073	1586	CYP17A1	umls:C0376358	BeFree	We investigated the association of prostate cancer (PCa) and benign prostatic hyperplasia (BPH) with genetic polymorphisms in prostate-specific antigen (PSA) (-158 G/A) and 17-hydroxylase (CYP17) (-34 T/C) genes in a Turkish population.	0.095743629	2007	CYP17A1	10	102837395	A	G,T
rs743572	25323563	1586	CYP17A1	umls:C0376358	BeFree	Quantitative assessment of the association between CYP17 rs743572 polymorphism and prostate cancer risk.	0.095743629	2015	CYP17A1	10	102837395	A	G,T
rs748120	22086326	7182	NR2C2	umls:C0376358	BeFree	It identified two high-ranking, biologically interesting interactions: (1) rs748120 of NR2C2 and subregions of 8q24 that contain independent susceptibility loci specific to PRCA and (2) rs4810671 of SULF2 and both JAZF1 and HNF1B that are associated with PRCA and type 2 diabetes.	0.001085767	2011	NR2C2	3	14993932	G	A
rs748120	22086326	221895	JAZF1	umls:C0376358	BeFree	It identified two high-ranking, biologically interesting interactions: (1) rs748120 of NR2C2 and subregions of 8q24 that contain independent susceptibility loci specific to PRCA and (2) rs4810671 of SULF2 and both JAZF1 and HNF1B that are associated with PRCA and type 2 diabetes.	0.037134131	2011	NR2C2	3	14993932	G	A
rs748120	22086326	6928	HNF1B	umls:C0376358	BeFree	It identified two high-ranking, biologically interesting interactions: (1) rs748120 of NR2C2 and subregions of 8q24 that contain independent susceptibility loci specific to PRCA and (2) rs4810671 of SULF2 and both JAZF1 and HNF1B that are associated with PRCA and type 2 diabetes.	0.168773794	2011	NR2C2	3	14993932	G	A
rs749804502	NA	51426	POLK	umls:C0376358	CLINVAR	NA	0.12	NA	POLK	5	75573790	G	T
rs7501939	19767753	6928	HNF1B	umls:C0376358	GWASCAT	Identification of seven new prostate cancer susceptibility loci through a genome-wide association study.	0.168773794	2009	HNF1B	17	37741165	C	T
rs7501939	18264097	6928	HNF1B	umls:C0376358	GWASCAT	Multiple newly identified loci associated with prostate cancer susceptibility.	0.168773794	2008	HNF1B	17	37741165	C	T
rs7501939	20676098	6928	HNF1B	umls:C0376358	GWASCAT	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	0.168773794	2010	HNF1B	17	37741165	C	T
rs7558615	17903305	4481	MSR1	umls:C0376358	BeFree	In analysis of selected candidate cancer susceptibility genes, two MSR1 SNPs (rs9325782, GEE p = 0.008 and rs2410373, FBAT p = 0.021) were associated with prostate cancer and three ERBB4 SNPs (rs905883 GEE p = 0.0002, rs7564590 GEE p = 0.003, rs7558615 GEE p = 0.0078) were associated with breast cancer.	0.167839916	2007	ERBB4	2	212081424	T	C
rs7564590	17903305	4481	MSR1	umls:C0376358	BeFree	In analysis of selected candidate cancer susceptibility genes, two MSR1 SNPs (rs9325782, GEE p = 0.008 and rs2410373, FBAT p = 0.021) were associated with prostate cancer and three ERBB4 SNPs (rs905883 GEE p = 0.0002, rs7564590 GEE p = 0.003, rs7558615 GEE p = 0.0078) were associated with breast cancer.	0.167839916	2007	ERBB4	2	212523176	C	T
rs7579	20852007	6414	SEPP1	umls:C0376358	BeFree	Furthermore, there was an association between rs7579 genotype in SEPP1 and prostate cancer risk (OR, 1.72; 95% CI, 0.99-2.98).	0.006362715	2010	SEPP1;CCDC152	5	42800706	C	T
rs7602358	19934327	1408	CRY2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005276948	2009	KLHL30	2	238147187	G	T
rs7602358	19934327	406	ARNTL	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	KLHL30	2	238147187	G	T
rs7602358	19934327	8863	PER3	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005005506	2009	KLHL30	2	238147187	G	T
rs7602358	19934327	5187	PER1	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.00554839	2009	KLHL30	2	238147187	G	T
rs7602358	19934327	4862	NPAS2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005276948	2009	KLHL30	2	238147187	G	T
rs7602358	19934327	8864	PER2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	KLHL30	2	238147187	G	T
rs7602358	19934327	9575	CLOCK	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002909916	2009	KLHL30	2	238147187	G	T
rs7602358	19934327	1407	CRY1	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	KLHL30	2	238147187	G	T
rs7611694	23535732	54847	SIDT1	umls:C0376358	GWASCAT	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	0.12	2013	SIDT1	3	113556777	A	C,T
rs7643645	24924803	8856	NR1I2	umls:C0376358	BeFree	The PXR rs7643645 polymorphism is associated with the risk of higher prostate-specific antigen levels in prostate cancer patients.	0.003528744	2014	NR1I2	3	119806650	A	G
rs7643645	24924803	354	KLK3	umls:C0376358	BeFree	The PXR rs7643645 polymorphism is associated with the risk of higher prostate-specific antigen levels in prostate cancer patients.	0.261542831	2014	NR1I2	3	119806650	A	G
rs7679673	24832084	54790	TET2	umls:C0376358	BeFree	SNP rs7679673, ~6.3kb upstream of TET2 and previously reported to be associated with prostate cancer risk, was associated with endometrial cancer risk in the direction opposite to that for prostate cancer [meta-analysis odds ratio = 0.87 (per copy of the C allele), 95% confidence interval = 0.81, 0.93; P = 7.37×10(-5)] with no evidence of heterogeneity across studies (P heterogeneity = 0.66).	0.005005506	2014	NA	4	105140377	C	A
rs76934034	25217961	220972	8-Mar	umls:C0376358	GWASCAT	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	0.12	2014	8-Mar	10	45587537	T	C
rs770984846	NA	51426	POLK	umls:C0376358	CLINVAR	NA	0.12	NA	POLK	5	75590368	G	A
rs77130927	12533788	11200	CHEK2	umls:C0376358	UNIPROT	Mutations in CHEK2 associated with prostate cancer risk.	0.138349765	2003	CHEK2	22	28725031	G	A
rs7726159	25296732	7015	TERT	umls:C0376358	BeFree	TERT polymorphisms rs2853669 and rs7726159 influence on prostate cancer risk in Russian population.	0.12643866	2014	TERT	5	1282204	C	A
rs77375493	20966544	6776	STAT5A	umls:C0376358	BeFree	Future work should focus on determining the molecular mechanisms other than V617F mutation of Jak2 resulting in continuous Stat5 activation in clinical prostate cancers.	0.003800186	2010	JAK2;INSL6	9	5073770	G	A,T
rs77375493	20966544	6777	STAT5B	umls:C0376358	BeFree	Future work should focus on determining the molecular mechanisms other than V617F mutation of Jak2 resulting in continuous Stat5 activation in clinical prostate cancers.	0.002985861	2010	JAK2;INSL6	9	5073770	G	A,T
rs77375493	20966544	3717	JAK2	umls:C0376358	BeFree	Activating mutation (V617F) in the tyrosine kinase JAK2 is absent in locally-confined or castration-resistant prostate cancer.	0.002171535	2010	JAK2;INSL6	9	5073770	G	A,T
rs781194178	NA	51426	POLK	umls:C0376358	CLINVAR	NA	0.12	NA	POLK	5	75596385	G	T
rs784411	22219177	22995	CEP152	umls:C0376358	GWASCAT	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	0.12	2012	CEP152	15	48747600	T	C
rs786205688	NA	51426	POLK	umls:C0376358	CLINVAR	NA	0.12	NA	POLK	5	75598084	T	C
rs7903146	20142250	6934	TCF7L2	umls:C0376358	BeFree	The TCF7L2 rs7903146 T allele was inversely associated with PrCa using a dominant genetic model (HR, 0.79; 95% CI, 0.65-0.97).	0.006905599	2010	TCF7L2	10	112998590	C	T
rs7950226	19934327	1408	CRY2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005276948	2009	ARNTL	11	13296592	G	A
rs7950226	19934327	406	ARNTL	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	ARNTL	11	13296592	G	A
rs7950226	19934327	8864	PER2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	ARNTL	11	13296592	G	A
rs7950226	19934327	8863	PER3	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005005506	2009	ARNTL	11	13296592	G	A
rs7950226	19934327	4862	NPAS2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005276948	2009	ARNTL	11	13296592	G	A
rs7950226	19934327	9575	CLOCK	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002909916	2009	ARNTL	11	13296592	G	A
rs7950226	19934327	5187	PER1	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.00554839	2009	ARNTL	11	13296592	G	A
rs7950226	19934327	1407	CRY1	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	ARNTL	11	13296592	G	A
rs7986346	22844442	653	BMP5	umls:C0376358	BeFree	Our results suggest that CASP3 rs4862396, BMP5 rs3734444 and IRS2 rs7986346 may affect the survival in patients after ADT for prostate cancer, and the analysis of these SNPs can help identify patients at higher risk of poor outcome.	0.000271442	2012	LOC105370360	13	109801260	G	T
rs7986346	22844442	836	CASP3	umls:C0376358	BeFree	Our results suggest that CASP3 rs4862396, BMP5 rs3734444 and IRS2 rs7986346 may affect the survival in patients after ADT for prostate cancer, and the analysis of these SNPs can help identify patients at higher risk of poor outcome.	0.005428837	2012	LOC105370360	13	109801260	G	T
rs7986346	22844442	8660	IRS2	umls:C0376358	BeFree	Our results suggest that CASP3 rs4862396, BMP5 rs3734444 and IRS2 rs7986346 may affect the survival in patients after ADT for prostate cancer, and the analysis of these SNPs can help identify patients at higher risk of poor outcome.	0.00554839	2012	LOC105370360	13	109801260	G	T
rs8008270	23535732	10979	FERMT2	umls:C0376358	GWASCAT	Identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array.	0.120271442	2013	FERMT2;LOC105370500	14	52905612	T	C
rs80130819	25217961	728114	LOC728114	umls:C0376358	GWASCAT	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	0.12	2014	COL2A1;LOC105369750	12	48025835	A	C
rs8014671	25217961	101928075	LOC101928075	umls:C0376358	GWASCAT	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	0.12	2014	LOC101928075	14	70625539	G	A
rs80359328	NA	675	BRCA2	umls:C0376358	CLINVAR	NA	0.182769219	NA	BRCA2	13	32336685	-	A
rs861539	25834539	7517	XRCC3	umls:C0376358	BeFree	The association of XRCC3 Thr241Met genetic variant with risk of prostate cancer: a meta-analysis.	0.008458305	2015	KLC1;XRCC3	14	103699416	G	A
rs861539	19914098	7517	XRCC3	umls:C0376358	BeFree	We examined the association between PC risk with nonsynonymous SNPs (nsSNPs) in 5 genes involved in 3 DNA-repair pathways: (1) base excision repair (BER): hOGG1 C1245G (Ser326Cys) and XRCC1 G28152A (Arg399Gln); (2) nucleotide excision repair (NER): XPD G23591A (Asp312Asn); (3) homologous recombination repair: RAD51 G135C (in 5' untranslated region) and XRCC3 C18067T (Thr241Met).	0.008458305	2011	KLC1;XRCC3	14	103699416	G	A
rs861539	19914098	7515	XRCC1	umls:C0376358	BeFree	We examined the association between PC risk with nonsynonymous SNPs (nsSNPs) in 5 genes involved in 3 DNA-repair pathways: (1) base excision repair (BER): hOGG1 C1245G (Ser326Cys) and XRCC1 G28152A (Arg399Gln); (2) nucleotide excision repair (NER): XPD G23591A (Asp312Asn); (3) homologous recombination repair: RAD51 G135C (in 5' untranslated region) and XRCC3 C18067T (Thr241Met).	0.04702559	2011	KLC1;XRCC3	14	103699416	G	A
rs861539	19914098	2068	ERCC2	umls:C0376358	BeFree	We examined the association between PC risk with nonsynonymous SNPs (nsSNPs) in 5 genes involved in 3 DNA-repair pathways: (1) base excision repair (BER): hOGG1 C1245G (Ser326Cys) and XRCC1 G28152A (Arg399Gln); (2) nucleotide excision repair (NER): XPD G23591A (Asp312Asn); (3) homologous recombination repair: RAD51 G135C (in 5' untranslated region) and XRCC3 C18067T (Thr241Met).	0.01482102	2011	KLC1;XRCC3	14	103699416	G	A
rs861539	19914098	5888	RAD51	umls:C0376358	BeFree	We examined the association between PC risk with nonsynonymous SNPs (nsSNPs) in 5 genes involved in 3 DNA-repair pathways: (1) base excision repair (BER): hOGG1 C1245G (Ser326Cys) and XRCC1 G28152A (Arg399Gln); (2) nucleotide excision repair (NER): XPD G23591A (Asp312Asn); (3) homologous recombination repair: RAD51 G135C (in 5' untranslated region) and XRCC3 C18067T (Thr241Met).	0.003995683	2011	KLC1;XRCC3	14	103699416	G	A
rs863225454	NA	51426	POLK	umls:C0376358	CLINVAR	NA	0.12	NA	POLK	5	75573739	C	T
rs863225455	NA	51426	POLK	umls:C0376358	CLINVAR	NA	0.12	NA	POLK	5	75596726	C	T
rs863225456	NA	51426	POLK	umls:C0376358	CLINVAR	NA	0.12	NA	POLK	5	75596885	T	A
rs863225457	NA	51426	POLK	umls:C0376358	CLINVAR	NA	0.12	NA	POLK	5	75596434	G	A
rs884419	20303520	1956	EGFR	umls:C0376358	GAD	[The EGFR polymorphism rs884419 is associated with freedom from recurrence in patients with resected prostate cancer.]	0.03444078	2010	NA	7	55208587	G	A
rs884419	20303520	354	KLK3	umls:C0376358	BeFree	There was a statistically significant association between the single nucleotide polymorphism rs884419 and prostate cancer recurrence, as defined in the study by at least prostate specific antigen biochemical recurrence (log rank test p <0.001).	0.261542831	2010	NA	7	55208587	G	A
rs884419	20303520	1956	EGFR	umls:C0376358	BeFree	The EGFR polymorphism rs884419 is associated with freedom from recurrence in patients with resected prostate cancer.	0.03444078	2010	NA	7	55208587	G	A
rs885747	19934327	1407	CRY1	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	PER1	17	8147419	G	T,C,A
rs885747	19934327	8863	PER3	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005005506	2009	PER1	17	8147419	G	T,C,A
rs885747	19934327	4862	NPAS2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005276948	2009	PER1	17	8147419	G	T,C,A
rs885747	19934327	1408	CRY2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005276948	2009	PER1	17	8147419	G	T,C,A
rs885747	19934327	406	ARNTL	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	PER1	17	8147419	G	T,C,A
rs885747	19934327	8864	PER2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	PER1	17	8147419	G	T,C,A
rs885747	19934327	9575	CLOCK	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002909916	2009	PER1	17	8147419	G	T,C,A
rs885747	19934327	5187	PER1	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.00554839	2009	PER1	17	8147419	G	T,C,A
rs895521	19934327	8864	PER2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	NPAS2	2	100935633	T	C
rs895521	19934327	5187	PER1	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.00554839	2009	NPAS2	2	100935633	T	C
rs895521	19934327	1408	CRY2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005276948	2009	NPAS2	2	100935633	T	C
rs895521	19934327	9575	CLOCK	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002909916	2009	NPAS2	2	100935633	T	C
rs895521	19934327	406	ARNTL	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	NPAS2	2	100935633	T	C
rs895521	19934327	4862	NPAS2	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005276948	2009	NPAS2	2	100935633	T	C
rs895521	19934327	1407	CRY1	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.002638474	2009	NPAS2	2	100935633	T	C
rs895521	19934327	8863	PER3	umls:C0376358	BeFree	Our results showed that at least one SNP in nine core circadian genes (rs885747 and rs2289591 in PER1; rs7602358 in PER2; rs1012477 in PER3; rs1534891 in CSNK1E; rs12315175 in CRY1; rs2292912 in CRY2; rs7950226 in ARNTL; rs11133373 in CLOCK; and rs1369481, rs895521, and rs17024926 in NPAS2) was significantly associated with susceptibility to prostate cancer (either overall risk or risk of aggressive disease), and the risk estimate for four SNPs in three genes (rs885747 and rs2289591 in PER1, rs1012477 in PER3, and rs11133373 in CLOCK) varied by disease aggressiveness.	0.005005506	2009	NPAS2	2	100935633	T	C
rs905883	17903305	4481	MSR1	umls:C0376358	BeFree	In analysis of selected candidate cancer susceptibility genes, two MSR1 SNPs (rs9325782, GEE p = 0.008 and rs2410373, FBAT p = 0.021) were associated with prostate cancer and three ERBB4 SNPs (rs905883 GEE p = 0.0002, rs7564590 GEE p = 0.003, rs7558615 GEE p = 0.0078) were associated with breast cancer.	0.167839916	2007	ERBB4	2	212323745	C	T,G
rs9282858	17136762	6716	SRD5A2	umls:C0376358	BeFree	Our study provides evidence that the SRD5A2 A49T A variant is associated with an increased risk of prostate cancer, lower levels of circulating 3alpha-diolG and decreased risk of baldness.	0.09601507	2007	SRD5A2	2	31580756	C	T
rs9282858	14991867	79017	GGCT	umls:C0376358	BeFree	The prostate is an androgen-regulated organ and polymorphisms in genes involved in testosterone synthesis, in particular, SRD5A2 (A49T and V89L variants), CYP17 (MspAI variant), and the AR (CAG, GGC repeats), represent candidate risk factors for prostate cancer incidence and aggressiveness.	0.003528744	2004	SRD5A2	2	31580756	C	T
rs9282858	19443907	6716	SRD5A2	umls:C0376358	BeFree	Longer (TA)n repeat but not A49T and V89L polymorphisms in SRD5A2 gene may confer prostate cancer risk in South Indian men.	0.09601507	2009	SRD5A2	2	31580756	C	T
rs9282858	16039774	6716	SRD5A2	umls:C0376358	BeFree	The SRD5A2 high-activity allele variants A49T AT and V89L LL were more frequent in CaP-patients compared to general population, p=0.026 and p=0.05, respectively.	0.09601507	2005	SRD5A2	2	31580756	C	T
rs9282858	12712437	6716	SRD5A2	umls:C0376358	BeFree	Our results do not support the hypothesis that the V89L and A49T polymorphisms in the SRD5A2 gene are related to the risk of prostate cancer, but are compatible with the suggestion from earlier studies that men who are homozygous for the TA(9) or (18) alleles and men who have the TA(9)/TA(18) genotype are at a modestly reduced risk.	0.09601507	2003	SRD5A2	2	31580756	C	T
rs9282858	11847524	367	AR	umls:C0376358	BeFree	The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer.	0.28	2002	SRD5A2	2	31580756	C	T
rs9282858	11847524	1586	CYP17A1	umls:C0376358	BeFree	The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer.	0.095743629	2002	SRD5A2	2	31580756	C	T
rs9282858	16039774	199720	GGN	umls:C0376358	BeFree	The SRD5A2 polymorphisms A49T, V89L and R227Q, the androgen receptor CAG and GGN repeats and sex hormone status was investigated in men with prostate cancer (CaP) (n=89), benign prostate hyperplasia (n=45) and healthy military conscripts (n=223).	0.002714419	2005	SRD5A2	2	31580756	C	T
rs9282858	11847524	199720	GGN	umls:C0376358	BeFree	The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer.	0.002714419	2002	SRD5A2	2	31580756	C	T
rs9282858	12210487	6715	SRD5A1	umls:C0376358	BeFree	Cytosine-adenine-guanine repeat length of the androgen receptor gene and the A49T and V89L polymorphisms of the 5 alpha-reductase (SRD5A2) gene have been associated with prostate cancer.	0.017415887	2002	SRD5A2	2	31580756	C	T
rs9282858	23277398	6716	SRD5A2	umls:C0376358	BeFree	Steroid 5-alpha-reductase type 2 (SRD5A2) V89L and A49T polymorphisms and sporadic prostate cancer risk: a meta-analysis.	0.09601507	2013	SRD5A2	2	31580756	C	T
rs9282858	18469342	6716	SRD5A2	umls:C0376358	BeFree	No association between the SRD5A2 gene A49T missense variant and prostate cancer risk: lessons learned.	0.09601507	2008	SRD5A2	2	31580756	C	T
rs9282858	14991867	1586	CYP17A1	umls:C0376358	BeFree	The prostate is an androgen-regulated organ and polymorphisms in genes involved in testosterone synthesis, in particular, SRD5A2 (A49T and V89L variants), CYP17 (MspAI variant), and the AR (CAG, GGC repeats), represent candidate risk factors for prostate cancer incidence and aggressiveness.	0.095743629	2004	SRD5A2	2	31580756	C	T
rs9282858	11847524	6716	SRD5A2	umls:C0376358	BeFree	The aim of the present study was to evaluate the distribution of polymorphisms for the androgen receptor (AR) (CAG, StuI, GGN), SRD5A2 (Ala49Thr, Val89Leu) and CYP17 (MspA1) genes that are considered to be relevant for risk of prostate cancer.	0.09601507	2002	SRD5A2	2	31580756	C	T
rs9284813	20676098	100846978	LINC00506	umls:C0376358	GWASCAT	Genome-wide association study identifies five new susceptibility loci for prostate cancer in the Japanese population.	0.12	2010	LINC00506	3	87103019	A	G
rs9287719	25217961	79954	NOL10	umls:C0376358	GWASCAT	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	0.12	2014	NOL10	2	10570604	C	T
rs9311171	17903305	10217	CTDSPL	umls:C0376358	GAD	[The top SNP associations in GEE models for each trait were as follows: breast cancer, rs2075555, p = 8.0 x 10(-8) in COL1A1; and prostate cancer, rs9311171, p = 1.75 x 10(-6) in CTDSPL.]	0.002638474	2007	CTDSPL	3	37954986	T	G
rs9311171	17903305	10217	CTDSPL	umls:C0376358	BeFree	The top SNP associations in GEE models for each trait were as follows: breast cancer, rs2075555, p = 8.0 x 10(-8) in COL1A1; and prostate cancer, rs9311171, p = 1.75 x 10(-6) in CTDSPL.	0.002638474	2007	CTDSPL	3	37954986	T	G
rs9325782	17903305	4481	MSR1	umls:C0376358	BeFree	In analysis of selected candidate cancer susceptibility genes, two MSR1 SNPs (rs9325782, GEE p = 0.008 and rs2410373, FBAT p = 0.021) were associated with prostate cancer and three ERBB4 SNPs (rs905883 GEE p = 0.0002, rs7564590 GEE p = 0.003, rs7558615 GEE p = 0.0078) were associated with breast cancer.	0.167839916	2007	NA	8	16232964	C	T
rs9332964	16039774	199720	GGN	umls:C0376358	BeFree	The SRD5A2 polymorphisms A49T, V89L and R227Q, the androgen receptor CAG and GGN repeats and sex hormone status was investigated in men with prostate cancer (CaP) (n=89), benign prostate hyperplasia (n=45) and healthy military conscripts (n=223).	0.002714419	2005	SRD5A2	2	31529325	C	T
rs9340799	24859835	2099	ESR1	umls:C0376358	BeFree	The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk.	0.060793181	2014	ESR1	6	151842246	A	G
rs9340799	24859835	2100	ESR2	umls:C0376358	BeFree	The influence of ESR1 rs9340799 and ESR2 rs1256049 polymorphisms on prostate cancer risk.	0.043724681	2014	ESR1	6	151842246	A	G
rs9364554	18264097	6581	SLC22A3	umls:C0376358	GWASCAT	Multiple newly identified loci associated with prostate cancer susceptibility.	0.154571602	2008	SLC22A3	6	160412632	C	T
rs9443189	25217961	4646	MYO6	umls:C0376358	GWASCAT	A meta-analysis of 87,040 individuals identifies 23 new susceptibility loci for prostate cancer.	0.121357209	2014	MYO6	6	75786165	A	G
rs9623117	19117981	23112	TNRC6B	umls:C0376358	GWASCAT	Sequence variants at 22q13 are associated with prostate cancer risk.	0.127101096	2009	TNRC6B	22	40056115	T	C
rs9623117	19117981	23112	TNRC6B	umls:C0376358	GAD	[Sequence variants at 22q13 are associated with prostate cancer risk.]	0.127101096	2009	TNRC6B	22	40056115	T	C
rs964184	24623848	84811	BUD13	umls:C0376358	BeFree	An SNP (rs964184) near budding-site selection protein 13 (yeast) (BUD13), zinc finger protein 259 (ZNF259), and apolipoprotein A5 (APOA5) on 11q23.3 was significantly associated with prostate cancer risk (per-allele OR = 0.75; 95% CI: 0.58, 0.98; P-trend = 0.03).	0.000271442	2014	ZPR1	11	116778201	G	C
rs9649213	22219177	55971	BAIAP2L1	umls:C0376358	GWASCAT	A genome-wide search for loci interacting with known prostate cancer risk-associated genetic variants.	0.12	2012	BAIAP2L1	7	98391899	A	G
rs9904341	23883402	332	BIRC5	umls:C0376358	BeFree	Functional promoter -31G/C variant of Survivin gene predict prostate cancer susceptibility among Chinese: a case control study.	0.001357209	2013	BIRC5	17	78214286	G	C
rs9939609	20976066	79068	FTO	umls:C0376358	BeFree	Associations between an obesity related genetic variant (FTO rs9939609) and prostate cancer risk.	0.002638474	2010	FTO	16	53786615	T	A
rs9939609	20976066	79068	FTO	umls:C0376358	GAD	[Associations between an obesity related genetic variant (FTO rs9939609) and prostate cancer risk.]	0.002638474	2010	FTO	16	53786615	T	A

GWASdb Annotation(Total Genotypes:0)
(Waiting for update.)

GWASdb Snp Trait(Total Genotypes:2379)
CHR	POS	SNPID	REF	ALT	ORI_SNPID	PMID	P_VALUE	P_VALUE_TEXT	OR/BETA	CI95_TEXT	GWAS_INITIAL_SAMPLE_SIZE	SUB_POPULATION	SUPER_POPULATION	GWAS_TRAIT	HPO_ID	HPO_TERM	DO_ID	DO_TERM	MESH_ID	MESH_TERM	EFO_ID	EFO_TERM	DOLITE_TERM	RISK_ALLELE	PUBLICATION_TYPE	AA	GENE_SYMBOL	TYPE	REFGENE
1	5475663	rs6603835	C	A	rs6603835	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	5478901	rs6688540	C	T	rs6688540	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	8423510	rs10779702	A	G	rs10779702	20978177	4.75E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
1	8468372	rs301791	A	T	rs301791	20978177	8.20E-05	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
1	8490320	rs302719	T	G	rs302719	20978177	5.03E-05	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
1	8495590	rs172531	A	G	rs172531	20978177	4.11E-05	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
1	8495945	rs301801	T	C	rs301801	20978177	4.11E-05	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
1	15871023	rs78309148	G	A	rs78309148	23555315	0.00067	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
1	17576638	rs12562867	A	C	rs12562867	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	18900554	rs114799364	C	T	rs114799364	24185611	2.72E-06	GWAS stage only	3.03	NA	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs114799364-C	NA	C	NA
1	19843354	rs10917468	T	C	rs10917468	23555315	0.00025	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
1	19965927	rs10917504	C	A	rs10917504	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	21823292	rs1697421	C	T	rs1697421	23555315	0.00082	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
1	22698447	rs7524102	A	G	rs7524102	23555315	0.00038	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
1	22702858	rs6696981	G	T	rs6696981	23555315	0.00063	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
1	22711473	rs6426749	G	C	rs6426749	23555315	0.00018	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
1	30185662	rs1866967	A	G	rs1866967	22219177	5.00E-06	rs8102476	1.22	[1.12-1.33]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
1	31320651	rs2488230	G	A	rs2488230	22923026	3.63E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
1	31330844	rs3935266	G	A	rs3935266	22923026	9.68E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
1	33292008	rs61739743	G	A	rs61739743	23555315	0.00025	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
1	33931116	rs4653152	G	A	rs4653152	pha002878	3.88E-05	phs000207	1.37	[1.09-1.72]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	G	NA	NA	NA
1	34238283	rs474474	T	C	rs474474	23555315	0.00087	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
1	38191538	rs7541350	T	C	rs7541350	pha002878	7.58E-06	phs000207	1.11	[0.85-1.45]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	EPHA10	intron	NM_001099439
1	38192537	rs17464981	T	C	rs17464981	pha002878	8.93E-06	phs000207	1.11	[0.85-1.45]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	EPHA10	intron	NM_001099439
1	38196841	rs731174	T	C	rs731174	22219177	5.00E-06	rs4430796	1.27	[1.15-1.40]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
1	38919423	rs2252153	G	A	rs2252153	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	38919983	rs2252059	G	A	rs2252059	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	41306571	rs12402583	T	C	rs12402583	23555315	0.000059	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
1	45808863	rs9429157	G	A	rs9429157	23555315	0.00079	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
1	47726087	rs13376679	T	C	rs13376679	23555315	0.00013	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
1	52337039	rs1538881	T	C	rs1538881	pha002878	5.42E-05	phs000207	1.47	[1.15-1.89]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	NRD1	intron	NM_002525
1	55191644	rs1180937	T	C	rs1180937	pha002878	8.38E-05	phs000207	1.39	[1.09-1.79]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	G	TTC4	intron	NM_004623
1	55464986	rs34561376	G	A	rs34561376	23555315	0.0008	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
1	56035952	rs6658576	T	C	rs6658576	23555315	0.00039	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
1	57769516	rs12057381	G	A	rs12057381	24185611	8.44E-06	GWAS stage only	2.22	[1.56-3.23]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs12057381-G	NA	G	DAB1
1	58537102	rs17116836	G	A	rs17116836	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	59042425	rs201254365	C	A	rs201254365	23555315	0.000000163	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate-specific antigen	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
1	59184738	rs2811856	T	C	rs2811856	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	61708978	rs17121853	C	G	rs17121853	20978177	5.07E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
1	67109277	rs17490057	G	C	rs17490057	23555315	0.0006	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
1	67793935	rs191377276	T	A	rs191377276	23555315	0.000033	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
1	68905294	rs114379164	G	A,C	rs114379164	23555315	0.00021	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
1	69445925	rs4650310	A	G	rs4650310	23023329	9.64E-04	NA	NA	NA	1,417 Han Chinese cases; 1,008 Han Chinese controls	Han Chinese(2425)	ALL(2425)	ASN(2425)	ALL(2425)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	C	NA
1	70896038	rs145785987	T	C	rs145785987	23555315	0.000031	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
1	77726980	rs10518441	A	G	rs10518441	pha002878	6.12E-05	phs000207	1.29	[1.01-1.65]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	NA	NA	NA
1	87748856	rs10127691	T	C	rs10127691	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	89473175	rs1409150	T	C	rs1409150	20978177	4.28E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
1	94486905	rs61754056	C	T	rs61754056	23555315	0.000000163	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate-specific antigen	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
1	98666125	rs11577139	C	A	rs11577139	21743057	8.00E-07	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	99096771	rs12129212	T	C	rs12129212	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	105396240	rs11811929	C	T	rs11811929	20978177	5.12E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
1	105612342	rs1584633	C	T	rs1584633	20978177	7.58E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
1	107195059	rs10494048	G	T	rs10494048	pha002878	9.66E-05	phs000207	1.06	[0.83-1.35]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	G	NA	NA	NA
1	107865978	rs7411507	G	A	rs7411507	18264096	1.91E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	108523670	rs12121990	G	T	rs12121990	23555315	0.00035	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
1	109392853	rs11583007	C	T	rs11583007	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	118002719	rs7514323	A	G	rs7514323	24740154	3.20E-06	(GWAS stage)	1.37	[1.23-1.51]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs7514323-G	Research Support, N.I.H., Extramural	G	MAN1A2
1	118078875	rs2622366	C	T	rs2622366	18264096	1.40E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	119117589	rs10802044	G	C	rs10802044	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	144931387	rs61805374	T	G	rs61805374	23555315	0.00031	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
1	153934820	rs61755890	C	T	rs61755890	23555315	0.0008	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
1	154834183	rs1218582	G	A	rs1218582	23535732	2.00E-08	NA	1.06	[1.03-1.09]	11,085 European ancestry cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs1218582-G	NA	C	KCNN3
1	154898899	rs16836525	C	T	rs16836525	23555315	0.0003	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
1	155912426	rs142470296	A	G	rs142470296	23555315	0.000058	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
1	156641200	rs147070824	T	A	rs147070824	23555315	0.00009	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
1	159842779	rs145923860	C	T	rs145923860	23555315	0.00011	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
1	159858278	rs145722573	G	T	rs145722573	23555315	0.000067	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
1	161681869	rs71634903	A	G	rs71634903	23555315	0.000019	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
1	163829349	rs796694	C	A	rs796694	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	163838187	rs781934	C	T	rs781934	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	169519112	rs6020	C	T	rs6020	23555315	0.000047	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
1	170965700	rs139086068	G	A	rs139086068	23555315	0.00067	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
1	171486912	rs10913157	G	A	rs10913157	23555315	0.00073	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
1	179711649	rs1052447	T	G	rs1052447	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	179721771	rs10913876	G	T	rs10913876	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	204039160	rs12046258	G	A	rs12046258	18264096	4.93E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	204518842	rs4245739	C	A	rs4245739	23535732	2.00E-11	NA	1.1	[1.05-1.14]	11,085 European ancestry cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs4245739-A	NA	A	MDM4
1	205638222	rs12409639	G	A	rs12409639	23269536	2.00E-19	NA	0.2	NA	1,999 Chinese ancestry men	Chinese(1999)	ALL(1999)	ASN(1999)	ALL(1999)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	rs12409639-A	Randomized Controlled Trial	Multicenter Study	Research Support, Non-U.S. Gov't
1	205638464	rs16856139	C	T	rs16856139	24919509	2.00E-11	NA	0.08	[0.059-0.109] unit increase	1,086 Japanese ancestry males	Japanese(1086)	ALL(1086)	ASN(1086)	ALL(1086)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, Non-U.S. Gov't	C	SLC45A3
1	208543562	rs10779476	C	T	rs10779476	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	208547582	rs696985	G	T	rs696985	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	208548174	rs696984	T	C	rs696984	21743057	5.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	208548223	rs696983	T	C	rs696983	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	208549846	rs696981	C	T	rs696981	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	208551533	rs701642	C	T	rs701642	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	210929893	rs1934636	C	A	rs1934636	22532847	0.000045	NA	NA	NA	135 prostate cancer cases; 270 controls; 525 adenoma cases; 630 colorectal cancer cases; 690 controls (shared)	NOPOP(2250)	ALL(2250)	NOPOP(2250)	ALL(2250)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	A	KCNH1
1	213094034	rs1284864	G	A	rs1284864	pha002878	6.75E-05	phs000207	1.04	[0.78-1.37]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	NA	NA	NA
1	216373416	rs148135241	A	C	rs148135241	23555315	0.000038	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
1	216942781	rs2813694	A	C	rs2813694	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	220180562	rs148551457	T	C	rs148551457	23555315	0.00042	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
1	221617076	rs12032381	A	C	rs12032381	23555315	0.00041	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
1	222206887	rs2584315	G	A	rs2584315	pha002877	9.27E-05	phs000207	1.15	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	G	NA	NA	NA
1	222211329	rs2584316	A	G	rs2584316	pha002877	6.35E-05	phs000207	1.14	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	A	NA	NA	NA
1	228505275	rs113376653	C	T	rs113376653	23555315	0.000072	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
1	228548255	rs147709306	G	C	rs147709306	23555315	0.000015	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
1	228660501	rs10733022	C	A	rs10733022	23555315	0.00089	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
1	229334294	rs12023401	A	G	rs12023401	23023329	6.73E-04	NA	NA	NA	1,417 Han Chinese cases; 1,008 Han Chinese controls	Han Chinese(2425)	ALL(2425)	ASN(2425)	ALL(2425)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	A	NA
1	229594003	rs41307728	C	T	rs41307728	23555315	0.00068	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
1	234740880	rs1329125	C	T	rs1329125	22923026	3.05E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
1	236389655	rs188136623	C	A	rs188136623	23555315	0.000029	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
1	237713081	rs2779383	A	G	rs2779383	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	240370313	rs140911005	G	A	rs140911005	23555315	0.000006	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
1	241755925	rs640718	A	G	rs640718	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
1	242030355	rs148510810	G	A	rs148510810	23555315	0.00028	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
1	242159566	rs112610111	C	T	rs112610111	23555315	0.00041	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
1	246319482	rs4654092	A	G	rs4654092	pha002877	1.74E-05	phs000207	1.41	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	A	SMYD3	intron	NM_022743
2	609326	rs17728164	C	T	rs17728164	20978177	9.76E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
2	4855697	rs1975386	A	G	rs1975386	20978177	6.91E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
2	5197986	rs4669203	G	C	rs4669203	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	5215885	rs12613788	C	T	rs12613788	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	5218148	rs16863306	G	C	rs16863306	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	6085200	rs13432692	C	T	rs13432692	24185611	7.02E-06	GWAS stage only	1.59	[1.30-1.96]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs13432692-C	NA	G	LOC150622
2	9637331	rs56237316	A	G	rs56237316	23555315	0.000023	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
2	10117868	rs11902236	C	T	rs11902236	23535732	3.00E-08	NA	1.07	[1.03-1.10]	11,085 European ancestry cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs11902236-A	NA	T	GRHL1
2	14603290	rs2056150	A	G	rs2056150	24185611	1.03E-05	GWAS stage only	1.7	[1.34-2.15]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs2056150-A	NA	A	NA
2	14658053	rs12473205	C	A	rs12473205	22923026	4.15E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
2	15131647	rs6737611	A	G	rs6737611	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	15895707	rs1345564	C	A	rs1345564	22923026	6.59E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
2	16176894	rs10194143	T	C	rs10194143	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	20888265	rs13385191	A	G	rs13385191	20676098	8.00E-08	NA	1.15	[1.10-1.21]	1,583 Japanese cases; 3,386 Japanese controls	Japanese(4969)	ALL(4969)	ASN(4969)	ALL(4969)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs13385191-G	Research Support, Non-U.S. Gov't	A	C2orf43
2	22335940	rs7561156	A	G	rs7561156	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	22336150	rs7576134	G	A	rs7576134	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	22336757	rs4533497	A	G	rs4533497	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	22336964	rs2138885	G	A	rs2138885	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	22348539	rs7601596	G	T	rs7601596	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	23774752	rs4665609	A	C	rs4665609	24740154	4.20E-06	(GWAS stage)	1.28	[1.18-1.38]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs4665609-A	Research Support, N.I.H., Extramural	C	KLHL29
2	27371203	rs1275512	A	G	rs1275512	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	27854369	rs6547740	G	A	rs6547740	20978177	7.87E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
2	28389846	rs17006590	A	C	rs17006590	20978177	9.58E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
2	28542934	rs1546029	A	G	rs1546029	20978177	3.78E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
2	29497967	rs35228363	G	A	rs35228363	23555315	0.00025	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
2	30034279	rs11694445	A	G	rs11694445	20978177	4.48E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
2	30993308	rs200944264	T	A	rs200944264	23555315	0.00076	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
2	31142852	rs17010471	T	C	rs17010471	22923026	2.42E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
2	32110725	rs17011668	T	C	rs17011668	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	38066683	rs17411119	T	C	rs17411119	pha002877	7.59E-05	phs000207	1.39	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	NA	NA	NA
2	38066716	rs7598641	T	C	rs7598641	pha002877	6.12E-05	phs000207	1.41	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
2	40387489	rs1861427	A	G	rs1861427	pha002877	7.16E-05	phs000207	1.47	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	SLC8A1	intron	NM_021097
2	40578171	rs10180986	T	A	rs10180986	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	43553949	rs1465618	T	C	rs1465618	19767753	2.00E-08	NA	1.08	[1.03-1.12]	1,854 European ancestry cases; 1,894 European ancestry controls	European(3748)	ALL(3748)	EUR(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	43553949	rs1465618	T	C	rs1465618	23555315	0.00016	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
2	43638185	rs7567607	C	T	rs7567607	23555315	0.000039	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
2	43796811	rs17031053	T	A	rs17031053	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	43803468	rs17031076	T	A,C	rs17031076	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	43873144	rs10174938	A	C	rs10174938	20978177	7.49E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
2	43930616	rs6759851	G	C	rs6759851	20978177	9.87E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
2	43935725	rs6716551	T	C	rs6716551	20978177	7.49E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
2	43962562	rs7561861	G	T	rs7561861	18264096	7.64E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	45387774	rs992618	C	T	rs992618	23023329	4.06E-05	NA	NA	NA	1,417 Han Chinese cases; 1,008 Han Chinese controls	Han Chinese(2425)	ALL(2425)	ASN(2425)	ALL(2425)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	T	NA
2	49933279	rs4402808	C	T	rs4402808	20978177	8.52E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
2	49955497	rs17039212	C	A	rs17039212	20978177	2.86E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
2	49990368	rs1518823	C	T	rs1518823	20978177	4.37E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
2	52040359	rs11563262	G	T	rs11563262	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	54759730	rs4671950	G	A	rs4671950	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	54767792	rs11895933	A	G	rs11895933	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	60133565	rs17050485	C	T	rs17050485	20978177	5.12E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
2	60195954	rs6736566	A	C	rs6736566	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	60202617	rs1863160	T	C	rs1863160	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	63131731	rs721048	G	A	rs721048	18264098	8.00E-09		1.15	[1.10-1.21]	1,854 cases; 21,372 controls	NOPOP(23226)	ALL(23226)	NOPOP(23226)	ALL(23226)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs721048-A	Multicenter Study	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't
2	63301164	rs6545977	G	A	rs6545977	19767753	5.00E-07	NA	NA	NA	1,854 European ancestry cases; 1,894 European ancestry controls	European(3748)	ALL(3748)	EUR(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	63301164	rs6545977	G	A	rs6545977	23555315	0.000006	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
2	65932417	rs2860851	T	C	rs2860851	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	68613681	rs140933780	C	T	rs140933780	23555315	0.00013	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
2	70052624	rs146778617	G	T	rs146778617	23555315	0.000006	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
2	71722096	rs4852261	A	G	rs4852261	pha002878	4.73E-05	phs000207	1.14	[0.87-1.47]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	G	DYSF	intron	NM_003494
2	85794297	rs10187424	T	C	rs10187424	21743467	3.00E-15	NA	1.09	[1.06-1.12]	6,621 European ancestry cases; 6,939 European ancestry controls	European(13560)	ALL(13560)	EUR(13560)	ALL(13560)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs10187424-A	Multicenter Study	Comparative Study	C
2	86182258	rs11891625	C	T	rs11891625	20978177	4.72E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
2	86182648	rs4514874	T	C	rs4514874	20978177	4.28E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
2	86183897	rs1438155	A	G	rs1438155	20978177	4.72E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
2	86260785	rs78239085	C	T	rs78239085	23555315	0.00069	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
2	86903017	rs1018311	C	T	rs1018311	20978177	9.33E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
2	88436001	rs6735524	G	A	rs6735524	20978177	6.74E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
2	101023110	rs150069978	C	T	rs150069978	23555315	0.00011	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
2	101591304	rs2305160	A	G	rs2305160	23555315	0.00044	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
2	109678210	rs417999	A	G	rs417999	20978177	4.62E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
2	109682341	rs260659	C	T	rs260659	20978177	6.67E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
2	109685399	rs260654	G	T	rs260654	20978177	8.68E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
2	110278908	rs9711994	C	T	rs9711994	22923026	1.93E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
2	111797531	rs3789080	C	T	rs3789080	22219177	4.00E-06	rs7127900	1.41	[1.22-1.64]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
2	113819725	rs28938777	A	G	rs28938777	23555315	0.00046	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
2	119218881	rs1437690	C	T	rs1437690	20978177	5.02E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
2	120125058	rs3731607	C	T	rs3731607	23555315	0.00068	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
2	121081260	rs12477565	G	T	rs12477565	24185611	2.25E-06	GWAS stage only	1.68	[1.35-2.08]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs12477565-T	NA	T	NA
2	121788630	rs280213	G	T	rs280213	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	121788901	rs7608862	C	T	rs7608862	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	121789026	rs280215	T	C	rs280215	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	121790225	rs1867907	C	T	rs1867907	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	122953150	rs1432302	C	T	rs1432302	23359319	3.96E-05	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
2	127233566	rs715915	G	A	rs715915	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	127234126	rs10928884	T	C	rs10928884	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	130667081	rs10445703	T	A	rs10445703	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	130674793	rs10192960	G	T	rs10192960	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	136366433	rs6723890	A	G	rs6723890	20978177	9.56E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
2	144177579	rs16822484	T	C	rs16822484	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	144899559	rs3731958	C	A	rs3731958	23555315	0.000011	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
2	148875566	rs41477845	C	T	rs41477845	20978177	6.35E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
2	150773549	rs1437959	A	G	rs1437959	pha002878	2.24E-05	phs000207	1.96	[1.35-2.86]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
2	150870860	rs331124	C	T	rs331124	pha002878	2.19E-05	phs000207	1.85	[1.27-2.70]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	NA	NA	NA
2	152499355	rs76767949	T	C	rs76767949	23555315	0.00032	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
2	152521983	rs117271684	A	G	rs117271684	23555315	0.00069	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
2	152534545	rs117048449	T	C	rs117048449	23555315	0.00069	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
2	153388487	rs17327752	G	A	rs17327752	20978177	8.85E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
2	155706411	rs4467223	T	A	rs4467223	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	155711357	rs17642086	T	C	rs17642086	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	155713421	rs1979004	T	A	rs1979004	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	159851423	rs10497203	A	C	rs10497203	24974847	8.84E-11	(late toxicity)	0.39	[NA] unit increase	Up to 652 European ancestry cases	European(652)	ALL(652)	EUR(652)	ALL(652)	Response to radiotherapy in prostate cancer (toxicity)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs10497203-C	Randomized Controlled Trial	Multicenter Study	Clinical Trial
2	159899489	rs7582141	G	T	rs7582141	24974847	5.00E-11	(late toxicity)	0.37	[NA] unit increase	Up to 652 European ancestry cases	European(652)	ALL(652)	EUR(652)	ALL(652)	Response to radiotherapy in prostate cancer (toxicity)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs7582141-T	Randomized Controlled Trial	Multicenter Study	Clinical Trial
2	159899913	rs6432512	C	T	rs6432512	24974847	1.97E-10	(late toxicity)	0.35	[NA] unit increase	Up to 652 European ancestry cases	European(652)	ALL(652)	EUR(652)	ALL(652)	Response to radiotherapy in prostate cancer (toxicity)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs6432512-T	Randomized Controlled Trial	Multicenter Study	Clinical Trial
2	159936391	rs264588	C	A	rs264588	24974847	3.08E-10	(late toxicity)	0.37	[NA] unit increase	Up to 652 European ancestry cases	European(652)	ALL(652)	EUR(652)	ALL(652)	Response to radiotherapy in prostate cancer (toxicity)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs264588-A	Randomized Controlled Trial	Multicenter Study	Clinical Trial
2	159950865	rs264631	C	G	rs264631	24974847	6.40E-10	(late toxicity)	0.36	[NA] unit increase	Up to 652 European ancestry cases	European(652)	ALL(652)	EUR(652)	ALL(652)	Response to radiotherapy in prostate cancer (toxicity)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs264631-G	Randomized Controlled Trial	Multicenter Study	Clinical Trial
2	165042064	rs1121308	T	C	rs1121308	20978177	8.01E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
2	166031792	rs12615864	G	A	rs12615864	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	166032837	rs139585434	G	A	rs139585434	23555315	0.000000161	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate-specific antigen	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
2	167033344	rs16851722	G	T	rs16851722	20978177	9.11E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
2	167056428	rs4303728	G	A	rs4303728	20978177	7.20E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
2	170139387	rs111704488	A	C	rs111704488	23555315	0.00022	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
2	172841213	rs73976541	C	T	rs73976541	23555315	0.00082	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
2	173108443	rs4972740	C	T	rs4972740	20978177	1.71E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
2	173152508	rs7574709	A	C	rs7574709	20978177	9.94E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
2	173311553	rs12621278	A	G	rs12621278	19767753	9.00E-23	NA	1.33	[1.25-1.43]	1,854 European ancestry cases; 1,894 European ancestry controls	European(3748)	ALL(3748)	EUR(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs12621278-G	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	173311553	rs12621278	A	G	rs12621278	23555315	0.000054	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
2	173311553	rs12621278	A	G	rs12621278	24740154	5.20E-05	(GWAS stage)	1.72	[1.72-1.72]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs12621278-A	Research Support, N.I.H., Extramural	A	ITGA6
2	176389860	rs9646737	C	T	rs9646737	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	176398354	rs6723304	G	A	rs6723304	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	178553569	rs6739583	A	T	rs6739583	20978177	2.58E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
2	179593761	rs72648951	T	C	rs72648951	23555315	0.00021	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
2	180348245	rs2271759	T	G	rs2271759	20978177	2.05E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
2	180352726	rs6708300	A	G	rs6708300	20978177	1.23E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
2	180396787	rs6715181	C	T	rs6715181	20978177	1.10E-06	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
2	180396869	rs6715297	C	T	rs6715297	20978177	1.52E-06	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
2	181041286	rs16867225	G	A	rs16867225	22219177	3.00E-06	rs1859962	1.56	[1.30-1.89]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
2	193360531	rs1994245	T	C	rs1994245	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	196825573	rs192646926	G	A	rs192646926	23555315	0.0003	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
2	198143591	rs10931777	C	T	rs10931777	22923026	1.23E-07	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
2	198143871	rs6727480	A	G	rs6727480	22923026	3.79E-07	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
2	198263146	rs16865262	T	C	rs16865262	22923026	1.30E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
2	198327314	rs3754822	G	A	rs3754822	22923026	1.84E-06	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
2	198506466	rs2045244	C	T	rs2045244	22923026	2.68E-06	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
2	198621506	rs2293255	T	C	rs2293255	22923026	7.48E-07	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
2	198631714	rs700651	G	A	rs700651	23555315	0.00027	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
2	198647108	rs1851779	C	T	rs1851779	22923026	5.41E-07	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
2	198684342	rs16824376	C	T	rs16824376	22923026	5.00E-07	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
2	198685609	rs996427	G	A	rs996427	22923026	5.51E-07	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
2	198713231	rs6707521	G	A	rs6707521	22923026	5.47E-07	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
2	198836777	rs7581202	A	G	rs7581202	22923026	7.60E-06	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
2	198875464	rs1595825	G	A	rs1595825	22923026	1.47E-06	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
2	198881668	rs1016883	G	A	rs1016883	22923026	2.56E-06	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
2	198946551	rs6434955	G	A	rs6434955	22923026	8.00E-06	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
2	199169096	rs13398206	T	C	rs13398206	22219177	4.00E-06	rs10896449	1.24	[1.13-1.36]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
2	201337629	rs199940720	G	T	rs199940720	23555315	0.000082	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
2	201565685	rs2540055	A	C	rs2540055	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	201568369	rs2348113	G	C	rs2348113	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	201568999	rs2540052	C	T	rs2540052	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	205883547	rs11896055	A	G	rs11896055	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	206141889	rs10490296	G	C	rs10490296	20978177	2.71E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
2	206144833	rs7606468	G	A	rs7606468	20978177	3.78E-05	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
2	207355354	rs2269183	G	T	rs2269183	20978177	4.65E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
2	207441588	rs3770978	C	G	rs3770978	20978177	8.28E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
2	207486889	rs10186957	C	T	rs10186957	20978177	5.87E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
2	207631446	rs147727753	G	C	rs147727753	23555315	0.00047	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
2	208929312	rs10932231	G	C	rs10932231	20978177	9.67E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
2	210263288	rs11889366	G	A	rs11889366	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	210403912	rs288095	A	C	rs288095	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	210559865	rs35927101	G	A	rs35927101	23555315	0.00027	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
2	211471071	rs2371002	G	A	rs2371002	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	211526922	rs6726148	A	T	rs6726148	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	211529850	rs12997383	C	T	rs12997383	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	211535278	rs16844777	C	T	rs16844777	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	213164907	rs1857795	A	C	rs1857795	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	219530662	rs41272683	G	A	rs41272683	23555315	0.00071	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
2	223085955	rs2234675	G	T	rs2234675	23555315	0.0001	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
2	224610232	rs4673075	C	T	rs4673075	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	225670901	rs4674941	G	C	rs4674941	23555315	0.00029	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
2	233854397	rs11885626	G	A	rs11885626	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	235229127	rs2885958	C	T	rs2885958	20978177	3.44E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
2	236267980	rs11691626	C	T	rs11691626	22923026	7.60E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
2	238387228	rs7584330	A	G	rs7584330	21743467	3.00E-09	NA	1.06	[1.02-1.09]	6,621 European ancestry cases; 6,939 European ancestry controls	European(13560)	ALL(13560)	EUR(13560)	ALL(13560)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs7584330-C	Multicenter Study	Comparative Study	G
2	238415117	rs12469812	C	T	rs12469812	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	238443226	rs2292884	A	G	rs2292884	21743057	4.00E-08	NA	1.14	[1.09-1.19]	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs2292884-G	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	239049718	rs199604026	G	A	rs199604026	23555315	1.70E-09	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
2	239398488	rs103718	G	A	rs103718	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	239398809	rs523437	C	T	rs523437	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
2	241729993	rs6708456	C	T	rs6708456	pha002878	3.45E-05	phs000207	1.35	[1.07-1.69]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	KIF1A	intron	NM_004321
2	241969887	rs185349960	G	A	rs185349960	23555315	0.00035	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
2	242065754	rs141663644	C	T	rs141663644	23555315	0.00048	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
2	242382864	rs3771570	C	T	rs3771570	23535732	5.00E-09	NA	1.12	[1.08-1.17]	11,085 European ancestry cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs3771570-A	NA	C	FARP2
3	149986	rs12485321	G	A	rs12485321	22219177	3.00E-06	rs6465657	1.23	[1.14-1.35]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
3	1512587	rs6763848	C	A	rs6763848	22219177	4.00E-06	rs9623117	1.3	[1.16-1.45]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
3	2796414	rs3897737	G	A	rs3897737	22923026	1.06E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
3	3773131	rs7628234	A	G	rs7628234	pha002877	6.45E-05	phs000207	1.13	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	G	NA	NA	NA
3	5714159	rs4283565	C	T	rs4283565	22923026	3.96E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
3	5716365	rs6791910	T	C	rs6791910	22923026	1.10E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
3	6935066	rs114246623	G	A	rs114246623	24185611	7.70E-07	GWAS stage only	4.93	[2.53-9.59]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs114246623-A	NA	A	GRM7
3	10084828	rs35625434	G	A	rs35625434	23555315	0.00036	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
3	12551807	rs6766510	T	C	rs6766510	22219177	2.00E-06	rs10993994	1.58	[1.31-1.91]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
3	14700046	rs4684236	T	C	rs4684236	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	14701635	rs9830735	G	A	rs9830735	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	14706848	rs3773487	G	A	rs3773487	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	14707132	rs3773489	A	C	rs3773489	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	14712042	rs3773491	A	G	rs3773491	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	14713306	rs11709673	A	G	rs11709673	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	14755667	rs141714657	G	C	rs141714657	23555315	0.000016	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
3	18031212	rs7432256	A	G	rs7432256	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	18129219	rs4688911	T	C	rs4688911	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	18133207	rs938180	A	C	rs938180	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	21658582	rs17029417	C	T	rs17029417	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	21719246	rs1490157	C	T	rs1490157	23555315	0.00089	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
3	27053802	rs1402991	A	G	rs1402991	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	27054896	rs939838	A	C	rs939838	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	29925518	rs2218724	A	G	rs2218724	pha002878	3.77E-05	phs000207	1.25	[0.99-1.59]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	RBMS3	intron	NM_001003793
3	30519860	rs4461455	C	T	rs4461455	20978177	7.21E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
3	33126972	rs73043340	C	T	rs73043340	24185611	3.76E-07	Less than 7,GWAS stage only	12.04	[3.98-36.46]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs73043340-T	NA	C	GLB1
3	35536237	rs7650296	C	T	rs7650296	23555315	0.00016	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
3	37996477	rs9311171	T	G	rs9311171	17903305	2.00E-06	NA	NA	NA	1,345 individuals(Framingham)	Framingham(1345)	ALL(1345)	EUR(1345)	ALL(1345)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	G	CTDSPL
3	39118649	rs144954527	C	T	rs144954527	23555315	0.00087	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
3	45962752	rs7652331	T	C	rs7652331	18073375	4.47E-05	NA	NA	NA	1,235 cases; 1,599 controls	NOPOP(2834)	ALL(2834)	NOPOP(2834)	ALL(2834)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
3	46005478	rs1545985	G	A	rs1545985	18073375	6.61E-06	NA	NA	NA	1,235 cases; 1,599 controls	NOPOP(2834)	ALL(2834)	NOPOP(2834)	ALL(2834)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
3	52852538	rs4687657	G	T	rs4687657	23555315	0.00027	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
3	52861211	rs13072536	A	T	rs13072536	23555315	0.00021	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
3	52874288	rs6445538	T	C	rs6445538	23555315	0.00025	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
3	54244778	rs9840694	C	T	rs9840694	21743057	3.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	54247916	rs9828664	C	T	rs9828664	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	54250489	rs9840489	G	A	rs9840489	21743057	8.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	54253658	rs6806229	G	A	rs6806229	21743057	8.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	54254041	rs3923436	T	G	rs3923436	21743057	8.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	55625184	rs904622	A	G	rs904622	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	57394766	rs1916284	T	C	rs1916284	22219177	1.00E-06	rs12418451	1.27	[1.15-1.41]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
3	60512889	rs241704	A	G	rs241704	pha002878	3.95E-05	phs000207	1.44	[1.14-1.82]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	A	FHIT	intron	NM_002012
3	60610341	rs2885865	G	A	rs2885865	20978177	7.26E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
3	61615565	rs1320234	C	T	rs1320234	22923026	4.02E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
3	64643533	rs4688495	A	T	rs4688495	20978177	9.68E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
3	65486388	rs1524976	A	G	rs1524976	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	65486793	rs9864728	A	C	rs9864728	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	65487427	rs1404550	G	C	rs1404550	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	65501649	rs1554664	A	G	rs1554664	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	66807194	rs6796957	A	G	rs6796957	23023329	2.07E-04	NA	NA	NA	1,417 Han Chinese cases; 1,008 Han Chinese controls	Han Chinese(2425)	ALL(2425)	ASN(2425)	ALL(2425)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	A	NA
3	69513198	rs9843168	C	T	rs9843168	22923026	1.26E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
3	70684565	rs11915836	C	T	rs11915836	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	70730524	rs6549348	G	A	rs6549348	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	73476665	rs13063715	T	C	rs13063715	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	73636020	rs9830956	G	A	rs9830956	20978177	5.11E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
3	73974792	rs941068	C	T	rs941068	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	73976514	rs6770247	G	A	rs6770247	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	73976539	rs10048995	C	G,T	rs10048995	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	85525323	rs12637791	T	G	rs12637791	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	85580328	rs4856584	A	T	rs4856584	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	85587729	rs11127898	C	G	rs11127898	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	86894478	rs9757252	T	C	rs9757252	22219177	5.00E-06	rs17021918	1.25	[1.13-1.37]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
3	87110674	rs2660753	T	C	rs2660753	18264097	3.00E-08	NA	1.18	[1.06-1.31]	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs2660753-T	Research Support, Non-U.S. Gov't	T	NA
3	87134800	rs17023900	A	G	rs17023900	18264097	3.10E-07	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	A	NA
3	87134800	rs17023900	A	G	rs17023900	22923026	6.00E-08	Japanese and Latin American	1.41	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Hispanic American ancestry cases; 1,057 Hispanic American ancestry controls	Japanese(2075)	Hispanic American(2100)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs17023900-G	Research Support, N.I.H., Extramural
3	87152169	rs9284813	A	G	rs9284813	20676098	5.00E-09	NA	NA	NA	1,583 Japanese cases; 3,386 Japanese controls	Japanese(4969)	ALL(4969)	ASN(4969)	ALL(4969)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	A	NA
3	87152169	rs9284813	A	G	rs9284813	23555315	0.00001	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
3	87172005	rs9836404	G	A	rs9836404	23023329	1.05E-04	NA	NA	NA	1,417 Han Chinese cases; 1,008 Han Chinese controls	Han Chinese(2425)	ALL(2425)	ASN(2425)	ALL(2425)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	G	NA
3	87173324	rs17181170	G	A	rs17181170	19767753	3.00E-08	NA	NA	NA	1,854 European ancestry cases; 1,894 European ancestry controls	European(3748)	ALL(3748)	EUR(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	87173324	rs17181170	G	A	rs17181170	23555315	0.00011	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
3	87241497	rs7629490	C	T	rs7629490	21743057	1.00E-07	conditioned on rs2660753	1.06	[1.04-1.09]	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs7629490-T	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	87241497	rs7629490	C	T	rs7629490	23555315	0.00004	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
3	93598157	rs76877671	A	G	rs76877671	23555315	0.00073	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
3	94335547	rs9809680	G	A	rs9809680	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	94342853	rs6791440	T	C	rs6791440	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	94343965	rs9290624	T	A	rs9290624	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	94345578	rs6791218	C	G	rs6791218	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	94345961	rs1873072	T	C	rs1873072	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	98169442	rs75457563	A	G	rs75457563	23555315	0.00014	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
3	100834291	rs12636874	A	T	rs12636874	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	112497880	rs1002979	T	C	rs1002979	22219177	3.00E-06	rs12621278	1.59	[1.32-1.92]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
3	113275624	rs7611694	A	C	rs7611694	23535732	4.00E-13	NA	1.1	[1.08-1.14]	11,085 European ancestry cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs7611694-A	NA	A	SIDT1
3	116381899	rs10934362	C	T	rs10934362	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	116386909	rs1543175	G	A	rs1543175	21743057	3.00E-07	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	116390670	rs13325108	C	G	rs13325108	21743057	1.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	116394204	rs11711002	T	C	rs11711002	21743057	6.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	116394860	rs7647681	C	G	rs7647681	21743057	6.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	116395890	rs4429629	C	G	rs4429629	21743057	6.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	116396116	rs13087427	A	G	rs13087427	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	117230623	rs12629904	C	T	rs12629904	22532847	0.000125	NA	NA	NA	135 prostate cancer cases; 270 controls; 525 adenoma cases; 630 colorectal cancer cases; 690 controls (shared)	NOPOP(2250)	ALL(2250)	NOPOP(2250)	ALL(2250)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	C	NA
3	120106820	rs1733329	T	C	rs1733329	22532847	0.000141	NA	NA	NA	135 prostate cancer cases; 270 controls; 525 adenoma cases; 630 colorectal cancer cases; 690 controls (shared)	NOPOP(2250)	ALL(2250)	NOPOP(2250)	ALL(2250)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	T	NA
3	124462824	rs3772809	A	G	rs3772809	23555315	0.00081	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
3	126787276	rs9843758	G	A	rs9843758	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	126788323	rs9848844	C	T	rs9848844	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	126792461	rs13318335	A	T	rs13318335	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	127125439	rs2594228	G	A	rs2594228	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	128038373	rs10934853	C	A	rs10934853	19767754	3.00E-10	NA	1.12	[1.08-1.16]	Up to 1,968 Icelandic cases; 35,382 Icelandic controls	Icelandic(37350)	ALL(37350)	EUR(37350)	ALL(37350)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs10934853-A	Research Support, Non-U.S. Gov't	A	EEFSEC
3	128127805	rs7612413	T	C	rs7612413	23555315	0.00084	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
3	128204951	rs2335052	C	T	rs2335052	23023329	3.40E-05	NA	NA	NA	1,417 Han Chinese cases; 1,008 Han Chinese controls	Han Chinese(2425)	ALL(2425)	ASN(2425)	ALL(2425)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	G	GATA2
3	128260550	rs4857855	C	T	rs4857855	23555315	0.00027	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
3	128329920	rs2253144	A	G	rs2253144	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	138001553	rs6796663	A	G	rs6796663	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	138002064	rs6797207	A	G	rs6797207	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	138009184	rs3886726	A	G	rs3886726	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	139496471	rs6772801	A	G	rs6772801	22367438	0.0003	NA	NA	NA	1,176 PCa cases; 1,101 controls	NOPOP(2277)	ALL(2277)	NOPOP(2277)	ALL(2277)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
3	141102833	rs6763931	G	A	rs6763931	21743467	2.00E-08	NA	1.04	[1.01-1.07]	6,621 European ancestry cases; 6,939 European ancestry controls	European(13560)	ALL(13560)	EUR(13560)	ALL(13560)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs6763931-T	Multicenter Study	Comparative Study	A
3	143377573	rs1242058	C	A	rs1242058	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	144786831	rs6762817	G	T	rs6762817	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	145173788	rs345013	A	G	rs345013	17903305	5.00E-06	NA	NA	NA	1,345 individuals(Framingham)	Framingham(1345)	ALL(1345)	EUR(1345)	ALL(1345)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	T	NA
3	150114504	rs12639090	C	T	rs12639090	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	150998157	rs10935835	A	G	rs10935835	20978177	7.09E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
3	153022780	rs9824588	T	C	rs9824588	23023329	2.19E-04	NA	NA	NA	1,417 Han Chinese cases; 1,008 Han Chinese controls	Han Chinese(2425)	ALL(2425)	ASN(2425)	ALL(2425)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	C	NA
3	154491978	rs11927211	A	G	rs11927211	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	154493381	rs10935990	G	T	rs10935990	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	158928265	rs7634829	G	A	rs7634829	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	159094569	rs1868415	C	T	rs1868415	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	166743282	rs1949532	T	A	rs1949532	20978177	9.88E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
3	169597186	rs7628292	G	T	rs7628292	22923026	8.95E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
3	170130102	rs10936632	C	A	rs10936632	21743467	7.00E-22	NA	1.11	[1.08-1.14]	6,621 European ancestry cases; 6,939 European ancestry controls	European(13560)	ALL(13560)	EUR(13560)	ALL(13560)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs10936632-A	Multicenter Study	Comparative Study	C
3	172231986	rs3774315	A	G	rs3774315	21467234	7.34E-05	Aggressive prostate cancer	NA	NA	202 European ancestry more aggressive cases; 100 European ancestry controls	European(302)	ALL(302)	EUR(302)	ALL(302)	Prostate cancer(aggressive)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Randomized Controlled Trial	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't
3	172770280	rs6445094	A	G	rs6445094	20978177	6.73E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
3	172843277	rs11720607	T	G	rs11720607	22219177	5.00E-06	rs10486567	1.37	[1.20-1.59]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
3	174029045	rs13074924	A	G	rs13074924	23555315	0.0001	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
3	174951756	rs4371530	T	C	rs4371530	22923026	5.16E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
3	174953393	rs6795495	T	C	rs6795495	22923026	8.79E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
3	177191841	rs9835831	T	C	rs9835831	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	177196292	rs1995241	T	C	rs1995241	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	177197754	rs12696443	C	T	rs12696443	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	179664102	rs9842133	T	C	rs9842133	22923026	4.20E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
3	179666018	rs7623941	A	C	rs7623941	22923026	7.50E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
3	179666298	rs1524516	A	G	rs1524516	22923026	6.47E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
3	183653718	rs4912515	A	G	rs4912515	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	187294550	rs4472044	C	T	rs4472044	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	187696291	rs17807098	C	T	rs17807098	20978177	3.15E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
3	189607152	rs148076109	C	A	rs148076109	23555315	0.00068	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
3	191699597	rs1392203	A	G	rs1392203	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	191713147	rs2649832	C	T	rs2649832	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	191988845	rs4686602	A	G	rs4686602	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	195594494	rs112384084	C	T	rs112384084	23555315	0.00041	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
3	195952731	rs1476332	C	G	rs1476332	21743057	6.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	195952900	rs7625886	T	C	rs7625886	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
3	196554952	rs6789365	C	A	rs6789365	24740154	9.30E-06	(GWAS stage)	1.61	[1.39-1.83]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs6789365-A	Research Support, N.I.H., Extramural	A	PAK2
4	2695585	rs139214890	C	T	rs139214890	23555315	0.000063	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
4	3151813	rs11731237	C	T	rs11731237	pha002878	6.25E-05	phs000207	1.06	[0.84-1.35]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	HTT	intron	NM_002111
4	4267298	rs2980089	G	A	rs2980089	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	4799692	rs2933572	G	A	rs2933572	pha002878	2.79E-05	phs000207	1.49	[1.19-1.89]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	A	NA	NA	NA
4	5758869	rs735172	T	C	rs735172	22219177	2.00E-06	rs887391	1.31	[1.17-1.46]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
4	6614168	rs10937748	A	G	rs10937748	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	7435721	rs6850206	C	T	rs6850206	23555315	0.00054	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
4	7436486	rs11548325	C	A	rs11548325	23555315	0.00072	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
4	8002391	rs16841542	T	G	rs16841542	pha002877	5.19E-05	phs000207	1.6	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	ABLIM2	intron	NM_001130083
4	9943624	rs149454410	C	T	rs149454410	23555315	0.00014	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
4	10165779	rs16894270	G	T	rs16894270	20978177	7.37E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
4	14063844	rs10516271	A	G	rs10516271	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	14208007	rs3096573	C	A	rs3096573	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	15835365	rs3796866	T	C	rs3796866	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	15835983	rs2286553	C	T	rs2286553	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	15836072	rs2286552	T	C	rs2286552	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	15836135	rs16892438	G	A	rs16892438	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	15836237	rs16892441	G	A	rs16892441	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	15840781	rs11574928	G	A	rs11574928	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	15849375	rs16892453	T	C	rs16892453	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	15849588	rs1004124	C	G	rs1004124	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	16834490	rs207709	A	G	rs207709	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	22715030	rs16873068	C	T	rs16873068	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	22718654	rs2013715	C	T	rs2013715	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	25849141	rs139899954	C	A	rs139899954	23555315	0.00000116	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Ratio of free to total prostate-specific antigen	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
4	35653192	rs13145490	T	A,C,G	rs13145490	23555315	0.00061	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
4	41686809	rs3765034	T	C	rs3765034	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	41700361	rs1061562	A	G	rs1061562	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	47427873	rs41311286	C	G	rs41311286	23555315	0.00077	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
4	56225353	rs11133375	G	A	rs11133375	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	56231119	rs7663650	C	T	rs7663650	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	56274132	rs2048564	G	A	rs2048564	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	56275230	rs11945371	G	T	rs11945371	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	56319088	rs4864996	A	C	rs4864996	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	56321067	rs2412648	T	G	rs2412648	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	56331332	rs6843722	A	C	rs6843722	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	56352885	rs11133389	C	T	rs11133389	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	56356395	rs4864543	C	T	rs4864543	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	56368671	rs13124436	G	A	rs13124436	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	56376344	rs2272073	C	T	rs2272073	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	56380484	rs12649507	G	A	rs12649507	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	56392813	rs13132420	G	A	rs13132420	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	56393331	rs13140173	C	T	rs13140173	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	56395953	rs2035691	C	T	rs2035691	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	56997350	rs998064	A	G	rs998064	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	57143037	rs629242	C	T	rs629242	18073375	7.25E-07	NA	NA	NA	1,235 cases; 1,599 controls	NOPOP(2834)	ALL(2834)	NOPOP(2834)	ALL(2834)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
4	57143037	rs629242	C	T	rs629242	pha002878	1.08E-05	phs000207	1.26	[1.00-1.58]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	KIAA1211	intron	NM_020722
4	60440722	rs1486307	G	A	rs1486307	24740154	5.00E-06	(GWAS stage)	1.32	[1.19-1.44]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs1486307-G	Research Support, N.I.H., Extramural	G	NA
4	71506120	rs2609426	A	G	rs2609426	20978177	2.89E-05	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
4	72835532	rs950110	C	T	rs950110	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	72835953	rs1520503	A	G	rs1520503	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	74349158	rs1894292	G	A	rs1894292	23535732	5.00E-13	NA	1.1	[1.06-1.12]	11,085 European ancestry cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs1894292-G	NA	A	AFM
4	80435307	rs12502383	C	T	rs12502383	20978177	4.89E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
4	81185974	rs17004857	G	A	rs17004857	20978177	7.58E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
4	81581498	rs756237	G	A	rs756237	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	81605788	rs10516646	G	A	rs10516646	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	84691811	rs6815226	G	A	rs6815226	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	84706464	rs7679666	A	G	rs7679666	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	87924979	rs340639	T	C	rs340639	23555315	0.00021	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
4	90687927	rs356192	G	A	rs356192	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	90691132	rs356189	T	C	rs356189	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	90696827	rs356163	A	C	rs356163	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	90720365	rs2583958	T	C	rs2583958	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	90721560	rs2737024	A	G	rs2737024	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	90721637	rs2583959	C	G	rs2583959	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	90722433	rs2619373	G	A	rs2619373	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	90856383	rs146236543	G	A	rs146236543	23555315	0.00054	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
4	94088158	rs7661752	G	A,C	rs7661752	18264096	4.95E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	95514609	rs12500426	A	C	rs12500426	19767753	1.00E-11	NA	1.08	[1.05-1.12]	1,854 European ancestry cases; 1,894 European ancestry controls	European(3748)	ALL(3748)	EUR(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs12500426-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	95562877	rs17021918	C	T	rs17021918	19767753	4.00E-15	NA	1.11	[1.08-1.15]	1,854 European ancestry cases; 1,894 European ancestry controls	European(3748)	ALL(3748)	EUR(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs17021918-T	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	95912221	rs1444922	A	G	rs1444922	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	95912925	rs1545328	G	T	rs1545328	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	102588509	rs6532954	T	C	rs6532954	20978177	6.35E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
4	103023049	rs173218	T	C	rs173218	22923026	6.24E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
4	103044377	rs238476	T	C	rs238476	20978177	6.77E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
4	103048019	rs2658533	T	G	rs2658533	20978177	8.66E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
4	103059680	rs236762	C	A	rs236762	20978177	6.64E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
4	103075983	rs236768	G	A	rs236768	20978177	4.05E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
4	103084574	rs236781	G	A	rs236781	20978177	2.84E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
4	103085133	rs189328	A	G	rs189328	20978177	2.88E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
4	106061534	rs7679673	C	A	rs7679673	19767753	3.00E-14	NA	1.1	[1.06-1.14]	1,854 European ancestry cases; 1,894 European ancestry controls	European(3748)	ALL(3748)	EUR(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs7679673-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	111006785	rs11943595	G	A	rs11943595	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	114000956	rs7694725	T	C	rs7694725	22219177	2.00E-06	rs10086908	1.36	[1.20-1.55]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
4	117370706	rs114918764	C	T	rs114918764	24185611	3.65E-07	Less than 7,GWAS stage only	34.07	[6.45-179.92]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs114918764-T	NA	C	NA
4	118072289	rs2196712	G	A	rs2196712	pha002877	2.24E-06	phs000207	1.56	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
4	118072289	rs2196712	G	A	rs2196712	pha002878	2.59E-05	phs000207	1.49	[1.15-1.92]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
4	118093624	rs11098380	T	C	rs11098380	pha002878	2.16E-05	phs000207	1.52	[1.16-1.96]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	NA	NA	NA
4	118190581	rs12644393	G	A	rs12644393	pha002877	4.36E-05	phs000207	1.21	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	G	NA	NA	NA
4	118416030	rs9999424	A	G	rs9999424	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	118417970	rs7666064	A	T	rs7666064	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	118449874	rs17866976	G	A	rs17866976	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	118469677	rs17865054	C	T	rs17865054	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	118472222	rs10003442	A	G	rs10003442	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	118475602	rs11562916	G	A	rs11562916	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	125593261	rs145437766	T	C	rs145437766	23555315	0.00012	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
4	127577302	rs313121	G	A	rs313121	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	127626494	rs313047	T	C	rs313047	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	127632219	rs313111	C	T	rs313111	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	127633098	rs313112	G	A	rs313112	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	134710417	rs7668810	T	C	rs7668810	20978177	5.80E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
4	141254086	rs4956342	A	G	rs4956342	20978177	6.63E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
4	141492685	rs1430579	G	C	rs1430579	22532847	0.000091	NA	NA	NA	135 prostate cancer cases; 270 controls; 525 adenoma cases; 630 colorectal cancer cases; 690 controls (shared)	NOPOP(2250)	ALL(2250)	NOPOP(2250)	ALL(2250)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	C	NA
4	146750966	rs13149290	C	T	rs13149290	18073375	2.56E-05	NA	NA	NA	1,235 cases; 1,599 controls	NOPOP(2834)	ALL(2834)	NOPOP(2834)	ALL(2834)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
4	148735644	rs10519917	C	T	rs10519917	20978177	1.43E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
4	155776405	rs3925665	C	A	rs3925665	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	155777902	rs6536033	C	G	rs6536033	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	155777927	rs6536034	A	G	rs6536034	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	155778084	rs6826923	G	A	rs6826923	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	155778598	rs6832295	A	G	rs6832295	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	155778672	rs6832974	G	A	rs6832974	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	155778784	rs1559690	G	A	rs1559690	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	155778844	rs1559689	C	T	rs1559689	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	155778978	rs1559688	A	C	rs1559688	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	155779283	rs1566470	A	G	rs1566470	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	155779367	rs1566471	G	A	rs1566471	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	155779475	rs1566472	T	C	rs1566472	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	155779863	rs17032131	G	A	rs17032131	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	155781759	rs17032135	T	C	rs17032135	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	155782044	rs11936192	G	A	rs11936192	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	155785658	rs10517604	C	T	rs10517604	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	159934179	rs11931163	G	A,C,T	rs11931163	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	159934356	rs10016573	A	G	rs10016573	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	160084403	rs7681750	A	G	rs7681750	20978177	5.55E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
4	162822306	rs2033404	T	G	rs2033404	pha002878	5.18E-05	phs000207	1.3	[0.98-1.71]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	FSTL5	intron	NM_020116
4	162826777	rs1440606	T	C	rs1440606	pha002878	5.27E-05	phs000207	1.29	[0.98-1.70]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	FSTL5	intron	NM_020116
4	168888096	rs7685473	G	A	rs7685473	21743057	4.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	169500402	rs17650886	G	A	rs17650886	20978177	3.99E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
4	172966378	rs1505483	G	C	rs1505483	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
4	177966548	rs17720291	C	T	rs17720291	20978177	7.10E-05	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
4	184930646	rs61730738	G	A	rs61730738	23555315	0.00056	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
5	1225626	rs7728667	T	A	rs7728667	23555315	0.00025	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
5	1280028	rs2242652	G	A	rs2242652	21743467	3.00E-24	NA	1.15	[1.11-1.19]	6,621 European ancestry cases; 6,939 European ancestry controls	European(13560)	ALL(13560)	EUR(13560)	ALL(13560)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs2242652-G	Multicenter Study	Comparative Study	C
5	1294086	rs2736098	C	T	rs2736098	21160077	8.80E-07	NA	NA	NA	15,757 Icelandic men	Icelandic(15757)	ALL(15757)	EUR(15757)	ALL(15757)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
5	1322087	rs401681	C	T	rs401681	21160077	1.00E-10	NA	7	[NA] % increase	7,538 European ancestry individuals	European(7538)	ALL(7538)	EUR(7538)	ALL(7538)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	rs401681-C	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
5	1409938	rs115254960	G	A	rs115254960	23555315	0.000000163	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate-specific antigen	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
5	1895829	rs12653946	C	T	rs12653946	20676098	4.00E-18	NA	1.26	[1.20-1.33]	1,583 Japanese cases; 3,386 Japanese controls	Japanese(4969)	ALL(4969)	ASN(4969)	ALL(4969)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs12653946-T	Research Support, Non-U.S. Gov't	T	NA
5	1895829	rs12653946	C	T	rs12653946	22923026	3.00E-07	Japanese	1.39	[1.22-1.57]	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Hispanic American ancestry cases; 1,057 Hispanic American ancestry controls	Japanese(2075)	Hispanic American(2100)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs12653946-T	Research Support, N.I.H., Extramural
5	1895829	rs12653946	C	T	rs12653946	23555315	0.00000041	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
5	13505432	rs4463179	G	A	rs4463179	22219177	2.00E-06	rs887391	1.56	[1.30-1.89]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
5	16676247	rs61744227	G	A	rs61744227	23555315	0.00078	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
5	16701796	rs112696559	A	C,G,T	rs112696559	23555315	0.00042	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
5	17775485	rs16887626	C	T	rs16887626	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	25108834	rs13189107	A	T	rs13189107	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	30242594	rs4295402	G	A	rs4295402	pha002878	1.70E-05	phs000207	1.19	[0.92-1.53]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	A	NA	NA	NA
5	31080763	rs6881843	T	G	rs6881843	23023329	6.70E-04	NA	NA	NA	1,417 Han Chinese cases; 1,008 Han Chinese controls	Han Chinese(2425)	ALL(2425)	ASN(2425)	ALL(2425)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	T	NA
5	38264735	rs2006889	A	G	rs2006889	22923026	4.78E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
5	38264735	rs2006889	A	G	rs2006889	23555315	0.00011	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
5	38278416	rs10941389	T	C	rs10941389	22923026	8.19E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
5	38281744	rs1428247	T	C	rs1428247	22923026	8.30E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
5	38527308	rs3729734	G	A	rs3729734	23555315	0.00025	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
5	38694483	rs1428499	G	T	rs1428499	pha002878	5.69E-05	phs000207	1.45	[1.15-1.82]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
5	44365545	rs2121875	C	A	rs2121875	21743467	4.00E-08	NA	1.05	[1.02-1.08]	6,621 European ancestry cases; 6,939 European ancestry controls	European(13560)	ALL(13560)	EUR(13560)	ALL(13560)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs2121875-G	Multicenter Study	Comparative Study	G
5	44396679	rs11949823	T	A	rs11949823	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	44397285	rs10078685	G	A	rs10078685	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	44402722	rs9292905	T	C	rs9292905	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	44414594	rs10039581	C	T	rs10039581	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	44423773	rs11950089	A	G	rs11950089	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	44425624	rs10473359	C	A	rs10473359	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	44425702	rs6865277	C	T	rs6865277	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	44427163	rs10472395	C	T	rs10472395	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	44431402	rs13361348	C	A	rs13361348	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	45727866	rs12110137	T	C	rs12110137	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	45742624	rs7706116	G	T	rs7706116	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	45752862	rs4455566	T	C	rs4455566	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	45759165	rs12654213	T	G	rs12654213	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	45759876	rs9687260	A	G	rs9687260	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	52418582	rs30099	G	A	rs30099	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	52420522	rs27420	T	A	rs27420	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	53949560	rs7720197	G	A	rs7720197	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	53953264	rs11749226	T	C	rs11749226	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	53953279	rs11745165	C	A	rs11745165	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	57130818	rs10940579	T	A,C	rs10940579	22219177	4.00E-06	rs4962416	1.32	[1.18-1.49]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
5	57917792	rs425203	G	A	rs425203	22923026	3.05E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
5	58569284	rs2112959	T	C	rs2112959	20978177	6.02E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
5	66002754	rs4700159	G	A	rs4700159	22923026	7.08E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
5	66833257	rs7717572	G	A	rs7717572	22219177	3.00E-06	rs2660753	1.94	[1.47-2.56]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
5	72400190	rs683633	T	C	rs683633	pha002878	1.71E-05	phs000207	1.33	[1.01-1.79]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	A	NA	NA	NA
5	77224666	rs7712357	T	C	rs7712357	pha002878	5.64E-05	phs000207	1.39	[1.08-1.79]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	NA	NA	NA
5	79506057	rs17259420	G	A	rs17259420	22923026	9.06E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
5	82985739	rs4466137	T	G	rs4466137	17903305	3.00E-06	NA	NA	NA	1,345 individuals(Framingham)	Framingham(1345)	ALL(1345)	EUR(1345)	ALL(1345)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	G	HAPLN1
5	82985739	rs4466137	T	G	rs4466137	23555315	0.00059	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
5	84120872	rs4432885	T	C	rs4432885	20978177	5.07E-05	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
5	93767365	rs2042003	T	G	rs2042003	20978177	6.80E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
5	104110119	rs11242536	A	G	rs11242536	18264096	6.91E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	106190158	rs17159187	C	T	rs17159187	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	115108261	rs1472623	C	T	rs1472623	20978177	7.58E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
5	115113448	rs731649	C	G	rs731649	20978177	6.45E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
5	115630004	rs37181	T	G	rs37181	21743467	2.20E-05	NA	NA	NA	6,621 European ancestry cases; 6,939 European ancestry controls	European(13560)	ALL(13560)	EUR(13560)	ALL(13560)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Multicenter Study	Comparative Study	A
5	119879295	rs10063718	G	A	rs10063718	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	120095803	rs1080833	A	G	rs1080833	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	120097830	rs7728842	G	C	rs7728842	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	120099815	rs7701417	A	G	rs7701417	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	120099875	rs7701827	G	A	rs7701827	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	120099898	rs7701686	C	T	rs7701686	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	120100197	rs7705746	A	T	rs7705746	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	120100225	rs7705890	C	A	rs7705890	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	122406325	rs3924912	T	C	rs3924912	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	127926190	rs6883598	A	C	rs6883598	20978177	3.66E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
5	127962841	rs9327479	G	A	rs9327479	20978177	4.42E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
5	127983935	rs6897794	C	T	rs6897794	20978177	5.57E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
5	130413981	rs6867265	A	G	rs6867265	23555315	0.00062	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
5	132669374	rs17166584	G	A	rs17166584	20978177	5.20E-05	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
5	132669995	rs10515458	C	A	rs10515458	20978177	1.39E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
5	132680491	rs13159148	T	G	rs13159148	20978177	9.44E-05	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
5	132690232	rs17166628	A	G	rs17166628	20978177	6.00E-05	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
5	132690433	rs10515460	T	C	rs10515460	20978177	9.44E-05	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
5	133076898	rs7719165	G	A	rs7719165	20978177	3.39E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
5	133090197	rs721077	C	T	rs721077	20978177	6.58E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
5	133101508	rs258067	C	A	rs258067	20978177	9.04E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
5	133190639	rs7719102	T	G	rs7719102	20978177	1.89E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
5	133191011	rs4246020	C	T	rs4246020	20978177	1.89E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
5	133224088	rs731590	C	T	rs731590	20978177	6.99E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
5	133224404	rs903077	G	A	rs903077	20978177	9.36E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
5	139929877	rs6889768	T	G	rs6889768	24185611	3.81E-07	Greater than or even to 7,GWAS stage only	3.7	[2.20-6.24]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs6889768-G	NA	T	SRA1
5	139941943	rs7715021	C	G	rs7715021	24185611	2.09E-06	Greater than or even to 7,GWAS stage only	3.1	[1.92-5.01]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs7715021-G	NA	C	APBB3
5	139961837	rs17119623	T	C	rs17119623	24185611	1.19E-06	Greater than or even to 7,GWAS stage only	3.17	[1.97-5.10]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs17119623-C	NA	T	NA
5	140041187	rs115338764	G	A	rs115338764	24185611	1.98E-07	Greater than or even to 7,GWAS stage only	3.34	[2.09-5.34]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs115338764-A	NA	C	IK
5	140070148	rs7706544	C	T	rs7706544	24185611	1.94E-07	Greater than or even to 7,GWAS stage only	3.34	[2.09-5.34]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs7706544-T	NA	C	HARS
5	140166953	rs34575154	A	G	rs34575154	24185611	3.56E-06	GWAS stage only	2.8	[1.79-4.38]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs34575154-G	NA	T	PCDHA1
5	140177075	rs116776862	G	A	rs116776862	24185611	6.86E-06	GWAS stage only	2.67	[1.72-4.14]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs116776862-A	NA	G	PCDHA2
5	140187201	rs113425597	G	C	rs113425597	24185611	6.36E-07	Greater than or even to 7,GWAS stage only	3.55	[2.13-5.91]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs113425597-C	NA	G	PCDHA4
5	140213805	rs4151685	A	C	rs4151685	24185611	3.52E-06	GWAS stage only	2.8	[1.79-4.38]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs4151685-C	NA	A	PCDHA6
5	140215956	rs6880234	C	G	rs6880234	24185611	7.49E-07	Greater than or even to 7,GWAS stage only	3.53	[2.12-5.88]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs6880234-G	NA	C	PCDHA7
5	140230548	rs140013560	C	A	rs140013560	23555315	0.000069	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
5	140603601	rs200378467	A	G	rs200378467	23555315	0.000000163	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate-specific antigen	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
5	140604011	rs61734412	A	T	rs61734412	23555315	0.000049	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
5	140711097	rs17097185	C	G	rs17097185	24185611	2.70E-06	GWAS stage only	3.02	[1.88-4.84]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs17097185-G	NA	C	PCDHGA1
5	140711954	rs116679801	C	G	rs116679801	24185611	8.49E-06	GWAS stage only	3	[1.83-4.91]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs116679801-G	NA	C	PCDHGA1
5	140718552	rs6878145	A	G	rs6878145	24185611	1.93E-06	Greater than or even to 7,GWAS stage only	3.43	[2.03-5.80]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs6878145-G	NA	A	PCDHGA2
5	140718552	rs6878145	A	G	rs6878145	24185611	4.94E-06	GWAS stage only	2.94	[1.83-4.73]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs6878145-G	NA	A	PCDHGA2
5	140718750	rs61749035	G	T	rs61749035	24185611	7.50E-07	GWAS stage only	3.22	NA	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs61749035-T	NA	NA	PCDHGA2
5	140736146	rs115115119	A	G	rs115115119	23555315	0.000037	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
5	141026884	rs251177	T	C	rs251177	18073375	1.88E-04	NA	NA	NA	1,235 cases; 1,599 controls	NOPOP(2834)	ALL(2834)	NOPOP(2834)	ALL(2834)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
5	141395998	rs6580215	T	G	rs6580215	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	149219663	rs138772212	G	A	rs138772212	23555315	0.0000026	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
5	149900889	rs145198292	A	G	rs145198292	23555315	0.00071	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
5	150441761	rs147561136	T	C	rs147561136	23555315	0.000069	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
5	155593908	rs10866716	C	T	rs10866716	pha002878	1.49E-05	phs000207	1.23	[0.98-1.56]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
5	155642709	rs249881	G	A	rs249881	pha002878	9.55E-05	phs000207	1.32	[1.04-1.64]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
5	155666794	rs249888	C	T	rs249888	pha002878	6.01E-05	phs000207	1.33	[1.05-1.67]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
5	155812596	rs6556570	G	C	rs6556570	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	156111223	rs32076	T	C	rs32076	20830292	6.74E-07	Selenium resistance	NA	NA	46 NCI cancer cell lines (mixed ancestry)	NOPOP(46)	ALL(46)	NOPOP(46)	ALL(46)	Selenium resistance in NCI60 cancer cell lines	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, Non-U.S. Gov't	C	SGCD
5	160316265	rs10069908	A	C	rs10069908	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	163340237	rs2546324	G	A	rs2546324	22923026	8.04E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
5	163906721	rs17063523	C	G	rs17063523	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	163908589	rs10515881	C	A	rs10515881	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	163912860	rs17081859	G	T	rs17081859	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	163912895	rs17081861	C	T	rs17081861	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	163920951	rs17839824	A	T	rs17839824	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	163928148	rs17068611	C	T	rs17068611	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	163933160	rs17311376	G	A	rs17311376	21743057	7.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
5	172939426	rs6869841	C	T	rs6869841	23535732	5.00E-08	NA	1.07	[1.04-1.11]	11,085 European ancestry cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs6869841-A	NA	C	NA
5	173989235	rs1844516	G	C	rs1844516	20978177	8.31E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
5	174948557	rs157474	A	G	rs157474	20978177	8.73E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
5	176520243	rs351855	G	A	rs351855	23555315	0.0002	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C,G
5	176637576	rs28932178	T	C	rs28932178	23555315	0.000061	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
5	180634426	rs10066307	T	C	rs10066307	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	475154	rs9503977	C	T	rs9503977	22923026	9.65E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
6	3546794	rs17716079	T	C	rs17716079	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	3587548	rs7743238	T	C	rs7743238	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	3594782	rs9502023	G	T	rs9502023	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	3608887	rs9502029	A	G	rs9502029	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	3615820	rs9502033	T	G	rs9502033	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	4074822	rs77132955	C	A	rs77132955	23555315	0.00024	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
6	5910329	rs1001290	T	C	rs1001290	20978177	5.81E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
6	6266854	rs140712764	C	T	rs140712764	23555315	0.00000091	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
6	7231754	rs201520366	C	G	rs201520366	23555315	0.000054	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
6	7976745	rs197119	G	A	rs197119	20978177	2.54E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
6	10902439	rs6910232	A	G	rs6910232	23555315	0.00013	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
6	11920517	rs169713	T	C	rs169713	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	11923194	rs209780	C	T	rs209780	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	11929602	rs864244	C	A	rs864244	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	13267547	rs182148	G	A	rs182148	22923026	3.56E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
6	16552503	rs9464918	C	T	rs9464918	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	16559980	rs9477163	C	A	rs9477163	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	17531409	rs4712300	G	A	rs4712300	20978177	7.40E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
6	17794494	rs3734234	G	A	rs3734234	24740154	7.00E-06	(GWAS stage)	1.27	[1.16-1.37]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs3734234-G	Research Support, N.I.H., Extramural	G	KIF13A
6	17813825	rs10456809	C	T	rs10456809	22219177	5.00E-06	rs10086908	1.25	[1.14-1.38]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	21209123	rs9368288	G	A	rs9368288	20978177	6.20E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
6	22711757	rs9358581	A	T	rs9358581	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	23316593	rs12195633	C	T	rs12195633	20978177	4.77E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
6	23325833	rs6902688	A	G	rs6902688	20978177	7.82E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
6	25855404	rs116645668	G	A	rs116645668	23555315	0.00036	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
6	29702510	rs2523395	G	A	rs2523395	22219177	2.00E-06	rs1512268	1.24	[1.14-1.35]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	30851933	rs7757648	G	A	rs7757648	23555315	0.00086	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
6	31118511	rs130067	T	G	rs130067	21743467	3.00E-08	NA	1.05	[1.02-1.09]	6,621 European ancestry cases; 6,939 European ancestry controls	European(13560)	ALL(13560)	EUR(13560)	ALL(13560)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs130067-G	Multicenter Study	Comparative Study	A
6	31355318	rs2596560	T	C	rs2596560	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	31365707	rs2523457	G	A	rs2523457	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	32192331	rs3096702	A	G	rs3096702	23535732	5.00E-09	NA	1.07	[1.04-1.10]	11,085 European ancestry cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs3096702-A	NA	C	NOTCH4
6	32218989	rs9296015	G	A	rs9296015	23555315	0.00011	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
6	32219725	rs4959089	A	G	rs4959089	23555315	0.00011	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
6	32257566	rs926070	G	A	rs926070	23555315	0.00088	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
6	32261153	rs16870005	C	T	rs16870005	23555315	0.00018	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
6	32655508	rs28747043	A	G	rs115850745	24185611	1.05E-06	GWAS stage only	1.79	[1.41-2.27]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs115850745-A	NA	A	NA
6	32802938	rs140654840	C	T	rs140654840	23555315	0.000033	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
6	32814942	rs1057149	C	T	rs1057149	23555315	0.00061	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
6	32816772	rs41550019	C	A	rs41550019	23555315	0.00053	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
6	32829714	rs9276825	G	A	rs9276825	20978177	9.98E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
6	33271971	rs138516982	C	T	rs138516982	23555315	0.000018	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
6	36871931	rs6931297	A	G	rs6931297	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	36872657	rs6932579	A	G	rs6932579	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	36875883	rs9462242	C	T	rs9462242	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	38800164	rs9357283	G	A	rs9357283	23555315	0.000096	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
6	39127045	rs9470983	C	T	rs9470983	20978177	3.83E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
6	39128424	rs9470986	C	T	rs9470986	20978177	3.83E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
6	40084864	rs115899206	A	G	rs115899206	24185611	1.59E-06	GWAS stage only	4.91	[2.49-9.68]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs115899206-G	NA	A	NA
6	41536427	rs1983891	C	T	rs1983891	20676098	8.00E-08	NA	1.15	[1.09-1.21]	1,583 Japanese cases; 3,386 Japanese controls	Japanese(4969)	ALL(4969)	ASN(4969)	ALL(4969)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs1983891-T	Research Support, Non-U.S. Gov't	C	FOXP4
6	41536427	rs1983891	C	T	rs1983891	23555315	0.00033	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
6	43719391	rs9394963	G	T	rs9394963	22923026	9.60E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
6	44772113	rs7766901	G	A	rs7766901	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	44774828	rs6912535	C	T	rs6912535	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	44808110	rs9472381	C	T	rs9472381	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	44813340	rs13436998	C	T	rs13436998	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	44817557	rs9472384	A	T	rs9472384	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	44822936	rs9296447	C	T	rs9296447	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	44827696	rs16872751	T	C	rs16872751	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	45898002	rs3777566	C	G	rs3777566	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	46684222	rs1805017	C	T	rs1805017	23555315	0.0002	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
6	47663326	rs1329536	T	C	rs1329536	24185611	6.20E-06	GWAS stage only	2.54	[1.68-3.84]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs1329536-T	NA	G	GPR111
6	48282352	rs603284	T	G	rs603284	20978177	6.28E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
6	48284790	rs482581	C	G	rs482581	20978177	7.01E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
6	48285824	rs659675	G	A	rs659675	20978177	6.28E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
6	48286594	rs673410	C	A	rs673410	20978177	6.25E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
6	48286611	rs973094	G	T	rs973094	20978177	6.28E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
6	48286655	rs973093	T	C	rs973093	20978177	6.28E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
6	51666631	rs10498792	T	C	rs10498792	17903305	3.00E-06	NA	NA	NA	1,345 individuals(Framingham)	Framingham(1345)	ALL(1345)	EUR(1345)	ALL(1345)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	T	PKHD1
6	53310839	rs9367532	G	A	rs9367532	23555315	0.000081	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
6	65321689	rs604490	A	G	rs604490	pha002878	8.05E-05	phs000207	1.1	[0.87-1.41]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	EYS	intron	NM_001142800
6	68800495	rs7753361	G	A	rs7753361	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	69294485	rs9351730	G	A	rs9351730	22219177	5.00E-06	rs9364554	1.25	[1.13-1.37]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	74998457	rs9360769	T	C	rs9360769	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	75461769	rs2502467	C	T	rs2502467	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	80562589	rs4706803	A	G	rs4706803	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	83795119	rs4437440	A	G	rs4437440	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	83803769	rs9294271	G	C	rs9294271	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	83808673	rs7742531	A	G	rs7742531	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	86871444	rs66504230	T	C	rs66504230	24185611	1.77E-07	Less than 7,GWAS stage only	3.15	[2.01-4.95]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs66504230-C	NA	T	NA
6	88125542	rs61731441	G	A	rs61731441	23555315	0.00026	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
6	88423165	rs16879736	C	T	rs16879736	pha002877	8.25E-05	phs000207	1.62	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
6	88660007	rs1940893	G	A	rs1940893	20978177	5.91E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
6	88717766	rs366676	A	G	rs366676	23555315	0.00024	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
6	92429905	rs437932	C	T	rs437932	20978177	6.34E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
6	92828724	rs4571541	G	A	rs4571541	22923026	3.59E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
6	92840842	rs6908539	C	T	rs6908539	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	94493290	rs9345399	C	T	rs9345399	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	95072929	rs13203547	A	G	rs13203547	20978177	7.32E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
6	97469390	rs1206100	G	A	rs1206100	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	99878619	rs7745110	G	C	rs7745110	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	99880839	rs6915401	T	A	rs6915401	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	99883137	rs6570064	A	G	rs6570064	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	99888013	rs4840044	A	G	rs4840044	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	109040488	rs17069794	C	T	rs17069794	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	109052040	rs7751556	T	C	rs7751556	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	109285189	rs2273669	A	G	rs2273669	23535732	8.00E-09	NA	1.07	[1.03-1.11]	11,085 European ancestry cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs2273669-G	NA	G	ARMC2
6	113377048	rs2185710	A	G	rs2185710	24185611	5.95E-08	Less than 7,GWAS stage only	2.77	[1.89-4.05]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs2185710-G	NA	T	NA
6	114865780	rs17076203	A	G	rs17076203	pha002878	5.00E-05	phs000207	1.37	[1.02-1.85]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	A	NA	NA	NA
6	114939097	rs7761443	A	C	rs7761443	pha002878	6.01E-05	phs000207	1.41	[1.05-1.92]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
6	116574940	rs149060725	C	T	rs149060725	23555315	0.00036	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
6	117128107	rs140603319	A	G	rs140603319	23555315	0.000095	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
6	117130704	rs2274911	G	A	rs2274911	23555315	0.000013	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
6	117210052	rs339331	T	C	rs339331	20676098	2.00E-12	NA	1.22	[1.15-1.28]	1,583 Japanese cases; 3,386 Japanese controls	Japanese(4969)	ALL(4969)	ASN(4969)	ALL(4969)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs339331-T	Research Support, Non-U.S. Gov't	T	RFX6
6	117210052	rs339331	T	C	rs339331	23555315	0.000021	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
6	123282941	rs13192613	G	T	rs13192613	22219177	3.00E-06	rs11649743	1.37	[1.20-1.56]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
6	129695667	rs7758663	T	C	rs7758663	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	129697164	rs17057193	T	C	rs17057193	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	129697887	rs9492314	G	A	rs9492314	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	129699605	rs9483018	T	A	rs9483018	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	129700639	rs9483020	G	A	rs9483020	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	129700896	rs9483022	T	C	rs9483022	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	129700964	rs9483023	T	C	rs9483023	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	129980436	rs6569617	T	C	rs6569617	23555315	0.0002	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
6	130499476	rs1034263	C	T	rs1034263	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	134589331	rs9483670	A	G	rs9483670	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	139831757	rs634869	T	C	rs634869	20978177	2.56E-05	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
6	139834012	rs632057	T	G	rs632057	20978177	1.69E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
6	139840693	rs592423	A	C	rs592423	20978177	9.01E-05	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
6	143074549	rs117019703	G	A	rs117019703	23555315	0.00086	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
6	143429476	rs3789783	A	G	rs3789783	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	149074229	rs9498147	A	G	rs9498147	22923026	9.53E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
6	151672914	rs200925112	A	G	rs200925112	23555315	0.00036	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
6	153431125	rs12055786	C	T	rs12055786	23555315	0.000089	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
6	153441079	rs1933488	A	G	rs1933488	23535732	4.00E-18	NA	1.12	[1.09-1.15]	11,085 European ancestry cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs1933488-A	NA	A	RGS17
6	156428091	rs9478688	G	T	rs9478688	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	160581374	rs651164	A	G	rs651164	19767753	2.00E-09	NA	NA	NA	1,854 European ancestry cases; 1,894 European ancestry controls	European(3748)	ALL(3748)	EUR(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	160581374	rs651164	A	G	rs651164	21743057	2.00E-10	conditioned on rs9364554	1.15	[1.10-1.20]	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs651164-G	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	160833664	rs9364554	C	T	rs9364554	18264097	6.00E-10	NA	1.17	[1.08-1.26]	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs9364554-T	Research Support, Non-U.S. Gov't	C	SLC22A3
6	160833664	rs9364554	C	T	rs9364554	24740154	1.90E-04	(GWAS stage)	1.24	[1.24-1.24]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs9364554-T	Research Support, N.I.H., Extramural	C	SLC22A3
6	161083272	rs9365200	T	C	rs9365200	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	161083481	rs9365201	T	C	rs9365201	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	161083633	rs9347438	T	C	rs9347438	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	161084642	rs9346833	C	T	rs9346833	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	165711487	rs145070973	G	A	rs145070973	23555315	0.00013	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
6	166913485	rs9457173	T	G	rs9457173	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	166915130	rs10946174	G	A	rs10946174	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	166916557	rs3778430	T	C	rs3778430	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
6	167343141	rs11159	G	A	rs11159	23555315	0.00067	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
6	167343185	rs35716361	G	T	rs35716361	23555315	0.0000011	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
6	167754401	rs34740867	A	G	rs34740867	23555315	0.0000044	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
7	1243525	rs7456553	T	C	rs7456553	23359319	2.10E-06	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
7	1484418	rs61747084	T	C	rs61747084	23555315	0.00011	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
7	1976457	rs1801368	C	A,G,T	rs1801368	23555315	0.00055	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
7	2113327	rs1860827	T	C	rs1860827	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	2114785	rs3778938	A	G	rs3778938	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	3096687	rs12113392	A	G	rs12113392	20978177	7.20E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
7	6476104	rs117103601	G	A	rs117103601	23555315	0.000055	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
7	7412808	rs182575990	C	T	rs182575990	23555315	0.00069	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
7	7796886	rs11982195	C	T	rs11982195	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	7897715	rs2348763	A	C	rs2348763	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	8580081	rs12667696	C	T	rs12667696	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	11446658	rs61996269	A	G	rs61996269	23555315	0.00083	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
7	12392897	rs10249315	T	C	rs10249315	pha002877	2.33E-06	phs000207	1.66	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	VWDE	intron	NM_001135924
7	12392897	rs10249315	T	C	rs10249315	pha002878	2.26E-05	phs000207	1.73	[1.31-2.27]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	VWDE	intron	NM_001135924
7	12393310	rs7809990	C	T	rs7809990	pha002877	2.61E-06	phs000207	1.65	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	VWDE	intron	NM_001135924
7	12393310	rs7809990	C	T	rs7809990	pha002878	2.62E-05	phs000207	1.71	[1.30-2.24]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	VWDE	intron	NM_001135924
7	12409522	rs3823844	A	G	rs3823844	pha002877	4.73E-07	phs000207	1.78	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	VWDE	missense	NM_001135924
7	12409522	rs3823844	A	G	rs3823844	pha002878	2.24E-06	phs000207	1.61	[1.22-2.11]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	VWDE	missense	NM_001135924
7	12414725	rs17165936	G	A	rs17165936	pha002877	1.13E-07	phs000207	1.84	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	G	VWDE	STOP-GAIN	NM_001135924
7	12414725	rs17165936	G	A	rs17165936	pha002878	6.77E-07	phs000207	1.67	[1.27-2.19]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	G	VWDE	STOP-GAIN	NM_001135924
7	12448482	rs10254572	C	T	rs10254572	pha002877	2.00E-06	phs000207	1.7	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
7	12448482	rs10254572	C	T	rs10254572	pha002878	1.73E-05	phs000207	1.56	[1.20-2.04]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
7	12488535	rs4721099	C	T	rs4721099	pha002878	1.41E-05	phs000207	1.55	[1.19-2.02]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
7	18631217	rs140585698	C	G	rs140585698	23555315	0.000098	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
7	20774091	rs6959944	A	C	rs6959944	20978177	2.78E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
7	20994491	rs12155172	A	G	rs12155172	19767753	9.00E-06	NA	1.05	[1.00-1.10]	1,854 European ancestry cases; 1,894 European ancestry controls	European(3748)	ALL(3748)	EUR(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	20994491	rs12155172	A	G	rs12155172	23535732	5.00E-13	NA	1.11	[1.07-1.15]	11,085 European ancestry cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs12155172-A	NA	G	NA
7	21085264	rs13243044	G	A	rs13243044	pha002877	1.55E-05	phs000207	1.1	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	G	NA	NA	NA
7	21659659	rs200581574	C	T	rs200581574	23555315	0.000021	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
7	21765452	rs12536928	C	T	rs12536928	23555315	0.00039	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
7	23299676	rs201982196	C	T	rs201982196	23555315	0.00000158	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Ratio of free to total prostate-specific antigen	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
7	25269753	rs3807887	T	G	rs3807887	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	25563961	rs11975146	G	A	rs11975146	23555315	0.00044	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
7	26474874	rs10238880	T	C	rs10238880	23359319	8.82E-05	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
7	27159136	rs6969780	G	C	rs6969780	23555315	0.00079	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
7	27976563	rs10486567	G	A	rs10486567	18264096	2.00E-06		1.12	[1.02-1.25]	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs10486567-G	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	27976563	rs10486567	G	A	rs10486567	23555315	0.0000077	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
7	32398094	rs215698	C	T	rs215698	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	33139147	rs17472556	G	A	rs17472556	23555315	0.00086	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
7	36492159	rs141247770	A	G	rs141247770	23555315	0.00083	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
7	37443902	rs13226064	G	A	rs13226064	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	40965127	rs7789197	G	A	rs7789197	22219177	3.00E-06	rs1447295	1.52	[1.27-1.79]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
7	42607637	rs1880408	A	G	rs1880408	24740154	7.10E-06	(GWAS stage)	1.63	[1.41-1.85]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs1880408-G	Research Support, N.I.H., Extramural	A	NA
7	45140914	rs1042984	C	T	rs1042984	20978177	6.09E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
7	46246580	rs9691259	A	G	rs9691259	23023329	2.08E-05	NA	NA	NA	1,417 Han Chinese cases; 1,008 Han Chinese controls	Han Chinese(2425)	ALL(2425)	ASN(2425)	ALL(2425)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	A	NA
7	51096992	rs61737866	G	A	rs61737866	23555315	0.00037	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
7	55214348	rs2072454	C	T	rs2072454	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	55214647	rs2270247	G	T	rs2270247	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	55215018	rs730437	A	C	rs730437	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	57354138	rs13240208	C	T	rs13240208	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	57366135	rs13228111	G	A	rs13228111	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	57366459	rs1916783	C	A	rs1916783	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	67865802	rs73146440	A	G	rs73146440	24185611	7.53E-06	GWAS stage only	5.26	[2.44-11.11]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs73146440-A	NA	A	NA
7	68470479	rs6973814	T	C	rs6973814	20978177	2.74E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
7	68495804	rs1485709	T	A	rs1485709	20978177	9.16E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T,A
7	68497399	rs1385704	C	T	rs1385704	20978177	9.16E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
7	69601819	rs4557583	C	G	rs4557583	20978177	7.30E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
7	73279484	rs201563407	G	A	rs201563407	23555315	0.000013	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
7	73971995	rs149209759	A	G	rs149209759	23555315	0.00037	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
7	75949617	rs2908192	C	T	rs2908192	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	82785304	rs61738783	G	A	rs61738783	23555315	0.00024	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
7	83174363	rs1639309	A	G	rs1639309	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	87911975	rs201304806	C	T	rs201304806	23555315	0.00068	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
7	93160671	rs6973591	A	G	rs6973591	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	93168766	rs6962312	G	C	rs6962312	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	93169389	rs12704677	T	C	rs12704677	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	93174631	rs13229065	T	G	rs13229065	21743057	5.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	93177533	rs12670169	T	A	rs12670169	21743057	5.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	93179970	rs12704683	A	G	rs12704683	21743057	5.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	93179990	rs5014937	A	C	rs5014937	21743057	5.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	93197732	rs9641123	G	C	rs9641123	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	96798820	rs10252691	A	C	rs10252691	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	97014330	rs10264553	C	A	rs10264553	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	97017222	rs6948852	T	G	rs6948852	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	97103593	rs10240105	G	A	rs10240105	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	97103911	rs7800682	T	G	rs7800682	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	97104598	rs7786172	C	T	rs7786172	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	97107457	rs10234240	C	T	rs10234240	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	97107498	rs10250050	T	C	rs10250050	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	97695363	rs705308	C	A	rs705308	18264097	4.70E-08	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	T	NA
7	97786282	rs6465654	G	A	rs6465654	18264097	7.50E-08	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	G	LMTK2
7	97816327	rs6465657	C	T	rs6465657	18264097	1.00E-09		1.12	[1.05-1.20]	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs6465657-C	Research Support, Non-U.S. Gov't	C	LMTK2
7	97816327	rs6465657	C	T	rs6465657	19767753	2.00E-08	NA	NA	NA	1,854 European ancestry cases; 1,894 European ancestry controls	European(3748)	ALL(3748)	EUR(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	97860299	rs115819213	G	A	rs115819213	23555315	0.00000074	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
7	97875349	rs79382137	C	T	rs79382137	23555315	0.00078	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
7	98021211	rs9649213	A	G	rs9649213	22219177	1.00E-06	rs4962416	1.28	[1.16-1.42]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
7	99695787	rs139603502	T	C	rs139603502	23555315	0.0000074	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
7	100014711	rs6465770	T	C	rs6465770	23555315	0.00046	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
7	100033389	rs200078456	C	T	rs200078456	23555315	0.00011	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
7	100634145	rs143984295	G	A	rs143984295	23555315	0.000000015	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
7	100680521	rs73712043	G	A	rs73712043	23555315	0.000069	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
7	100681751	rs73712044	A	G	rs73712044	23555315	0.00011	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
7	103595363	rs722278	A	C	rs722278	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	109003574	rs10277209	C	T	rs10277209	22219177	4.00E-06	rs1859962	1.36	[1.19-1.55]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
7	112261226	rs2966478	T	C	rs2966478	22923026	9.78E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
7	112290310	rs2966479	T	C	rs2966479	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	115611309	rs11764575	G	A	rs11764575	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	115619298	rs11767053	C	T	rs11767053	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	117704706	rs12537079	T	G	rs12537079	24185611	6.95E-07	Greater than or even to 7,GWAS stage only	2.86	[1.89-4.35]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs12537079-T	NA	T	NA
7	120971816	rs116350731	T	C	rs116350731	23555315	0.000022	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
7	124936442	rs62477096	A	G	rs62477096	24185611	6.63E-07	Less than 7,GWAS stage only	2.45	[1.70-3.53]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs62477096-G	NA	A	NA
7	124944982	rs6965492	G	T	rs6965492	24185611	6.92E-07	Less than 7,GWAS stage only	2.49	[1.72-3.61]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs6965492-T	NA	G	NA
7	127293963	rs3808115	T	C	rs3808115	20978177	8.87E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
7	128360997	rs339078	A	G	rs339078	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	128773770	rs11975493	G	A	rs11975493	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	134079073	rs17772766	G	C	rs17772766	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	136542022	rs10257657	A	T	rs10257657	20978177	6.79E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
7	136542373	rs10228878	C	T	rs10228878	20978177	8.76E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T,C
7	137691708	rs13232124	T	C	rs13232124	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	137692888	rs11972734	A	G	rs11972734	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	137694764	rs10954596	A	G	rs10954596	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	144300725	rs1476625	G	T	rs1476625	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	147524566	rs10246029	C	T	rs10246029	21743057	8.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	147549110	rs10246598	C	T	rs10246598	21743057	8.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	147554296	rs10263791	T	C	rs10263791	21743057	8.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	147568889	rs17170715	G	T	rs17170715	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	147569131	rs10255352	G	A	rs10255352	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	147569595	rs6947415	C	T	rs6947415	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	147578229	rs10270982	G	T	rs10270982	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	147579634	rs17170724	T	C	rs17170724	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	147583054	rs10232583	G	A	rs10232583	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	147583978	rs17170728	C	T	rs17170728	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	147584109	rs10263426	T	C	rs10263426	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	147605413	rs7797634	T	C	rs7797634	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	149475056	rs200849829	G	A	rs200849829	23555315	0.00075	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
7	150160458	rs11769211	G	A	rs11769211	pha002878	1.51E-05	phs000207	1.15	[0.91-1.45]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	G	GIMAP8	intron	NM_175571
7	150167583	rs6969414	A	G	rs6969414	pha002878	2.05E-05	phs000207	1.15	[0.90-1.45]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	G	GIMAP8	intron	NM_175571
7	150253913	rs1403222	A	G	rs1403222	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	150255583	rs6949018	G	A	rs6949018	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	150256384	rs9986903	T	C	rs9986903	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
7	151874581	rs149373512	G	C	rs149373512	23555315	0.00089	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
7	157931144	rs1130499	C	T	rs1130499	23555315	0.0000091	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
8	3247408	rs147739031	A	G	rs147739031	24185611	9.96E-07	GWAS stage only	11.48	[3.78-34.90]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs147739031-G	NA	A	CSMD1
8	5732000	rs6992867	G	A	rs6992867	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	5755548	rs12677512	A	G	rs12677512	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	5755611	rs11136938	A	G	rs11136938	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	6175712	rs7004340	G	C	rs7004340	20978177	4.60E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
8	6715751	rs2980945	A	G	rs2980945	23023329	3.25E-04	NA	NA	NA	1,417 Han Chinese cases; 1,008 Han Chinese controls	Han Chinese(2425)	ALL(2425)	ASN(2425)	ALL(2425)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	T	NA
8	8501322	rs7013418	T	G	rs7013418	24740154	3.70E-06	(GWAS stage)	1.35	[1.22-1.48]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs7013418-G	Research Support, N.I.H., Extramural	T	NA
8	10466933	rs199965589	C	T	rs199965589	23555315	0.00081	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
8	12824163	rs10108595	G	T	rs10108595	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	12844441	rs10101284	C	T	rs10101284	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	12846619	rs10109366	C	T	rs10109366	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	12854134	rs10108476	G	A	rs10108476	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	12855077	rs10104432	T	C	rs10104432	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	18271190	rs13276600	C	T	rs13276600	pha002878	5.82E-06	phs000207	1.19	[0.93-1.52]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
8	18277119	rs1466753	C	T	rs1466753	pha002878	4.36E-05	phs000207	1.27	[0.99-1.64]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
8	18904368	rs919149	G	A	rs919149	22923026	1.27E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	18905049	rs890519	C	A	rs890519	22923026	7.70E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	18905296	rs7833499	C	T	rs7833499	22923026	1.56E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	21173055	rs898250	C	G	rs898250	20978177	2.96E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
8	21180713	rs2610984	G	A	rs2610984	20978177	2.19E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
8	21368779	rs4739207	G	A	rs4739207	22923026	6.19E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	22267473	rs79856562	T	A	rs79856562	23555315	0.000033	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
8	23491191	rs11135762	G	A	rs11135762	22923026	1.32E-07	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	23501606	rs1398240	C	A	rs1398240	22923026	9.64E-08	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	23514289	rs4872171	A	G	rs4872171	22923026	2.46E-07	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	23514343	rs4872172	T	A,C,G	rs4872172	22923026	1.22E-07	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	23526463	rs1512268	T	C	rs1512268	19767753	3.00E-30	NA	1.18	[1.14-1.22]	1,854 European ancestry cases; 1,894 European ancestry controls	European(3748)	ALL(3748)	EUR(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs1512268-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	23526463	rs1512268	T	C	rs1512268	20676098	4.00E-11	NA	NA	NA	1,583 Japanese cases; 3,386 Japanese controls	Japanese(4969)	ALL(4969)	ASN(4969)	ALL(4969)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	A	NA
8	23526463	rs1512268	T	C	rs1512268	22923026	5.00E-06	Japanese	1.35	[1.19-1.53]	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Hispanic American ancestry cases; 1,057 Hispanic American ancestry controls	Japanese(2075)	Hispanic American(2100)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs1512268-T	Research Support, N.I.H., Extramural
8	23526463	rs1512268	T	C	rs1512268	23555315	0.00000024	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
8	23526463	rs1512268	T	C	rs1512268	24740154	1.20E-04	(GWAS stage)	1.23	[1.23-1.23]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs1512268-A	Research Support, N.I.H., Extramural	A	NA
8	23534018	rs10503733	G	T	rs10503733	22923026	8.00E-08	Japanese and Latin American	1.29	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Hispanic American ancestry cases; 1,057 Hispanic American ancestry controls	Japanese(2075)	Hispanic American(2100)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs10503733-T	Research Support, N.I.H., Extramural
8	25398570	rs7845279	A	C	rs7845279	20978177	5.05E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
8	25892142	rs11135910	C	T	rs11135910	23535732	8.00E-11	NA	1.11	[1.07-1.16]	11,085 European ancestry cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs11135910-A	NA	C	EBF2
8	27069943	rs7841213	G	C	rs7841213	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	27124966	rs4733045	T	C	rs4733045	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	27702453	rs11136015	T	C	rs11136015	22923026	9.94E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	27711673	rs4732776	T	C	rs4732776	22923026	4.36E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	27716308	rs7823922	C	T	rs7823922	22923026	3.62E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	29108379	rs10503851	T	C	rs10503851	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	29109127	rs12682460	G	A	rs12682460	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	29630942	rs6982080	G	T	rs6982080	18264096	2.28E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	33143930	rs4427132	A	G	rs4427132	22923026	5.93E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	33171588	rs10954904	A	G	rs10954904	22923026	6.67E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	33179652	rs11773958	G	A	rs11773958	22923026	5.75E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	33235671	rs7837460	A	G	rs7837460	22923026	1.48E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	33240084	rs11996351	T	G	rs11996351	22923026	1.48E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	33246591	rs17855838	G	C	rs17855838	23555315	0.00054	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
8	34005746	rs7839708	G	A	rs7839708	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	40988523	rs7827040	C	T	rs7827040	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	41666874	rs10090395	T	C	rs10090395	pha002877	9.03E-05	phs000207	1.26	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	ANK1	intron	NM_001142446
8	51842345	rs11785563	G	T	rs11785563	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51843851	rs16915613	A	T	rs16915613	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51844394	rs2893613	A	G	rs2893613	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51845693	rs7820203	A	C	rs7820203	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51848452	rs10958207	T	A	rs10958207	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51853927	rs7004006	A	G	rs7004006	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51855262	rs13268263	G	A	rs13268263	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51858459	rs16915637	T	G	rs16915637	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51859233	rs1159997	T	C	rs1159997	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51860365	rs6473538	C	T	rs6473538	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51860828	rs1471727	A	T	rs1471727	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51862244	rs6473539	T	C	rs6473539	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51862991	rs1484125	C	T	rs1484125	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51865104	rs7837741	A	G	rs7837741	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51871507	rs2170853	G	A	rs2170853	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51871658	rs2129112	C	T	rs2129112	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51871861	rs2170854	C	T	rs2170854	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51873582	rs6989442	A	T	rs6989442	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51874673	rs9969399	T	C	rs9969399	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51882116	rs4873486	G	A	rs4873486	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51883407	rs1484130	G	C	rs1484130	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51883927	rs12114822	A	G	rs12114822	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51898028	rs1601197	A	G	rs1601197	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51908977	rs1531083	T	G	rs1531083	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51910303	rs7828653	T	G	rs7828653	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51914146	rs6473558	T	G	rs6473558	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51924336	rs12681234	C	T	rs12681234	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51924347	rs12681235	C	T	rs12681235	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51925820	rs10958231	A	G	rs10958231	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51936209	rs2198695	C	T	rs2198695	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51936945	rs13262736	C	T	rs13262736	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	51937911	rs966216	T	C	rs966216	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	52297865	rs994127	C	T	rs994127	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	52314595	rs2977013	G	A	rs2977013	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	52315863	rs2977016	T	C	rs2977016	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	52320669	rs200259163	T	A	rs200259163	23555315	0.0000183	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Ratio of free to total prostate-specific antigen	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
8	55540418	rs114797722	G	C	rs114797722	23555315	0.00000002	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
8	56924058	rs2668011	C	T	rs2668011	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	58306018	rs954295	T	G	rs954295	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	59909747	rs10098381	G	A	rs10098381	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	59913422	rs10504273	A	C	rs10504273	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	63463330	rs1451856	T	C	rs1451856	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	67505363	rs141575513	A	T	rs141575513	23555315	0.00065	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
8	67896026	rs16933125	A	G	rs16933125	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	67970243	rs6997490	A	G	rs6997490	23555315	0.00035	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
8	67983796	rs11985037	G	A	rs11985037	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	67993933	rs11989855	G	A	rs11989855	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	68019208	rs7004549	A	G	rs7004549	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	68032058	rs11992626	G	T	rs11992626	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	68091026	rs1466283	G	A	rs1466283	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	68124170	rs6991974	G	A	rs6991974	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	68132706	rs3780131	C	T	rs3780131	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	68189124	rs6993324	C	T	rs6993324	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	68195817	rs7823436	G	A	rs7823436	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	68196817	rs12678025	A	G	rs12678025	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	68205187	rs13267015	C	T	rs13267015	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	68207909	rs12682412	G	A	rs12682412	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	68218476	rs1821026	T	A	rs1821026	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	68219564	rs10957384	C	A	rs10957384	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	68225858	rs12675528	T	C	rs12675528	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	68239000	rs6987724	T	C	rs6987724	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	68245202	rs7830183	A	C	rs7830183	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	69811773	rs16919120	A	G	rs16919120	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	72081678	rs7819928	C	A	rs7819928	pha002878	5.42E-05	phs000207	1.67	[1.28-2.13]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	A	NA	NA	NA
8	74746209	rs6982398	T	C	rs6982398	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	74760815	rs6996756	C	G	rs6996756	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	76615663	rs4735692	A	G	rs4735692	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	76636044	rs2596127	T	G	rs2596127	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	76640621	rs2596126	A	G	rs2596126	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	78956658	rs2219968	G	A	rs2219968	22219177	6.00E-07	rs1571801	1.3	[1.17-1.43]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
8	81089866	rs7814569	A	G	rs7814569	pha002878	5.13E-05	phs000207	1.2	[0.90-1.61]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	G	NA	NA	NA
8	83073829	rs13264970	C	T	rs13264970	22219177	4.00E-06	rs1571801	1.3	[1.16-1.45]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
8	85762603	rs4740033	A	C	rs4740033	20978177	1.35E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
8	85789366	rs1365671	C	T	rs1365671	20978177	5.21E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
8	85791349	rs1427067	G	A	rs1427067	20978177	6.43E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
8	85794689	rs9298430	T	C	rs9298430	20978177	4.42E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
8	85796202	rs7818056	T	G	rs7818056	20978177	4.42E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
8	85796332	rs7834730	G	A	rs7834730	20978177	2.51E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
8	85803697	rs10097414	A	G	rs10097414	20978177	4.42E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
8	85803833	rs10112387	T	C	rs10112387	20978177	4.42E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
8	85809058	rs1025233	A	G	rs1025233	20978177	4.42E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
8	85821389	rs10095682	A	G	rs10095682	20978177	8.95E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
8	85825440	rs10046686	T	A	rs10046686	20978177	5.57E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
8	85832512	rs1991352	T	G	rs1991352	20978177	9.75E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
8	85832854	rs3937521	C	A	rs3937521	20978177	7.55E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
8	85833817	rs12604	G	A	rs12604	20978177	7.55E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
8	85838265	rs10958230	A	T	rs10958230	20978177	5.57E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
8	85863234	rs1524646	G	C	rs1524646	20978177	8.18E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
8	86028331	rs7829144	T	C	rs7829144	20978177	6.38E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
8	86104754	rs4150893	T	C	rs4150893	20978177	5.96E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
8	87162515	rs10094744	G	A	rs10094744	23555315	0.00033	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
8	87580944	rs4961199	G	A	rs4961199	18264096	1.26E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	88932269	rs10091380	T	A	rs10091380	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	88948825	rs10088179	G	A	rs10088179	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	88962865	rs16875583	T	C	rs16875583	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	88975898	rs278897	A	G	rs278897	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	92008044	rs73694351	C	A	rs73694351	23555315	0.00053	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
8	94738629	rs36117362	G	A	rs36117362	23555315	0.00012	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
8	98386508	rs9649913	A	G	rs9649913	pha002878	1.80E-05	phs000207	1.33	[1.05-1.67]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	G	NA	NA	NA
8	104142090	rs11774996	T	A	rs11774996	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	107064887	rs1864318	C	T	rs1864318	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	107064929	rs1864319	A	G	rs1864319	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	107083663	rs1366968	T	C	rs1366968	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	107084000	rs1366966	A	T	rs1366966	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	107209378	rs11993758	C	T	rs11993758	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	109096029	rs374810	G	A	rs374810	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	109235457	rs635941	G	A	rs635941	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	109348150	rs6994837	C	A	rs6994837	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	115022709	rs10109903	A	G	rs10109903	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	115028312	rs13261349	C	T	rs13261349	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	118403267	rs1387434	C	G	rs1387434	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	118404959	rs1686354	G	A	rs1686354	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	118418008	rs1586601	G	A	rs1586601	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	124526607	rs2294088	G	A	rs2294088	23555315	0.00014	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
8	124714722	rs13258681	T	C	rs13258681	22219177	4.00E-06	rs7127900	1.32	[1.17-1.48]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
8	127924659	rs12543663	C	A	rs12543663	18264097	9.10E-07	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	A	NA
8	127924659	rs12543663	C	A	rs12543663	24740154	9.10E-05	(GWAS stage)	1.25	[1.25-1.25]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs12543663-C	Research Support, N.I.H., Extramural	A	NA
8	128093297	rs1016343	C	T	rs1016343	18264097	1.00E-07		1.37	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs1016343-T	Research Support, Non-U.S. Gov't	C	NA
8	128093297	rs1016343	C	T	rs1016343	21743057	4.00E-10	NA	1.31	[1.20-1.42]	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs1016343-T	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128093297	rs1016343	C	T	rs1016343	22923026	6.70E-09	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	128093297	rs1016343	C	T	rs1016343	23555315	1.50E-15	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
8	128095156	rs13252298	A	G	rs13252298	21743057	4.00E-06	conditioned on 5 SNPs	1.12	[1.05-1.18]	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs13252298-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128095156	rs13252298	A	G	rs13252298	23555315	0.000000043	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
8	128103937	rs1456315	T	C	rs1456315	20676098	2.00E-29	NA	NA	NA	1,583 Japanese cases; 3,386 Japanese controls	Japanese(4969)	ALL(4969)	ASN(4969)	ALL(4969)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	A	NA
8	128103937	rs1456315	T	C	rs1456315	22923026	2.30E-12	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	128103937	rs1456315	T	C	rs1456315	23023329	1.00E-12	NA	NA	NA	1,417 Han Chinese cases; 1,008 Han Chinese controls	Han Chinese(2425)	ALL(2425)	ASN(2425)	ALL(2425)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	A	NA
8	128103937	rs1456315	T	C	rs1456315	23555315	8.60E-22	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
8	128104343	rs13254738	C	A	rs13254738	22923026	4.00E-10	Japanese	1.59	[1.38-1.84]	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Hispanic American ancestry cases; 1,057 Hispanic American ancestry controls	Japanese(2075)	Hispanic American(2100)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs13254738-C	Research Support, N.I.H., Extramural
8	128106880	rs6983561	A	C	rs6983561	22923026	4.00E-13	Japanese	1.87	[1.58-2.22]	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Hispanic American ancestry cases; 1,057 Hispanic American ancestry controls	Japanese(2075)	Hispanic American(2100)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs6983561-C	Research Support, N.I.H., Extramural
8	128110252	rs16901966	A	G	rs16901966	18264097	2.90E-08	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	A	NA
8	128110252	rs16901966	A	G	rs16901966	22923026	1.07E-14	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	128112715	rs16901970	T	G	rs16901970	18264097	2.90E-08	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	G	NA
8	128112715	rs16901970	T	G	rs16901970	22923026	1.07E-14	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	128116500	rs1456306	G	A	rs1456306	22923026	7.47E-08	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	128122659	rs1378897	C	T	rs1378897	22923026	1.64E-07	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	128124916	rs16901979	C	A	rs16901979	17401366	1.00E-12	EA	1.79	[1.53-2.11]	1,453 cases; 3,064 controls	NOPOP(4517)	ALL(4517)	NOPOP(4517)	ALL(4517)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs16901979-A	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.	A
8	128124916	rs16901979	C	A	rs16901979	19767754	3.00E-14	NA	1.8	[1.55-2.09]	Up to 1,968 Icelandic cases; 35,382 Icelandic controls	Icelandic(37350)	ALL(37350)	EUR(37350)	ALL(37350)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs16901979-A	Research Support, Non-U.S. Gov't	A	NA
8	128124916	rs16901979	C	A	rs16901979	23555315	0.0000012	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
8	128124916	rs16901979	C	A	rs16901979	23555315	6.20E-25	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
8	128125195	rs10505483	C	T	rs10505483	18264097	4.20E-08	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	A	NA
8	128125195	rs10505483	C	T	rs10505483	22923026	7.00E-15	Japanese and Latin American	1.73	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Hispanic American ancestry cases; 1,057 Hispanic American ancestry controls	Japanese(2075)	Hispanic American(2100)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs10505483-T	Research Support, N.I.H., Extramural
8	128125504	rs7817677	A	G	rs7817677	18264097	6.20E-08	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	A	NA
8	128125504	rs7817677	A	G	rs7817677	22923026	3.38E-14	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	128192981	rs2456449	A	G	rs2456449	23555315	0.0000081	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
8	128269154	rs6992863	C	T	rs6992863	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128320346	rs16902094	A	G	rs16902094	19767754	6.00E-15	NA	1.21	[1.15-1.26]	Up to 1,968 Icelandic cases; 35,382 Icelandic controls	Icelandic(37350)	ALL(37350)	EUR(37350)	ALL(37350)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs16902094-G	Research Support, Non-U.S. Gov't	G	NA
8	128323181	rs445114	T	C	rs445114	19767754	5.00E-10	NA	1.14	[1.10-1.19]	Up to 1,968 Icelandic cases; 35,382 Icelandic controls	Icelandic(37350)	ALL(37350)	EUR(37350)	ALL(37350)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs445114-T	Research Support, Non-U.S. Gov't	T	NA
8	128323181	rs445114	T	C	rs445114	21743057	5.00E-07	NA	1.22	[1.12-1.32]	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs445114-T	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128323181	rs445114	T	C	rs445114	23555315	0.00000059	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
8	128335673	rs620861	G	A	rs620861	18264097	4.90E-07	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	C	NA
8	128335673	rs620861	G	A	rs620861	24740154	8.80E-05	(GWAS stage)	1.25	[1.25-1.25]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs620861-G	Research Support, N.I.H., Extramural	C	NA
8	128407443	rs10505477	A	G	rs10505477	18264096	3.16E-08	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128407443	rs10505477	A	G	rs10505477	23555315	0.00000044	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
8	128407443	rs10505477	A	G	rs10505477	24740154	9.00E-09	(GWAS stage)	1.39	[1.28-1.50]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs10505477-A	Research Support, N.I.H., Extramural	T	NA
8	128408116	rs10505476	C	T	rs10505476	18264096	3.94E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128413147	rs10808556	C	T	rs10808556	18264097	4.40E-08	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	C	NA
8	128413305	rs6983267	G	T	rs6983267	17401363	9.00E-13	NA	1.26	[1.13-1.41]	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs6983267-G	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128413305	rs6983267	G	T	rs6983267	18264096	7.00E-12	NA	1.28	[1.15-1.45]	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs6983267-G	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128413305	rs6983267	G	T	rs6983267	18264097	9.00E-13	NA	1.42	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs6983267-G	Research Support, Non-U.S. Gov't	G	NA
8	128413305	rs6983267	G	T	rs6983267	21743057	9.00E-06	NA	1.2	[1.11-1.32]	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs6983267-G	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128413305	rs6983267	G	T	rs6983267	23555315	0.00000039	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
8	128413305	rs6983267	G	T	rs6983267	24740154	1.00E-08	(GWAS stage)	1.36	NA	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs6983267-G	Research Support, N.I.H., Extramural	G	NA
8	128413305	rs6983267	G	T	rs6983267	24753544	4.00E-15	NA	0.29	[0.22-0.36] unit increase	1,146 European ancestry cases; 1,804 European ancestry controls	European(2950)	ALL(2950)	EUR(2950)	ALL(2950)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs6983267-G	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
8	128417504	rs10505474	T	C	rs10505474	18264096	1.54E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128423127	rs7837328	A	G	rs7837328	18264096	7.81E-08	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128423127	rs7837328	A	G	rs7837328	18264097	2.00E-08	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	G	NA
8	128424792	rs7014346	A	G	rs7014346	18264096	9.91E-08	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128424792	rs7014346	A	G	rs7014346	18264097	1.40E-08	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	G	NA
8	128424792	rs7014346	A	G	rs7014346	23555315	0.00011	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
8	128472320	rs1447293	C	T	rs1447293	18264096	1.46E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128472320	rs1447293	C	T	rs1447293	18264097	1.60E-07	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	G	LOC727677
8	128475185	rs921146	G	T	rs921146	18264096	9.93E-06	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128475185	rs921146	G	T	rs921146	18264097	2.00E-08	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	A	LOC727677
8	128482642	rs4871799	G	A	rs4871799	18264096	7.20E-06	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128485038	rs1447295	A	C	rs1447295	17401363	2.00E-14	NA	1.43	[1.29-1.59]	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs1447295-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128485038	rs1447295	A	C	rs1447295	17401366	6.00E-18	NA	1.6	[1.43-1.77]	1,453 cases; 3,064 controls	NOPOP(4517)	ALL(4517)	NOPOP(4517)	ALL(4517)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs1447295-A	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.	C
8	128485038	rs1447295	A	C	rs1447295	18264096	1.36E-17	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128485038	rs1447295	A	C	rs1447295	18264097	1.10E-16	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	C	LOC727677
8	128485038	rs1447295	A	C	rs1447295	19767754	2.00E-19	NA	1.58	[1.43-1.74]	Up to 1,968 Icelandic cases; 35,382 Icelandic controls	Icelandic(37350)	ALL(37350)	EUR(37350)	ALL(37350)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs1447295-A	Research Support, Non-U.S. Gov't	C	LOC727677
8	128485038	rs1447295	A	C	rs1447295	22923026	3.61E-09	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	128485038	rs1447295	A	C	rs1447295	23555315	9.90E-16	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
8	128485038	rs1447295	A	C	rs1447295	24740154	7.80E-05	(GWAS stage)	1.38	[1.38-1.38]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs1447295-A	Research Support, N.I.H., Extramural	C	LOC727677
8	128485038	rs1447295	A	C	rs1447295	24753544	6.00E-18	NA	0.51	[0.40-0.63] unit increase	1,146 European ancestry cases; 1,804 European ancestry controls	European(2950)	ALL(2950)	EUR(2950)	ALL(2950)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs1447295-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
8	128491792	rs7836840	T	G	rs7836840	23555315	0.00014	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
8	128492029	rs7831028	C	G	rs7831028	18264096	6.64E-06	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128496776	rs6985504	A	G	rs6985504	18264096	3.16E-06	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128517573	rs4242382	A	G	rs4242382	18264096	3.00E-19	NA	1.66	[1.47-1.87]	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs4242382-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128517573	rs4242382	A	G	rs4242382	18264097	5.40E-17	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	A	NA
8	128517573	rs4242382	A	G	rs4242382	22923026	2.93E-13	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	128517573	rs4242382	A	G	rs4242382	23555315	1.30E-17	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
8	128518554	rs4242384	C	A	rs4242384	18264096	1.13E-18	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128518554	rs4242384	C	A	rs4242384	18264097	3.00E-16	NA	1.88	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs4242384-C	Research Support, Non-U.S. Gov't	A	NA
8	128518554	rs4242384	C	A	rs4242384	19767753	2.00E-24	NA	NA	NA	1,854 European ancestry cases; 1,894 European ancestry controls	European(3748)	ALL(3748)	EUR(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs4242384-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128518554	rs4242384	C	A	rs4242384	21743057	3.00E-16	NA	1.56	[1.40-1.73]	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs4242384-C	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128518554	rs4242384	C	A	rs4242384	22923026	7.37E-13	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	128518554	rs4242384	C	A	rs4242384	23555315	0.0000019	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
8	128518554	rs4242384	C	A	rs4242384	23555315	6.80E-21	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
8	128518554	rs4242384	C	A	rs4242384	pha002877	2.98E-05	phs000207	1.5	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	A	NA	NA	NA
8	128525268	rs7017300	C	A	rs7017300	18264096	3.67E-13	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128525268	rs7017300	C	A	rs7017300	18264097	2.20E-11	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	A	NA
8	128531873	rs11988857	G	A	rs11988857	18264096	8.69E-16	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128531873	rs11988857	G	A	rs11988857	18264097	1.80E-13	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	A	NA
8	128531873	rs11988857	G	A	rs11988857	pha002877	2.85E-05	phs000207	1.43	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	A	NA	NA	NA
8	128532137	rs10090154	T	C	rs10090154	22923026	3.00E-06	Latin American	1.68	[1.35-2.09]	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Hispanic American ancestry cases; 1,057 Hispanic American ancestry controls	Japanese(2075)	Hispanic American(2100)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs10090154-T	Research Support, N.I.H., Extramural
8	128534654	rs9656816	G	A	rs9656816	18264096	4.34E-13	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128534654	rs9656816	G	A	rs9656816	18264097	2.10E-14	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	G	NA
8	128537583	rs12542685	A	T	rs12542685	18264096	7.24E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128539360	rs7837688	T	G	rs7837688	17401363	1.89E-15	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128539360	rs7837688	T	G	rs7837688	18264096	4.63E-17	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	128539360	rs7837688	T	G	rs7837688	18264097	5.90E-17	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	G	NA
8	128539360	rs7837688	T	G	rs7837688	20676098	1.00E-25	NA	NA	NA	1,583 Japanese cases; 3,386 Japanese controls	Japanese(4969)	ALL(4969)	ASN(4969)	ALL(4969)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	G	NA
8	128539360	rs7837688	T	G	rs7837688	22923026	9.15E-13	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
8	128539360	rs7837688	T	G	rs7837688	23555315	0.000000015	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
8	128539360	rs7837688	T	G	rs7837688	23555315	6.80E-22	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
8	128545383	rs6991990	C	T	rs6991990	18264096	5.57E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	129316014	rs975730	G	A	rs975730	23555315	0.00012	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
8	134107312	rs73354644	G	A	rs73354644	23555315	0.00033	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
8	138442904	rs2992718	A	G	rs2992718	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	138909719	rs62531686	T	C	rs62531686	23555189	8.00E-07	NA	0.83	[0.76-0.90] unit increase	1,371 European ancestry individuals	European(1371)	ALL(1371)	EUR(1371)	ALL(1371)	PCA3 expression level	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	EFOID:0005127	cancer biomarker measurement	Prostate cancer	rs62531686-C	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
8	138909719	rs62531686	T	C	rs62531686	23555189	8.04E-07	Imputed	0.83	[0.76-0.9] unit increase	1,371 European ancestry individuals	European(1371)	ALL(1371)	EUR(1371)	ALL(1371)	PCA3 expression level	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	EFOID:0005127	cancer biomarker measurement	Prostate cancer	rs62531686-C	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
8	140907637	rs4736010	A	G	rs4736010	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	140908579	rs898803	A	G	rs898803	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	140909484	rs7845933	G	T	rs7845933	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	140909760	rs11166933	A	G	rs11166933	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
8	144942477	rs138137510	C	T	rs138137510	23555315	0.00024	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
8	144945012	rs200744657	G	A	rs200744657	23555315	0.000065	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
9	1826401	rs10810919	C	T	rs10810919	23668334	2.00E-05	Discovery stage, not in replication	5.03	[2.22-11.40]	90 Tunisian cases; 131 Tunisian controls	Tunisian(221)	ALL(221)	MEA(221)	ALL(221)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs10810919-C	Research Support, Non-U.S. Gov't	C	NA
9	1835334	rs10963540	A	G	rs10963540	23668334	2.00E-05	Discovery stage, not in replication	4.81	[2.23-10.40]	90 Tunisian cases; 131 Tunisian controls	Tunisian(221)	ALL(221)	MEA(221)	ALL(221)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs10963540-A	Research Support, Non-U.S. Gov't	A	NA
9	4068946	rs1417155	G	A	rs1417155	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	4487024	rs2150192	A	G	rs2150192	22923026	5.56E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
9	8012418	rs12682851	A	G	rs12682851	22219177	2.00E-06	rs1447295	1.39	[1.22-1.59]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
9	8236122	rs1339289	C	T	rs1339289	20978177	5.42E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
9	8339203	rs3765142	A	T	rs3765142	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	8357036	rs12004215	T	A	rs12004215	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	8361934	rs12552493	C	T	rs12552493	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	8381926	rs7030727	G	A	rs7030727	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	8383887	rs12343475	T	C	rs12343475	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	8405242	rs12000147	A	T	rs12000147	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	8432417	rs7023863	C	G	rs7023863	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	10126201	rs159224	G	T	rs159224	20978177	2.45E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
9	10128645	rs150409	T	C	rs150409	20978177	9.75E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
9	15111573	rs10961884	T	C	rs10961884	24185611	1.11E-06	GWAS stage only	3.96	[2.23-7.02]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs10961884-C	NA	T	NA
9	19290794	rs41269019	A	C	rs41269019	23555315	0.00073	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
9	20536297	rs7037941	T	G	rs7037941	20978177	9.83E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
9	21061642	rs2383176	G	A	rs2383176	22923026	8.37E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
9	23817548	rs17551174	A	G	rs17551174	pha002877	5.13E-05	phs000207	1.33	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	A	ELAVL2	intron	NM_004432
9	23817548	rs17551174	A	G	rs17551174	pha002878	8.95E-05	phs000207	1.45	[1.12-1.85]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	A	ELAVL2	intron	NM_004432
9	26184578	rs10738747	G	A	rs10738747	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	26184917	rs2571519	C	T	rs2571519	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	26609613	rs10812426	T	C	rs10812426	pha002877	5.75E-05	phs000207	1.48	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	NA	NA	NA
9	27488092	rs17779457	T	G	rs17779457	23376709	7.00E-07	at 2-3 yrs	2.4	[1.1-3.6] unit increase	346 European, African, Hispanic and Asian individuals	Asia,African,European,Hispanic(346)	ALL(346)	ASN,AFR,EUR,HIS(346)	ALL(346)	Urinary symptoms in response to radiotherapy in prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
9	27610657	rs2889829	A	G	rs2889829	23555189	2.00E-07	NA	0.82	[0.75-0.89] unit increase	1,371 European ancestry individuals	European(1371)	ALL(1371)	EUR(1371)	ALL(1371)	PCA3 expression level	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	EFOID:0005127	cancer biomarker measurement	Prostate cancer	rs2889829-G	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
9	27610657	rs2889829	A	G	rs2889829	23555189	2.13E-07	Genotyped	0.82	[0.75-0.89] unit increase	1,371 European ancestry individuals	European(1371)	ALL(1371)	EUR(1371)	ALL(1371)	PCA3 expression level	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	EFOID:0005127	cancer biomarker measurement	Prostate cancer	rs2889829-G	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
9	27724226	rs10812654	A	G	rs10812654	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	27875069	rs2383739	G	A	rs2383739	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	31100423	rs7037780	A	T	rs7037780	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	79300111	rs476612	G	T	rs476612	23555315	0.00062	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
9	79611959	rs10781406	A	G	rs10781406	20978177	1.40E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
9	84462943	rs4999155	C	T	rs4999155	22923026	6.17E-07	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
9	86617349	rs149512376	C	T	rs149512376	23555315	0.0001	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
9	93555739	rs290258	A	G	rs290258	22219177	1.00E-06	rs7679673	1.33	[1.19-1.49]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
9	104171770	rs61755102	G	A	rs61755102	23555315	0.00083	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
9	110156300	rs817826	C	T	rs817826	23023329	5.00E-14	NA	1.41	[1.29-1.54]	1,417 Han Chinese cases; 1,008 Han Chinese controls	Han Chinese(2425)	ALL(2425)	ASN(2425)	ALL(2425)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs817826-C	Research Support, Non-U.S. Gov't	C	NA
9	110699777	rs1339761	G	C	rs1339761	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	110704087	rs10979119	T	C	rs10979119	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	110705341	rs12340808	T	A	rs12340808	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	110706865	rs10512376	G	C	rs10512376	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	114386599	rs10121085	C	T	rs10121085	pha002878	4.99E-05	phs000207	1.03	[0.75-1.40]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
9	114706886	rs10817244	T	A	rs10817244	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	114706973	rs10817245	C	T	rs10817245	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	114707212	rs10817246	T	C	rs10817246	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	114707438	rs10981171	T	C	rs10981171	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	114707622	rs7028129	G	A	rs7028129	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	114708331	rs10513152	A	G	rs10513152	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	117170310	rs2274160	C	T	rs2274160	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	117830812	rs7847271	G	A	rs7847271	22219177	4.00E-06	rs10934853	1.49	[1.27-1.79]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
9	120068520	rs7022764	A	G	rs7022764	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	120275073	rs10983677	T	G	rs10983677	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	120275159	rs12337381	T	C	rs12337381	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	120275407	rs10983678	C	G	rs10983678	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	120275665	rs10983680	A	G	rs10983680	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	120599426	rs16906273	T	C	rs16906273	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	123122187	rs1112863	G	A	rs1112863	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	124427373	rs1571801	G	T	rs1571801	18073375	2.84E-05	NA	NA	NA	1,235 cases; 1,599 controls	NOPOP(2834)	ALL(2834)	NOPOP(2834)	ALL(2834)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
9	124950477	rs16911551	C	T	rs16911551	24740154	6.20E-06	(GWAS stage)	1.97	[1.68-2.26]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs16911551-T	Research Support, N.I.H., Extramural	C	MORN5
9	125589057	rs143503466	G	A	rs143503466	23555315	0.000029	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
9	130042369	rs1333005	G	A	rs1333005	20978177	3.98E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A,G
9	130224593	rs150292099	A	G	rs150292099	23555315	0.00000035	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
9	130580575	rs116330805	C	T	rs116330805	23555315	0.00001	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
9	133264096	rs11244127	G	A	rs11244127	18264096	4.17E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	133358199	rs11243474	G	T	rs11243474	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	133358656	rs10901080	G	T	rs10901080	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	133359756	rs12005118	G	C	rs12005118	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
9	136501728	rs77273740	C	T	rs77273740	23555315	0.000093	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
9	136599026	rs147006467	C	G	rs147006467	23555315	0.00015	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
9	138516420	rs200428393	G	T	rs200428393	23555315	0.000006	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
9	139914819	rs140319041	G	A	rs140319041	23555315	0.00012	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
10	135853	rs7906287	A	G	rs7906287	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	137186	rs4287273	C	G	rs4287273	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	159299	rs4881552	A	T	rs4881552	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	2387282	rs12779267	G	A	rs12779267	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	2404079	rs11813772	T	C	rs11813772	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	3854018	rs12358872	C	T	rs12358872	20978177	4.21E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
10	5529329	rs11592540	G	A	rs11592540	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	6914071	rs17142092	C	T	rs17142092	20978177	8.39E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
10	7112076	rs9423765	G	A	rs9423765	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	7310004	rs10508328	T	C	rs10508328	22923026	7.00E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
10	8462439	rs2993385	T	C	rs2993385	24185611	5.94E-06	GWAS stage only	2	[1.47-2.70]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs2993385-T	NA	T	NA
10	8474595	rs7918885	T	G	rs7918885	24185611	1.29E-07	GWAS stage only	2.5	[1.75-3.57]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs7918885-T	NA	T	NA
10	8479257	rs12251624	T	C	rs12251624	24185611	2.62E-06	GWAS stage only	2.17	[1.56-3.03]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs12251624-T	NA	C	NA
10	8479868	rs7090925	A	G	rs7090925	24185611	2.62E-06	GWAS stage only	2.17	[1.56-3.03]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs7090925-A	NA	G	NA
10	8480044	rs10905371	A	G	rs10905371	24185611	2.77E-07	GWAS stage only	2.44	[1.72-3.45]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs10905371-A	NA	A	NA
10	8481486	rs10905374	G	A	rs10905374	24185611	4.43E-07	GWAS stage only	2.38	[1.69-3.45]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs10905374-G	NA	G	NA
10	8484113	rs7096374	C	T	rs7096374	24185611	5.16E-07	GWAS stage only	2.38	[1.69-3.33]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs7096374-C	NA	C	NA
10	8486161	rs7896254	G	A	rs7896254	24185611	3.27E-07	GWAS stage only	3.03	[1.96-4.76]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs7896254-G	NA	G	NA
10	10011994	rs10905646	T	C	rs10905646	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	10012257	rs10905647	T	C	rs10905647	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	10014581	rs12249528	A	G	rs12249528	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	10020194	rs7918807	T	C	rs7918807	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	10020278	rs7915591	A	G	rs7915591	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	10022005	rs1591891	A	G	rs1591891	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	10023340	rs1339681	A	G	rs1339681	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	10023597	rs1339683	G	T	rs1339683	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	10024686	rs1995578	A	G	rs1995578	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	10025584	rs1339685	C	A,T	rs1339685	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	10034807	rs6602387	G	A	rs6602387	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	10035016	rs6602388	G	A	rs6602388	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	10035465	rs7074507	T	C	rs7074507	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	12051816	rs10795917	G	A	rs10795917	22219177	7.00E-07	rs8102476	1.24	[1.14-1.36]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
10	12215734	rs34863826	A	G	rs34863826	23555315	0.000018	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
10	13820420	rs10796119	C	A	rs10796119	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	14071061	rs2447038	C	T	rs2447038	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	14278130	rs7898553	C	A	rs7898553	22923026	9.43E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
10	14291542	rs11258977	G	A	rs11258977	22923026	2.84E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
10	14295301	rs1218374	T	G	rs1218374	22923026	3.93E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
10	14318773	rs1218355	T	C	rs1218355	22923026	6.61E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
10	19725665	rs10827414	C	T	rs10827414	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	19902779	rs10827645	A	G	rs10827645	21743057	5.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	24621080	rs17384657	G	A	rs17384657	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	29156072	rs4747633	A	G	rs4747633	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	29159490	rs7088136	G	A	rs7088136	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	31810679	rs141194628	A	G	rs141194628	23555315	0.00013	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
10	32038493	rs10826987	C	T	rs10826987	pha002878	4.70E-05	phs000207	1.2	[0.94-1.54]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
10	43793625	rs2503872	C	T	rs2503872	pha002878	9.52E-05	phs000207	1.04	[0.83-1.32]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	G	NA	NA	NA
10	45171582	rs11239202	C	T	rs11239202	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	45183876	rs7077918	T	C	rs7077918	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	45187031	rs11239209	G	A	rs11239209	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	45193060	rs10900094	G	A	rs10900094	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	45194727	rs7071236	T	C	rs7071236	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	45194916	rs7083361	G	A	rs7083361	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	45195541	rs10508887	C	T	rs10508887	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	45195716	rs11239212	T	A	rs11239212	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	45197293	rs7902711	A	G	rs7902711	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	45199031	rs10793554	C	T	rs10793554	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	45200119	rs7082194	G	A,C	rs7082194	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	45208025	rs10900097	G	A	rs10900097	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	45213993	rs10900098	G	A	rs10900098	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	45214296	rs9326520	T	C	rs9326520	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	45221505	rs10900099	G	A	rs10900099	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	46122794	rs10793621	G	A	rs10793621	21743057	8.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	46129300	rs11239577	A	C	rs11239577	21743057	8.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	46158519	rs11239587	T	C	rs11239587	21743057	8.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	46208186	rs11239591	G	A	rs11239591	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	50532542	rs190417157	A	G	rs190417157	23555315	0.00012	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
10	51515534	rs2611512	A	G	rs2611512	18264097	2.70E-12	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	T	NA
10	51517356	rs2926494	T	C	rs2926494	23555189	3.00E-07	Genotyped	1.21	[1.14-1.28] unit increase	1,371 European ancestry individuals	European(1371)	ALL(1371)	EUR(1371)	ALL(1371)	PCA3 expression level	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	EFOID:0005127	cancer biomarker measurement	Prostate cancer	rs2926494-T	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
10	51524971	rs3123078	C	T	rs3123078	18264097	1.20E-15	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	T	NA
10	51524971	rs3123078	C	T	rs3123078	19767753	1.00E-19	NA	NA	NA	1,854 European ancestry cases; 1,894 European ancestry controls	European(3748)	ALL(3748)	EUR(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs3123078-T	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	51532621	rs7920517	G	A	rs7920517	18264097	1.30E-19	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	G	NA
10	51538176	rs11006207	T	C	rs11006207	18264096	2.81E-08	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	51538176	rs11006207	T	C	rs11006207	18264097	3.90E-14	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	T	NA
10	51549496	rs10993994	T	C	rs10993994	18264096	7.00E-13	NA	1.16	[1.04-1.29]	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs10993994-T	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	51549496	rs10993994	T	C	rs10993994	18264097	9.00E-29	NA	1.25	[1.17-1.34]	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs10993994-T	Research Support, Non-U.S. Gov't	T	MSMB
10	51549496	rs10993994	T	C	rs10993994	20676098	3.00E-08	NA	NA	NA	1,583 Japanese cases; 3,386 Japanese controls	Japanese(4969)	ALL(4969)	ASN(4969)	ALL(4969)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	T	MSMB
10	51549496	rs10993994	T	C	rs10993994	21160077	7.00E-13	NA	9.2	[NA] % increase	7,538 European ancestry individuals	European(7538)	ALL(7538)	EUR(7538)	ALL(7538)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	rs10993994-T	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
10	51549496	rs10993994	T	C	rs10993994	21743057	5.00E-06	NA	1.18	[1.10-1.27]	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs10993994-T	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	51549496	rs10993994	T	C	rs10993994	23269536	5.00E-17	NA	0.12	NA	1,999 Chinese ancestry men	Chinese(1999)	ALL(1999)	ASN(1999)	ALL(1999)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	rs10993994-T	Randomized Controlled Trial	Multicenter Study	Research Support, Non-U.S. Gov't
10	51549496	rs10993994	T	C	rs10993994	23555189	1.00E-09	NA	1.25	[1.18-1.32] unit increase	1,371 European ancestry individuals	European(1371)	ALL(1371)	EUR(1371)	ALL(1371)	PCA3 expression level	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	EFOID:0005127	cancer biomarker measurement	Prostate cancer	rs10993994-T	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
10	51549496	rs10993994	T	C	rs10993994	24740154	1.90E-07	(GWAS stage)	1.32	[1.32-1.32]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs10993994-T	Research Support, N.I.H., Extramural	T	MSMB
10	51549496	rs10993994	T	C	rs10993994	24740154	2.00E-07	(GWAS stage)	1.32	[1.21-1.43]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs10993994-T	Research Support, N.I.H., Extramural	T	MSMB
10	51549496	rs10993994	T	C	rs10993994	24753544	3.00E-26	NA	0.4	[0.33-0.47] unit increase	1,146 European ancestry cases; 1,804 European ancestry controls	European(2950)	ALL(2950)	EUR(2950)	ALL(2950)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs10993994-T	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
10	53588040	rs10508958	A	C	rs10508958	20830292	3.20E-06	Selenium resistance	NA	NA	46 NCI cancer cell lines (mixed ancestry)	NOPOP(46)	ALL(46)	NOPOP(46)	ALL(46)	Selenium resistance in NCI60 cancer cell lines	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, Non-U.S. Gov't	T	PRKG1
10	55581779	rs79854148	T	C	rs79854148	23555315	0.0009	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
10	55881882	rs7100992	C	G	rs7100992	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	60515022	rs7094271	T	C	rs7094271	22923026	4.78E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
10	66694248	rs2452420	A	G	rs2452420	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	67894481	rs7895803	G	A	rs7895803	23555315	0.00076	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
10	70863698	rs146830092	C	T	rs146830092	23555315	0.00021	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
10	71571595	rs2763352	G	A	rs2763352	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	75156284	rs148945182	G	T	rs148945182	23555315	0.000099	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
10	75565704	rs150846687	C	T	rs150846687	23555315	0.0000049	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
10	79322453	rs2619641	A	C	rs2619641	20830292	2.96E-08	Selenium resistance	NA	NA	46 NCI cancer cell lines (mixed ancestry)	NOPOP(46)	ALL(46)	NOPOP(46)	ALL(46)	Selenium resistance in NCI60 cancer cell lines	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, Non-U.S. Gov't	NA	KCNMA1
10	82381181	rs6586112	T	G	rs6586112	20978177	1.93E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
10	82389526	rs7099231	G	T	rs7099231	20978177	9.62E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
10	83880748	rs765833	G	C	rs765833	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	83893143	rs2434065	A	C	rs2434065	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	84065840	rs7097003	G	A	rs7097003	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	89355313	rs12771728	T	C	rs12771728	18264096	1.01E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	93668692	rs200280119	G	A	rs200280119	23555315	0.00015	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
10	96788561	rs1934955	A	G	rs1934955	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	96792328	rs1592037	G	A	rs1592037	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	96802124	rs1934982	A	C	rs1934982	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	96824975	rs2185571	C	T	rs2185571	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	98920840	rs17502307	G	A	rs17502307	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	100047975	rs10748724	A	C	rs10748724	20978177	5.37E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
10	102554029	rs2902399	G	A	rs2902399	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	103920344	rs11191224	G	T	rs11191224	23555315	0.000026	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
10	104414221	rs3850699	A	G	rs3850699	23535732	5.00E-10	NA	1.1	[1.06-1.12]	11,085 European ancestry cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs3850699-A	NA	T	TRIM8
10	106025864	rs116993524	C	T	rs116993524	23555315	0.00042	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
10	108182513	rs2418804	A	G	rs2418804	pha002878	1.22E-05	phs000207	1.04	[0.81-1.34]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	G	NA	NA	NA
10	108565036	rs4918256	C	A	rs4918256	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	109347602	rs4917504	A	G	rs4917504	20978177	2.32E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
10	114576753	rs1047468	C	T	rs1047468	pha002877	5.35E-05	phs000207	1.28	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	VTI1A	UTR-3	NM_145206
10	114576753	rs1047468	C	T	rs1047468	pha002878	7.92E-05	phs000207	1.4	[1.11-1.75]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	VTI1A	UTR-3	NM_145206
10	116327550	rs10885582	T	C	rs10885582	22219177	4.00E-06	rs1447295	1.37	[1.20-1.59]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
10	120032416	rs7087553	G	C	rs7087553	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	120032904	rs12249758	C	T	rs12249758	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	123032519	rs11199874	G	A	rs11199874	22130093	3.00E-10	NA	NA	NA	316 cases; 229 controls	NOPOP(545)	ALL(545)	NOPOP(545)	ALL(545)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
10	123033549	rs10788160	G	A	rs10788160	21160077	5.00E-15	NA	10.2	[NA] % increase	7,538 European ancestry individuals	European(7538)	ALL(7538)	EUR(7538)	ALL(7538)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	rs10788160-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
10	123052728	rs12413088	C	T	rs12413088	21160077	3.00E-06	NA	NA	NA	15,757 Icelandic men	Icelandic(15757)	ALL(15757)	EUR(15757)	ALL(15757)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
10	123491643	rs2936875	T	G	rs2936875	22923026	9.05E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
10	123911345	rs7078373	T	C	rs7078373	20978177	5.20E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
10	126192376	rs7090933	A	G	rs7090933	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	126617169	rs4962708	T	C	rs4962708	18264096	2.03E-06	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	126650696	rs11245446	A	G	rs11245446	18264096	1.22E-06	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	126695673	rs1561589	G	A	rs1561589	18264096	6.86E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	126696872	rs4962416	T	C	rs4962416	18264096	2.00E-07		1.17	[1.05-1.30]	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs4962416-C	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	126696872	rs4962416	T	C	rs4962416	pha002877	6.76E-05	phs000207	1.36	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	CTBP2	intron	NM_022802
10	126697210	rs7077275	T	C	rs7077275	18264096	1.65E-06	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	129149464	rs1006217	T	C	rs1006217	20978177	6.31E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
10	129901717	rs61729197	G	A	rs61729197	23555315	0.0000024	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
10	130144139	rs10829385	A	G	rs10829385	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	130147655	rs1936420	T	A	rs1936420	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	130154470	rs1857384	T	C	rs1857384	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	130154533	rs2387611	T	C	rs2387611	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	130504906	rs1887244	G	A	rs1887244	pha002878	2.30E-06	phs000207	1.56	[1.21-2.00]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	NA	NA	NA
10	131200443	rs2792980	T	C	rs2792980	23555315	0.00047	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
10	132323344	rs4751221	G	T	rs4751221	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
10	133608237	rs4897783	G	A	rs4897783	23555315	0.00035	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
11	551741	rs139348192	C	T	rs139348192	23555315	0.000039	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
11	1081112	rs41345745	G	C	rs41345745	23555315	0.00058	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
11	1348338	rs7118481	G	C	rs7118481	20978177	5.13E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
11	2228952	rs7126629	C	A	rs7126629	24740154	2.00E-08	(GWAS stage)	1.44	[1.31-1.57]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs7126629-C	Research Support, N.I.H., Extramural	C	NA
11	2233574	rs7127900	A	C,G	rs7127900	19767753	3.00E-33	NA	1.22	[1.17-1.27]	1,854 European ancestry cases; 1,894 European ancestry controls	European(3748)	ALL(3748)	EUR(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs7127900-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	2233574	rs7127900	A	C,G	rs7127900	24740154	1.00E-07	(GWAS stage)	1.4	NA	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs7127900-A	Research Support, N.I.H., Extramural	G	NA
11	4452824	rs7122384	A	G	rs7122384	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	5411122	rs114517600	C	T	rs114517600	23555315	0.00016	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
11	5583915	rs16932923	T	G	rs16932923	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	5584786	rs16932932	A	T	rs16932932	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	6661352	rs150834672	C	T	rs150834672	23555315	0.00069	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
11	6898587	rs112511001	C	A	rs112511001	23555315	0.00087	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
11	10111991	rs12421096	T	C	rs12421096	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	10117334	rs11042623	T	G	rs11042623	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	10534866	rs10770123	C	T	rs10770123	20978177	9.31E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
11	10540343	rs1993819	A	G	rs1993819	20978177	4.96E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
11	12720560	rs4454698	G	A	rs4454698	20978177	4.37E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
11	13909116	rs9651632	A	C	rs9651632	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	14133293	rs1919302	G	A	rs1919302	23023329	4.95E-05	NA	NA	NA	1,417 Han Chinese cases; 1,008 Han Chinese controls	Han Chinese(2425)	ALL(2425)	ASN(2425)	ALL(2425)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	G	SPON1
11	15282324	rs1540138	A	G	rs1540138	22923026	5.14E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
11	15284845	rs2350983	G	T	rs2350983	22923026	5.14E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
11	15355246	rs11605083	T	C	rs11605083	22219177	4.00E-06	rs7679673	1.28	[1.15-1.43]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
11	16877497	rs11024058	C	T	rs11024058	20978177	1.99E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
11	16882049	rs11024061	C	T	rs11024061	20978177	2.45E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
11	17015557	rs6486334	T	C	rs6486334	pha002878	6.52E-06	phs000207	1.35	[1.07-1.70]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	PLEKHA7	intron	NM_175058
11	20139768	rs144927008	T	A	rs144927008	23555315	0.000011	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
11	23533827	rs1850823	G	C	rs1850823	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	23533902	rs1850822	C	T	rs1850822	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	24909408	rs16913464	A	T	rs16913464	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	25426535	rs4244516	T	A	rs4244516	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	32386448	rs11822134	G	T	rs11822134	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	34655363	rs286913	A	G	rs286913	23555315	0.00068	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
11	36057654	rs200117745	G	C	rs200117745	23555315	0.00012	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
11	38306585	rs2045737	G	T	rs2045737	23555315	0.00061	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
11	39981948	rs10837311	G	A	rs10837311	18264096	1.83E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	45001370	rs12291023	G	T	rs12291023	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	45002697	rs11607247	C	T	rs11607247	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	47831332	rs10838771	A	G	rs10838771	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	47858755	rs2305983	C	T	rs2305983	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	47868474	rs7942031	T	C	rs7942031	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	47873883	rs6485788	A	G	rs6485788	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	47893120	rs7924699	A	T	rs7924699	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	47940925	rs747782	T	C	rs747782	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	47999218	rs1017875	C	T	rs1017875	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	48013484	rs7123436	G	A	rs7123436	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	48050995	rs7130876	A	G	rs7130876	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	48145166	rs2270993	G	A	rs2270993	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	48150576	rs7129364	G	A	rs7129364	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	48168664	rs3741410	T	G	rs3741410	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	48183565	rs17198985	T	C	rs17198985	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	48485877	rs9667626	T	C	rs9667626	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	48520270	rs7942042	A	G	rs7942042	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	48520424	rs7942284	C	T	rs7942284	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	48534864	rs10838923	G	C	rs10838923	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	48541517	rs6485848	G	T	rs6485848	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	48590678	rs7950737	T	G	rs7950737	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	48592510	rs10769383	G	C	rs10769383	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	48598859	rs10437592	G	T	rs10437592	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	48599491	rs10160381	A	G	rs10160381	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	48612024	rs6485891	T	A	rs6485891	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	48612063	rs12278284	G	C	rs12278284	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	48626363	rs7108164	A	C	rs7108164	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	48652198	rs6485908	A	G	rs6485908	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	55322500	rs141941152	C	T	rs141941152	23555315	0.0006	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
11	55945018	rs139773791	C	T	rs139773791	23555315	0.00013	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
11	57428280	rs147951568	T	C	rs147951568	23555315	0.0000069	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
11	58864405	rs7950640	G	C	rs7950640	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	58877909	rs4409856	C	T	rs4409856	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	59276813	rs17592656	A	G	rs17592656	20978177	9.94E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
11	59616860	rs4620739	C	T	rs4620739	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	60830260	rs175122	C	A	rs175122	20978177	3.74E-06	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
11	61552680	rs174537	G	T	rs174537	22923026	6.57E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
11	61557803	rs102275	T	C	rs102275	22923026	6.15E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
11	61569830	rs174546	C	T	rs174546	22923026	4.92E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
11	61580635	rs174556	C	T	rs174556	22923026	7.19E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
11	61597212	rs174570	C	T	rs174570	22923026	7.95E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
11	61597972	rs1535	A	G	rs1535	22923026	3.54E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
11	61603510	rs174576	C	A	rs174576	22923026	4.00E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
11	61609750	rs174583	C	T	rs174583	23555315	0.00033	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
11	61908440	rs2277283	T	A,C,G	rs2277283	23555315	0.00074	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
11	63869596	rs641811	G	A	rs641811	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	68701997	rs140221316	A	G	rs140221316	23555315	0.000028	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
11	68777323	rs11544721	T	C	rs11544721	23555315	0.00072	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
11	68785803	rs11600377	A	G	rs11600377	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	68789606	rs11603763	G	A	rs11603763	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	68978580	rs11228565	G	A	rs11228565	19767754	7.00E-12	NA	1.23	[1.16-1.31]	Up to 1,968 Icelandic cases; 35,382 Icelandic controls	Icelandic(37350)	ALL(37350)	EUR(37350)	ALL(37350)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs11228565-A	Research Support, Non-U.S. Gov't	G	NA
11	68978580	rs11228565	G	A	rs11228565	23555315	0.0000029	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
11	68994497	rs7931342	T	G	rs7931342	18264097	2.00E-12	NA	1.19	[1.11-1.27]	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs7931342-G	Research Support, Non-U.S. Gov't	G	NA
11	68994497	rs7931342	T	G	rs7931342	24740154	1.00E-06	(GWAS stage)	1.3	NA	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs7931342-G	Research Support, N.I.H., Extramural	G	NA
11	68994667	rs10896449	A	G	rs10896449	18264096	2.00E-09		1.1	[0.98-1.23]	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs10896449-G	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	68994667	rs10896449	A	G	rs10896449	18264097	2.10E-07	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	G	NA
11	68994667	rs10896449	A	G	rs10896449	23555315	0.00000011	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
11	68995958	rs7130881	A	G	rs7130881	19767753	8.00E-13	NA	NA	NA	1,854 European ancestry cases; 1,894 European ancestry controls	European(3748)	ALL(3748)	EUR(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs7130881-G	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	68995958	rs7130881	A	G	rs7130881	21743057	9.00E-09	NA	1.31	[1.20-1.44]	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs7130881-G	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	68995958	rs7130881	A	G	rs7130881	23555315	0.000000094	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
11	69008114	rs10896450	A	G	rs10896450	18264097	3.30E-07	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	G	NA
11	69009114	rs11228583	G	T	rs11228583	24740154	2.00E-07	(GWAS stage)	1.33	[1.22-1.44]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs11228583-T	Research Support, N.I.H., Extramural	G	NA
11	69010651	rs12799883	T	G	rs12799883	18264097	2.60E-07	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	G	NA
11	71521071	rs4517550	G	C	rs4517550	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	71993202	rs506041	A	T	rs506041	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	71995656	rs2508865	T	G	rs2508865	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	71996827	rs487288	G	T	rs487288	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	71998325	rs1783632	A	C	rs1783632	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	72061218	rs12418637	G	A	rs12418637	21743057	7.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	73753106	rs142277857	A	G	rs142277857	23555315	0.00087	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
11	74168361	rs17215437	C	T	rs17215437	23555315	0.00077	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
11	75439894	rs141331999	A	G	rs141331999	23555315	0.00000094	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
11	76796077	rs185836777	G	A	rs185836777	23555315	0.00008	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
11	80614777	rs4945452	A	G	rs4945452	23555315	0.00041	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
11	81807219	rs7103364	G	A	rs7103364	20978177	9.41E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
11	81979892	rs611530	C	T	rs611530	23555315	0.00039	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
11	82746365	rs1079338	G	A	rs1079338	20978177	2.00E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
11	82763218	rs11822105	G	A	rs11822105	20978177	2.00E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
11	82788439	rs17144544	C	T	rs17144544	20978177	5.40E-06	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
11	82791213	rs11825381	A	G	rs11825381	20978177	1.78E-05	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
11	82813947	rs11233462	C	T	rs11233462	20978177	2.40E-05	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
11	82814094	rs12279768	T	A	rs12279768	20978177	4.83E-05	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
11	89099263	rs7944576	C	T	rs7944576	23023329	1.07E-04	NA	NA	NA	1,417 Han Chinese cases; 1,008 Han Chinese controls	Han Chinese(2425)	ALL(2425)	ASN(2425)	ALL(2425)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	C	NOX4
11	89875437	rs11018874	G	A	rs11018874	23555315	0.00068	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
11	93015765	rs8181486	T	C	rs8181486	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	93072893	rs7130117	T	C	rs7130117	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	97162589	rs1834639	C	A	rs1834639	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	99884736	rs770577	A	G	rs770577	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	101218192	rs4754010	C	T	rs4754010	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	101218544	rs1938980	T	A	rs1938980	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	101219339	rs12223715	G	C	rs12223715	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	101219495	rs12226605	C	T	rs12226605	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	101223389	rs1892883	T	A	rs1892883	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	101224362	rs12795332	T	C	rs12795332	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	101225730	rs4754752	T	C	rs4754752	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	101227985	rs11224728	A	T	rs11224728	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	101228512	rs11224729	G	T	rs11224729	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	101264879	rs2508375	A	C	rs2508375	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	102401661	rs11568818	T	C	rs11568818	23535732	2.00E-11	NA	1.1	[1.06-1.14]	11,085 European ancestry cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs11568818-A	NA	A	NA
11	102800914	rs4754052	T	C	rs4754052	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	107600282	rs2128114	T	A	rs2128114	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	107884390	rs11212484	C	A	rs11212484	20978177	8.20E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
11	111109258	rs7119658	G	A	rs7119658	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	111111729	rs7952641	C	A	rs7952641	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	112005939	rs243908	A	G	rs243908	20978177	2.95E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
11	112016921	rs360729	A	T	rs360729	20978177	2.05E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
11	113629371	rs142759842	G	A	rs142759842	23555315	0.000067	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
11	115122033	rs7123503	A	C	rs7123503	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	124765168	rs12421354	C	T	rs12421354	pha002878	9.86E-05	phs000207	1.04	[0.81-1.33]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	A	ROBO4	intron	NM_019055
11	126884015	rs1287146	T	C	rs1287146	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	128687305	rs500081	G	T	rs500081	20978177	4.48E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
11	128687835	rs504760	A	G	rs504760	20978177	4.48E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
11	128688420	rs651213	T	A	rs651213	20978177	9.69E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
11	128690596	rs2155549	T	C	rs2155549	20978177	3.96E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
11	129739816	rs200010268	G	A	rs200010268	23555315	0.00008	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
11	130784838	rs185989409	G	A	rs185989409	23555315	0.00057	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
11	131543391	rs873801	C	T	rs873801	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	131981852	rs10894502	G	T	rs10894502	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
11	134128968	rs200170162	A	G	rs200170162	23555315	0.000032	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
12	662873	rs148059237	C	T	rs148059237	23555315	0.000046	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
12	3039437	rs192385949	G	A,C	rs192385949	23555315	0.00036	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
12	4074906	rs672304	A	C	rs672304	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	4074907	rs672303	A	C	rs672303	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	4075855	rs631750	T	C	rs631750	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	4076265	rs629690	C	T	rs629690	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	4553669	rs2970828	T	C	rs2970828	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	5214153	rs667472	T	A	rs667472	22532847	0.000313	NA	NA	NA	135 prostate cancer cases; 270 controls; 525 adenoma cases; 630 colorectal cancer cases; 690 controls (shared)	NOPOP(2250)	ALL(2250)	NOPOP(2250)	ALL(2250)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	A	NA
12	5642112	rs11063732	C	T	rs11063732	22923026	4.68E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
12	5673427	rs10849295	G	A	rs10849295	22923026	3.06E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
12	6137456	rs11610629	A	C	rs11610629	20978177	9.16E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
12	7849144	rs10845708	A	G	rs10845708	22923026	4.83E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
12	7856726	rs12582518	T	C	rs12582518	22923026	2.54E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
12	9924912	rs10772132	G	T	rs10772132	20978177	5.60E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
12	10817860	rs7968284	T	C	rs7968284	20978177	3.77E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
12	10880356	rs2607901	G	A	rs2607901	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	10883422	rs813321	G	A	rs813321	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	13951931	rs2300267	T	C	rs2300267	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	13952707	rs10744039	T	C	rs10744039	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	13953118	rs2058878	T	A	rs2058878	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	14488914	rs6488674	T	G	rs6488674	23359319	2.70E-06	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
12	14521376	rs6488679	G	T	rs6488679	23359319	9.73E-07	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
12	14523972	rs7137532	G	T	rs7137532	23359319	1.02E-06	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
12	14533490	rs7312042	G	A	rs7312042	23359319	9.38E-07	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
12	14534426	rs11055956	G	A	rs11055956	23359319	5.72E-07	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
12	14536666	rs11055960	T	G	rs11055960	23359319	1.93E-06	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
12	14542541	rs10734875	A	G	rs10734875	23359319	6.29E-07	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
12	14548314	rs7954210	A	C	rs7954210	23359319	1.80E-07	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
12	14551025	rs7966054	T	C	rs7966054	23359319	1.12E-06	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
12	14575459	rs7970587	A	G	rs7970587	23359319	2.05E-07	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
12	14581449	rs2417349	C	T	rs2417349	23359319	1.06E-07	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
12	14587301	rs3213764	A	G	rs3213764	23359319	2.00E-09	NA	0.05	[NA] % increase	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	rs3213764-G	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
12	14592843	rs10772782	A	G	rs10772782	23359319	3.96E-07	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
12	14593902	rs7310929	T	C	rs7310929	23359319	1.69E-07	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
12	14595756	rs7964899	G	A	rs7964899	23359319	1.47E-06	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
12	14607721	rs7298685	C	A	rs7298685	23359319	4.09E-06	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
12	14608799	rs12366507	G	A	rs12366507	23359319	6.31E-06	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
12	14610439	rs962504	A	G	rs962504	23359319	1.03E-06	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
12	14611522	rs11055980	C	T	rs11055980	23359319	4.52E-07	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
12	14612323	rs4764090	A	G	rs4764090	23359319	4.38E-07	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
12	14624574	rs4237951	A	C	rs4237951	23359319	2.15E-07	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
12	14653867	rs2900333	C	T	rs2900333	23359319	6.51E-08	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
12	19599001	rs11616166	A	G	rs11616166	22532847	0.0000142	NA	NA	NA	135 prostate cancer cases; 270 controls; 525 adenoma cases; 630 colorectal cancer cases; 690 controls (shared)	NOPOP(2250)	ALL(2250)	NOPOP(2250)	ALL(2250)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	A	AEBP2
12	24135271	rs17401403	A	G	rs17401403	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	44842114	rs11182500	C	T	rs11182500	20978177	5.86E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
12	47372270	rs2711721	C	T	rs2711721	22219177	2.00E-06	rs5759167	1.28	[1.16-1.42]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
12	48538908	rs41291971	G	A	rs41291971	23555315	0.00073	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
12	48811100	rs4489787	T	C	rs4489787	22219177	1.00E-06	rs4430796	1.47	[1.25-1.72]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
12	49676010	rs10875943	T	C	rs10875943	21743467	7.00E-12	NA	1.07	[1.04-1.10]	6,621 European ancestry cases; 6,939 European ancestry controls	European(13560)	ALL(13560)	EUR(13560)	ALL(13560)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs10875943-C	Multicenter Study	Comparative Study	C
12	50190667	rs3741554	A	T	rs3741554	23555315	0.00061	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
12	51595505	rs11169761	G	A	rs11169761	20978177	2.38E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
12	51642543	rs7305016	A	G	rs7305016	20978177	6.72E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
12	52282460	rs150919589	C	T	rs150919589	23555315	0.00012	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
12	53273904	rs902774	G	A	rs902774	18264097	2.00E-07	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	G	NA
12	53273904	rs902774	G	A	rs902774	21743057	5.00E-09	NA	1.17	[1.11-1.24]	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs902774-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	56034204	rs7133243	A	G	rs7133243	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	56680745	rs3816804	C	T	rs3816804	20978177	8.38E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
12	58017860	rs113207856	G	A	rs113207856	23555315	0.00027	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
12	61080039	rs17124060	T	G	rs17124060	23023329	1.47E-04	NA	NA	NA	1,417 Han Chinese cases; 1,008 Han Chinese controls	Han Chinese(2425)	ALL(2425)	ASN(2425)	ALL(2425)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	T	NA
12	64240002	rs17099873	A	G	rs17099873	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	64253778	rs11837218	T	A	rs11837218	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	64257969	rs17099879	T	C	rs17099879	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	66212017	rs1870566	T	C	rs1870566	18073375	7.00E-04	NA	NA	NA	1,235 cases; 1,599 controls	NOPOP(2834)	ALL(2834)	NOPOP(2834)	ALL(2834)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
12	66581616	rs1732887	G	A	rs1732887	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	68842405	rs1861933	A	G	rs1861933	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	68852933	rs11177242	A	G	rs11177242	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	70949014	rs61758735	G	A	rs61758735	23555315	0.00054	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
12	70965009	rs149998223	G	A	rs149998223	23555315	0.00087	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
12	73521180	rs12311315	C	T	rs12311315	20978177	8.67E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
12	77122733	rs7974465	C	T	rs7974465	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	81528625	rs61745251	C	T	rs61745251	23555315	0.00087	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
12	82262731	rs4240731	A	G	rs4240731	22923026	2.60E-06	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
12	83164556	rs12317459	G	A	rs12317459	22219177	4.00E-06	rs16901979	2.06	[1.52-2.80]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
12	84999922	rs1471239	A	G	rs1471239	20978177	8.29E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
12	85623348	rs1395676	C	A	rs1395676	23555315	0.00028	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
12	85833160	rs1849384	A	C	rs1849384	23555315	0.00034	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
12	87604084	rs11104342	G	T	rs11104342	20978177	5.84E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
12	92903958	rs11106601	C	T	rs11106601	pha002878	2.38E-05	phs000207	1.3	[1.03-1.67]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
12	96437554	rs2540477	G	A	rs2540477	20978177	3.48E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
12	99148667	rs10860363	T	C	rs10860363	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	100775956	rs7311096	T	C	rs7311096	23555315	0.00086	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
12	105092213	rs312141	G	A	rs312141	20978177	1.76E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T,C
12	105149126	rs2730291	T	C	rs2730291	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	107296830	rs2024519	G	A	rs2024519	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	107563247	rs4964527	T	C	rs4964527	23555315	0.00033	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
12	107696626	rs876662	T	A	rs876662	20978177	9.81E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
12	107704114	rs2374690	A	G	rs2374690	20978177	9.10E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
12	108765463	rs11113842	T	G	rs11113842	20978177	9.11E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
12	108803755	rs17040470	G	A	rs17040470	20978177	4.82E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
12	109028341	rs8179106	A	G	rs8179106	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	113565637	rs146551951	G	A	rs146551951	23555315	0.000022	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
12	113737574	rs2241543	G	T	rs2241543	22923026	5.86E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
12	113758166	rs16942745	G	A	rs16942745	22923026	5.79E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
12	114685571	rs1270884	A	G	rs1270884	23535732	7.00E-11	NA	1.07	[1.04-1.10]	11,085 European ancestry cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs1270884-A	NA	T	NA
12	115094260	rs11067228	A	G	rs11067228	21160077	2.00E-11	NA	8.3	[NA] % increase	7,538 European ancestry individuals	European(7538)	ALL(7538)	EUR(7538)	ALL(7538)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	rs11067228-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
12	116252862	rs1424611	G	A	rs1424611	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	116252945	rs1424612	C	T	rs1424612	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	116254605	rs12320046	C	T	rs12320046	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	116985064	rs7300418	C	G	rs7300418	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	128274870	rs10773432	T	G	rs10773432	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
12	129811613	rs3861080	G	A	rs3861080	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
13	22798237	rs2503334	C	T	rs2503334	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
13	23056758	rs17422614	G	C	rs17422614	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
13	25919624	rs9511762	C	T	rs9511762	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
13	30562130	rs75404762	T	A,C,G	rs75404762	24185611	7.04E-06	GWAS stage only	4.49	[2.27-8.90]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs75404762-C	NA	T	NA
13	32744352	rs9315157	C	T	rs9315157	22923026	7.77E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
13	36087703	rs17052316	G	A	rs17052316	22923026	8.43E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
13	36102523	rs7337804	T	C	rs7337804	22923026	4.88E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
13	36597522	rs9575140	C	T	rs9575140	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
13	37879168	rs1324038	C	T	rs1324038	20978177	6.86E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
13	38156538	rs117103342	C	T	rs117103342	23555315	0.00066	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
13	42259195	rs78161810	T	G	rs78161810	23555315	0.00084	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
13	44637405	rs9567349	A	G	rs9567349	22219177	4.00E-06	rs1465618	1.64	[1.33-2.04]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
13	46444922	rs11841875	C	T	rs11841875	20978177	5.76E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
13	47286938	rs2762130	C	G	rs2762130	20978177	2.71E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
13	51824328	rs10492519	A	G	rs10492519	18073375	5.60E-06	NA	NA	NA	1,235 cases; 1,599 controls	NOPOP(2834)	ALL(2834)	NOPOP(2834)	ALL(2834)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
13	58768855	rs17054854	G	C	rs17054854	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
13	67572850	rs7324298	C	T	rs7324298	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
13	73728139	rs9600079	G	T	rs9600079	20676098	3.00E-09	NA	1.18	[1.12-1.24]	1,583 Japanese cases; 3,386 Japanese controls	Japanese(4969)	ALL(4969)	ASN(4969)	ALL(4969)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs9600079-T	Research Support, Non-U.S. Gov't	T	NA
13	75101810	rs9543671	C	T	rs9543671	pha002877	2.08E-05	phs000207	1.47	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
13	75101810	rs9543671	C	T	rs9543671	pha002878	3.59E-06	phs000207	1.59	[1.22-2.04]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
13	75121202	rs2038946	A	G	rs2038946	pha002878	9.56E-06	phs000207	1.52	[1.18-1.96]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	A	NA	NA	NA
13	76371876	rs1570555	A	G	rs1570555	pha002878	2.53E-05	phs000207	1.01	[0.80-1.28]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	A	LMO7	intron	NM_005358
13	77257495	rs9530584	C	T	rs9530584	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
13	78952348	rs2247058	T	C	rs2247058	20978177	1.77E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
13	82773712	rs7984395	A	G	rs7984395	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
13	82797648	rs7992071	T	A	rs7992071	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
13	82866573	rs7984003	T	C	rs7984003	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
13	83502205	rs9546275	C	T	rs9546275	21743057	7.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
13	83505743	rs1471932	C	T	rs1471932	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
13	85555284	rs1932917	A	G	rs1932917	23555315	0.00088	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
13	89921892	rs314530	C	A	rs314530	23555315	0.00076	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
13	90865546	rs16944141	G	A	rs16944141	22219177	3.00E-06	rs1512268	1.54	[1.28-1.85]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
13	99449717	rs2282133	C	T	rs2282133	23555315	0.00024	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
13	100100700	rs4369516	A	G	rs4369516	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
13	103710685	rs117447044	G	A	rs117447044	23555315	0.0000114	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Ratio of free to total prostate-specific antigen	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
13	103928007	rs1529276	T	A	rs1529276	17903305	2.00E-06	NA	NA	NA	1,345 individuals(Framingham)	Framingham(1345)	ALL(1345)	EUR(1345)	ALL(1345)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	A	NA
13	104058539	rs16962226	G	C	rs16962226	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
13	106702358	rs9514490	G	A	rs9514490	22923026	5.78E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
13	107063042	rs11839053	T	C	rs11839053	24740154	8.70E-10	(GWAS stage)	4.02	[3.59-4.45]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs11839053-C	Research Support, N.I.H., Extramural	G,A	NA
13	108922556	rs201543678	G	A	rs201543678	23555315	0.000072	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
13	110453607	rs7986346	G	T	rs7986346	pha002877	2.79E-05	phs000207	1.25	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	NA	NA	NA
13	112164871	rs1163852	G	A	rs1163852	18264096	3.71E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
13	112548383	rs11164148	G	A	rs11164148	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	20503541	rs17122640	G	A	rs17122640	21743057	3.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	21024619	rs1243647	A	G	rs1243647	22219177	1.00E-06	rs12418451	1.33	[1.19-1.49]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
14	22083298	rs7142691	G	T	rs7142691	20978177	5.10E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
14	22133463	rs193176078	A	G	rs193176078	23555315	0.00000726	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Ratio of free to total prostate-specific antigen	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
14	23120629	rs1242940	A	T	rs1242940	20978177	9.99E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
14	26512456	rs718203	G	A	rs718203	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	27867946	rs10498288	T	C	rs10498288	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	32881246	rs8013938	T	G	rs8013938	20830292	7.41E-07	Selenium resistance	NA	NA	46 NCI cancer cell lines (mixed ancestry)	NOPOP(46)	ALL(46)	NOPOP(46)	ALL(46)	Selenium resistance in NCI60 cancer cell lines	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, Non-U.S. Gov't	T	AKAP6
14	40401266	rs8012860	C	T	rs8012860	21743057	7.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40408290	rs10134315	A	G	rs10134315	21743057	7.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40423929	rs10149309	A	C	rs10149309	21743057	2.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40429562	rs12050352	A	G	rs12050352	21743057	2.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40439847	rs10138216	G	C	rs10138216	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40447700	rs417245	T	C	rs417245	21743057	1.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40452133	rs395080	C	T	rs395080	21743057	1.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40453714	rs365586	G	A	rs365586	21743057	1.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40460206	rs438079	T	A,C,G	rs438079	21743057	4.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40467749	rs380886	G	A	rs380886	21743057	4.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40524965	rs4903274	G	A	rs4903274	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40534612	rs11157095	G	T	rs11157095	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40541480	rs996183	G	A	rs996183	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40545454	rs4134425	T	C	rs4134425	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40547273	rs8011680	G	C	rs8011680	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40548650	rs11157097	C	T	rs11157097	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40559143	rs12883545	A	G	rs12883545	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40559775	rs12886023	T	C	rs12886023	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40562197	rs2208197	C	T	rs2208197	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40566655	rs17196	G	C	rs17196	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40580535	rs1018511	T	C	rs1018511	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40586440	rs11625373	C	A	rs11625373	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40588184	rs6571985	A	C	rs6571985	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40601252	rs7146621	G	C	rs7146621	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40602103	rs11157107	A	G	rs11157107	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40608324	rs11626582	T	C	rs11626582	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40623598	rs11623348	T	C	rs11623348	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40639294	rs1955533	G	T	rs1955533	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40647832	rs2144031	C	A	rs2144031	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40651337	rs7161024	G	C	rs7161024	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40651864	rs11157114	A	C	rs11157114	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	40653830	rs1983651	T	A	rs1983651	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	42698006	rs12895935	C	T	rs12895935	22923026	3.79E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
14	42699090	rs12434985	A	G	rs12434985	22923026	1.18E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
14	42717951	rs1393835	G	A	rs1393835	22923026	2.64E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
14	43803481	rs4641644	C	A	rs4641644	pha002878	7.31E-07	phs000207	1.34	[0.98-1.84]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
14	47510417	rs7155342	T	G	rs7155342	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	47518240	rs11157536	A	G	rs11157536	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	47521489	rs961616	T	C	rs961616	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	47525103	rs1573007	T	A	rs1573007	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	47534306	rs10134228	G	A	rs10134228	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	47537891	rs17118000	G	A	rs17118000	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	47539662	rs7159021	C	T	rs7159021	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	47540754	rs9972259	T	G	rs9972259	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	47543188	rs12888648	T	C	rs12888648	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	47543336	rs10135298	T	C	rs10135298	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	47886106	rs12897676	G	A	rs12897676	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	47886923	rs7142096	T	C	rs7142096	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	47888104	rs7152765	T	C	rs7152765	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	47889952	rs7159493	G	T	rs7159493	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	50877983	rs1265879	A	G	rs1265879	22923026	9.21E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
14	50877983	rs1265879	A	G	rs1265879	23555315	0.00016	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
14	52127059	rs9671722	A	G	rs9671722	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	53372330	rs8008270	T	C	rs8008270	23535732	2.00E-14	NA	1.12	[1.08-1.16]	11,085 European ancestry cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs8008270-G	NA	C	FERMT2
14	55841447	rs8015211	T	C	rs8015211	21467234	1.64E-05	Aggressive prostate cancer	NA	NA	202 European ancestry more aggressive cases; 100 European ancestry controls	European(302)	ALL(302)	EUR(302)	ALL(302)	Prostate cancer(aggressive)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Randomized Controlled Trial	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't
14	55949626	rs12433615	A	G	rs12433615	21467234	4.06E-05	Aggressive prostate cancer	NA	NA	202 European ancestry more aggressive cases; 100 European ancestry controls	European(302)	ALL(302)	EUR(302)	ALL(302)	Prostate cancer(aggressive)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Randomized Controlled Trial	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't
14	55969956	rs1188069	T	G	rs1188069	21467234	6.38E-05	Aggressive prostate cancer	NA	NA	202 European ancestry more aggressive cases; 100 European ancestry controls	European(302)	ALL(302)	EUR(302)	ALL(302)	Prostate cancer(aggressive)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Randomized Controlled Trial	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't
14	55985012	rs2341883	G	A	rs2341883	21467234	1.01E-04	Aggressive prostate cancer	NA	NA	202 European ancestry more aggressive cases; 100 European ancestry controls	European(302)	ALL(302)	EUR(302)	ALL(302)	Prostate cancer(aggressive)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Randomized Controlled Trial	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't
14	56884403	rs1189136	C	A	rs1189136	22923026	6.81E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
14	57618262	rs2186075	G	A	rs2186075	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	57618423	rs8019635	T	C	rs8019635	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	60591199	rs3742642	A	T	rs3742642	23555315	0.00023	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
14	61180657	rs3742636	T	G	rs3742636	23555315	0.00004	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
14	64519035	rs1890908	A	G	rs1890908	23555315	0.00047	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A,G
14	69126744	rs7141529	T	C	rs7141529	23535732	3.00E-10	NA	1.09	[1.06-1.12]	11,085 European ancestry cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs7141529-G	NA	T	NA
14	70924072	rs4143920	A	G	rs4143920	22367438	0.00082	NA	NA	NA	1,176 PCa cases; 1,101 controls	NOPOP(2277)	ALL(2277)	NOPOP(2277)	ALL(2277)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
14	70935875	rs2293877	A	G	rs2293877	pha002878	4.55E-05	phs000207	1.32	[1.00-1.74]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
14	73425681	rs7144738	A	C	rs7144738	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	74535660	rs139579994	G	A	rs139579994	23555315	0.00073	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
14	76060181	rs2110566	G	A	rs2110566	pha002878	3.38E-06	phs000207	1.2	[0.96-1.52]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	A	FLVCR2	intron	NM_017791
14	79073108	rs17107912	G	A	rs17107912	20978177	5.22E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G,A
14	79983619	rs8022699	G	A	rs8022699	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	79985980	rs10149537	G	C	rs10149537	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	79993106	rs2371100	C	T	rs2371100	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	80001655	rs9652378	G	A	rs9652378	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	80002462	rs1424849	G	A	rs1424849	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	80008914	rs1424846	G	A	rs1424846	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	82289937	rs1571379	T	C	rs1571379	22923026	3.82E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
14	83170722	rs2150333	A	T	rs2150333	24740154	2.90E-06	(GWAS stage)	2	[1.69-2.31]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs2150333-A	Research Support, N.I.H., Extramural	A	NA
14	88587120	rs11159841	T	C	rs11159841	pha002878	3.98E-05	phs000207	1.69	[1.32-2.17]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	NA	NA	NA
14	88614541	rs6574994	A	G	rs6574994	pha002878	5.73E-06	phs000207	1.82	[1.43-2.33]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	G	NA	NA	NA
14	92624111	rs117009742	A	G	rs117009742	23555315	0.00041	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
14	94121728	rs2296687	A	G	rs2296687	23555315	0.00078	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
14	94545604	rs148489393	C	T	rs148489393	23555315	0.00042	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
14	95582086	rs114947750	C	A	rs114947750	23555315	0.00028	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
14	96781800	rs201736391	T	C	rs201736391	23555315	0.00038	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
14	98970164	rs8003296	G	A	rs8003296	20978177	9.74E-05	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
14	98987472	rs8022320	G	A	rs8022320	20978177	2.17E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
14	99046062	rs7154523	T	A	rs7154523	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	99046230	rs7153428	C	T	rs7153428	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	99049575	rs2145524	T	C	rs2145524	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
14	101727107	rs2400997	C	T	rs2400997	22219177	3.00E-06	rs10934853	1.25	[1.14-1.38]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
14	102391577	rs3742424	G	C	rs3742424	23555315	0.00056	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
14	105407770	rs201648026	T	A	rs201648026	23555315	0.000051	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
15	28440287	rs6497287	T	C	rs6497287	21467234	5.20E-05	Aggressive prostate cancer	NA	NA	202 European ancestry more aggressive cases; 100 European ancestry controls	European(302)	ALL(302)	EUR(302)	ALL(302)	Prostate cancer(aggressive)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Randomized Controlled Trial	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't
15	29603003	rs10519646	C	T	rs10519646	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	32084744	rs1160721	G	C	rs1160721	20978177	8.48E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
15	32347464	rs35114543	T	C	rs35114543	23555315	0.00076	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
15	35068309	rs543686	C	T	rs543686	22219177	4.00E-06	rs6983267	1.24	[1.13-1.35]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
15	37163634	rs8039481	G	A	rs8039481	20978177	8.91E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
15	39005898	rs4924292	C	T	rs4924292	20978177	4.60E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T,C
15	39012579	rs8024474	C	T	rs8024474	pha002878	7.53E-05	phs000207	1.44	[1.14-1.81]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
15	44218366	rs483800	A	G	rs483800	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44244523	rs8035382	T	C	rs8035382	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44245931	rs2929282	A	T	rs2929282	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44266081	rs2929281	G	T	rs2929281	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44266692	rs2412845	C	T	rs2412845	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44269353	rs2412846	G	A	rs2412846	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44270531	rs2930528	A	G	rs2930528	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44278441	rs2412851	G	A	rs2412851	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44284168	rs10851415	G	A	rs10851415	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44289418	rs6493092	C	T	rs6493092	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44291244	rs4924729	T	C	rs4924729	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44296724	rs4924731	A	G	rs4924731	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44304308	rs10851416	G	A	rs10851416	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44305495	rs6493093	C	G	rs6493093	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44310206	rs9920249	T	A	rs9920249	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44327179	rs11070419	C	G	rs11070419	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44340555	rs2899103	A	T	rs2899103	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44364901	rs4924737	T	A	rs4924737	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44380904	rs2555375	G	A	rs2555375	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44389870	rs2733221	T	C	rs2733221	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44406021	rs2615297	A	C	rs2615297	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44412620	rs2615294	C	A	rs2615294	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44431145	rs2555389	A	G	rs2555389	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44433142	rs2162365	G	A	rs2162365	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44433377	rs2217108	C	T	rs2217108	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44434312	rs1834641	T	G	rs1834641	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	44439380	rs2162366	G	A	rs2162366	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	46639808	rs4775302	G	A	rs4775302	22130093	4.00E-08	NA	NA	NA	316 cases; 229 controls	NOPOP(545)	ALL(545)	NOPOP(545)	ALL(545)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
15	49039797	rs784411	T	C	rs784411	22219177	1.00E-07	rs12418451	1.42	[1.25-1.61]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
15	49622269	rs12910584	C	T	rs12910584	22923026	2.83E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
15	49676889	rs16962414	A	G	rs16962414	22923026	2.28E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
15	49684785	rs16962418	C	T	rs16962418	22923026	5.35E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
15	49712097	rs1429555	C	T	rs1429555	22923026	3.42E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
15	54363105	rs17634084	C	A	rs17634084	20978177	2.92E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
15	54368844	rs1897023	A	G	rs1897023	20978177	1.25E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
15	54386040	rs12901124	G	T	rs12901124	20978177	8.01E-05	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
15	54388623	rs2414270	C	T	rs2414270	20978177	1.62E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
15	54388892	rs2899527	G	A	rs2899527	20978177	1.62E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
15	55916703	rs148011047	T	G	rs148011047	23555315	0.00048	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
15	58476204	rs143394617	T	C	rs143394617	23555315	0.000076	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
15	58680954	rs2043085	T	C	rs2043085	23555315	0.00051	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
15	63191944	rs729198	C	A	rs729198	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	63192448	rs4274387	G	C	rs4274387	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	63192751	rs2171689	T	C	rs2171689	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	63192772	rs2899685	C	G	rs2899685	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	63194063	rs8042820	G	A	rs8042820	21743057	3.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	63195772	rs7172773	C	T	rs7172773	21743057	3.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	63198937	rs8030784	G	A	rs8030784	21743057	3.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	65321780	rs188718836	A	T	rs188718836	23555315	0.00052	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
15	66981329	rs7359178	C	T	rs7359178	22923026	2.27E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
15	67013821	rs2439397	G	A	rs2439397	21743057	9.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	67019313	rs2439391	A	C	rs2439391	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	71305225	rs150157186	G	A	rs150157186	23555315	0.00086	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
15	72057477	rs148016609	G	A	rs148016609	23555315	0.000031	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
15	74133091	rs8030745	T	C	rs8030745	pha002878	5.39E-05	phs000207	1.07	[0.81-1.41]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	NA	NA	NA
15	75393720	rs8040061	C	A	rs8040061	23555315	0.00014	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
15	81308426	rs16972648	G	A	rs16972648	21743057	1.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	81314310	rs6495536	T	A	rs6495536	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	81578139	rs4072111	C	T	rs4072111	18264096	1.19E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	84679158	rs1531683	T	C	rs1531683	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	85397374	rs16974567	G	A	rs16974567	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	89277150	rs7174169	G	T	rs7174169	22923026	4.16E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
15	89837098	rs150544323	A	G	rs150544323	23555315	0.0006	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
15	90190186	rs151155363	G	A	rs151155363	23555315	0.0000184	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Ratio of free to total prostate-specific antigen	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
15	92139237	rs4383118	G	A	rs4383118	23555315	0.00058	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
15	93903068	rs4587928	C	T	rs4587928	pha002877	9.82E-05	phs000207	1.46	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
15	94773470	rs1350090	G	A	rs1350090	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	96841524	rs7173576	C	T	rs7173576	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
15	97002653	rs11637980	A	G	rs11637980	22219177	2.00E-06	rs1447295	1.47	[1.27-1.72]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
15	100014303	rs8026271	T	C	rs8026271	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	347063	rs117208012	C	T	rs117208012	23555315	0.000066	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
16	774193	rs148595483	G	T	rs148595483	23555315	0.000000024	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate-specific antigen	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
16	847033	rs80165523	C	G	rs80165523	23555315	0.00014	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
16	1260481	rs8063574	T	C	rs8063574	23555315	0.00033	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
16	1391388	rs150730105	G	A	rs150730105	23555315	0.0000143	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Ratio of free to total prostate-specific antigen	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
16	2296877	rs141206306	C	T	rs141206306	23555315	0.00035	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
16	5751221	rs766209	C	T	rs766209	20978177	6.29E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
16	5752636	rs4786060	C	T	rs4786060	20978177	6.29E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
16	5753180	rs1558221	C	T	rs1558221	20978177	6.29E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
16	5753958	rs17432899	A	T	rs17432899	20978177	6.29E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
16	5755043	rs2041255	A	G	rs2041255	20978177	9.00E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
16	5758532	rs12933690	G	A	rs12933690	20978177	4.40E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
16	5758907	rs12922826	C	G,T	rs12922826	20978177	3.79E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
16	5759019	rs12447242	C	T	rs12447242	20978177	3.89E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
16	5759070	rs12447100	G	A	rs12447100	20978177	5.31E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
16	8019611	rs1395593	T	G	rs1395593	pha002877	5.91E-06	phs000207	1.25	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	NA	NA	NA
16	8019611	rs1395593	T	G	rs1395593	pha002878	6.99E-05	phs000207	1.19	[0.94-1.52]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	NA	NA	NA
16	14471261	rs1533079	G	A	rs1533079	pha002877	4.77E-05	phs000207	1.52	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	A	NA	NA	NA
16	16018589	rs13335375	C	T	rs13335375	23555315	0.0005	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
16	19041595	rs28583298	G	A	rs28583298	23555315	0.00032	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
16	24221758	rs10852263	C	T	rs10852263	20978177	2.12E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
16	24229885	rs2239339	G	C	rs2239339	20978177	9.11E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
16	25255366	rs61746620	G	A	rs61746620	23555315	0.000089	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
16	25278777	rs2112814	A	G	rs2112814	20978177	7.07E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
16	25281220	rs9926115	T	C	rs9926115	20978177	9.96E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
16	25281593	rs7197703	C	T	rs7197703	20978177	5.64E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
16	25281848	rs918536	A	G	rs918536	20978177	5.07E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
16	25285100	rs7199745	C	G	rs7199745	20978177	7.24E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
16	25286743	rs6497820	A	G	rs6497820	20978177	5.31E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
16	25753251	rs4268750	T	C	rs4268750	23555315	0.00031	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
16	25865578	rs4448943	G	C	rs4448943	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	27772891	rs9944296	C	T	rs9944296	23555315	0.00000939	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Ratio of free to total prostate-specific antigen	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
16	30004603	rs146278367	T	C,G	rs146278367	23555315	0.000017	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
16	31391887	rs59889488	C	T	rs59889488	23555315	0.0006	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
16	48201432	rs16945916	T	C	rs16945916	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	48213167	rs11861031	T	C	rs11861031	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	48877631	rs1872694	A	G	rs1872694	pha002878	1.12E-05	phs000207	1.7	[1.34-2.16]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	G	NA	NA	NA
16	48891102	rs7404239	A	G	rs7404239	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	48891213	rs9934172	A	G	rs9934172	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	48891621	rs3095652	G	A	rs3095652	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	48892246	rs8055353	T	C	rs8055353	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	48892858	rs1362586	T	C	rs1362586	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	48893109	rs1362587	C	T	rs1362587	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	48896563	rs3103020	T	A	rs3103020	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	49394276	rs8057939	T	C	rs8057939	22219177	5.00E-06	rs6465657	1.37	[1.20-1.57]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
16	51201830	rs10852613	C	T	rs10852613	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	51705337	rs16950188	C	T	rs16950188	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	51715875	rs1381451	G	A	rs1381451	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	53135032	rs7199440	C	T	rs7199440	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	56883438	rs8044753	G	A	rs8044753	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	63363717	rs219607	T	C	rs219607	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	63364524	rs219605	C	A	rs219605	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	63367138	rs178141	T	A	rs178141	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	63986686	rs9927100	T	C	rs9927100	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	67919696	rs139776238	G	A	rs139776238	23555315	0.00024	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
16	69547741	rs4783718	T	C	rs4783718	23555315	0.00045	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
16	71509207	rs75731908	A	C	rs75731908	23555315	0.000019	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
16	75144408	rs1043509	A	T	rs1043509	20978177	1.35E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
16	76241475	rs2194295	C	A,G,T	rs2194295	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	78407063	rs11150069	A	C	rs11150069	21467234	9.43E-06	Aggressive prostate cancer	NA	NA	202 European ancestry more aggressive cases; 100 European ancestry controls	European(302)	ALL(302)	EUR(302)	ALL(302)	Prostate cancer(aggressive)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Randomized Controlled Trial	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't
16	78563832	rs11645676	C	T	rs11645676	20978177	5.51E-05	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
16	78574676	rs9989362	T	C	rs9989362	20978177	4.61E-05	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
16	81198254	rs74029003	T	C	rs74029003	23555315	0.00026	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
16	82447854	rs7202694	A	G	rs7202694	22923026	6.33E-06	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
16	82448109	rs7202575	C	T	rs7202575	22923026	2.92E-06	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
16	82701333	rs4782726	A	G	rs4782726	18264096	2.50E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	84020685	rs68004739	G	T	rs68004739	23555315	0.00028	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
16	84212647	rs150717903	T	C	rs150717903	23555315	0.0000083	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
16	84270476	rs11646443	G	A	rs11646443	23555315	0.00057	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
16	87394386	rs1834022	A	G	rs1834022	23555315	0.00044	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
16	90112226	rs4628973	A	G	rs4628973	21467234	4.62E-07	Aggressive prostate cancer	NA	NA	202 European ancestry more aggressive cases; 100 European ancestry controls	European(302)	ALL(302)	EUR(302)	ALL(302)	Prostate cancer(aggressive)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Randomized Controlled Trial	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't
16	90158838	rs9922277	T	C	rs9922277	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
16	90160064	rs7498369	A	G	rs7498369	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
17	618965	rs684232	T	C	rs684232	23535732	5.00E-15	NA	1.1	[1.07-1.14]	11,085 European ancestry cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs684232-G	NA	A	NA
17	1553040	rs200942821	C	T	rs200942821	23555315	0.000085	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
17	3394215	rs16953074	A	G	rs16953074	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
17	4579638	rs8071990	G	A	rs8071990	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
17	5765353	rs888326	A	G	rs888326	22923026	6.76E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
17	7128292	rs148584617	G	A	rs148584617	23555315	0.0005	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
17	7846713	rs35421969	G	A	rs35421969	23555315	0.00032	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
17	9698244	rs4791868	G	C	rs4791868	20978177	4.30E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
17	9703299	rs17207745	G	A	rs17207745	20978177	2.56E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
17	9795420	rs4791905	C	G	rs4791905	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
17	10429123	rs187438258	G	A	rs187438258	23555315	0.00011	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
17	13625024	rs4054823	T	C	rs4054823	21467234	2.10E-06	Aggressive prostate cancer	NA	NA	202 European ancestry more aggressive cases; 100 European ancestry controls	European(302)	ALL(302)	EUR(302)	ALL(302)	Prostate cancer(aggressive)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Randomized Controlled Trial	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't
17	16322676	rs4792739	T	C	rs4792739	23555315	0.00013	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
17	17942293	rs149036879	C	T	rs149036879	23555315	0.00029	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
17	26051702	rs4595846	G	T	rs4595846	23555315	0.00025	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
17	32688826	rs138527286	T	C	rs138527286	23555315	0.00016	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
17	33313129	rs35071763	C	CG	rs3744356	23555315	0.000089	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
17	33313129	rs3744356	C	T	rs3744356	23555315	0.000089	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
17	36074979	rs11649743	G	A	rs11649743	18264096	5.60E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
17	36090885	rs3744763	G	A	rs3744763	18264097	2.00E-07	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	T	HNF1B
17	36090885	rs3744763	G	A	rs3744763	21160077	6.50E-08	NA	NA	NA	15,757 Icelandic men	Icelandic(15757)	ALL(15757)	EUR(15757)	ALL(15757)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
17	36096300	rs2005705	A	G	rs2005705	24740154	1.00E-06	(GWAS stage)	1.35	[1.23-1.47]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs2005705-G	Research Support, N.I.H., Extramural	T	HNF1B
17	36098040	rs4430796	G	A	rs4430796	18264096	1.00E-09		1.18	[1.04-1.32]	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs4430796-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
17	36098040	rs4430796	G	A	rs4430796	18264097	8.30E-12	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	G	HNF1B
17	36098040	rs4430796	G	A	rs4430796	19767754	8.00E-06	NA	1.19	[1.10-1.28]	Up to 1,968 Icelandic cases; 35,382 Icelandic controls	Icelandic(37350)	ALL(37350)	EUR(37350)	ALL(37350)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs4430796-A	Research Support, Non-U.S. Gov't	G	HNF1B
17	36098040	rs4430796	G	A	rs4430796	21160077	6.00E-11	NA	9.4	[NA] % increase	7,538 European ancestry individuals	European(7538)	ALL(7538)	EUR(7538)	ALL(7538)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	rs4430796-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
17	36098040	rs4430796	G	A	rs4430796	23555315	0.00009	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
17	36098040	rs4430796	G	A	rs4430796	24740154	2.50E-06	(GWAS stage)	1.33	[1.33-1.33]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs4430796-A	Research Support, N.I.H., Extramural	G	HNF1B
17	36101156	rs7501939	T	C	rs7501939	18264096	8.88E-09	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
17	36101156	rs7501939	T	C	rs7501939	18264097	9.00E-12	NA	1.41	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs7501939-C	Research Support, Non-U.S. Gov't	C	HNF1B
17	36101156	rs7501939	T	C	rs7501939	19767753	3.00E-18	NA	NA	NA	1,854 European ancestry cases; 1,894 European ancestry controls	European(3748)	ALL(3748)	EUR(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs7501939-C	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
17	36101156	rs7501939	T	C	rs7501939	20676098	1.00E-12	NA	NA	NA	1,583 Japanese cases; 3,386 Japanese controls	Japanese(4969)	ALL(4969)	ASN(4969)	ALL(4969)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	C	HNF1B
17	36101156	rs7501939	T	C	rs7501939	21160077	5.30E-07	NA	NA	NA	15,757 Icelandic men	Icelandic(15757)	ALL(15757)	EUR(15757)	ALL(15757)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
17	36101156	rs7501939	T	C	rs7501939	21743057	2.00E-06	NA	1.19	[1.11-1.28]	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs7501939-C	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
17	36101156	rs7501939	T	C	rs7501939	23555315	0.000086	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
17	36106313	rs3760511	T	G	rs3760511	18264097	3.60E-08	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	A	HNF1B
17	36131437	rs17705445	C	T	rs17705445	20978177	2.21E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
17	39520119	rs150620728	C	T	rs150620728	23555315	0.00000058	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
17	44788310	rs183211	G	A	rs183211	22923026	8.11E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
17	44800046	rs7224296	G	A	rs7224296	22923026	9.41E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
17	44814884	rs7226263	T	C	rs7226263	22923026	4.31E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
17	44816132	rs12325819	G	T	rs12325819	22923026	3.93E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
17	46894377	rs3959442	A	C,G,T	rs3959442	23555315	0.00023	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
17	46939658	rs10278	C	G	rs10278	23555315	0.00054	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
17	47345186	rs11650494	G	A	rs11650494	23535732	2.00E-09	NA	1.15	[1.09-1.22]	11,085 European ancestry cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs11650494-A	NA	G	NA
17	47436749	rs7210100	G	A	rs7210100	21602798	3.00E-13	NA	1.51	[1.35-1.69]	3,425 African American cases; 3,290 African American controls	African American(6715)	ALL(6715)	AFR(6715)	ALL(6715)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, U.S. Gov't, P.H.S.	Research Support, Non-U.S. Gov't
17	47436749	rs7210100	G	A	rs7210100	23555315	0.00037	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
17	47789865	rs8064701	G	C	rs8064701	24740154	4.80E-06	(GWAS stage)	1.43	[1.28-1.58]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs8064701-G	Research Support, N.I.H., Extramural	C	FAM117A
17	48068913	rs151180891	C	T	rs151180891	23555315	0.00019	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
17	48618243	rs145595403	C	G	rs145595403	23555315	0.00009	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
17	48628160	rs62621401	A	G	rs62621401	23555315	0.00089	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
17	50358178	rs2769577	T	A	rs2769577	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
17	53918388	rs9910335	G	T	rs9910335	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
17	54450134	rs8069322	G	A	rs8069322	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
17	54559801	rs139388119	G	A	rs139388119	23555315	0.000032	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
17	58235051	rs185658468	A	T	rs185658468	23555315	0.00000051	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
17	63726773	rs1034764	C	T	rs1034764	22923026	6.69E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
17	64917033	rs17645023	A	T	rs17645023	23555315	0.000067	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
17	69108753	rs1859962	G	T	rs1859962	18264097	1.00E-06		1.26	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs1859962-G	Research Support, Non-U.S. Gov't	T	NA
17	69108753	rs1859962	G	T	rs1859962	19767753	2.00E-16	NA	NA	NA	1,854 European ancestry cases; 1,894 European ancestry controls	European(3748)	ALL(3748)	EUR(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs1859962-T	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
17	69108753	rs1859962	G	T	rs1859962	21743057	3.00E-11	NA	1.27	[1.18-1.37]	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs1859962-G	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
17	69108753	rs1859962	G	T	rs1859962	22532847	0.00042	NA	NA	NA	135 prostate cancer cases; 270 controls; 525 adenoma cases; 630 colorectal cancer cases; 690 controls (shared)	NOPOP(2250)	ALL(2250)	NOPOP(2250)	ALL(2250)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	T	NA
17	69108753	rs1859962	G	T	rs1859962	23555315	0.000067	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
17	69108753	rs1859962	G	T	rs1859962	24740154	2.60E-04	(GWAS stage)	1.21	[1.21-1.21]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs1859962-G	Research Support, N.I.H., Extramural	T	NA
17	69115146	rs9889335	T	G	rs9889335	18264097	5.70E-07	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	G	NA
17	69118636	rs4793529	T	C	rs4793529	24753544	2.00E-13	NA	0.28	[0.20-0.35] unit increase	1,146 European ancestry cases; 1,804 European ancestry controls	European(2950)	ALL(2950)	EUR(2950)	ALL(2950)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs4793529-T	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
17	69245735	rs2058005	T	C	rs2058005	pha002878	4.69E-06	phs000207	1.24	[0.99-1.54]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	NA	NA	NA
17	69257833	rs2158906	G	A	rs2158906	pha002878	1.37E-05	phs000207	1.25	[1.00-1.56]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	G	NA	NA	NA
17	69286681	rs11077554	T	G	rs11077554	pha002878	2.80E-06	phs000207	1.24	[0.99-1.55]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	NA	NA	NA
17	69290669	rs4468671	C	T	rs4468671	pha002878	7.07E-06	phs000207	1.26	[1.01-1.58]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
17	72758167	rs41282065	G	A	rs41282065	23555315	0.00015	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
17	74076415	rs2257020	G	A	rs2257020	23555315	0.00082	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
17	74725812	rs201999820	C	T	rs201999820	23555315	0.00051	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
17	74729764	rs147321492	T	C	rs147321492	23555315	0.0000042	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
17	76497940	rs139273056	C	T	rs139273056	23555315	0.000085	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
17	76497940	rs139273056	C	T	rs139273056	23555315	0.00083	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
17	77266394	rs4789878	G	C	rs4789878	20978177	8.18E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
17	77844799	rs8078624	T	G	rs8078624	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
17	78573872	rs9913181	T	G	rs9913181	20978177	5.29E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
17	78596158	rs12952285	C	G	rs12952285	20978177	7.97E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
17	78872953	rs12232521	A	G	rs12232521	20978177	3.76E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
18	3701841	rs342484	G	C	rs342484	20978177	1.11E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
18	5765682	rs16948784	A	T	rs16948784	21743057	9.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	7231881	rs144753731	A	G	rs144753731	23555315	0.00017	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
18	7877629	rs9304004	G	A	rs9304004	20978177	9.79E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
18	8391829	rs656068	A	G	rs656068	pha002878	5.64E-05	phs000207	1.37	[1.08-1.73]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	T	PTPRM	intron	NM_002845
18	8959613	rs1573320	C	T	rs1573320	20978177	9.46E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
18	13029986	rs116020861	G	A	rs116020861	23555315	0.00029	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
18	13057655	rs61740922	C	T	rs61740922	23555315	0.00054	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
18	20913598	rs7238618	G	A	rs7238618	20978177	4.16E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
18	21828099	rs9964923	T	A	rs9964923	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	23054030	rs16941509	G	A	rs16941509	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	23684907	rs7228783	T	G	rs7228783	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	27376270	rs12454815	A	T	rs12454815	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	27376503	rs12457327	C	G	rs12457327	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	30927775	rs6507016	C	T	rs6507016	22219177	4.00E-06	rs5945619	1.28	[1.15-1.41]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
18	31328519	rs12957087	C	T	rs12957087	23555315	0.00068	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
18	33251159	rs635462	G	T	rs635462	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	33260373	rs508284	C	T	rs508284	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	33264057	rs549804	G	A	rs549804	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	33273553	rs496841	T	A	rs496841	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	33276380	rs475231	G	A	rs475231	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	33281464	rs644489	C	T	rs644489	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	33304652	rs1628083	A	T	rs1628083	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	38015530	rs16973345	A	G	rs16973345	22923026	3.15E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
18	39530811	rs12961563	G	A	rs12961563	20978177	8.13E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
18	41796551	rs17767634	C	T	rs17767634	20978177	7.35E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
18	41797982	rs17767808	T	G	rs17767808	20978177	7.86E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
18	42725662	rs998124	A	G	rs998124	22219177	5.00E-06	rs10934853	1.33	[1.18-1.51]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
18	43307246	rs11877062	C	T	rs11877062	23555315	0.00085	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
18	46343818	rs9951895	T	C	rs9951895	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	48081138	rs4939987	C	G	rs4939987	20978177	5.63E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
18	48096752	rs8089517	C	G	rs8089517	20978177	7.48E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
18	48118360	rs4322755	G	A	rs4322755	20978177	9.63E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
18	48124715	rs992595	A	G	rs992595	20978177	7.48E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
18	48330625	rs2586777	T	C	rs2586777	20978177	4.79E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
18	48331553	rs2849233	T	C	rs2849233	20978177	3.63E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
18	51976374	rs8092229	A	G	rs8092229	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	51976578	rs7238584	T	C	rs7238584	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	51976885	rs6508305	T	C	rs6508305	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	51978349	rs16958339	A	G	rs16958339	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	52003106	rs1608516	A	T	rs1608516	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	52035521	rs940312	C	T	rs940312	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	52044425	rs16960608	G	A	rs16960608	21743057	7.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	53640779	rs1424401	G	A	rs1424401	23555315	0.00086	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
18	56735130	rs4940807	A	C	rs4940807	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	58093902	rs11152222	T	G	rs11152222	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	59028063	rs11664910	A	G	rs11664910	24740154	2.30E-06	(GWAS stage)	1.42	[1.30-1.54]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs11664910-G	Research Support, N.I.H., Extramural	A	NA
18	60063622	rs6567280	A	G	rs6567280	18264096	9.05E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	61377579	rs1395268	A	C	rs1395268	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	61393959	rs931849	C	T	rs931849	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	61497804	rs986982	G	A	rs986982	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	69153381	rs768718	C	T	rs768718	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	69153703	rs10469188	A	G	rs10469188	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	69158858	rs7238698	A	G	rs7238698	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	69159876	rs9319819	C	A	rs9319819	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	69160768	rs8095198	G	T	rs8095198	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	69161026	rs2627	A	G	rs2627	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	69161140	rs8096472	T	C	rs8096472	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	69162557	rs2187422	A	G	rs2187422	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	69171321	rs11151670	G	A	rs11151670	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	69172373	rs7238469	T	A	rs7238469	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	69172939	rs7239293	T	C	rs7239293	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	70399988	rs4892034	A	T	rs4892034	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	70402118	rs4891485	T	C	rs4891485	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	70403694	rs4892036	T	C	rs4892036	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	71897381	rs12606263	A	G	rs12606263	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	75366853	rs11663447	G	C	rs11663447	21743057	5.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	75817704	rs7228984	T	C	rs7228984	pha002878	8.83E-05	phs000207	1.59	[1.22-2.04]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
18	76047493	rs8085865	A	G	rs8085865	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	76684386	rs3933778	A	G	rs3933778	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
18	76773973	rs7241993	C	T	rs7241993	23535732	2.00E-09	NA	1.09	[1.05-1.12]	11,085 European ancestry cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs7241993-G	NA	T	NA
18	77539764	rs585811	C	A	rs585811	pha002878	4.11E-05	phs000207	1.2	[0.94-1.54]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
19	4552446	rs201218136	G	A	rs201218136	23555315	3.80E-09	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate-specific antigen	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
19	5590371	rs150472516	C	T	rs150472516	23555315	0.000025	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
19	5687901	rs200586681	G	C	rs200586681	23555315	0.00041	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
19	6147676	rs74980839	C	A	rs74980839	23555315	0.00039	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
19	6320963	rs7260240	G	A	rs7260240	23023329	1.98E-04	NA	NA	NA	1,417 Han Chinese cases; 1,008 Han Chinese controls	Han Chinese(2425)	ALL(2425)	ASN(2425)	ALL(2425)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	G	ACER1
19	6941867	rs465543	G	A	rs465543	pha002878	9.12E-05	phs000207	1.35	[1.08-1.69]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	A	NA	NA	NA
19	8564474	rs4239541	G	A,C,T	rs4239541	23555315	0.0002	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T,G
19	9237457	rs118114660	G	T	rs118114660	23555315	0.00045	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
19	9578028	rs141562027	C	T	rs141562027	23555315	0.00051	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
19	15483942	rs61757556	C	T	rs61757556	23555315	0.00025	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
19	16908639	rs73008597	C	T	rs73008597	23555315	0.0003	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
19	18054132	rs8104153	G	C	rs8104153	23555315	0.00039	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
19	21666210	rs2562456	C	T	rs2562456	23555315	0.00085	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
19	29136582	rs10401833	T	C	rs10401833	pha002877	6.79E-05	phs000207	1.08	NA	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C	NA	NA	NA
19	38127024	rs147806327	T	C	rs147806327	23555315	0.000024	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
19	38735613	rs8102476	C	T	rs8102476	19767754	2.00E-11	NA	1.12	[1.08-1.15]	Up to 1,968 Icelandic cases; 35,382 Icelandic controls	Icelandic(37350)	ALL(37350)	EUR(37350)	ALL(37350)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs8102476-C	Research Support, Non-U.S. Gov't	T	NA
19	38942248	rs3745844	G	A	rs3745844	18264096	1.65E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
19	41884327	rs77399851	T	C	rs77399851	23555315	0.00063	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
19	41985587	rs11672691	A	G	rs11672691	23065704	1.00E-08	Aggressive	1.11	[1.02-1.20]	5,132 European ancestry non-aggressive cases; 5,953 European ancestry aggressive cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs11672691-G	Research Support, N.I.H., Extramural	Meta-Analysis	Research Support, Non-U.S. Gov't
19	41985587	rs11672691	A	G	rs11672691	23065704	2.00E-12	All	1.08	[1.04-1.12]	5,132 European ancestry non-aggressive cases; 5,953 European ancestry aggressive cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs11672691 -G	Research Support, N.I.H., Extramural	Meta-Analysis	Research Support, Non-U.S. Gov't
19	43414890	rs116433230	C	A	rs116433230	23555315	0.000043	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
19	45296806	rs3208856	C	A,G,T	rs3208856	23555315	0.000073	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
19	48528656	rs16959498	C	T	rs16959498	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
19	48608472	rs1653554	A	G	rs1653554	18264096	9.91E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
19	49376683	rs45533432	A	G	rs45533432	23555315	0.000000012	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
19	49376683	rs45533432	A	G	rs45533432	23555315	0.0001	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
19	49899076	rs10405154	G	A	rs10405154	23555315	0.00018	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
19	49954807	rs2293012	T	G	rs2293012	23555315	0.00064	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
19	51335943	rs2659056	T	C	rs2659056	18264097	1.20E-07	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	A	KLK15
19	51349090	rs266849	G	A	rs266849	18264097	8.90E-17	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	A	NA
19	51349090	rs266849	G	A	rs266849	21160077	6.00E-10	NA	NA	NA	7,538 European ancestry individuals	European(7538)	ALL(7538)	EUR(7538)	ALL(7538)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	rs266849-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
19	51349090	rs266849	G	A	rs266849	23555315	1.68E-08	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate-specific antigen	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
19	51351934	rs266870	T	C	rs266870	18264097	2.10E-09	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	T,C	NA
19	51351934	rs266870	T	C	rs266870	21160077	1.30E-09	NA	NA	NA	15,757 Icelandic men	Icelandic(15757)	ALL(15757)	EUR(15757)	ALL(15757)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T,C
19	51361757	rs17632542	T	C	rs17632542	21160077	3.00E-46	NA	39.1	[NA] % increase	7,538 European ancestry individuals	European(7538)	ALL(7538)	EUR(7538)	ALL(7538)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	rs17632542-T	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
19	51361757	rs17632542	T	C	rs17632542	23555315	9.95E-09	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate-specific antigen	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
19	51361757	rs17632542	T	C	rs17632542	24740154	1.00E-07	(GWAS stage)	1.85	[1.61-2.09]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs17632542-T	Research Support, N.I.H., Extramural	T	KLK3
19	51361757	rs17632542	T	C	rs17632542	24753544	2.00E-28	NA	0.73	[0.60-0.86] unit increase	1,146 European ancestry cases; 1,804 European ancestry controls	European(2950)	ALL(2950)	EUR(2950)	ALL(2950)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs17632542-T	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
19	51363398	rs1058205	C	T	rs1058205	18264097	1.80E-20	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	T	KLK3
19	51363398	rs1058205	C	T	rs1058205	21160077	5.40E-20	NA	NA	NA	15,757 Icelandic men	Icelandic(15757)	ALL(15757)	EUR(15757)	ALL(15757)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
19	51363398	rs1058205	C	T	rs1058205	24919509	8.00E-21	NA	0.09	[0.067-0.103] unit increase	1,086 Japanese ancestry males	Japanese(1086)	ALL(1086)	ASN(1086)	ALL(1086)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, Non-U.S. Gov't	T	KLK3
19	51364623	rs2735839	A	G	rs2735839	18264097	2.00E-18	NA	1.2	[1.10-1.33]	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs2735839-G	Research Support, Non-U.S. Gov't	G,A	NA
19	51364623	rs2735839	A	G	rs2735839	21160077	1.80E-21	NA	NA	NA	15,757 Icelandic men	Icelandic(15757)	ALL(15757)	EUR(15757)	ALL(15757)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G,A
19	51364623	rs2735839	A	G	rs2735839	23269536	6.00E-37	NA	0.19	NA	1,999 Chinese ancestry men	Chinese(1999)	ALL(1999)	ASN(1999)	ALL(1999)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	rs2735839-G	Randomized Controlled Trial	Multicenter Study	Research Support, Non-U.S. Gov't
19	51364623	rs2735839	A	G	rs2735839	23555315	0.00031	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G,A
19	51364623	rs2735839	A	G	rs2735839	23555315	6.39E-08	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate-specific antigen	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G,A
19	51364623	rs2735839	A	G	rs2735839	24740154	3.70E-05	(GWAS stage)	1.39	[1.39-1.39]	931 European ancestry cases; 4,120 European ancestry controls	European(5051)	ALL(5051)	EUR(5051)	ALL(5051)	Prostate cancer (early onset)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	rs2735839-G	Research Support, N.I.H., Extramural	G,A	NA
19	51369074	rs2739459	G	A	rs2739459	23555189	1.89E-07	Imputed	1.22	[1.15-1.29] unit increase	1,371 European ancestry individuals	European(1371)	ALL(1371)	EUR(1371)	ALL(1371)	PCA3 expression level	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	EFOID:0005127	cancer biomarker measurement	Prostate cancer	rs2739459-G	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
19	51369451	rs2739461	T	C	rs2739461	23555189	1.00E-07	Imputed	1.23	[1.16-1.3] unit increase	1,371 European ancestry individuals	European(1371)	ALL(1371)	EUR(1371)	ALL(1371)	PCA3 expression level	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	EFOID:0005127	cancer biomarker measurement	Prostate cancer	rs2739461-T	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C,T
19	51369848	rs2739464	G	A	rs2739464	23555189	1.13E-07	Imputed	1.22	[1.15-1.29] unit increase	1,371 European ancestry individuals	European(1371)	ALL(1371)	EUR(1371)	ALL(1371)	PCA3 expression level	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	EFOID:0005127	cancer biomarker measurement	Prostate cancer	rs2739464-G	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
19	51370252	rs2739466	A	G	rs2739466	23555189	1.13E-07	Imputed	1.22	[1.15-1.29] unit increase	1,371 European ancestry individuals	European(1371)	ALL(1371)	EUR(1371)	ALL(1371)	PCA3 expression level	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	EFOID:0005127	cancer biomarker measurement	Prostate cancer	rs2739466-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G,A
19	51370543	rs2739468	A	C	rs2739468	23555189	6.94E-08	Imputed	1.23	[1.16-1.3] unit increase	1,371 European ancestry individuals	European(1371)	ALL(1371)	EUR(1371)	ALL(1371)	PCA3 expression level	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	EFOID:0005127	cancer biomarker measurement	Prostate cancer	rs2739468-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C,A
19	51370593	rs2739469	T	C	rs2739469	23555189	1.13E-07	Imputed	1.22	[1.15-1.29] unit increase	1,371 European ancestry individuals	European(1371)	ALL(1371)	EUR(1371)	ALL(1371)	PCA3 expression level	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	EFOID:0005127	cancer biomarker measurement	Prostate cancer	rs2739469-T	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C,T
19	51371419	rs1506684	A	G	rs1506684	21160077	1.90E-09	NA	NA	NA	15,757 Icelandic men	Icelandic(15757)	ALL(15757)	EUR(15757)	ALL(15757)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
19	51371419	rs1506684	A	G	rs1506684	23555189	1.00E-07	Genotyped	1.22	[1.15-1.29] unit increase	1,371 European ancestry individuals	European(1371)	ALL(1371)	EUR(1371)	ALL(1371)	PCA3 expression level	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	EFOID:0005127	cancer biomarker measurement	Prostate cancer	rs1506684-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
19	51372395	rs2569739	C	T	rs2569739	23555189	4.74E-07	Imputed	1.21	[1.14-1.28] unit increase	1,371 European ancestry individuals	European(1371)	ALL(1371)	EUR(1371)	ALL(1371)	PCA3 expression level	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	EFOID:0005127	cancer biomarker measurement	Prostate cancer	rs2569739-C	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
19	51372797	rs965537	C	T	rs965537	23555189	1.10E-07	Imputed	1.22	[1.15-1.29] unit increase	1,371 European ancestry individuals	European(1371)	ALL(1371)	EUR(1371)	ALL(1371)	PCA3 expression level	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	EFOID:0005127	cancer biomarker measurement	Prostate cancer	rs965537-C	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
19	51373190	rs1997563	T	C	rs1997563	23555189	2.28E-07	Imputed	1.22	[1.15-1.29] unit increase	1,371 European ancestry individuals	European(1371)	ALL(1371)	EUR(1371)	ALL(1371)	PCA3 expression level	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	EFOID:0005127	cancer biomarker measurement	Prostate cancer	rs1997563-T	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T,C
19	51373279	rs2739472	T	C	rs2739472	23555189	1.13E-07	Imputed	1.22	[1.15-1.29] unit increase	1,371 European ancestry individuals	European(1371)	ALL(1371)	EUR(1371)	ALL(1371)	PCA3 expression level	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	EFOID:0005127	cancer biomarker measurement	Prostate cancer	rs2739472-T	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C,T
19	51373385	rs2739473	A	G	rs2739473	23555189	1.13E-07	Imputed	1.22	[1.15-1.29] unit increase	1,371 European ancestry individuals	European(1371)	ALL(1371)	EUR(1371)	ALL(1371)	PCA3 expression level	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	EFOID:0005127	cancer biomarker measurement	Prostate cancer	rs2739473-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
19	51373626	rs2739475	A	G	rs2739475	23555189	1.13E-07	Imputed	1.22	[1.15-1.29] unit increase	1,371 European ancestry individuals	European(1371)	ALL(1371)	EUR(1371)	ALL(1371)	PCA3 expression level	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	EFOID:0005127	cancer biomarker measurement	Prostate cancer	rs2739475-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G,A
19	51373818	rs2739476	A	G	rs2739476	23555189	1.39E-07	Imputed	1.22	[1.15-1.29] unit increase	1,371 European ancestry individuals	European(1371)	ALL(1371)	EUR(1371)	ALL(1371)	PCA3 expression level	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	EFOID:0005127	cancer biomarker measurement	Prostate cancer	rs2739476-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
19	51374967	rs10424878	A	G	rs10424878	23555189	1.00E-08	NA	1.24	[1.17-1.31] unit increase	1,371 European ancestry individuals	European(1371)	ALL(1371)	EUR(1371)	ALL(1371)	PCA3 expression level	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	EFOID:0005127	cancer biomarker measurement	Prostate cancer	rs10424878-A	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A,G
19	51379893	rs198972	C	T	rs198972	23359319	2.78E-07	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
19	51381777	rs198977	C	T	rs198977	23555315	2.73E-20	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Ratio of free to total prostate-specific antigen	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
19	51385253	rs16987929	A	G	rs16987929	23359319	7.90E-11	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
19	51385402	rs8103659	A	G	rs8103659	23359319	1.35E-10	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
19	51389560	rs198957	C	T	rs198957	23359319	1.81E-10	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
19	51390353	rs198956	A	G	rs198956	23359319	1.83E-10	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C,T
19	51390809	rs7256586	C	A	rs7256586	23359319	6.51E-11	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
19	51393118	rs1354774	A	G	rs1354774	23359319	6.00E-20	NA	0.06	[NA] % increase	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	rs1354774-G	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
19	51394286	rs2739482	C	T	rs2739482	23359319	2.28E-10	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
19	51396922	rs61044983	G	T	rs61044983	23359319	7.77E-11	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
19	51398071	rs8105985	C	A	rs8105985	23359319	7.77E-11	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
19	51398888	rs1629856	A	C	rs1629856	23359319	1.68E-10	NA	NA	NA	3,192 European ancestry individuals	European(3192)	ALL(3192)	EUR(3192)	ALL(3192)	Prostate-specific antigen levels	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D017430	Prostate-Specific Antigen	EFOID:0004624	prostate specific antigen measurement	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G,T
19	51519225	rs78983379	C	T	rs78983379	23555315	0.000082	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
19	54797848	rs103294	C	T	rs103294	23023329	5.00E-16	NA	1.28	[1.21-1.36]	1,417 Han Chinese cases; 1,008 Han Chinese controls	Han Chinese(2425)	ALL(2425)	ASN(2425)	ALL(2425)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs103294-C	Research Support, Non-U.S. Gov't	C	NA
19	55526359	rs1654413	A	T	rs1654413	23555315	0.00025	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
19	55527081	rs2304167	C	T	rs2304167	23555315	0.00007	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
19	55897956	rs147614077	G	A	rs147614077	23555315	0.00018	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
19	55913678	rs12709950	C	A	rs12709950	20978177	5.26E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
19	56370608	rs140863186	A	G	rs140863186	23555315	0.000093	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
19	58004563	rs7259303	G	A	rs7259303	23555315	0.00065	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
20	210061	rs13045643	G	A	rs13045643	23555315	0.00023	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
20	2198899	rs6047451	A	C	rs6047451	20978177	3.00E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
20	5818658	rs237098	G	A	rs237098	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
20	5819545	rs237097	T	C	rs237097	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
20	5819844	rs237096	C	T	rs237096	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
20	5820000	rs237094	T	C	rs237094	21743057	2.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
20	5824893	rs1287021	T	C	rs1287021	21743057	3.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
20	5827061	rs6053740	G	A	rs6053740	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
20	5827321	rs2655015	T	C	rs2655015	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
20	5828375	rs1287071	A	G	rs1287071	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
20	7313534	rs2423194	G	A	rs2423194	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
20	7323563	rs7262084	G	A	rs7262084	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
20	10283150	rs6039824	T	C	rs6039824	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
20	10418801	rs6074138	G	A	rs6074138	22923026	9.61E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
20	10766162	rs6108701	C	T	rs6108701	pha002878	5.51E-05	phs000207	1.85	[1.43-2.44]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	C,T	NA	NA	NA
20	11900442	rs141676257	G	A	rs141676257	23555315	0.00021	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
20	15998826	rs6080097	C	T	rs6080097	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
20	16295704	rs12480966	G	A	rs12480966	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
20	19951534	rs3803981	T	A	rs3803981	23555315	0.00001	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
20	20039506	rs6035539	T	A	rs6035539	20978177	7.63E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
20	20258395	rs1927333	C	T	rs1927333	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
20	20298483	rs1000269	G	A	rs1000269	20978177	1.90E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
20	20303376	rs6046790	G	A	rs6046790	20978177	1.90E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
20	23862844	rs6076157	G	A	rs6076157	pha002878	8.33E-05	phs000207	1.37	[1.08-1.72]	NA	ALL(0)	ALL(0)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	NA	G	NA	NA	NA
20	30610508	rs140563493	A	T	rs140563493	23555315	0.000087	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
20	33711831	rs149260082	T	C	rs149260082	23555315	0.000091	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
20	34572607	rs138969375	C	T	rs138969375	23555315	0.00002	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
20	36339324	rs6020395	G	C	rs6020395	18264096	3.46E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
20	36382521	rs16986921	C	T	rs16986921	18264096	5.88E-07	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
20	36386612	rs6020712	G	A	rs6020712	18264096	7.92E-07	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
20	36399580	rs6013029	G	T	rs6013029	18264096	2.69E-07	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
20	36405667	rs6020846	A	G	rs6020846	18264096	2.45E-05	NA	NA	NA	1,172 cases; 1,157 controls	NOPOP(2329)	ALL(2329)	NOPOP(2329)	ALL(2329)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
20	39672618	rs6029526	T	A	rs6029526	23555315	0.00058	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
20	39721373	rs2076574	A	G	rs2076574	22923026	2.24E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
20	39746403	rs6129760	A	G	rs6129760	22923026	9.83E-06	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
20	39872768	rs6102322	C	T	rs6102322	22923026	5.70E-06	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
20	42364734	rs285198	G	A	rs285198	24185611	7.87E-06	GWAS stage only	1.64	[1.32-2.03]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs285198-A	NA	G	NA
20	42371095	rs370971	G	A	rs370971	24185611	4.92E-06	GWAS stage only	1.65	[1.33-2.04]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs370971-A	NA	G	NA
20	44237357	rs139643257	G	A	rs139643257	23555315	0.00062	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
20	44511697	rs142962530	A	G	rs142962530	23555315	0.000019	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
20	48033171	rs237461	T	C	rs237461	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
20	48033203	rs237462	C	T	rs237462	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
20	51722623	rs2800999	G	T	rs2800999	23555315	0.0005	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
20	52328338	rs10854193	G	A	rs10854193	22923026	9.58E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
20	54397951	rs6024466	A	C	rs6024466	20978177	4.51E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
20	55108617	rs3209183	C	A	rs3209183	23555315	0.00026	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
20	60768573	rs41284984	C	T	rs41284984	23555315	0.0003	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
20	61015611	rs2427345	C	T	rs2427345	23535732	4.00E-08	NA	1.06	[1.03-1.10]	11,085 European ancestry cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs2427345-G	NA	T	NA
20	61391977	rs746192	G	T	rs746192	23555315	0.00064	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
20	61669036	rs6089829	A	G	rs6089829	22219177	3.00E-06	rs2735839	1.35	[1.19-1.54]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
20	61910270	rs2273499	G	A	rs2273499	23555315	0.00056	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
20	62362563	rs6062509	G	T	rs6062509	23535732	4.00E-16	NA	1.12	[1.09-1.16]	11,085 European ancestry cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs6062509-A	NA	G	ZGPAT
20	62364653	rs199550529	G	T	rs199550529	23555315	0.00085	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
21	11001104	rs456706	C	T	rs456706	20978177	8.26E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
21	20174695	rs2825131	A	G	rs2825131	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
21	20176411	rs2825133	C	T	rs2825133	21743057	8.00E-06	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
21	24840017	rs2828183	G	A	rs2828183	22923026	8.27E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
21	27326859	rs2829997	G	A	rs2829997	21743057	1.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
21	29140076	rs243727	A	G	rs243727	20978177	9.53E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
21	29207605	rs200753086	G	GTT	rs243698	20978177	7.59E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
21	29207605	rs243698	G	T	rs243698	20978177	7.59E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
21	33285300	rs2833556	G	A	rs2833556	23555315	0.0007	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
21	35880072	rs727957	G	T	rs727957	23555315	0.00025	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
21	38390362	rs150799198	G	A	rs150799198	23555315	0.000077	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
21	41764387	rs765310	G	T	rs765310	20978177	8.34E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
21	41764987	rs2205082	G	A	rs2205082	20978177	9.71E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
21	41765016	rs2205083	G	A	rs2205083	20978177	8.02E-05	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
21	43548239	rs2839470	T	C	rs2839470	21743057	8.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
21	44270229	rs6586250	C	T	rs6586250	23555315	0.00019	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
21	44874605	rs8131995	G	A	rs8131995	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
21	46337565	rs3788151	C	T	rs3788151	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
21	46393090	rs3827260	C	T	rs3827260	21743057	4.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
22	18076523	rs5992749	G	A	rs5992749	21743057	9.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
22	18102393	rs737995	C	T	rs737995	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
22	18102627	rs5992761	A	G	rs5992761	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
22	18486017	rs424765	T	C	rs424765	20978177	8.34E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
22	18609493	rs145621219	G	A	rs145621219	23555315	0.000046	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
22	20115562	rs175164	C	T	rs175164	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
22	22845240	rs5751168	T	C	rs5751168	22219177	4.00E-06	rs7679673	1.44	[1.23-1.67]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
22	24717850	rs204710	A	G	rs204710	23555315	0.00042	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
22	24761467	rs204718	G	A	rs204718	23555315	0.00042	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
22	25010855	rs186765281	A	G	rs186765281	23555315	0.00054	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
22	25775535	rs5761054	C	T	rs5761054	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
22	25907905	rs507715	C	A	rs507715	22923026	7.23E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
22	25909811	rs2780695	G	A	rs2780695	22923026	7.53E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
22	26678128	rs5997062	C	T	rs5997062	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
22	27852183	rs6005451	T	C	rs6005451	22219177	4.00E-06	rs445114	1.42	[1.22-1.65]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
22	28090207	rs5762311	G	A	rs5762311	23555315	0.00058	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
22	29828751	rs12484045	A	C	rs12484045	20978177	9.91E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
22	36537725	rs61731692	G	A	rs61731692	23555315	0.00031	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
22	37396024	rs146129761	G	C	rs146129761	23555315	0.0008	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
22	38483189	rs200068984	A	G	rs200068984	23555315	0.0000024	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	NA
22	38898051	rs138457	T	C	rs138457	23555315	0.00003	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
22	38925719	rs1980455	A	C	rs1980455	22923026	4.80E-06	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
22	39016182	rs4821797	T	C	rs4821797	22923026	4.84E-06	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
22	39100128	rs5757251	G	A	rs5757251	23555315	0.00029	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
22	39105707	rs4821815	G	A	rs4821815	22923026	6.47E-06	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
22	39124912	rs2235229	C	T	rs2235229	22923026	2.99E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
22	39133803	rs138705	C	T	rs138705	22923026	2.20E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
22	39138332	rs138708	G	A	rs138708	23555315	0.00022	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
22	39141600	rs138712	G	A	rs138712	23668334	2.00E-05	Discovery stage, not in replication	2.47	[1.63-3.76]	90 Tunisian cases; 131 Tunisian controls	Tunisian(221)	ALL(221)	MEA(221)	ALL(221)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs138712-G	Research Support, Non-U.S. Gov't	G	SUN2
22	39813759	rs35469986	T	A,C,G	rs35469986	23555315	0.00077	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
22	40436973	rs11704416	G	C	rs11704416	23065704	4.00E-06	Aggressive	1.05	[0.96-1.15]	5,132 European ancestry non-aggressive cases; 5,953 European ancestry aggressive cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs11704416-C	Research Support, N.I.H., Extramural	Meta-Analysis	Research Support, Non-U.S. Gov't
22	40436973	rs11704416	G	C	rs11704416	23065704	4.00E-07	All	1.06	[1.02-1.10]	5,132 European ancestry non-aggressive cases; 5,953 European ancestry aggressive cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs11704416-C	Research Support, N.I.H., Extramural	Meta-Analysis	Research Support, Non-U.S. Gov't
22	40452119	rs9623117	T	C	rs9623117	19117981	5.00E-07	NA	1.18	[1.11-1.26]	1,235 aggressive cases; 1,599 controls	NOPOP(2834)	ALL(2834)	NOPOP(2834)	ALL(2834)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs9623117-C	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
22	40654276	rs12628051	T	C	rs12628051	22219177	3.00E-06	rs7127900	1.3	[1.17-1.46]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
22	40675091	rs4821941	A	G	rs4821941	22219177	4.00E-06	rs7127900	1.3	[1.16-1.46]	4,723 cases; 4,792 controls	NOPOP(9515)	ALL(9515)	NOPOP(9515)	ALL(9515)	Prostate cancer (gene x gene interaction)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, U.S. Gov't, Non-P.H.S.
22	43424283	rs11912530	G	A	rs11912530	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
22	43432826	rs5751416	G	A	rs5751416	23555315	0.00057	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
22	43500212	rs5759167	G	T	rs5759167	19767753	6.00E-29	NA	1.16	[1.14-1.20]	1,854 European ancestry cases; 1,894 European ancestry controls	European(3748)	ALL(3748)	EUR(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs5759167-T	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
22	43500212	rs5759167	G	T	rs5759167	21743057	1.00E-05	NA	1.18	[1.10-1.27]	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs5759167-G	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
22	43500212	rs5759167	G	T	rs5759167	23555315	0.00025	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
22	43518275	rs742134	A	G	rs742134	21743057	6.00E-06	conditioned on rs5759167	1.16	[1.01-1.23]	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs742134-G	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
22	43654278	rs73420094	G	A	rs73420094	23555315	0.00037	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
22	43703991	rs5751478	A	G	rs5751478	21743057	1.00E-04	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
22	43831058	rs182725627	G	C	rs182725627	23555315	0.000041	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer (advanced)	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
22	44985305	rs16992538	G	A	rs16992538	22923026	6.84E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
22	45166701	rs4823252	A	G	rs4823252	22923026	4.79E-05	NA	NA	NA	1,033 Japanese ancestry cases; 1,042 Japanese ancestry controls; 1,043 Latin American ancestry cases; 1,057 Latin American ancestry controls	Latin American(2100)	Japanese(2075)	ALL(4175)	ASN(2075)	HIS(2100)	ALL(4175)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural
22	45767391	rs9614653	C	T	rs9614653	23555315	0.00016	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
22	45911714	rs2238809	G	A	rs2238809	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
22	45912376	rs2238810	G	A	rs2238810	21743057	6.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
22	46812585	rs6008813	G	A	rs6008813	24185611	4.34E-07	Greater than or even to 7,GWAS stage only	1.9	[1.47-2.44]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs6008813-A	NA	G	CELSR1
22	47200180	rs812942	A	G	rs812942	21743057	7.00E-05	NA	NA	NA	2,782 European ancestry cases; 4,458 European ancestry controls	European(7240)	ALL(7240)	EUR(7240)	ALL(7240)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
X	3228966	rs148675322	C	G	rs148675322	23555315	0.0008	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
X	5697701	rs7885928	T	C	rs7885928	20978177	2.28E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	C
X	9814135	rs2405942	G	A	rs2405942	23535732	2.00E-10	NA	1.14	[1.09-1.20]	11,085 European ancestry cases; 11,463 European ancestry controls	European(22548)	ALL(22548)	EUR(22548)	ALL(22548)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs2405942-A	NA	A	SHROOM2
X	36501470	rs12009741	A	G	rs12009741	23555315	0.00022	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	A
X	51210057	rs1327301	C	T	rs1327301	18264097	1.20E-07	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	C	NA
X	51210057	rs1327301	C	T	rs1327301	19767753	2.00E-10	NA	NA	NA	1,854 European ancestry cases; 1,894 European ancestry controls	European(3748)	ALL(3748)	EUR(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs1327301-T	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	Research Support, N.I.H., Intramural
X	51229683	rs5945572	A	G	rs5945572	18264097	9.60E-08	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	G	NA
X	51229683	rs5945572	A	G	rs5945572	18264098	4.00E-13	NA	1.23	[1.16-1.30]	1,854 cases; 21,372 controls	NOPOP(23226)	ALL(23226)	NOPOP(23226)	ALL(23226)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs5945572-A	Multicenter Study	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't
X	51229683	rs5945572	A	G	rs5945572	23555315	0.000068	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
X	51241672	rs5945619	C	T	rs5945619	18264097	2.00E-09	NA	1.19	[1.07-1.31]	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs5945619-C	Research Support, Non-U.S. Gov't	C	NA
X	51352035	rs1419040	G	A	rs1419040	18264097	1.80E-08	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	T	NA
X	51387252	rs4604628	C	T	rs4604628	18264097	2.10E-08	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	G	NA
X	51552884	rs5991735	G	A	rs5991735	18264097	2.40E-08	NA	NA	NA	1,854 cases; 1,894 controls	NOPOP(3748)	ALL(3748)	NOPOP(3748)	ALL(3748)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	G	MAGED1
X	62747056	rs12688535	T	C	rs12688535	23023329	7.35E-04	NA	NA	NA	1,417 Han Chinese cases; 1,008 Han Chinese controls	Han Chinese(2425)	ALL(2425)	ASN(2425)	ALL(2425)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	T	LOC92249
X	67021550	rs5919432	C	T	rs5919432	21743467	1.00E-08	NA	1.06	[1.02-1.12]	6,621 European ancestry cases; 6,939 European ancestry controls	European(13560)	ALL(13560)	EUR(13560)	ALL(13560)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs5919432-A	Multicenter Study	Comparative Study	T
X	85528760	rs195034	C	T	rs195034	20978177	8.79E-04	NA	NA	NA	222 Caucasian lethal cases; 415 Caucasian long-term survivors	Caucasian(637)	ALL(637)	EUR(637)	ALL(637)	Prostate cancer mortality	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
X	87398933	rs17279546	T	C	rs17279546	23023329	3.07E-04	NA	NA	NA	1,417 Han Chinese cases; 1,008 Han Chinese controls	Han Chinese(2425)	ALL(2425)	ASN(2425)	ALL(2425)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	T	NA
X	100117807	rs149219547	T	C	rs149219547	23555315	0.00000192	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Ratio of free to total prostate-specific antigen	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	NA	NA	NA	NA	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	T
X	102640667	rs3924343	G	A	rs3924343	23023329	4.81E-04	NA	NA	NA	1,417 Han Chinese cases; 1,008 Han Chinese controls	Han Chinese(2425)	ALL(2425)	ASN(2425)	ALL(2425)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, Non-U.S. Gov't	C	NA
X	126962295	rs226644	T	C	rs226644	23555315	0.00015	NA	NA	NA	3141 breast cancer cases; 3568 controlos; 4376 prostate cancer cases; 3977 controls	NOPOP(15062)	ALL(15062)	NOPOP(15062)	ALL(15062)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	NA	Research Support, N.I.H., Extramural	Research Support, Non-U.S. Gov't	G
X	148538099	rs985081	T	C	rs985081	24185611	8.66E-09	Less than 7,GWAS stage only	3.08	[2.01-4.73]	474 West African ancestry cases; 458 West African ancestry controls	West African(932)	ALL(932)	AFR(932)	ALL(932)	Prostate cancer	HPOID:0012125	Prostate cancer	DOID:10283	prostate cancer	D011471	Prostatic Neoplasms	EFOID:0001663	prostate carcinoma	Prostate cancer	rs985081-C	NA	T	NA

Mapped by lexical matching(Total Items:0)
(Waiting for update.)

Mapped by homologous gene(Total Items:0)
(Waiting for update.)

Chemical(Total Drugs:0)
(Waiting for update.)

FDA approved drug and dosage information(Total Drugs:0)
(Waiting for update.)

FDA labeling changes(Total Drugs:0)
(Waiting for update.)